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Copper is an essential trace element for living organisms and has both 
known and additional suspected roles in human health and disease. The current 
understanding of copper metabolism is substantial but incomplete, particularly in 
regard to its storage and exchange at the subcellular level, although available 
evidence indicates exchangeable intracellular copper is in the monovalent 
oxidation state. Selective fluorescent probes with sufficient sensitivity to detect 
Cu(I) availability at physiologically relevant levels and at subcellular resolution 
would be valuable tools for studying copper metabolism.  As a contribution 
toward this goal, this work describes the development of Cu(I)-selective 
fluorescent probes with greatly improved aqueous solubility, contrast ratio, and 
fluorescence quantum yield. This work also describes the development of water-
soluble, 1:1-binding chelators that form colorless, air-stable copper(I)-complexes. 
By acting as copper(I) buffering agents and affinity standards, these compounds 
can serve a complementary role to fluorescent probes in the study of copper 
biochemistry. 
Chapter 1 gives a short introduction to the biological importance of 
copper, the current knowledge regarding intracellular exchangeable copper, the 
techniques available for detection of copper in biological samples, and the 
potential benefits of more effective copper(I)-selective fluorescent probes and 
affinity standards. 
 Chapter 2 provides an introduction to fluorescence turn-on probes based 
on photoinduced electron transfer (PET), then describes pilot studies in organic 
solvents that laid the groundwork for the development of high-contrast Cu(I)-




began with demonstrations of the utility of 1,3,5-triarylpyrazolines as 
electronically tunable fluorophores, then progressed to contrast optimization of 
triarylpyrazoline-based methanolic Cu(I)-probes. While the author contributed to 
the synthetic aspects of the latter work, this chapter is intended primarily as a 
literature review and is referenced frequently in the subsequent chapters. 
 Chapter 3 describes the development of CTAP-2,
1
 a water-soluble Cu(I)-
selective fluorescent probe designed to operate on the tunable PET-based 
fluorescence switching mechanism previously demonstrated  with the methanolic 
Cu(I)-probes described in Chapter 2. To achieve aqueous solubility without 
producing a strongly amphiphilic, detergent-like structure, CTAP-2 is based on a 
balanced hydrophilic functionalization approach combining a tetrahydroxylated 
thiazacrown Cu(I)-ligand with a sulfonated triarylpyrazoline fluorophore. Much 
of Chapter 3 is devoted to the initially challenging synthesis of this structure. 
CTAP-2 was found to dissolve directly in water to milimolar concentrations, a 
characteristic never before reported for Cu(I)-selective fluorescence turn-on 
probes, and yielded a 65-fold emission enhancement on Cu(I)-saturation, slightly 
exceeding the maximum contrast ratio of 50 observed for its methanolic 
forerunners, although providing only a modest fluorescence quantum yield of 
8.3%. Linear profiles of absorbance and fluorescence versus concentration of 
CTAP-2 and its Cu(I)-complex revealed no evidence of aggregation at typical 
working concentrations in aqueous solution. Experiments by Pritha Bagchi 
demonstrated that CTAP-2 is able to selectively detect the copper-bound form of 
the metallochaperone Atox1 within a native electrophoresis gel, thus 
demonstrating another potentially important application of Cu(I)-selective 
fluorescence turn-on probes beyond cellular imaging.   
During our careful characterization of CTAP-2, another Cu(I)-selective 
fluorescent probe, Coppersensor-3 (CS3),
2




contrast response to Cu(I) in aqueous solution, although it contained no water-
solubilizing functional groups and the published emission spectrum was 
suspiciously cut off at shorter wavelengths while still at over half-maximum 
intensity. Dynamic light scattering experiments conducted by Pritha Bagchi 
revealed that not only CS3 but also the earlier aqueous Cu(I)-probes CS1 and 
CTAP-1 form colloidal aggregates at micromolar concentrations in aqueous 
solution, while CTAP-2 does not. Based on these results, it appears that CTAP-2 
is actually the first truly water-soluble Cu(I)-selective fluorescence turn-on probe. 
 Chapter 4 describes an initial unsuccessful attempt to improve upon the 
fluorescence contrast ratio and quantum yield offered by CTAP-2, followed by 
detailed studies to determine the factors responsible for the low fluorescence 
quantum yield. Analysis of time-resolved fluorescence decay profiles revealed 
that the fluorescence quantum yield and contrast ratio of both CTAP-2 and the 
new probe are limited by formation of multiple Cu(I)-coordination species 
providing varying degrees of PET inhibition, presumably due to incomplete 
Cu(I)-N coordination as previously observed for the methanolic Cu(I)-probes 
described in Chapter 2. Furthermore, the fluorescence quantum yield in aqueous 
solution of both protonated CTAP-2 and a quaternary ammonium-based 
fluorophore analog are significantly lower than typically observed for related 
triarylpyrazolines in organic solvents, indicating the presence of an additional 
unknown fluorescence quenching pathway. This was initially suspected to be 
donor-excited PET, but solvent isotope effects revealed that it is actually an 
excited-state protonation or proton shift, which is hereafter referred to by the 
general term excited-state proton transfer (ESPT). Two distinct ESPT pathways 
were identified, an acid-mediated pathway that becomes important only at 
millimolar hydronium concentrations, and a separate pathway that occurs even in 




of H2O with D2O as the solvent. The latter pathway limits the maximum quantum 
yield available from the CTAP-2 fluorophore to about 30% in aqueous solution.
3
 
 Chapter 5 describes the development of water-soluble Cu(I)-probes that 
significantly exceed CTAP-2 in contrast ratio and quantum yield by iterative 
improvement of both the fluorophore and ligand designs. The knowledge gained 
through the experiments described in Chapter 4 was essential to this process. 
Based on evidence that the ESPT-mediated fluorescence quenching of 1,3,5-
triarylpyrazolines in protic solvents is suppressed by strong electron-withdrawing 
groups on the 1-aryl ring, we replaced both the 3-aryl p-cyano- and 1-aryl p-
sulfonate substituents of the CTAP-2 fluorophore with sulfonamide moieties, 
which are significantly stronger than -SO3
-
 and comparable to -CN in terms of 
electron-withdrawing power. This modification succeeded in inhibiting ESPT but 
also appeared to provide a higher-than-optimal PET driving force, resulting in an 
impressive contrast ratio of 160 but a modest fluorescence quantum yield of 14% 
after optimization of the ligand design. To decrease the PET driving force while 
maintaining ESPT inhibition, the 3-aryl sulfonamide substituent was isomerized 
from a strongly electron-withdrawing arenesulfonamide at the para-position to a 
weakly electron-withdrawing N-arylmethanesulfonamide at the meta-position, 
while the 1-aryl sulfonamide moiety was left unmodified. The resulting probe 
gave a remarkable 180-fold fluorescence turn-on response and reached a 
fluorescence quantum yield of 41% upon Cu(I)-saturation, which should be quite 
sufficient for imaging applications, although further modifications to improve the 
binding affinity will likely be necessary to detect Cu(I) at normal physiological 
concentrations. 
 Chapter 6 describes the development of sulfonated, thioether-based 
tetradentate Cu(I)-ligands as robust affinity standards. Two symmetrical tripodal 




crystallographic studies revealed 1:1 Cu(I) complexes as expected, with 
coordination modes similar to those of related non-sulfonated tripodal ligands. 
Both of these sulfonated tripods and their respective Cu(I)-complexes are water-
soluble, air-stable, and can be isolated by crystallization, making them useful as 
affinity standards, but the respective Cu(I)-binding affinities are so far separated 
at neutral pH that these two ligands alone cannot provide a continuous range of 
buffered Cu
+
 concentrations. This gap was bridged using a tetrasulfonated 
derivative of the thiocrown ligand [16]aneS4. Although [16]aneS4 itself has a 
similar Cu(I)-complex stability constant to the lower affinity tripodal ligand, 
placement of the solubilizing functional groups on the middle carbons of 
opposing trimethylene bridges of the macrocycle yielded a substantial increase in 
Cu(I)-binding affinity, presumably through preorganization of the free ligand. 
Like the tripodal amines, the sulfonated thiocrown also yielded a crystalline, 
water-soluble, air-stable Cu(I)-complex, making it well suited to use as an affinity 
standard or copper buffer. An extensive series of experiments conducted by Pritha 
Bagchi using the three sulfonated Cu(I)-chelators as well as several previously 
reported ligands yielded a web of accurately cross-verified Cu(I) affinities with 
several anchor points. The new series of Cu(I)-affinity standards can be used 
directly in ligand competition experiments to determine the Cu(I)-binding 
affinities of certain copper proteins, as has been demonstrated by Pritha Bagchi 
using the bacterial copper chaperone CusF, and can presumably be expanded by 
addition of higher affinity ligands to allow competition experiments with a wider 







 Copper, like iron and zinc, is an essential trace element for known life forms. 
Various enzymes essential for human life require copper as a cofactor, including lysyl 
oxidase, which is required for connective tissue maturation, and cytochrome C oxidase, 
the terminal component of the respiratory electron transport chain and the primary target 
of cyanide toxicity.
4
 Despite the essentiality of copper, free copper ions, either Cu(I) or 
Cu(II), exert strong toxic effects, and copper is therefore tightly regulated in biological 
systems. Defects in copper transport are known to be the underlying cause of Menkes 
disease and Wilson’s disease, and there is evidence suggesting that copper may also be 
involved in the pathology of much more common human ailments including Alzheimer’s 
disease and Parkinson’s disease
4,5
. 
  Given the importance of copper to both fundamental biology and human health, a 
large and continually evolving body of knowledge has amassed regarding the metabolism 
and homeostasis of this element, particularly in identification of the genes and proteins 
involved;
6
  however, many important questions about copper biochemistry remain 
unanswered, particularly with regard to storage, mobilization, and distribution at the 
subcellular level.
6,7
 For example, experiments have demonstrated rapid and substantial 
cellular uptake or efflux of Cu depending on the copper concentration of the surrounding 
medium, suggesting the presence of kinetically labile intracellular copper,
8
 yet arguments 
based on the kinetics of Cu incorporation into the enzyme superoxide dismutase indicate 
that intracellular free copper concentrations must lie well below the level of a single ion 
per cell.
9
 Furthermore, based on available kinetic data regarding the reaction of Cu(I) 
with dioxygen
10
 and of Cu(II) with glutathione,
11
 a persuasive argument can be made that 








normal intracellular conditions: Free aqueous Cu
+
 is highly reactive toward dioxygen, 
converting to Cu
2+





, however, is highly reactive toward the ubiquitous intracellular free thiol 
glutathione, and would be reduced in milliseconds by the millimolar glutathione 
concentrations present in healthy eukaryotic cells.
12
 Therefore, free aqueous copper ions 
of either oxidation state are incompatible with the coexistence of high concentrations of 
glutathione and molecular oxygen typically present in animal cells, and intracellular 
copper trafficking must proceed via associative exchange of copper between high affinity 




 ions. Several “copper chaperones” 
(including Atox1 and CCS) are now known to deliver Cu(I) ions to other proteins through 
an associative exchange mechanism, but little is currently known about the chemical 
nature and subcellular localization of the high capacity labile copper pools.
4
 Also 
currently unknown is the thermodynamic effective Cu
+
 concentration in various cellular 
compartments under normal physiological conditions and in disease states. Robust 
techniques to probe the kinetic accessibility and thermodynamic availability of Cu(I) in 
biological systems  should help to answer these questions. 
 While total copper concentrations can currently be determined at subcellular 
spatial resolution by direct detection techniques such as synchrotron-based x-ray 
fluorescence imaging (SXRF) and secondary ion mass spectrometry (SIMS), selective 
determination of kinetically available copper requires detection reagents that interact 
chemically with copper ions to produce a measurable signal.
13
 Historically, imaging of 
kinetically labile copper at the tissue level has been accomplished using chromogenic 
precipitating agents such as dithiooxamide (rubeanic acid) and p-dimethylamino-
benzylidene rhodanine,
14
 but the sensitivity offered by these methods is sufficient only 
for detection of the highly elevated copper levels present in certain disease states.
13
 
 Compared to chromogenic reagents, optical fluorescence turn-on probes offer 




the nondestructive nature of optical fluorescence microscopy, allow imaging of labile 
metal cation pools in live cells.
13,15
 Cation-selective fluorescent probes that respond 
reversibly to analyte binding offer the additional capability of dynamic imaging of metal 
ion fluxes within a given cell, which is not possible with direct detection techniques 
based on x-ray fluorescence or mass spectrometry.
13
 In this regard, such fluorescent 
indicators also provide an advantage over fluorogenic chemodosimeters, which yield an 
irreversible fluorescence response upon interaction with the analyte.
16
 
 While selective fluorescent probes for redox-inactive cations such as Ca(II) and 
Zn(II) have already seen widespread use,
13,15
 the design of fluorescence turn-on probes 
for Cu(I) is more challenging due to the ability of this ion to act as a fluorescence 
quencher.
17-19
 Prior to the beginning of this work, only two biologically applicable Cu(I) 
selective fluorescence turn-on probes, CTAP-1
8
 and Coppersensor-1 (CS1)
20
 had been 
reported. Both probes gave a significant increase in fluorescence emission in response to 
high-dose copper supplementation in live cells, but the direct physiological significance 
of the observed response is uncertain. This is in part because the contrast ratio, or fold 
increase in fluorescence output upon analyte binding, is relatively low for both CTAP-1 
and CS1 (4.6 and 10, respectively), thus providing a limited ability to distinguish actual 
differences in Cu(I) availability from local variations in probe concentration. 
Furthermore, these lipophilic probes do not dissolve directly in water and were instead 
introduced into aqueous buffer by dilution of a DMSO stock solution,
8,21
 yet no 
experiments were performed to ascertain whether the resulting solutions actually contain 
the monomeric probe as opposed to an aggregate. Therefore, it was uncertain whether the 
species characterized in aqueous buffer are actually the same as observed in cellular 




 With the ultimate goal of creating better tools for investigating copper(I) 




ratio and quantum yield available from water-soluble Cu(I)-selective fluorescent probes. 
This effort, which commenced with pilot studies in organic solvents,
22-26
 eventually lead 
to the development of CTAP-2,
1
 a Cu(I)-selective fluorescent probe which dissolves 
directly in water and yields a strong 65-fold fluorescence turn-on response, albeit with a 
somewhat reduced fluorescence quantum yield of 8.3% versus 15% for CTAP-1. 
Elucidation of the causes of this low fluorescence quantum yield ultimately paved the 
way for an improved water-soluble Cu(I) probe providing more than double the contrast 
ratio and a nearly five-fold higher fluorescence quantum yield versus CTAP-2, at last  
fully meeting the challenge of obtaining a strong yet reversible fluorescence turn-on 
response to Cu(I) in aqueous solution. The development of bright, high-contrast, water-
soluble fluorescence turn-on probes for Cu(I) described in this dissertation constitutes a 
significant step in the evolution of Cu(I)-responsive fluorescent probes from  proof-of-
concept to  mainstream analytical tools for studying Cu(I)-biochemistry. 
 In addition to fluorescent probes, this work also describes the development of new 
water-soluble, 1:1-binding chelators that form colorless, air-stable complexes with Cu(I) 
for use as robust affinity standards and copper buffering agents. In contrast to Cu(I) 
selective fluorescence probes, which are intended for use as indicators to report the Cu(I) 
availability set by more abundant biological ligands, these chelators and their respective 
Cu(I) complexes can be mixed in various ratios to set the thermodynamically buffered 
Cu
+
 concentration to a particular desired level while allowing spectrophotometric or 
fluorimetric monitoring of the copper occupancy of other ligands present in the solution. 
This capability could serve a variety of purposes in the study of copper biochemistry, 
including calibration of Cu(I)-selective fluorescent probes, detection of new Cu(I)-
binding proteins by selective metalation, and accurate determination of the Cu(I)-binding 
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SETTING THE STAGE: PHOTOINDUCED ELECTRON 
TRANSFER, ELECTRONIC TUNING, AND CONTRAST-




 CTAP-1, the first fluorescence turn-on probe for aqueous Cu(I), was introduced 
by Fahrni and coworkers in 2005. This probe operates on a photoinduced electron 
transfer (PET)-based fluorescence switching mechanism and gives a 4.6-fold 
enhancement in fluorescence emission upon analyte binding.
1
 While preliminary cellular 
imaging with CTAP-1 yielded results  qualitatively consistent the subcellular distribution 
of Cu(I) by x-ray fluorescence microscopy,
1
 a significantly larger fluorescence 
enhancement factor, preferably at least 50, would be desirable for biological imaging 
applications. In addition to improving the overall signal-to-noise ratio, a higher 
fluorescence enhancement factor, or contrast ratio, also reduces the likelihood that any 
local accumulation of the free probe will be misinterpreted as the presence of the analyte. 
With the ultimate goal of achieving a high contrast fluorescence turn-on response to 
aqueous Cu(I), Fahrni et al. conducted a series of pilot investigations on contrast 
optimization of PET-based fluorescence turn-on probes utilizing a tunable 1,3,5-
triarylpyrazoline fluorophore platform.
2,3,4,5
 These studies, which were conducted in 
nonaqueous solution to avoid interference from aggregation effects, culminated in the 
development of methanolic Cu(I)-probes with contrast ratios up to 50 and revealed the 




coordination mode to Cu(I) rather than the inherent properties of the fluorophore.
4,5
 
While the author was involved in the latter two works, this was primarily in optimizing 
the synthesis of intermediates to allow preparation of probe libraries. Nevertheless, these 
publications constitute an essential backdrop for the development of the aqueous Cu(I) 
probes presented in subsequent chapters, and are therefore described in a fair degree of 
detail. Although this chapter is to serve primarily as a literature review, the author’s 
synthetic work is described in the experimental section. 
2.2. Fluorescence turn-on probes based on photoinduced electron transfer (PET) 
 As mentioned in Chapter 1, the design of fluorescence turn-on probes for 
copper(I) is complicated by the propensity of this cation to act as a fluorescence 
quencher. Since direct binding of Cu(I) to a fluorophore typically results in a 
fluorescence turn-off response, the design of a fluorescence turn-on probe for this cation 
depends on coupling the output of the fluorophore to the interaction of Cu(I) with a 
remote binding site. This can be achieved using photoinduced electron transfer (PET) as a 
fluorescence quenching mechanism, which is the design strategy of CTAP-1.
1
 The 
process of fluorescence, fluorescence quenching by PET, and the utilization of PET to 
design fluorescence turn-on probes are described below. 
 2.2.1. The Process of fluorescence and quenching by PET 
  The process of fluorescence begins with absorption of a photon by the 
fluorophore in its ground state (S0) to produce an excited electronic state (normally the 
first singlet excited state S1). In simplified terms, the excitation can be viewed as 
promotion of an electron from the highest occupied molecular orbital (HOMO) to the 
lowest unoccupied molecular orbital (LUMO) of the fluorophore.  The actual electronic 
transition is extremely rapid, initially producing S1 in the geometry preferred by S0 




cooling, the fluorophore returns to the ground electronic state S0 by emission of a photon 
of lower energy (Figure 2.1).
6
 As S0 is initially produced in the preferred geometry of S1, 
a second vibrational cooling also occurs, yielding a Stokes shift, or energy difference 





Figure 2.1: Generalized Jablonski diagram for organic fluorophores 
 
 
 If an electron donor, a separate moiety capable of facile one-electron oxidation, is 
coupled to the fluorophore, then electron transfer can occur from the donor to the excited 
fluorophore, filling the vacancy in the fluorophore HOMO and blocking the normal 
radiative transition to S0. The ion pair resulting from electron transfer usually undergoes 
rapid nonradiative charge recombination to return the original ground state of the system. 










Figure 2.2: Simplified diagram of the PET process 
 
 





 If the electron donor in the system described above includes an appropriately 
designed cation binding site, then binding of the cation can impede oxidation of the 
electron donor. The result is a reduced rate of PET and a corresponding increase in 
fluorescence emission: a fluorescence turn-on response. Due to the indirect coupling 
between the cation and the fluorophore, this approach can be effective even for cations 
that normally behave as fluorescence quenchers provided that the cation-mediated 










Figure 2.3: Conceptual diagram of a PET-based fluorescence turn-on probe 
 
 
2.2.3. Relationships between PET driving force, PET rate, and fluorescence contrast 
ratio 
 
2.2.3.1. The Relationship between PET rate constants and fluorescence contrast ratio 
 For a PET-based fluorescence turn-on probe to achieve a high contrast ratio, the 
fluorescence of the free probe must be quenched as efficiently as possible. At the same 
time, binding of the analyte must suppress PET quenching to the extent that the analyte-


























bound probe recovers a significant fraction of the intrinsic fluorescence quantum yield of 
the free fluorophore. Assuming that binding of the analyte to the donor has no significant 
effect on the absorption spectrum of the fluorophore, the contrast ratio (fluorescence 
enhancement factor) upon analyte binding is the ratio of the fluorescence quantum yield 
of the analyte-bound probe to that of the free probe. The relevant quantum yields can be 
calculated as described below.
2
 The quantum yield of the fluorophore in the absence of 
PET (Φf
0
) is given by Equation 2.1, where kr is the rate constant of radiative deactivation 
of the excited state (fluorescence emission) and knr is the sum of the rate constants of all 






𝑘 + 𝑘  
 (2.1) 
 
 If PET serves as an additional nonradiative deactivation pathway, then the 
fluorescence quantum yield (Φf) is given by Equation 2.2, where k0 = kr + knr = 1/τf , τf is 






𝑘 + 𝑘  
 (2.2) 
 
Accordingly, the fluorescence enhancement factor (fe) upon analyte binding is given by 
Equation 2.3, where Φf’ is the fluorescence quantum yield in the presence of analyte and 
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2.2.3.2. Dependence of the PET rate constant on the PET driving force 
 For systems such as 1,3,5-triarylpyrazolines where the donor is separated from the 
fluorophore by a saturated carbon spacer, the electronic coupling between the two units is 
relatively small and the electron transfer can be modeled as a nonadiabatic reaction 
according to semiclassical Marcus theory.
7,8
 The relationship between electron transfer 
rate constant and electron transfer driving force (ΔGet) is then given by Equation 2.4, 
where h is Planck’s constant, kB is Boltzmann’s constant, T is the absolute temperature, λ 
is the reorganization energy, and HDA is the electronic coupling between the state 
preceding electron transfer and the electron transfer state. 
 
 













 According to Equation 2.4, the rate of electron transfer increases with increasing 
driving force (more negative ΔGet), provided that −ΔGet is less than the reorganization 
energy λ. At larger values of −ΔGet, the electron transfer rate actually decreases with 
increasing driving force. This regime, known as the Marcus inverted region, is not 
normally reached by systems such as 1,3,5-triarylpyrazolines utilized in fluorescent probe 
design,
2
 so an increase in −ΔGet results in a reduced fluorescence quantum yield via an 
increased ket. 
 
2.2.3.3. Dependence of the PET driving force on donor and fluorophore parameters 
 The value of ΔGet can be estimated from physical parameters of the fluorophore 
and donor according to the Rehm-Weller equation
9
 (Eq. 2.5), where E(D
+
/D) is the 
reduction potential of the oxidized donor, E(A/A
-
) is the ground state reduction potential 
of the fluorophore, ΔE00 is the excited state energy (zero-zero transition energy) for the S0 




corresponding to the energy released (negative value) when the ions generated by 
electron transfer are brought from infinite separation to their actual spatial separation in 
the product ion pair or zwitterion. The magnitude of wp is small compared to the other 
terms in polar solvents due to dielectric screening. 
 ∆𝐺  = 𝐸(D
 /D) −  𝐸(A/A )  − 𝛥𝐸   + 𝑤  (2.5) 
 
 It is important to note that the E(D
+
/D) term, also known as the donor potential, is 
written as a reduction potential although the electron transfer involves oxidation of the 
donor. Therefore, a more positive value of E(D
+
/D) corresponds to weaker driving force 
for electron transfer (more positive ΔGet), while a more positive value of E(A/A
-
) or ΔE00 
corresponds to a stronger PET driving force. 
 
2.2.4. Triarylpyrazolines as tunable fluorophore platforms for PET based 
fluorescence turn-on probes 
 Based on Equation 2.5, it is possible to adjust the driving force for electron 
transfer, and hence the quantum yield of the fluorophore in the absence and presence of 
analyte, by manipulating the fluorophore parameters E(A/A
-
) and ΔE00. By careful tuning 
of these parameters, it is possible to maximize the ratio of the two quantum yields and 
thus the contrast ratio. Compared to other common fluorophore platforms, 1,3,5-triaryl-

2
-pyrazolines are advantageous for such tuning because  E(A/A
-
) and ΔE00 can be varied 
selectively and in a highly predictable manner:  Electron-withdrawing substituents on the 
3-aryl ring strongly increase E(A/A
-
), while electron-withdrawing substituents on the 1-
aryl ring primarily increase ΔE00.
3
 The reason for this behavior is apparent from the 
frontier molecular orbital structure of the parent 1,3,5-triphenylpyrazoline (Figure 2.4): 
The HOMO is shifted toward the 1-aryl ring, while the LUMO has much greater density 




of the HOMO with little effect on the LUMO, thus increasing the HOMO-LUMO gap 
and therefore the excited state energy. Analogous substitution of the 3-aryl ring will 
strongly lower the LUMO energy while also lowering the HOMO energy to a lesser 





Figure 2.4: Frontier molecular orbitals of 1,3,5-triphenyl-
2
-pyrazoline 
Calculations carried out by Dr. Christoph Fahrni 
 
 
 In addition to the tunability achievable through functionalization of the 1- and 3-
aryl rings, the 5-aryl ring, which is not part of the fluorophore π-system, can be 
functionalized with an electron-donating group to provide a built-in PET donor for a 
fluorescence turn-on probe. This design strategy is exemplified by CTAP-1,
1
 the first 
fluorescence turn-on probe for aqueous Cu
+







Figure 2.5: The Anatomy of CTAP-1 
 
 
 As noted in the introduction, CTAP-1, which was not systematically optimized by 
electronic tuning, gave a contrast ratio of only 4.6 upon saturation with Cu(I). To pave the 
way for higher contrast PET-based Cu(I) probes, Cody et al. conducted a detailed 
experimental and computational investigation into  maximizing the fluorescence contrast 




  Using a series of 1,3,5-
triarylpyrazolines bearing an N,N-dimethylaniline moiety as a pH sensitive PET donor,  
the values of HDA and λ were estimated by fitting experimentally derived electron transfer 
driving forces and rate constants to Equation 2.4 (See Section 2.2.3.2). Based on the 
fitted values (18 cm
-1





, an expression was derived for the fluorescence enhancement factor (fe) as a function 
of the switching potential ΔE(D
+
/D), which is the change in donor potential upon analyte 
binding, and the initial electron transfer driving force before binding of the  analyte 
(−ΔG
0
et).  A contour plot of the theoretical contrast ratio versus ΔE(D
+
/D)  and –ΔG
0
et  is 





   
Figure 2.6: Predicted contrast ratio as a function of PET driving force and switching 
potential for 1,3,5-triarylpyrazolines. Reprinted with permission from Cody, J.; Mandal, 
S.; Yang, L.; Fahrni, C. J.,  J. Am. Chem. Soc. 2008, 130 (39), 13023-13032. © 2008 
American Chemical Society. 
 
 
 As shown in Figure 2.5, that the maximum possible contrast ratio depends on the 
switching potential ΔE(D
+
/D), a property governed by the design of the donor and its 
cation binding site.  Furthermore, the initial electron transfer driving force –ΔG
0
et  must 
be tuned within a narrow range to achieve the maximum contrast ratio available for a 
given switching potential.  Protonation of the dimethylamino moiety of the pyrazolines 
should result in a very large increase in donor potential, and the maximum fluorescence 
enhancement factor observed in this study (400) corresponded to the derivative with the 
largest estimated –ΔG
0
et value (0.56 eV, approximately equal to the estimated 
reorganization energy). The observed maximum fluorescence enhancement is consistent 
with the relationship plotted in Figure 2.5, which predicts a maximum fluorescence 





2.3. Electronically tuned Cu(I) selective fluorescent probes  
 Tuning the PET driving force is expected to be more critical for achieving a high-
contrast response to a soft cation such as Cu(I) than for a strong, hard Lewis acid such as 
the proton. In contrast to protonation, which renders the arylamine PET donor essentially 
inert towards oxidation, Cu(I)-coordination may give only a small increase in E(D
+
/D). In 
this scenario, an insufficient initial PET driving force will give a low contrast ratio due to 
incomplete fluorescence quenching of the free probe, and excessive PET driving force 
will also give a low contrast ratio due to residual fluorescence quenching of the Cu(I)-
bound form. Therefore, a high contrast ratio can only be achieved if the initial PET 
driving force is tuned within a narrow range. For example, according to Figure 2.5, an 
increase in E(D
+
/D) of 0.4 eV upon analyte binding can give a fluorescence enhancement 
of over 100-fold, but only if -ΔG
0
et lies between 0.24 and 0.40 eV. The low contrast ratio  
observed for CTAP-1 is presumably due in part to an insufficient PET driving force, 
because the fluorescence quantum yield of the free probe is relatively high (3%). 
 
2.3.1. Probe design 
2.3.1.1. Ligand design 
 In addition to the low PET driving force as described above, another limiting 
factor for the contrast ratio of CTAP-1 may be the design of the Cu(I) binding site. The 
CTAP-1 ligand (Figure 2.6, structure 2.1) contains five donor atoms, but Cu(I) usually 
exhibits a maximum coordination number of four, even in macrocyclic ligands containing 
more than four donor atoms.
10
 It is therefore likely that the CTAP-1-Cu(I) is actually a 
fluxional 4-coordinate complex, and the predominant species in solution may not have a 
direct Cu-N bond. To enforce coordination of the arylamine nitrogen to Cu(I), a 
macrocyclic arylamine-thioether ligand with only four donor atoms was devised 




adjacent donor atoms were lengthened from two CH2 units to three. This modification 
should provide a sufficient macrocyclic cavity size for Cu(I), which is too large to fit 
within a similar 12 or 13 membered macrocycle.
11
 Furthermore, the switch from 5-
membered to 6-membered chelate rings is expected to increase the Cu(II)/Cu(I) reduction 
potential of the ligand-copper complex
12




Figure 2.7: Structural comparison of the CTAP-1 ligand and revised ligand 2.2 
 
 
2.3.1.2. Fluorophore design 
  Based on the previous electronic tuning study on triarylpyrazoline-based pH 
probes,
2
 the optimum value of the initial PET driving force ( –ΔG
0
et) for 1,3,5-
triarylpyrazoline-based Cu(I) probes should be greater than zero and presumably less 
than 0.56 eV (the optimum value for the proton probes). Based on a previous study of 
polyfluorinated 1,3,5-triarylpyrazolines
3
 and the measured donor potential of free ligand 
2.2 (0.45 eV), it was  determined that 3,5-difluoro-substitution of the 3-aryl ring would 
provide –ΔG
0
et values ranging from 0.03 to 0.56 eV as the 1-aryl ring is varied stepwise 
from phenyl to pentafluorophenyl.
4
 The probe structures chosen for synthesis (2.3a-f) are 






 stuctures 2.4b-f were also included.
5
 Structure 2.4a was omitted due to the 
anomalously low quantum yield previously observed for the parent triarylpyrazoline 















 (2.6) by syringe pump addition of both 
components to a large volume of solvent in the presence of base (Scheme 2.1). Although 
the use of cesium carbonate in DMF
15
 has become the standard procedure for the 




1,1,3,3-tetramethylguanidine (TMG) in acetonitrile greatly facilitated workup at the 
expense of only a small reduction in yield when the reaction was conducted on a 
multigram scale.   
 
 
Scheme 2.1: Synthesis of N-arylthiazacrown ligand 2.2 
 
 Triarylpyrazolines analogous to 2.3 and 2.4 had been previously prepared via 
condensation of arylhydrazines with the appropriately substituted chalcone derivatives, 
which in turn were prepared by condensation of aryl aldehydes with substituted 
acetophenones.
1,2,3
 By this methodology, the triarylpyrazoline 1-, 3-, and 5-aryl rings are 
derived from the arylhydrazine, the substituted acetophenone, and the aryl aldehyde, 
respectively. Accordingly, ligand 2.2 was subjected to Vilsmeier formylation to give 
aldehyde 2.7, which could then be condensed with 3,5-difluoroacetophenone or 4-







Scheme 2.2: Synthesis of probes 2.3a-f 
 
 Preparation of chalcone 2.8 was initially problematic. The standard conditions 
previously employed to prepare related chalcones
1,2
 (piperidine, ethanol, reflux) were 
unsuccessful with 3,5-difluoroacetophenone due to nucleophilic substitution of the aryl 
fluoride by piperidine.
3
 The conditions previously utilized to prepare chalcones from 
fluorinated acetophenones
3
 (NaOH, ethanol, rt) were also unsatisfactory, giving an 
impure product in only 21% yield (experiments conducted by Dr. Manjusha Verma). The 
author then found that the yield and purity of the product can be greatly improved by 
using pyrrolidine as the condensation catalyst, conducting the reaction at only 40°C to 
avoid nucleophilic aromatic substitution, and adjusting the solvent composition to 
promote complete dissolution of the starting materials while allowing the product to 
crystallize during the course of the reaction. This in situ crystallization should improve 
the yield by protecting the desired product from further reactions. Under these conditions, 
pure 2.8 was obtained in 73% yield by simple filtration from the reaction mixture. 




 were prepared by Dr. Manjusha Verma and 
Aneese Chaudhry by condensation of chalcones 2.8 and 2.9, respectively, with the 





2.3.3. Contrast optimization 
 The steady state photophysical characteristics of probes 2.3a-f and 2.4b-f are 
given in Table 2.1. Since the probes were not intended for direct biological application, 
they were characterized in methanol rather than in aqueous solution to avoid interference 
from aggregation effects. The values reported of ΔG0et were estimated using excited-state 




) measured in 

















b  𝑓 
c 
2.3a 371 476 2.97 -0.03 0.058 0.20 3 
2.3b 366 461 3.04 -0.13 0.029 0.19 7 
2.3c 355 451 3.12 -0.23 0.0084 0.12 14 
2.3d 350 436 3.19 -0.34 0.0014 0.07 50 
2.3e 330 420 3.35 -0.52 <0.001 0.024 n.d.
 
2.3f 323 423 3.38 -0.59 <0.001 0.0063 n.d. 
2.4b 394 487 2.85 -0.22 0.0072 0.15 21 
2.4c 381 480 2.92 -0.31 0.0033 0.095 29 
2.4d 373 464 3.00 -0.39 0.0024 0.048 20 
2.4e 356 445 3.13 -0.47 0.0010 0.020 20 
2.4f 350 448 3.15 -0.54 <0.001 0.020 n.d. 
a
 Estimated as the mean of the absorption and emission maxima on an energy scale. 
b
 Probes were 
saturated with Cu(I) provided as Cu(MeCN)4PF6. 
c
 Fluorescence enhancement factor (contrast 
ratio) given as the ratio of the fluorescence quantum yield of the Cu(I) saturated probe to that of 






 For both probe series, the absorption and emission maxima shift to shorter 
wavelengths with increasing fluorination of the 1-aryl ring, corresponding to a stepwise 
increase in ΔE00 from 2.97 to 3.38 eV for 2.3a-f and 2.85 to 3.15 eV for 2.4b-f. The 
overall PET driving force increases accordingly (ΔG0et becomes more negative), and the 
fluorescence quantum yields decrease for both the free and Cu(I)-saturated probes. The 
decline is more rapid for the free probes than for their Cu(I) complexes, resulting in 
maximum contrast at intermediate values of –ΔG
0
et. The optimum contrast ratios 
achieved with the two probe series are 50 and 29 for derivatives 2.3d and 2.4c, 
respectively. These dramatic improvements over the contrast ratio of 4.6 observed for 
CTAP-1 come at the expense of relatively minor reductions in fluorescence quantum 
yield (0.070 for 2.3d and 0.095 2.4c vs. 0.15 for CTAP-1). Notably, the less quenched 
derivative 2.4b achieves a contrast ratio of 21 with the same final quantum yield as 
CTAP-1, demonstrating a substantial improvement in performance beyond that due to 
electronic tuning alone. The ligand design modification described in Section 2.3.1.1 was 
intended to produce such an effect, although it is possible that the observed improvement 
is actually due to the change of solvent or an increase in the intrinsic fluorophore 
quantum yield. 
 
2.3.4. Incomplete fluorescence recovery due to ternary complex formation 
2.3.4.1. Degree of fluorescence recovery versus the unquenched fluorophore 
 Although the contrast ratios of probes 2.3d, 2.4b, and 2.4c represent a marked 
improvement over CTAP-1, the fluorescence quantum yields of the Cu(I) saturated 
probes remain relatively low. By contrast, acidification of the probe solutions in the 
absence of Cu(I) increased the quantum yields to around 0.5 (Table 2.2), a typical value 
for 1,3,5-triarylpyrazolines in methanolic solution.
16
 Protonation presumably occurs on 






 Furthermore, the emission maxima were identical for the free, 
Cu(I)-bound, and protonated probes, indicating that the site of protonation is indeed the 
arylamine moiety and not the pyrazoline ring itself. Assuming the fluorescence quantum 
yield under acidic conditions represents the intrinsic quantum yield of the isolated 
triarylpyrazoline fluorophore in methanolic solution, the degree of fluorescence recovery 
upon Cu(I)-coordination can be determined as the ratio of the quantum yield of the Cu(I) 
saturated probe to that of the protonated probe. These values are given in Table 2.2. 
 











   𝑓  
Cu(I) sat. 
 𝑓  
Acidic
c 
2.3d 0.070 0.47 15% 50 335 
2.4b 0.15 0.53 28% 21 74 
2.4c 0.095 0.54 18% 29 164 
a





 Φf(Acidic)/ Φf(free). Primary data acquired by Aneese Chaudhry. 
 
 
 From the data in Table 2.2, it is clear that the contrast-optimized probes recover 
only a small fraction of the intrinsic fluorophore quantum yield upon coordination to 
Cu(I). This low fluorescence recovery limits not only the brightness but also the contrast 
of the Cu(I) probes. This is shown by the much higher contrast ratios obtained by 
protonation than for Cu(I)-coordination, especially for 2.3d. As mentioned previously, a 
lower contrast ratio might be expected for coordination to the soft Cu(I) cation than for 
protonation due to weaker inhibition of PET. This would also manifest as a lower 
fluorescence quantum yield at the value of ΔG
0
et that gives the highest contrast ratio. 
However, even if the initial PET driving force (–ΔG
0
et ) is set significantly below the 
value required for maximum contrast (probe 2.4b), the fluorescence quantum yield of the 




fluorophore. Therefore, it appears that an additional factor is also hindering fluorescence 
recovery. 
 
2.3.4.2. Potential causes of incomplete fluorescence recovery 
 Although Cu(I) may quench fluorescence by direct interaction with a 
fluorophore,
17,18
 the low fluorescence recoveries observed for probe series 2.3 and 2.4 
cannot be explained by this effect: Upon titration of a 6.5 µM solution of probe 2.3d with 
Cu(I),  the fluorescence intensity increased linearly up to 1 molar equivalent (consistent 
with high affinity binding) but then leveled off to an essentially constant value up to 2 
molar equivalents, indicating that excess Cu(I) has no significant quenching effect at low 
micromolar concentrations.   
 Another seemingly likely explanation for the low fluorescence recovery would be 
photoinduced electron transfer from the probe-bound Cu(I) center to give a Cu(II) 
complex, but  previously observed electron self-exchange rate constants for Cu(I)/Cu(II) 
centers are usually less than 10
4








 Therefore, electron 
transfer from Cu(I) should be far too slow to compete with  fluorescence emission, which 
occurs on a nanosecond timescale for 1,3,5-triarylpyrazolines. Indeed, time resolved 
fluorescence spectroscopy revealed a lifetime of 3.76 ns for 2.4b in acidic solution (180 





 in the absence of PET. 
 When applied to Cu(I)-saturated 2.4b, the above technique yielded unexpected 
results. As shown in Figure 2.9, the decay profile of 2.4b-H
+
 is monoexponential, which 
is indicated by its linearity when plotted on a logarithmic y-axis (blue trace). This is the 
expected behavior for a homogeneous population of fluorophores with a single radiative 
deactivation pathway. By contrast, 2.4b-Cu(I) gave a multiexponential fluorescence 
decay profile, which is visible in Figure 2.9 as an obvious curvature in its fluorescence 




model with components of 84 ps (35%), 0.77 ns (36%) and 3.23 ns (29%) implying the 
presence of three distinct species in comparable abundance that do not equilibrate on the 




Figure 2.9: Fluorescence decay profiles of 2.4b in the presence of 10µM Cu(I) or 180 
mM TFA. Data acquired by Aneese Chaudhry. Adapted with permission from reference
5
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 In contrast to the fluorescence decay profile, the 2D fluorescence excitation-
emission profile
5
 of 2.4b-Cu(I) was consistent with a homogeneous fluorophore 
population and very similar to that of  2.4b-H
+
, implying that the  nature of the 
fluorophore and the radiative deactivation pathway are essentially identical for all 
emissive species present under both conditions.  Furthermore, pump-probe transient 
absorption spectroscopy experiments
5
 identified a very similar 
1
ET state for 2.4b and 
2.4b-Cu(I) and a similar radiative 
1
CT (charge transfer) state for  2.4b-Cu(I) and 2.4b-H
+
, 
but no photoproducts could be detected for 2.4b-Cu(I) that did not have a counterpart in 
either free 2.4b or 2.4b-H
+
, thus providing no evidence for electron transfer from the 
Cu(I) center.  Taken together, these data indicate that 2.4b-H
+




Cu(I) have effectively the same fluorophore, so the structural differences responsible for 
the distinct fluorescence lifetimes of the three apparent 2.4b-Cu(I) species probably lie in 
the coordination mode of the thiazacrown ligand to Cu(I). 
 
2.3.4.3. Evidence for ternary complex formation 
 Distinct coordination species would be expected to give different NMR chemical 
shifts for the protons of the ligand, so the behavior of the ligand 2.2-Cu(I) was 
investigated by 
1
H NMR in deuterated methanol.
5
  Titration of ligand 2.2 with the Cu(I) 
salt Cu(CH3CN)4PF6 gave a single set of sharp resonances which steadily increased in 
chemical shift, reaching saturation at 1 molar equivalent of Cu(I). This indicates that the 
coordination equilibria of ligand 2.2 at room temperature are much faster than the NMR 
timescale. Cooling the solution to -40°C failed to prevent rapid equilibration, but the 
aromatic ring protons ortho and para to the amine nitrogen showed a surprisingly large 
decrease in chemical shift with decreasing temperature. By contrast, the chemical shifts 

















Figure 2.10: Temperature dependence of NMR chemical shifts for 2.2-Cu(I). Data 
acquired by C. J. Fahrni. Adapted with permission from reference
5










 show increases in chemical shift for the Cu(I)-
complex versus the free ligand, which is presumably due to a reduction in π-donation 
from the amine nitrogen into the aromatic ring upon coordination to Cu(I). Therefore, a 
decrease in chemical shift with decreasing temperature is consistent with an equilibrium 
involving an exothermic, entropically unfavorable conversion of a species with the 
expected tetradentate coordination mode of the thiazacrown to one or more species 
lacking a Cu-N bond. The most logical explanation for a loss of entropy upon Cu-N bond 
dissociation is that the released coordination site on Cu(I) is occupied by a solvent 
molecule (the counterion, PF6
-
, is usually non-coordinating).   
 In further support of a mechanism involving Cu-N bond dissociation and ternary 
complex formation, computational modeling identified steric clashes between the 
aromatic ring and ligand backbone in the energy minimized structure of [2.2-Cu(I)]
+
 





Cu(I) center with cleavage of the Cu-N bond. Two energy-minimized ternary complex 
structures were found, one possessing a hydrogen bond from the methanol OH to the 
slightly pyramidalized thiazacrown nitrogen (Figure 2.11B) and the other with no 
hydrogen bond and a nearly trigonal planar geometry about the thiazacrown N. (Figure 
2.11C). The predicted gas phase association enthalpies were -12.4 and -10.2 kcal/mol for 





Figure 2.11: Computationally predicted structures of 2.2-Cu(I) coordination species 
Geometries optimized at the B3LYP/6-31G(d) level of theory. Calculations carried out by 
C. J. Fahrni. See reference
5
 supporting information for full details. 
 
 
 Although the above structures were computed in the gas phase, they are consistent 
with the three observed fluorescence lifetimes, presumably corresponding to the 3.23, 
0.77, and 0.084 ns components for the binary complex, H-bonded ternary complex, and 
non-H-bonded ternary complex, respectively. The decreasing pyramidalization about N 
for the ternary complexes should correspond to an increase in π-donor strength and 
therefore a reduction in E(D
+
/D) compared to the binary complex. Thus, it appears that 
















quantum yields of probe series 2.3 and 2.4 is sterically driven Cu-N bond dissociation 
and concomitant ternary complex formation with solvent molecules. In fact, if the 
speciation of 2.4b-Cu(I) could be restricted exclusively to the binary complex 
presumably responsible for the 3.23 ns fluorescence decay component, the fluorescence 
quantum yield should increase more than three-fold from 0.15 to 0.46 based on the 
fluorescence quantum yield of 0.53 and lifetime of 3.76 ns observed for the protonated 
probe (assuming no difference in kr). 
 
2.4. Conclusions 
 The works summarized in this chapter proved that it is possible to obtain a high 
contrast (50-fold) fluorescence turn-on response to the redox-active Cu(I) cation using 
PET-based probes. By modifying the design of the copper binding site and also 
optimizing the fluorescence contrast ratio via electronic tuning, the fluorescence contrast 
can be increased by an order of magnitude relative to CTAP-1 at the expense of only a 
two-fold reduction in quantum yield (probe 2.3d). Alternatively, the contrast can be 
improved nearly five-fold relative to CTAP-1 with no loss of fluorescence quantum yield 
(probe 2.4b). Importantly, it was discovered that primary limiting factor for both the 
contrast ratio and quantum yield of the new generation of Cu(I) probes is not electron 
transfer from the Cu(I) center but rather Cu-N bond dissociation in the thiazacrown-Cu(I) 
complex and concomitant ternary complex formation with solvent molecules. This 
suggests that further substantial improvements in contrast ratio and quantum yield can be 
achieved by modifying the design of the arylamine-thioether Cu(I)-binding site to enforce 
direct coordination of Cu(I) to the arylamine nitrogen. The obvious caveat of these 
studies is that they were conducted in methanol, whereas Cu(I) probes must operate in 
aqueous solution for biological applications. Although the PET switching mechanism is 




operation of PET-based probes should not be fundamentally different in aqueous versus 
methanolic solution. Since both water and methanol are small, hydroxylic solvents with 
no other coordinating functional groups, a large difference in Cu(I)-coordination 
chemistry is also unlikely. For the improved probe design strategies described in this 
chapter to be implemented in aqueous solution, the most significant challenges that must 
be met are actually the inherent aggregation propensity and low solubility associated with 
structures presenting a large hydrophobic surface area, which includes both the 
triarylpyrazoline fluorophores and thioether-rich Cu(I) ligand of probe series 2.3 and 2.4. 
These challenges are addressed in the following chapter. 
 
2.5. Experimental section 









C) or CCl3F (
19
F). MS: EI (70eV), selected peaks, m/z 
with relative intensity in parentheses. IR: NaCl windows (neat or film from CDCl3), KBr 
pellet (solids). TLC: 0.25 mm, Merck silica gel 60 F254. Spots were visualized under 254 
nm illumination or with PMA stain (5% phosphomolybdic acid in ethanol). 
 
Bis(3-mercaptopropyl)sulfide (2.5) 
 A mixture of 3-chloro-1-propanol (25 mL, 300 mmol) and Na2S·9H2O (35 g, 146 mmol) 
in 120 mL of 0.5% NaOH (aq) was refluxed for 12 h under nitrogen. The reaction 
mixture was cooled to 0 °C, and 37% HCl (aq) (100 mL, 1.2 mol) was added, followed 
by thiourea (34 g, 447 mmol). The mixture was refluxed under nitrogen for 2 days then 
cooled to 0 °C, and NaOH pellets (93 g, 2.3 mol) were added with rapid stirring. The 




37% aq. HCl (100 mL). The product was extracted with tert-butyl methyl ether (3 x 120 
mL), and the extract was dried with Na2SO4 and concentrated under reduced pressure to 
give the product as a colorless oil (21.3 g, 80%). 
1
H NMR indicated the presence of a 
trace of 1,3-propanedithiol, and this was completely removed by heating the product to 
150 °C for 45 min under a stream of nitrogen (purified yield 18.0 g, 68%). TLC Rf 0.41 





NMR (CDCl3, 400 MHz)  1.37 (t, J = 8.1 Hz, 2H), 1.88 (p, J = 7.0 Hz, 4H), 2.59–2.68 
(m, 8H). 
13
C NMR (CDCl3, 100 MHz)  23.2, 30.0, 33.0. MS m/z 182 ([M+], 100), 107 
(65), 74 (67), 41 (65). EI HRMS m/z calcd for [M
+
] C6H14S3 182.0258, found 182.0265. 
 
N,N-Bis(3-iodopropyl)aniline (2.6)  
A mixture of N,N-bis(3-hydroxypropyl)aniline
20
 (8.10 g, 38.7 mmol) and Et3N (22 mL,4 
equiv.) in CH2Cl2 (140 mL) was cooled in an ice bath under a stream of nitrogen, and 
methanesulfonyl chloride (9.0 mL, 3 equiv.) was added dropwise with rapid stirring over 
a period of 5 min. The reaction mixture was stirred for 1 h then quenched by adding 
crushed ice. A solution of NaH2PO4 (6.7 g in 40 mL H2O) was added. The organic layer 
was separated, dried with Na2SO4, and concentrated under reduced pressure. The residue 
was taken up in acetone (50 mL) and a solution of NaI (17.5 g, 3 equiv.) in acetone (50 
mL) was added. The mixture was stirred overnight, diluted with water (200 mL) and 
extracted with tert-butyl methyl ether. The extract was washed twice with water and 
brine, dried with Na2SO4, and concentrated under reduced pressure to give the product as 
a yellow-brown oil which was used without further purification. Yield 15.4 g (93%). TLC 





(CDCl3, 400 MHz)  2.08 (p, J = 6.8 Hz, 4H), 3.20 (t, J = 6.6 Hz, 4H), 3.42 (t, J = 7.0 
Hz, 4H), 6.69–6.74 (m, 3H), 7.19 7.25 (m, 2H). 
13




51.6, 112.7, 116.7, 129.3, 147.4. MS  m/z 429 ([M
+
], 26), 274 (100), 146 (28). EI HRMS 
m/z calcd for [M
+
] C12H17I2N 428.9450, found 428.9470. 
 
13-Phenyl-1,5,9-trithia-13-azacyclohexadecane (2.2)  
Diiodide 2.6 (8.99 g, 21.0 mmol), dithiol 2.5 (3.82 g, 21.0 mmol), and 1,1,3,3-
tetramethylguanidine (5.3 mL, 2.0 equiv.) were each dissolved in acetonitrile, placed in 
10 mL all-plastic syringes, and diluted to 10 mL. The resulting solutions were 
simultaneously and continuously added via syringe pump over a period of 60 h to a 
refluxing solution of 1,1,3,3-tetramethylguanidine (0.66 mL,0.25 equiv.) in acetonitrile 
(750 mL) under nitrogen. After cooling to rt, the reaction mixture was concentrated under 
reduced pressure. The residue was stirred with toluene (150 mL) for 1 h. The precipitated 
salts were filtered out, and the filtrate was chromatographed on silica gel (hexanes-tert-
butyl methyl ether) to give the product as a colorless, viscous oil. Yield 2.40 g (32%). Rf 
0.35 (8:1 hexanes- MTBE), 0.34 (10:1 Hexanes: EtOAc). IR (film) 2916, 2851, 1598, 




H NMR (CDCl3, 400 MHz) δ 1.92 (p, J = 7.0 Hz, 4H), 1.95 (p, J 
= 7.1 Hz, 4H), 2.62 (t, J = 6.9 Hz, 4H), 2.68 (t, J = 6.9 Hz, 4H), 2.69 (t, J = 7.0 Hz, 4H), 
3.46 (t, J = 7.2 Hz, 4H), 6.66 6.71 (m, 3H), 7.19–7.25 (m, 2H). 
13
C NMR (CDCl3, 100 
MHz) δ 27.5, 29.6, 29.8, 30.8, 31.0, 50.4, 112.5, 116.2, 129.2, 148.1. MS m/z 355 ([M+], 
100), 221 (18), 193 (17), 180 (27), 146 (46), 120 (29), 106 (26), 77 (11). EI HRMS m/z 
calcd for [M
+
] C18H29NS3 355.1462, found 355.1458. 
 
4-(1,5,9-Trithia-13-azacyclohexadecan-13-yl)benzaldehyde (2.7) 
N,N-Dimethylformamide (8.5 mL, 110 mmol) was cooled in an ice bath, and POCl3 (5.0 
mL, 55 mmol) was added over a period of 30 min. The resulting mixture was added to a 
solution of ligand 2.2 (2.40 g, 6.75 mmol) in DMF (8 mL). After stirring for 45 min at 75 




basic with NaOH. Dichloromethane (50mL) was added, and the mixture was stirred for 1 
h. The organic layer was separated, and the aqueous layer was extracted with DCM (2 x 
50 mL). The combined organic extracts were concentrated under reduced pressure, and 
the residue was taken up in benzene (25 mL). The solution was washed with water to 
remove DMF, dried with Na2SO4 and concentrated under reduced pressure to give the 
product as a yellow-brown oil which solidified after several hours. Yield: 2.56 g (99%). 
TLC Rf 0.44 (2 : 1 hexanes: EtOAc). IR (film) 2935, 2848, 1667, 1597, 1524, 1406, 




H NMR(CDCl3, 400 MHz) δ 1.93 (p, J = 6.9Hz, 4H), 1.99 
(p, J =7.0Hz, 4H), 2.64 (t, J =6.6Hz, 4H), 2.70 (t, J = 6.9 Hz, 4H), 2.72 (t, J = 7.0 Hz, 
4H), 3.61 (t, J = 7.5 Hz, 4H), 6.68 (d, J = 9.0 Hz, 2H), 7.72 (d, J = 9.0 Hz, 2H), 9.73 (s, 
1H). 
13
C NMR (CDCl3 , 100 MHz) δ 26.9, 29.1, 29.4, 30.5, 30.9, 49.9, 110.8, 124.9, 
132.0, 152.3, 189.8. MS m/z 383 ([M
+
], 100), 249 (15), 208 (26), 174 (44), 134 (25), 87 
(13), 41 (14). EI HRMS m/z calcd for [M
+
] C10H29NOS3 383.1411, found 383.1392. 
 
Chalcone 2.8 
Aldehyde 2.7 (385 mg, 1.0 mmol) and 3,5-difluoroacetophenone (172 mg, 1.1 mmol) 
were completely dissolved in 4 mL of ethanol–benzene (1:1) at 40 °C. Pyrrolidine (0.2 
mL, 2 equiv.) was added, the reaction flask was sealed, and the mixture was stirred at 40 
°C for 24 h. The resulting orange slurry was diluted with 25 mL of ethanol and 
concentrated to a volume of 10 mL to remove benzene. An additional 15 mL portion of 
ethanol was added, and the mixture was stirred at 0 °C for 4 h. The orange crystalline 
product was filtered off and dried under vacuum. Yield: 384 mg (73%). IR (KBr pellet) 




H NMR (CDCl3, 400 MHz) δ 1.93 
(p, J = 6.9 Hz, 4H), 1.98 (p, J = 7.0 Hz, 4H), 2.64 (t, J = 6.6 Hz, 4H), 2.70 (t, J = 7.0 Hz, 
4H), 2.72 (t, J = 7.1 Hz, 4H), 3.58 (t, J = 7.4 Hz, 4H), 6.66 (d, J = 8.9 Hz, 2H), 6.99 (tt, J 




J = 15.4 Hz, 1H). 
13
C NMR (CDCl3, 100 MHz) δ 27.2, 29.4, 29.6, 30.8, 31.1, 50.1, 107.3 
(t, JCF = 25.5 Hz), 111.1 (dd, JCF = 18.7, 7.1 Hz), 111.7, 115.3, 122.0, 131.0, 142.2 (t, JCF 
= 7.4 Hz), 147.1, 150.3, 162.9 (dd, JCF = 250.2, 12.0 Hz), 187.5 (t, JCF = 1.9 Hz, broad). 
19
F NMR (CDCl3, 376 MHz) δ -109.2 (t, J = 7.4 Hz, 2F). MS m/z 521 ([M+], 100), 387 
(23), 312 (30), 286 (35), 141 (21). EI HRMS m/z calcd for [M
+
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DEVELOPMENT OF A WATER SOLUBLE, AGGREGATION 
RESISTANT, HIGH CONTRAST FLUORESCENT PROBE FOR 
COPPER(I) 
 
   The majority of original research presented in this chapter has been published.
1 
3.1. Background: Lipophilicity and aggregation of fluorescent probes 
 Synthetic fluorescent probes for detection of biological metal ions are generally 
lipophilic compounds, due in part to the carbon-rich conjugated π-systems common to 
most organic fluorophores. Additionally, the number of charged or highly polar 
functional groups in the probe structure is often minimized to allow passive diffusion 
across lipid bilayer membranes.
2
 Although some degree of lipophilicity is beneficial from 
the standpoint of cell permeability, highly lipophilic substances are subject to strong 
hydrophobic interactions and therefore exhibit poor aqueous solubility and a propensity 
to aggregate in aqueous solution. Aggregation of fluorophores can profoundly alter their 
photophysical properties: spectral shifts, complete fluorescence quenching, or even 
dramatic fluorescence enhancements have all been observed upon aggregation of 
fluorescent dyes.
3,4,5
 Such effects are likely to confound the photophysical 
characterization of lipophilic fluorescent probes in aqueous solution. Furthermore, the 
aggregation state of these probes are likely to be altered by partitioning into lipid bilayers 
or other hydrophobic domains in a biological environment, thus calling into question the 
often presumed correspondence between the properties of a fluorescent probe observed 




 In the case of Cu(I)-responsive probes, high lipophilicity is especially likely due 
to the thioether-rich ligand designs typically used to achieve selectivity for the soft Cu(I) 
cation. The structures of three representative Cu(I)-selective fluorescence turn-on probes 
are shown in Figure 3.1. 
 
 
Figure 3.1: Structures of previously reported Cu(I)-selective fluorescent probes 
 
  The structures of  CS1
6
 and 2.4c (Chapter 2) are dominated by hydrophobic 
functional groups, and it is unlikely that such structures can exist in stable monomeric 
aqueous solution at the micromolar concentrations typically used for fluorescence 
experiments. It is for this reason that 2.4c and its analogs were characterized in 
methanolic rather than aqueous solution.
7,8
 CTAP-1 contains a carboxylic acid moiety, 
which should be ionized at neutral pH, to promote aqueous solubility,
9
 but placing a 
strongly hydrophilic functional group at only one end of a relatively large lipophilic 
molecule creates an amphiphilic structure which may still be very prone to aggregation. 
For example, Niu et al functionalized a distyryl-BODIPY fluorophore comparable in size 
to CTAP-1 with a tetraanionic sulfonated peptide to achieve water-solubility, but the 






 Since both the fluorophore and the thiazacrown ligand contribute 
substantially to the lipophilicity of probes such as CTAP-1 and 2.4c, hydrophilic 
functionalization of both moieties may be necessary to produce probes of similar 
architecture that remain monomeric at useful concentrations in aqueous solution. 
3.2. Probe design 
  The research described in Chapter 2 demonstrated that significant improvements 
in contrast ratio relative to the previously available Cu(I)-selective fluorescent probes 
CTAP-1 and CS1 can be achieved using a probe design comprising a tetradentate 
thiazacrown ligand coupled to an electronically tuned triarylpyrazoline fluorophore. 
These contrast optimized probes, however, were not designed to operate in an aqueous 
environment and instead were characterized in methanolic solution to avoid interference 
from aggregation. Therefore, in the work described in this chapter, we sought to develop 
a probe architecture that would allow application of the newly developed contrast 
optimization strategy in aqueous solution, with the ultimate goal of creating a higher 
contrast Cu(I)-selective fluorescence turn-on probe that would be suitable for biological 
applications. 
 
3.2.1. Hydroxymethylated thiazacrown ligand 
 To avoid creating a highly amphiphilic structure, we sought to functionalize not 
only the fluorophore but also the thioether-based Cu(I) binding site with hydrophilic 
groups. Taking ligand 2.2 as a starting point, we chose to symmetrically functionalize the 
macrocycle with four equivalent hydroxymethyl groups (design 3.1). This modification 
should substantially decrease lipophilicity without introducing additional stereogenic 
centers into the final probe structure. To further reduce lipophilicity and perhaps also 




to two, giving ligand 3.2. Although the resulting reduction in macrocycle cavity size 
might be expected to impair metal binding, studies on macrocyclic tetrathioethers have 
shown that16- and 14-membered rings provide almost identical Cu(I) binding 
affinities.
10,11




Figure 3.2: Modification of the thiazacrown ligand to reduce lipophilicity 
  
3.2.2. Sulfonated triarylpyrazoline fluorophore 
 In CTAP-1, the fluorophore was functionalized with a directly attached 
carboxylic acid as an ionizable group to promote aqueous solubility. This design strategy, 
however, is not well suited for contrast optimization by the electronic tuning strategy 
described in Chapter 2: The carboxylate existing in neutral solution would be 
reprotonated to the neutral form upon acidification, thus preventing the estimation of the 
intrinsic fluorophore quantum yield by protonation of the PET donor. Furthermore 
fluorophores bearing carbonyl substituents often exhibit low fluorescence quantum yields 
due to the existence of low-lying n,π* states, which do not have allowed radiative 
transitions back to the ground state.
12
  Evidence of this effect was previously encountered 




fluorophores, where derivatives bearing a carboxyl ester moiety on the 1-aryl ring 
showed dramatic decreases in fluorescence quantum yield with increasing fluorination 
even in the absence of a PET donor.
13
 Both of the above complications can be avoided by 
replacing the carboxylic acid with a sulfonic acid. As a strong acid, a sulfonic acid 
moiety will exist solely as an anionic sulfonate group at any pH accessible in dilute 
aqueous solution, and the use of sulfonates as solubilizing groups for organic 
fluorophores is well established.
12
 Furthermore, judging by the reported Hammett 
substituent constants of σp = 0.36 for SO3
-
  and  σm = 0.35 for F,
14
 a para-sulfonate group 
has comparable electron-withdrawing power to the meta-fluoro- substituent previously 
employed for electronic tuning (Chapter 2). 
3.2.3. Selection of the fluorophore substituents 
 Based on the results described in Chapter 2, the PET driving force for 
triarylpyrazoline Cu(I) probes with an N-arylthiazacrown ligand as the 5-aryl ring can be 
set within an appropriate tunable range using either a 3,5-difluorophenyl or 4-
cyanophenyl moiety for the 3-aryl ring (probe series 2.3 and 2.4, respectively). The PET 
driving force can then be tuned to maximize the contrast ratio by successive fluorination 
of the 1-aryl ring. For the new probe series, we selected a 4-cyanophenyl group for the 3-
aryl ring because it should be less lipophilic than 3,5-difluorophenyl and also provides 
longer excitation and emission wavelengths for a given PET driving force (Table 2.1), 
which would be beneficial if the probe is used for cellular imaging applications. For the 
1-aryl ring, the p-sulfonate group should already provide similar electron withdrawing 
power to a single m-fluoro-substituent (see above). The unfluorinated compound 3.3a 
was therefore expected to be analogous to the slightly under-quenched probe 2.4b 
(Chapter 2), thus providing a natural starting point for the tuning series. As in Chapter 2, 
successive fluorination of the 1-aryl ring should increase the PET driving force over a 




investigation since fluoro-substituents ortho to the sulfonate group may be susceptible to 
undesired nucleophilic aromatic substitution. The final structures selected for synthesis 




Figure 3.3: Initial probe designs 
 
 
3.3. Synthesis of the ligand framework 
3.3.1. Attempted synthesis via a neopentyl alcohol intermediate 
 A brief retrosynthetic analysis (Scheme 3.1) identified the commercially 
available, inexpensive compound pentaerythritol as an obvious starting point for the 






Scheme 3.1: Retrosynthetic analysis for ligand 3.2 
 
 A synthesis based on this approach would require selective protection of two of 
the four hydroxyl groups of pentaerythritol, followed by selective conversion of one of 
the two remaining hydroxyls to a suitable leaving group. Pentaerythritol can be converted 
to the cyclohexanone monoacetal 3.4 in 90% yield,
15
 so this reaction was chosen for the 
first protection step. The resulting diol would be converted to the monomesylate 3.5. The 
role of this neopentyl alcohol derivative in the synthesis of 3.2 would then be analogous 
to that of 3-chloro-1-propanol in the synthesis of ligand 2.2: The central thioether would 
be introduced by coupling two equivalents of the alcohol with sodium sulfide, and the 
resulting thioether-diol 3.6 would subsequently be converted to dithiol 3.7, which is the 
immediate precursor for macrocyclization to give the ligand framework. This proposed 





Scheme 3.2: Proposed synthesis of the dithiol intermediate 
 
 Intermediate 3.4 was synthesized according to the literature reaction conditions, 
but the product was isolated by recrystallization from toluene instead of the previously 
described procedure, which involved kugelrohr distillation followed by column 
chromatography.
15
 This modification substantially improved preparation time and 
scalability at the expense of a moderate reduction in percent yield. Mesylation of 3.4 was 
conducted at -78°C using just over one molar equivalent of methanesulfonyl chloride in 
an attempt to achieve selectivity for the mono-mesylate 3.5, but a substantial amount of 
the bis-mesylate 3.8 was also formed (Scheme 3.3). Nevertheless, the desired 
intermediate 3.5 was isolated in 35% yield by column chromatography and subsequently 





Scheme 3.3: Synthesis of neopentyl alcohol-mesylate intermediate 3.5 
(Isolated yields) 
 
3.3.2. Unexpected oxetane formation 
 The reaction of 3.5 with sodium sulfide was conducted under phase transfer 
catalysis in an attempt to overcome the low SN2 reactivity typical of neopentyl 
electrophiles, but the desired product was not identified. The major product was found to 
be oxetane 3.9, which was isolated in 42% yield relative to 3.5 or 76% relative to Na2S 
(Scheme 3.4). Substantial unconsumed starting material was also apparent by TLC. 
 
 
Scheme 3.4: Unexpected oxetane formation under phase-transfer catalysis 
 
 Although the low reactivity of neopentyl centers towards intermolecular 
nucleophilic substitution is well known, it was nevertheless surprising that an alkoxide 




strained 4-membered ring in the process. It was thought that this unusual behavior may 
be due to the high reactivity of alkoxides under phase transfer conditions combined with 
the high basicity of the sulfide dianion, which actually exists as a mixture of hydrosulfide 
and hydroxide in aqueous solution.
16
 To test this hypothesis, mesylate 3.5 was reacted 
with ethanethiolate under protic conditions in the presence of excess ethanethiol (pKa 
10.6 in H2O
16
) to minimize both the reactivity and concentration of alkoxide species 
(Scheme 3.5). In addition to the expected thioether 3.10, a surprisingly large amount of 
oxetane 3.9 was formed even under these conditions. 
 
 
Scheme 3.5: Oxetane formation under protic conditions in the presence of a thiol-thiolate 
mixture 




 Clearly, intermediate 3.5 is highly susceptible to oxetane formation, so an entirely 
different precursor was examined. The commercially available, water soluble bromide 
3.11 was reacted with aqueous sodium sulfide at room temperature in an attempt to 
produce thioether 3.12 (Scheme 3.6). Remarkably, the oxetane 3.13 was the major 
product and none of the desired thioether could be detected. A small amount of the alkene 
3.14 was also formed, presumably by simultaneous elimination of bromide and 
formaldehyde. An analogous elimination reaction has been previously observed for 3-







Scheme 3.6: Reaction of bromide 3.11 with aqueous sodium sulfide 




3.3.3. Synthesis of the ligand framework by a thietane ring-opening strategy 
 Based on the results shown in Schemes 3.4, 3.5, and 3.6, it appears that reaction 
of basic sulfur nucleophiles with hydroxylated neopentyl electrophiles such as 3.5 and 
3.11 inevitably results in substantial conversion of the starting material to the 
corresponding oxetane, which is presumably greatly accelerated by the Thorpe-Ingold 
effect.
18
 This remarkable facility of oxetane formation, however, suggests that the 
corresponding thietanes should also be easily accessible. A thietane ring can be opened 
by benzyl bromide to give a 3-bromopropyl thioether,
19
 which could presumably be 
converted to a bis(3-mercaptopropyl) thioether such as 3.7 by coupling with sodium 
sulfide followed by removal of the benzyl groups. This strategy was realized as shown in 
Scheme 3.7 via the previously reported thietane 3.15,
20
 which is easily prepared 
inexpensive starting materials via dibromide 3.16. Ring opening of the thietane to 
bromide 3.17 proved to be remarkably efficient, and coupling of this neopentyl bromide 
with sodium sulfide gave clean conversion to thioether 3.18 after optimization of the 
reaction conditions. The benzyl groups were removed by dissolving metal reduction to 
give dithiol 3.19. Cyclization with diiodide 3.20, which was prepared in two steps from 
commercially available N-phenyldiethanolamine, proceeded in good yield to give 










3.4. Synthesis of the sulfonated triarylpyrazoline fluorophore 
3.4.1. Potential synthetic routes 
 As described in Chapter 2, 1,3,5-triarylpyrazoline-based probes are generally 
prepared by condensation of a chalcone derivative containing the desired 3- and 5-aryl 
substituents with an arylhydrazine corresponding to the 1-aryl ring of the desired product.  
In the case of target compounds 3.3a-c, a sulfonic acid moiety must somehow be 
introduced at the  para position of the 1-aryl ring. This could in principle be accomplished 
by direct sulfonation after assembly of the triarylpyrazoline core, but the acetonide-
protected N-arylthiazacrown ligand would likely be damaged by electrophilic sulfonating 
agents. Alternatively, the sulfonic acid group could be introduced at the arylhydrazine 
stage, but the resulting triarylpyrazolines could not be purified by normal phase 
chromatography after the cyclization reaction, which sometimes gives fluorescent side 
products that complicate probe characterization and are difficult to remove by reversed-
phase HPLC.
8
 Therefore, a desirable route would be to introduce the sulfonic acid moiety 
in a protected form that could later be unmasked along with the hydroxyl groups of the 
ligand at the end of the synthesis.  
 
3.4.2. An acetonide-based neopentyl protective group for sulfonic acids 
 The surprisingly facile oxetane formation observed for the hydroxylated 
neopentyl mesylate 3.5 presumably involves displacement of the intact methanesulfonate 
anion as a leaving group, thus suggesting that a similar hydroxylated neopentyl derivative 
might serve as a protective group for sulfonic acids. The hydroxyl group required for 
sulfonate displacement could itself be protected with an acid-labile group, thus providing 
a neopentyl sulfonate that is stable under basic and moderately nucleophilic conditions, 




hydroxyl groups were already protected as acid-labile acetonides (intermediate 3.21), a 
similar acetonide moiety was incorporated into a neopentyl sulfonate ester to give 
protective group 3.22, which could be deprotected as shown in Scheme 3.8: 
 
 
Scheme 3.8: Sulfonate protective group 3.22 and proposed deprotection mechanism 
 
3.4.3. Synthesis of the target probe series 3.3a-c 
Synthesis of the arylhydrazine intermediates 
 As shown in Scheme 3.9, protective group 3.22 was easily introduced by reacting 
the corresponding alcohol 3.23 with commercially available fluorinated arenesulfonyl 
chlorides. The resulting fluorinated arenesulfonates 3.24a-c were converted in high yield 
to the corresponding arylhydrazines 3.25a-c by nucleophilic aromatic substitution with 
hydrazine hydrate. As might be expected, the reactivity of aryl fluorides 3.24a-c toward 
hydrazine increased dramatically upon additional fluorination; while the reaction of 3.24a 




had to be conducted in the less polar solvent acetonitrile to prevent thermal runaway and 




Scheme 3.9: Synthesis of arylhydrazine-sulfonate esters 3.25a-c 
 
 
 As indicated  in Scheme 3.9, protective group 3.22 remained intact even upon 




displacement, and all of the above reactions were sufficiently clean that the products 
could  be isolated simply by crystallization. Although a few other intramolecularly 
cleavable neopentyl sulfonate protective groups have been reported,
21-23
 3.22 has 
significant advantages for the present application: It can be introduced in one step from 
commercially available alcohol 3.23, whereas the t-butyl carbamate-based neopentyl 
protective group NeoN-B
21
 requires four synthetic steps to produce the alcohol precursor. 
Furthermore, it is resistant to both hydrazine and fluoride ion, which is presumably not 
the case for the more recently introduced silyl ether
22
 or carboxylic ester
23
 based 
neopentyl sulfonate protective groups. 
 
Construction of the triarylpyrazoline fluorophore 
 As shown in Scheme 3.10, the triarylpyrazoline core was assembled by aldol 
condensation of aldehyde 3.21 with 4-cyanoacetophenone followed by condensation of 
the resulting chalcone 3.26 with arylhydrazine 3.25a under mildly acidic conditions. 
Although the latter resulted in partial cleavage of the acetonide groups, the fully protected 
intermediate 3.27a was recovered by including a brief re-acetalization step in the workup 
procedure to allow for efficient chromatographic purification. Probe 3.3a was then 
obtained by complete hydrolysis of the acetonide moieties with trifluoroacetic acid-water 
mixture followed by treatment with potassium t-butoxide at room temperature to induce 
sulfonate elimination. This deprotection procedure, although requiring two steps, proved 
to be reasonably efficient, and the desired product was obtained in 63% yield by 
crystallization of the zwitterionic acid form. Although the resulting material appeared 
pure by NMR, it was further purified for photophysical characterization by conversion to 
the highly soluble ammonium salt followed by RP-HPLC using acetonitrile/aqueous 
NH4HCO3 as the mobile phase. Probes 3.3b and 3.3c were then prepared analogously to 
3.3a except that the final products were isolated directly as the ammonium salts by RP-










3.5. Initial characterization of the probe series 
 
 The ammonium salts of 3.3a-c dissolve rapidly in pure water, and millimolar 
stock solutions were easily prepared by direct dissolution without organic cosolvents. 




even CTAP-1, all of which can be introduced into aqueous solution only by pre-
dissolution in an organic solvent such as DMSO.  In neutral aqueous buffer (10 mM 
MOPS, pH 7.2), probes 3.3a-c gave only very weak fluorescence in the absence of 
analyte and exhibited large emission enhancements upon saturation with Cu(I). As 
expected for a PET-based fluorescence switching mechanism, saturation with Cu(I) had 
no effect on the emission wavelength and only a very small effect on the absorption 
spectrum for each probe. The absorption and emission maxima shifted toward shorter 
wavelength from 3.3a to 3.3c, giving a stepwise increase in the estimated excited-state 
energies (ΔE00) from 2.79 to 3.06 eV. The corresponding ΔG
0
et values in aqueous 
solution cannot be directly calculated from the Rehm-Weller equation (see Chapter 2) 
because the reduction potentials E(A/A
-
) are outside of the accessible potential window, 
but data on related triarylpyrazolines bearing a p-cyano substituent on the 3-aryl ring 
show that E(A/A
-
) is little affected by fluorination of the 1-aryl ring.
24
 Therefore, the PET 
driving force (−ΔG
0
et) should track the changes in ΔE00. Accordingly, the fluorescence 
quantum yields of the free and Cu(I) saturated probes 3.3a-c decrease with increasing 
excited state energy, corresponding to an increasing rate of PET for both the free and 
Cu(I)-bound forms (Table 3.1). 
 












b  𝑓 
c 
3.3a 396 508 2.79 0.0015 0.083 65 
3.3b 376 498 2.89 0.0006 0.033 41 
3.3c 358 467 3.06 0.0005 0.010 9 
a
 Estimated as the mean of the absorption and emission energies for the analyte-free probes. 
b
 
Probes were saturated with Cu(I) by titration with aq. CuSO4 in the presence of 20 µM sodium 
ascorbate. 
c
 Fluorescence enhancement factor (contrast ratio) given as the ratio of the emission 
intensity of the Cu(I)-saturated probe to that of the free probe at 380 nm excitation; emission 





3.6. Reduction of the PET driving force 
 
3.6.1. Probe design 
 As indicated in Table 3.1, the largest fluorescence enhancement, 65-fold, was 
observed with 3.3a, which also possesses the lowest excited state energy and therefore 
the lowest PET driving force. As demonstrated in Chapter 2, however, the contrast ratio 
should pass through a maximum at an intermediate value of –ΔG
0
et. Therefore, it was 
unclear whether the optimum contrast ratio is already achieved with 3.3a or if a 
derivative with lower excited state energy would offer an even larger fluorescence 
enhancement. To address this question, we devised probe 3.3d, in which the electron-
withdrawing sulfonate moiety is decoupled from the fluorophore π-system through a 









3.6.2. Synthesis of probe 3.3d 
 The synthesis of 3.3d required a slightly different route than used for 3.3a-c, 
because the corresponding arylhydrazine cannot be prepared by nucleophilic aromatic 
substitution of an aryl fluoride without the activating effect of the strongly electron-
withdrawing sulfonate ester on the aromatic ring. Therefore, amine 3.28 was chosen as 
the arylhydrazine precursor (Scheme 3.11).  Synthesis of 3.28 required the sulfonyl 
chloride 3.29, which has been previously prepared from the corresponding S-alkyl 
isothiourea derivative using aqueous chlorine
25
 or from the corresponding sodium 
sulfonate by reaction with thionyl chloride.
26
 The former procedure requires handling of 
chlorine gas and has the potential to produce explosive nitrogen trichloride. The latter 
procedure was also unsatisfactory; the authors reported no analytical data, and their 
conditions were found to give a tarry mixture containing more unreacted starting material 
than desired product. Therefore, a method was devised to generate the sulfonyl chloride 
by direct oxidative chlorination of the thiol 3.30 with chlorine generated in situ: Addition 
of hydrogen peroxide to a biphasic mixture containing a dichloromethane solution of 3.30 
and concentrated hydrochloric acid gave clean conversion to 3.29, which was obtained in 
higher yield and purity than previously reported.
25
  Coupling with alcohol 3.23 gave the 
sulfonate ester 3.31, which was subsequently reduced to amine 3.28 without disturbing 
the benzylic sulfonate ester or the acetonide moiety using zinc dust in a methanolic acetic 
acid-ammonium acetate buffer. The planned synthetic route entailed conversion of 3.28 
to a crystalline diazonium tosylate
27,28
 in the presence of acetone to preserve the 
acetonide moiety, followed by reduction to the corresponding arylhydrazine after 
removal of acetone.  Attempts to crystallize the diazonium salt were unsuccessful, so the 
amine was instead reacted with isoamyl nitrite under neutral conditions, a procedure 
known to convert arylamines to the corresponding 1,3-diaryltriazenes,
29




in one pot to give an amine-arylhydrazine mixture. The arylhydrazine appears to be 
somewhat unstable and could not be isolated in pure form, but an excess of the crude 
material was reacted with chalcone 3.26 to give the protected triarylpyrazoline 3.32 in 
52% yield. The deprotection procedure developed for the arenesulfonates 3.3a-c also 
proved effective for the benzylic methanesulfonate 3.3d, and the desired product was 








3.6.3. Evaluation of the expanded probe series 
 Probe 3.3d gave absorption and emission maxima of 404 and 532 nm, 
respectively, corresponding to a significantly lower excited state energy of 2.70 eV 
versus 2.79 eV for 3.3a (table 3.2). Consistent with a reduced PET driving force, the 
fluorescence quantum yield of the free probe nearly doubled from 0.15% to 0.26%. The 
quantum yield of the Cu(I)-saturated form, however, decreased slightly from 8.3% for 
3.3a to 7.7% for 3.3d, suggesting the presence of an efficient nonradiative deactivation 
pathway other than acceptor-excited PET. To gauge the intrinsic fluorophore quantum 
yield of 3.3d as well as 3.3a-c, the quantum yields were measured in 5 mM HCl, where 
the arylamine moiety is expected to be protonated and therefore inactive toward oxidative 
electron transfer.  As in Chapter 2, the fluorescence recoveries upon Cu(I) binding were 
determined as the ratio of the fluorescence quantum yield of the Cu(I)-saturated probe to 
that of the protonated probe. As shown in Table 3.2, the lower excited state energy of 
3.3d compared to the other probes does indeed result in a greater fluorescence recovery 
relative to the unquenched fluorophore upon Cu(I) coordination, but this does not result 
in a larger fluorescence enhancement factor or improved fluorescence quantum yield 
relative to 3.3a-Cu(I)  because the fluorophore of 3.3d apparently possesses an 
intrinsically lower quantum efficiency in aqueous solution. Interestingly, anomalously 
low fluorescence quantum yields in methanolic solution have been previously reported 






















   𝑓  
Cu(I) sat.
a 
3.3d 2.70 0.077 0.10 77% 32 
3.3a 2.79 0.083 0.25 33% 65 
3.3b 2.89 0.033 0.31 11% 41 
3.3c 3.06 0.010 0.62 2% 9 
a
 All values determined as in Table 3.1. 
b
Fluorescence quantum yield in 5 mM HCl (aq). 
c




3.7. Further characterization of the optimized probe CTAP-2 
 As indicated in Table 3.2, probe 3.3a gives the highest contrast ratio and also the 
highest fluorescence quantum yield upon Cu(I) saturation. This compound was therefore 
selected as the optimized probe for further study and given the designation CTAP-2.  
 
3.7.1. Copper(I) binding stoichiometry and reversibility 
 To confirm that CTAP-2 has the intended 1:1 copper coordination stoichiometry 
and high binding affinity, a 4.5 µM solution of the probe in deoxygenated buffer (5 mM 
MOPS-K
+
, pH 7.2) was titrated with Cu(I) in 0.5 µM increments up to 8 µM total. 
Whether Cu(I) was supplied directly from an acetonitrile stock solution of the 
hexafluorophosphate (Figure 3.5) or produced in situ by reduction of Cu(II) with 
ascorbate, the fluorescence intensity of CTAP-2 first increased linearly and then saturated 
sharply at 4.5 µM (1 molar equivalent) of Cu(I). These results indicate clean 1:1 binding 
with an association constant on the order of 10
9






Figure 3.5: Mole-ratio titration of CTAP-2 with Cu(I). Left: Smoothed 
fluorescence emission spectra. Right: Fluorescence emission intensity at 510 nm 
versus amount of added Cu(I). Adapted with permission from Ref. 1. © 2011 
American Chemical Society. 
 
 
 The response of CTAP-2 to Cu(I) was completely reversed by addition of an 
excess of the nonselective, high affinity transition metal chelating agent TPEN 
(N,N,N’,N’-tetrakis(2-pyridylmethyl)ethylenediamine), indicating that the response is 
indeed due to a reversible complexation reaction. 
 
3.7.2. Analyte selectivity 
 To determine the selectivity of CTAP-2 for Cu(I) over other biologically relevant 
metal ions, the fluorescence response of the probe to each cation was recorded in the 
absence and presence of Cu(I). As shown in Figure 3.6, no cation other than Cu(I) gave a 
significant fluorescence turn-on response, and none of the cations inhibited the response 
to Cu(I). A moderate concentration (10 mM) of chloride also did not interfere, despite the 






Figure 3.6: Analyte selectivity of CTAP-2. Adapted with permission from Ref. 1.  
© 2011 American chemical Society 
 
 Although slight fluctuations in the response to Cu(I) are discernible, these were 
poorly reproducible and are probably due to partial oxidation of Cu(I) during mixing of 
the solutions in air. Consistent with this notion, the strongest Cu(I) response was 
observed in the presence of the reducing cation Fe(II). 
 
3.7.3. Copper(I) binding affinity and pKa 
 The experiments and data fitting described in subsection 3.7.3 were carried out by 
Pritha Bagchi except where specified otherwise. 
 Cu(I) binding affinity of CTAP-2 
 As shown in Figure 3.5, direct titration of micromolar concentrations of CTAP-2 
with Cu(I) results in sharp saturation at one molar equivalent of the metal, indicating that 
the dissociation constant of CTAP-2-Cu(I) is much smaller than the probe concentration 
used in the experiment. The binding affinity cannot be accurately determined from these 
data, because essentially all of the metal remains bound to the probe up to the saturation 




smaller Cu(II)-association constant and  the redox potential of the CTAP-2-bound 
Cu(II/I) couple. According to the Nernst relationship, these values are related by 
Equation 3.1, where ECu(II/I)L is the reduction potential of the ligand-bound Cu(II/I) 
couple, ECu(II/I)solv is the “concentration potential”, the standard potential of the aqueous 
Cu(II/I) couple corrected for the activity coefficient of each ion under the conditions of 
measurement, F is the Faraday constant, KCu(II) is the ligand-Cu(II) complex stability 
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 The CTAP-2-Cu(II) complex stability constant was determined by 
spectrophotometrically monitored titration of CTAP-2 with excess CuSO4 at pH 5 (10 
mM PIPES/K
+
, 0.1 M KClO4), and the resulting data were fitted over the entire spectral 
range (250-500 nM) using the Specfit software package
33
 to yield a value of log KCu(II) = 
2.97 ± 0.07. The half-wave potential of the CTAP-2-bound Cu(II/I) couple was 
determined by cyclic voltammetry in the presence of 1 mM CuSO4 in the same PIPES-
KClO4 buffer described above, yielding a value of ECu(II/I)L = +0.626 V (vs. SHE). On the 
basis of these data and a value of 0.13 V vs. SHE for ECu(II/I)solv,
32
 the Cu(I) binding 
affinity of CTAP-2 was estimated as log KCu(I) = 11.4 ± 0.1, which corresponds to a 
dissociation constant of only 4 pM, at pH 5. Given the low pKa of CTAP-2 (see below), 
these values are not significantly influenced by protonation under the conditions of 
measurement and thus are unchanged at pH 7. 
 
Acid dissociation constant (pKa) of CTAP-2 
 As implied by its relatively high fluorescence quantum yield under acidic 




protonation of the arylamine PET donor. Therefore the pKa of CTAP-2 is important not 
only for binding affinity determination but also for the susceptibility of the Cu(I) 
response to interference from environmental pH. To determine the pKa, which is 
normally reported on the basis of hydronium concentration rather than activity, the 
fluorescence emission of CTAP-2 was recorded over a p[H] range from 2.4 to 5.0 at 
intervals of 0.1 log unit, and the data were analyzed using Specfit to yield a value of 3.97 
± 0.01 at 0.1 M ionic strength. Given this relatively low pKa value and the threefold 
higher fluorescence quantum yield of CTAP-2-H
+
 versus CTAP-2-Cu(I), the contrast 
ratio of CTAP-2 upon Cu(I) saturation should remain above 30 down to pH 6, which was 
experimentally verified by the author, and is expected to fall to unity near pH 4.5.   
 
3.7.4. Aggregation effects in aqueous solution 
 To determine whether CTAP-2 is affected by aggregate formation within the 
intended working concentration range, the absorbance of both free and Cu(I)-saturated 
CTAP-2, as well as the fluorescence emission intensity of the latter, were recorded over a 
range of concentrations from 0.5 to 5 µM in aqueous buffer (10 mM MOPS, pH 7.2). The 
presence of an aggregate with significantly different photophysical properties than the 
monomer would be indicated by deviation from linearity in a plot of absorbance or 
fluorescence intensity versus concentration, because the fraction of the probe in 
aggregated form should be concentration dependent. As shown in Figure 3.7, the 
absorption and fluorescence intensity of CTAP-2-Cu(I) scaled linearly with 
concentration, thus providing no evidence of aggregation up to the maximum working 
concentration of 5 µM. Higher concentrations are not appropriate for fluorescence 
measurements due to substantial inner filter effects that would result from the large 
absorbance of the solution, which is already above 0.13 at 380 nm for the 5 µM point. 
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Figure 3.7: Absorbance and fluorescence versus concentration of CTAP-2-Cu(I). A. 
absorbance at 380 nm. B. fluorescence emission intensity over λmax ± 10 nm at 380 nm 
excitation. 
 
 The absorbance of free CTAP-2 also scaled linearly with concentration up to the 
intended working maximum of 5 µM (Figure 3.8, inset). To determine whether 
observable aggregation of CTAP-2 occurs at all in aqueous solution, the absorbance was 
also measured at higher concentrations using a 0.5 cm path-length cuvette. Deviation 
from linearity became apparent above 10 µM, indicating that CTAP-2 does aggregate 
significantly at high concentration. To estimate the fraction of the probe that is likely 
aggregated at the maximum working concentration, the data were fitted to a simple 
dimerization model, which is shown as the red trace in Figure 3.8 (see Experimental 






Figure 3.8: Absorbance at 396 nm versus concentration of CTAP-2. All absorbances are 
scaled to 1 cm path length. Inset: 0-5 µM range. Dashed line: linear fit based on 0-5 µM 
range. Red curve: dimerization model fit over all data points. 
  
 







 at 396 nm for the CTAP-2 dimer and a dimerization equilibrium constant of log 
K = 3.98 ± 0.06, which implies that a 5 µM solution of CTAP-2 would contain about 4 
mol% of the dimer. While the exact nature of the CTAP-2 aggregate, and therefore the 
amount present at a given concentration, is uncertain, the fluorescence contrast ratio of 
CTAP-2 upon saturation with Cu(I) remained constant within experimental error over a 
range of concentrations spanning more than an order of magnitude (Table 3.3), indicating 
that any aggregate that may be present does not have an observable impact on the 





















 69 66 64 65 66 
a
 The 4.5 µM sample was prepared from a precise stock solution. Other concentrations 
were calculated from the absorbance at 380 nm (10 cm path length). 
b
 Ratio of the emission 
intensity of the Cu(I)-saturated probe to that of the free probe at 380 nm excitation; emission 
spectra were integrated over the range λmax ± 10 nm. 
 
 
3.8. Applications of CTAP-2 
 
All experiments presented in Section 3.8 were conducted by Pritha Bagchi. 
 
3.8.1. In-gel detection of a copper metallochaperone 
 During the development of CTAP-2, it was recognized by graduate student Pritha 
Bagchi that a water-soluble, high contrast Cu(I)-selective fluorescent probe may be useful 
for the selective detection of proteins bearing an accessible Cu(I)-binding site after 
separation by native gel electrophoresis. To test this concept, CTAP-2 was applied to a 
native PAGE gel containing the copper chaperone protein Atox1. Remarkably, CTAP-2 
gave visible fluorescent staining only for the copper-loaded form of the protein and not 
for the metal-free apo form obtained by treatment with cyanide. CTAP-2 also did not 
respond to carbonic anhydrase, a zinc protein, or to Cu/Zn superoxide dismutase, which 
contains a copper site buried within the interior of the protein. These results are shown in 
Figure 3.9. Note that the diffuse appearance of the protein bands is characteristic of the 
native PAGE method, which is sensitive to the presence of different isoforms of the same 





Figure 3.9: Selective in-gel detection of copper-loaded Atox1 with CTAP-2. (A) native 
PAGE gel incubated with 5 µM CTAP-2, then visualized at 365 nm excitation (emission 
537/35 nm BP, UV transillumination mode). (B) same gel stained with Coomassie blue to 
visualize all proteins. Lane 1: hAtox1 as isolated. Lane 2: hAtox1, KCN. Lane 3: hAtox1, 
TCEP, Cu(MeCN)4PF6. Lane 4: hAtox1, TCEP, Cu(MeCN)4PF6, then KCN. Lane 5: 
carbonic anhydrase. Lane 6: superoxide dismutase (SOD1). Experiment performed by 




 Although the results shown in Figure 3.9 indicate that CTAP-2 is able to detect 
copper bound to the metallochaperone Atox1, the actual detection mechanism is 
uncertain; the most reliable estimate for the Cu(I)-binding affinity of Atox1 is log KCu(I) = 
17.4,
34
 which is one million fold larger than our estimate of log KCu(I) = 11.4 for CTAP-2. 
Therefore, CTAP-2 should not be able to extract Cu(I) from its binding site on the 
protein, and the observed fluorescent species may be a CTAP-2-Cu(I)-Atox1 ternary 




as well as the macrocycle-Cu(I)-solvent ternary complex formation previously observed 
with thiazacrown-based probes (Chapter 2). 
 
3.8.2. Preliminary cellular imaging 
 Despite its hydrophilic nature and the presence of an anionic sulfonate group, 
CTAP-2 proved to be cell permeant. In live NIH 3T3 mouse fibroblasts grown under 
copper-supplemented conditions, CTAP-2 gave a perinuclear staining pattern (Figure 
3.10) resembling the total copper distribution previously recorded in this cell type by 





Figure 3.10: Fluorescence micrographs of live copper-supplemented NIH 3T3 cells with 
and without CTAP-2. Left: Grayscale image of cells incubated with 5 µM CTAP-2 for 1 
hour. Center: False color image of the same cells. Right: Control cells not incubated with 
CTAP-2 showing the cellular autofluorescence background under identical imaging 
conditions. Scale bar 20 µM. Experiment performed by Pritha Bagchi 
 
 
 Although these preliminary results appear promising, the significance of the 
observed staining pattern is not yet certain given the considerations of binding affinity 
and ternary complex formation noted above. Also, the ability of the fluorophore to 
interact with lipids, which might occur via the uncharged 3-aryl ring, has not yet been 




to avoid aggregation in aqueous solution while maintaining cellular permeability using a 
sulfonated triarylpyrazoline fluorophore platform, a valuable piece of information for the 
design of future Cu(I) probes. 
 
3.9. Colloidal aggregation of previously reported Cu(I)-selective fluorescent probes 
 Dynamic light scattering and gel imaging experiments described in this section 
were conducted by Pritha Bagchi. CS1 and CS3 were synthesized by Jonathan 
Hofmekler. 





 are expected to be too lipophilic to form stable monomeric 
aqueous solutions at the micromolar concentrations typically employed for fluorescence 
experiments. Even the carboxylic acid moiety of CTAP-1
9
 may be insufficient to prevent 
aggregation. The aggregation behavior of these probes in aqueous solution, however, had 
not been experimentally determined. Furthermore, during our studies with CTAP-2, the 
group that developed CS1 reported the probe Coppersensor-3 (CS3), in which the 
fluorine atoms of CS1 were replaced by methoxy groups, supposedly resulting in an even 
higher fluorescence contrast ratio and quantum yield than CTAP-2 upon saturation with 
Cu(I) in aqueous solution.
36
  CS3 also possesses a highly lipophilic structure with no 
charged functional groups, thus calling into question whether the extensive hydrophilic 
functionalization of CTAP-2 is actually necessary for reliable Cu(I) sensing in an 
aqueous environment. Therefore, following the suggestion of a skeptical reviewer during 
attempted publication of our studies with CTAP-2, we examined the aggregation 
behavior of the previously reported Cu(I) probes described above and also tested them for 
the in-gel detection of Atox1 as described for CTAP-2. 
 Following a widely used procedure for producing aqueous solutions of lipophilic 
dyes,
9,37




then diluted to a concentration of 5 µM in aqueous buffer (10 mM MOPS/K
+
 pH 7.2). All 
of the resulting solutions appeared transparent and homogeneous, but dynamic light 
scattering experiments revealed the presence of colloidal particles with hydrodynamic 










Figure 3.11: DLS autocorrelation curves and calculated hydrodynamic radii of colloidal 
particles. 
a
 Hydrodynamic radius calculated from the Stokes-Einstein relation (averaged 
over 20 measurements). 
b
 Standard deviation in calculated Rh. Data acquired by Pritha 
Bagchi. Adapted with permission from Ref. 1. © 2011 American Chemical Society. 
 
 
 Surprisingly, even the carboxylic acid-functionalized CTAP-1 produced a colloid, 
and this occurred regardless of whether the stock solution was prepared from the free acid 
or the potassium salt. Apparently, a single carboxylate group is insufficient to solubilize 
this relatively large structure to micromolar concentrations. CTAP-2, by contrast, gave no 
more signal than the background count rate of the buffer, thus confirming the absence of 
colloidal aggregates. Based on these results, it appears that only CTAP-2 was actually 
characterized in monomeric form in aqueous solution, and that the photophysical 
properties previously ascribed to CS1, CS3, and even CTAP-1 are actually due to 






2.4c 100 12 
CS1 49 6 
CS3 67 9 




probes may be altered by changes in aggregation state in applications involving a mixed-
polarity environment, including cellular imaging.  
 As might be expected based on their colloidal nature in aqueous solution, none of 
the above previously reported Cu(I)-probes gave detectable selective staining of Cu(I)-
loaded hAtox1 in native PAGE gels under the same conditions that were successful with 
CTAP-2. Therefore, it appears that the substantial effort expended in development of the 
hydrophilically functionalized CTAP-2 did indeed result in enhanced capabilities for this 
Cu(I)-selective fluorescent probe. 
 
3.10. Conclusions 
 Previously reported copper(I)-selective fluorescence turn-on probes based on a 
lipophilic, thioether-rich ligand coupled to an uncharged fluorophore have a strong 
propensity to aggregate in aqueous solution, an effect which we long suspected and 
ultimately proved via dynamic light scattering experiments. Even an ionizable carboxylic 
acid moiety attached to the fluorophore is not in itself sufficient to prevent aggregation. 
By combining a polyhydroxylated thiazacrown ligand with a sulfonated triarylpyrazoline 
fluorophore, we created the highly water-soluble Cu(I)-probe CTAP-2, which is devoid 
of observable aggregation effects at typical working concentrations of 1-5 µM in aqueous 
solution, although aggregation can be detected at higher concentrations even for this 
probe. The balanced solubilization strategy developed for CTAP-2 allows the previously 
developed strategy of contrast optimization by electronic tuning (Chapter 2) to be 
deployed in aqueous solution, although in this case CTAP-2 itself turned out to be the 
optimally tuned member of the probe series. Notably, the change from methanol to water 
does not adversely affect the tunable PET switching mechamism of triarylpyrazoline-
based Cu(I)-probes. In fact, the combination of fluorescence contrast ratio and quantum 




better than the maximum obtained for its predecessors in methanolic solution (50-fold 
and 7%, respectively for 2.3d, see Chapter 2).  
 The high contrast ratio and aqueous solubility of CTAP-2 allow this probe to be 
used for the selective in-gel detection of a metallochaperone containing an exchangeable 
copper(I) site. Although the sensitivity of CTAP-2 itself toward the tested 
metallochaperone Atox1 is not particularly high, this detection method constitutes an 
apparently novel and potentially valuable application for Cu(I)-selective fluorescent 
probes. The existing methods for in-gel detection of copper-containing proteins, laser 
ablation-ICP-MS
38
 and synchrotron-based X-ray fluorescence mapping,
39
 are sensitive 
only to total copper content, whereas Cu(I)-selective fluorescent probes can be used to 
differentiate the exchangeable Cu(I)-site of a copper trafficking protein from the buried 
copper site of an enzyme. 
 CTAP-2 also proved to be cell permeant despite its extensive hydrophilic 
functionalization, and can be applied for cellular imaging similarly to previous Cu(I) 
probes such as CTAP-1 and CS1. Recent measurements of the Cu(I) binding affinities of 
Atox1 and several other copper trafficking proteins, however, give association constants 






 several orders of magnitude higher than any of the available 
small molecule Cu(I)-selective fluorescence turn-on probes including CTAP-2. This 
suggests that intracellular free Cu
+
 concentrations should actually be buffered below the 
detection limit of any of these probes under normal physiological conditions. Therefore, 
the interpretation of the observed intracellular staining patterns is uncertain at present and 
requires further study, ideally with future Cu(I)-probes featuring higher binding affinities.  
 While CTAP-2 clearly represents an important step in the evolution of Cu(I)-
responsive fluorescent probes, it also leaves substantial room for improvement. In 
addition to the binding affinity considerations mentioned above, the fluorescence 
quantum yield of Cu(I)-saturated CTAP-2 remains relatively low at 8.3%. By contrast, 




quantum yields up to 71% in acetonitrile solution,
24
 and the 62% quantum yield observed 
for the difluorinated CTAP-2 derivative 3.3c under acidic conditions proves that 
comparable performance is possible even in aqueous solution. The three-fold higher 
quantum yield of protonated CTAP-2 over the copper-saturated form suggests that a 
weak Cu(I)-N interaction and associated ternary complex formation as observed for the 
probes described in Chapter 2 may also limit the fluorescence quantum yield of CTAP-2-
Cu(I); however, the quantum yield of protonated CTAP-2 in aqueous solution is 
approximately half of that shown by its predecessors 2.4b-f in acidified methanol, 
suggesting that an additional quenching mechanism is also involved. These limiting 
factors are investigated in more detail in Chapter 4.  
 















 (3.16), and 5-hydroxymethyl-2,2,5-trimethyl-1,3-dio-
xane
42
 (3.23), were prepared according to published procedures, although the latter is 
now commercially available. Dry THF (EMD), dry DMSO (EMD), and dry tert-butanol 
(Alfa Aesar) were used as received. All other reagents and solvents were acquired from 
standard commercial sources and used as received. 
 NMR: Spectra were recorded at 400 MHz (
1
H), 100 MHz (
13
C), and 376 MHz 
(
19




C) or CCl3F (
19
F) and 
are specified at ambient temperature unless noted otherwise. Carbon chemical shifts are 




(CD3OD). MS:  selected peaks, m/z. EI spectra were acquired at 70 eV. IR: NaCl 
windows (neat or film) or KBr pellet (solids). TLC: 0.25 mm Merck Silica Gel 60 F254 
visualized under 254 nm illumination or by staining with 5% phosphomolybdic acid in 
ethanol. Column chromatography: Flash chromatography on Sorbent Technologies 
standard grade silica gel (70-230 mesh). Reversed-phase HPLC was conducted with a 30 
x 1 cm R-18 column at ambient temperature using an elution gradient of 30%-37% 
MeCN/0.1% aqueous NH4HCO3 over 20 minutes. The eluted products were freed of 





 Pentaerythritol (24 g, 180 mmol), DMF (240 mL) and benzene (160 mL) were 
added to a 1 L three-necked flask equipped with a large stir bar, a thermometer, and a 
rubber septum. The middle neck was then connected to a Dean-Stark trap topped with a 
reflux condenser and calcium chloride drying tube.  The mixture was heated to reflux 
under stirring (liquid phase 115 °C), and cyclohexanone (12.4 mL, 120 mmol) was added 
in small portions over 3 hours. The mixture was left at reflux overnight, then allowed to 
cool and concentrated under reduced pressure. The gummy residue was stirred with 
water, then extracted with MTBE (4 x 100 mL). The combined extracts were dried and 
concentrated, and the residue was recrystallized from boiling toluene (220 mL). The 
product was collected by filtration, washed with hexanes, and dried by suction under 
warm air to give the product as a colorless, fluffy crystalline powder (14.9 g). After 
concentration of the mother liquor, a further 1.2 g of crystalline NMR-pure product was 





H NMR (CDCl3) δ 1.37-1.43 (m, 2H), 1.49-1.55 (m, 4H), 1.73-1.76 (m, 4H), 






 Diol 3.4 (1.00 g, 4.62 mmol) was dissolved in a mixture of triethylamine (2.0 mL, 
3.0 equiv.) and dichloromethane (50 mL) and the solution was cooled under nitrogen in a 
dry ice-acetone bath (-78°C). Methanesulfonyl chloride (379 µL, 1.06 equiv.) was added 
dropwise, and the mixture was stirred for 3 hours at -78°C, then allowed to warm slowly 
to room temperature and washed with a solution of KH2PO4 (1.9 g, 3 equiv.) in water (50 
mL) to remove excess triethylamine. The organic layer was collected and the aqueous 
layer was extracted with DCM (25 mL). The combined organic phases were dried with 
Na2SO4 and concentrated under reduced pressure. The residue was separated by column 
chromatography to give mesylate 3.5 (470 mg, 35%) and bis-mesylate 3.8 (488 mg, 
28%). Mesylate 3.5: 
1
H NMR (CDCl3) δ 1.38-1.44 (m, 2H), 1.47-1.57 (m, 4H), 1.68-1.71 
(m, 2H), 1.79-1.82 (m, 2H), 1.96 (br. t, J = 5.8 Hz, 2H), 3.07 (s, 3H), 3.59 (d, J = 5.8 Hz, 
2H), 3.71 (d, J = 12.3 Hz, 2H), 3.79 (d, J = 12.3 Hz, 2H), 4.41 (s, 2H). 
13
C NMR δ 22.2, 
22.3, 25.3, 30.3, 34.2, 36.7, 39.1, 60.98, 61.03, 68.9, 98.6. EI-MS m/z 294 (M
+
, 35), 265 
(22), 251 (100), 83 (35), 55 (50). EI-HRMS m/z calcd for C12H22O6S 294.1137, found 
294.1135. Bis-mesylate 3.8: 
1
H NMR δ 1.38-1.45 (m, 2H), 1.49-1.55 (m, 4 H) 1.73-1.76 
(m, 4H), 3.07 (s, 6H), 3.78 (s, 4H), 4.27 (s, 4H). 
 
Attempted synthesis of thioether-diol 3.6 (Scheme 3.4) 
 A mixture of mesylate 3.5 (328 mg, 1.11 mmol), sodium sulfide nonahydrate (290 
mg, 0.55 equiv.), tetrabutylammonium bisulfate (9.3 mg, 2.5 mole %), water (3 mL), and 
MTBE (10 mL) was stirred under nitrogen overnight. No reaction was apparent by TLC, 
so the mixture was heated at reflux for four hours. TLC (10:1 DCM-MTBE) then 
indicated a single major product at Rf 0.46 and traces of UV-active  products at Rf >0.9, 
as well as substantial unreacted starting material (Rf 0.17). The organic layer was 
collected, and the aqueous layer was extracted with MTBE. The combined organic phases 
were dried with sodium sulfate and concentrated under reduced pressure, and the residue 




amounted to less than 10 mg of material and were not characterized. The major product 
was obtained as a colorless solid and identified as the oxetane 7,11,14-
trioxadispiro[5.2.3.2]tetradecane (3.9). Yield 92.7 mg (468 µmol, 42% relative to 3.5, 
76% relative to Na2S • 9 H2O). 
1
H NMR (CDCl3) δ 1.38-1.43 (m, 2H), 1.50-1.54 (m, 
4H), 1.69-1.72 (m, 4 H), 4.03 (s, 4H), 4.46 (s, 4H). 
13
C NMR (CDCl3) δ 22.4, 25.5, 32.2, 
37.9, 65.4, 78.1, 97.9. EI-MS m/z 198 (M
+
, 55), 169 (25), 155 (100), 83 (58), 55 (70). EI-
HRMS m/z calcd for C11H18O3 198.1256, found 198.1262. 
 
Oxetane formation in the presence of a thiol-thiolate mixture (Scheme 3.5) 
 Mesylate 3.5 (225 mg, 0.679 mmol) and ethanethiol 170 µL, 3 equiv. were 
dissolved in ethanol (5 mL), and solid lithium hydroxide monohydrate (64 mg, 2 equiv.) 
was added to the stirred solution. The mixture was refluxed under argon for 3.5 hours 
then allowed to cool. An aliquot of the mixture was diluted into neutral phosphate buffer 
(0.5 M KH2PO4, 0.5 M Na2HPO4,1 mL), and the resulting suspension was extracted with 
CDCl3 (2 x 0.7 mL). TLC (10:1 DCM-MTBE) indicated complete consumption of the 
starting material and formation of two products in comparable abundance, one of which 
was identical to oxetane 3.9. The extract was dried with sodium sulfate, filtered through a 
cotton plug, and concentrated under a stream of argon in a warm water bath to give a 
colorless oil (16 mg), which was identified as a mixture containing 59 mol% 3-
ethylthiomethyl-3-hydroxymethyl-1,5-dioxaspiro[5.5]undecane (3.10) and 41 mol% 
oxetane 3.9 (calculated from the integrated 
1
H NMR spectrum). Thioether 3.10: 
1
H NMR 
(CDCl3) δ 1.27 (t, J = 7.4 Hz, 3H), 1.38-1.43 (m, 2H), 1.48-1.55 (m, 4H), 1.68-1.72 (m, 
2H), 1.78-1.81 (m, 2H), 1.92 (br. t, J = 5.6 Hz, 1H). 2.57 (q, J = 7.4 Hz, 2H), 2.65 (s, 
1H), 3.73 (d, J = 11.5 Hz, 2H), 3.73 (overlapping d, J ≈ 6 Hz, 2H), 3.77 (d, J = 11.5 Hz, 
2H). 
13
C NMR (CDCl3) δ 14.8, 22.5, 25.6, 28.0, 31.2, 33.8, 34.4, 38.7, 63.7, 63.8, 78.2, 
98.3. EI-MS m/z 260 (M
+
, 48), 217 (100), 75 (37), 55 (42). EI-HRMS m/z calcd for 





Reaction of bromide 3.11 with aqueous sodium sulfide (Scheme 3.6) 
 Pentaerythritol monobromide (3.11) (500.3 mg, 2.51 mmol) and sodium sulfide 
nonahydrate (302 mg, 0.50 equiv.) were stirred in H2O (12 mL) under nitrogen for 24 
hours. A 0.5 mL aliquot of the mixture was treated with 1 drop of 1% alcoholic 
phenolphthalein and titrated under a stream of nitrogen to a colorless endpoint with 1 M 
HCl. The resulting solution, which was neutral to pH paper, was concentrated under 
reduced pressure. The residue was dissolved in D2O, filtered , and analyzed by 
1
H NMR. 
The product distribution was calculated from the integrated 1H NMR spectrum on the 
basis of the following signals: Starting material 3.11: δ 3.49 (s, 2H), 3.60 (s, 6H). 
Oxetane 3.13: δ 3.82 (s, 4H), 4.55 (s, 4H). Alkene 3.14: δ 4.13 (br. s, 4H), 5.17 (br. s, 
2H). No other signals were observed except for water and a trace of phenolphthalein. The 
peak assignments of the starting material were confirmed by comparison to a spectrum of 
an authentic sample in D2O. To confirm the identities of the products , the NMR 
spectrum was also acquired in dry DMSO-d6 as follows: A second aliquot of the reaction 
mixture was neutralized by bubbling with CO2 and concentrated to dryness. The residue 
was stirred with acetone then filtered to remove salts, and the filtrate was concentrated 
nearly to dryness. The resulting colorless oil was stirred with 1 mL CDCl3, and DMSO-d6 
was added dropwise until the mixture became homogeneous. The solution was 
concentrated nearly to dryness under a stream of argon in a warm water bath, then diluted 
with DMSO-d6 and analyzed by 
1
H NMR. The identity of the commercially available 
alkene 3.14 was confirmed by comparison to the 
1
H NMR spectrum posted by Sigma-
Aldrich, and the peaks assigned to oxetane 3.13 are consistent with those previously 
reported.
43
 Starting material 3.11: δ 3.35 (d, J = 5.3 Hz, 6H), 3.47 (s, 2H), 4.47 (d, J = 5.3 
Hz, 3H). Oxetane 3.13: δ 3.54 (d, J = 5.4 Hz, 4H), 4.27 (s, 4H), 4.76 (t, J = 5.4 Hz, 2H). 






7,7-Dimethyl-6,8-dioxa-2-thiaspiro[3.5]nonane (3.15)  
 A mixture of 5,5-bis(bromomethyl)-2,2-dimethyl-1,3-dioxane
41
 (3.16) (38.67 g, 
128 mmol), sodium sulfide nonahydrate (46 g, 1.5 equiv.), sodium bicarbonate (16 g, 1.5 
equiv.), potassium iodide (21 g, 1 equiv.), methanol (400 mL) and water (100 mL) was 
stirred at reflux for 36 hours. The reaction mixture was then concentrated under reduced 
pressure, diluted with water (250 mL) and extracted with MTBE (3 x 150 mL). The 
extract was dried with MgSO4, concentrated under reduced pressure, and the residue was 
crystallized from MTBE-hexane to give the product as colorless crystals. Yield 17.65 g 




H NMR (CDCl3, 400 MHz)  1.39 (s, 
6H), 2.97 (s, 4H), 3.88 (s, 4H). 
13
C NMR (CDCl3, 100 MHz)  23.5, 30.8, 41.0, 68.3, 
97.7. IR (KBr pellet) 2998, 2933, 2864, 1370, 1269, 1197, 1116, 1064, 1029, 931, 825, 
731 661 cm
–1
. EI-MS m/z 174 (38, [M]
+
), 159 (100), 99 (68), 85 (63), 59 (48). EI-HRMS 
m/z calcd for [M]
+
 C8H14O2S 174.0715, found 174.0727. 
 
5-((Benzylthio)methyl)-5-(bromomethyl)-2,2-dimethyl-1,3-dioxane (3.17).  
 A mixture of thietane 3.15 (6.63 g, 38.0 mmol), benzyl bromide (6.64 g, 38.8 
mmol),  and potassium carbonate (100 mg, 0.02 equiv) in acetonitrile (13 mL) was stirred 
at 60°C in a sealed flask under argon for 2 days and then concentrated under reduced 
pressure. The residue was taken up in dichloromethane (100 mL), stirred with 2 g silica 
gel, and filtered through a 2 x 2 cm pad of silica gel. The silica gel was washed with 100 
mL of dichloromethane, and the combined filtrate and washing were concentrated under 
reduced pressure go give the product as a colorless oil. Yield 13.01 g (37.6 mmol, 99%). 
1
H NMR (CDCl3)  1.38 (s, 3H), 1.39 (s, 3H), 2.60 (s, 2H), 3.63 (s, 2H), 3.72 (s, 4H), 
3.75 (s, 2H), 7.22-7.36 (m, 5H). 
13
C NMR (CDCl3)  22.4, 24.7, 34.1, 37.1, 37.8, 37.9, 




1520, 1402, 1367, 1350, 1190, 1165, 1114, 1086, 1033, 843, 813, 739, 603, 521 cm
–1
. EI-
MS m/z 344 (10, [M]
+
), 329 (13), 286 (21), 189 (21), 91 (100). EI-HRMS m/z calcd for 
[M]
+
 C15H21BrO2S 344.0446, found 344.0435. 
 
Bis((5-((benzylthio)methyl)-2,2-dimethyl-1,3-dioxan-5-yl)methyl)sulfane (3.18).  
 To a stirred solution of bromide 3.17 (11.95 g, 34.6 mmol) and potassium iodide 
(5.74 g, 34.6 mmol) in DMF (50 mL) was added sodium sulfide nonahydrate (5.0 g, 0.6 
equiv.) in water (10 mL) followed by additional DMF (20 mL) and the mixture was 
stirred under nitrogen at 90°C for 20 hours. After cooling, the mixture was poured into 
water (300 mL) and extracted with MTBE (150 mL). The extract was washed 
sequentially with water (300 mL + 5 mL brine), 2.5% NaOH solution (2 x 200 mL), and 
brine (25 mL), dried with sodium sulfate, stirred with 3 g silica gel, filtered, and 
concentrated under reduced pressure to give the product as a pale yellow oil. Yield 9.02 g 
(16.0 mmol, 93%). 
1
H NMR (CDCl3)  1.38 (s, 6H), 1.40 (s, 6H), 2.62 (s, 4H), 2.72 (s, 
4H), 3.68 (d, J = 9.1 Hz, 4H), 3.70 (d, J = 9.1 Hz, 4H), 3.72 (s, 4H), 7.21-7.34 (m, 10H). 
13
C NMR (CDCl3)  23.7, 23.8, 34.5, 37.7, 37.9, 38.2, 66.1, 98.3, 127.0, 128.4, 128.9, 
138.2. IR (neat) 2990, 2938, 2863, 1494, 1452, 1383, 1371, 1251, 1194, 1153, 1115, 
1090, 1056, 1036, 836, 731, 701, 521 cm
–1
. EI-MS m/z 562 (2, [M]
+
), 561 (6), 471 (55) 
297 (22), 265 (36), 181 (34), 91 (100). EI-HRMS m/z calcd for [M-1]
+
 C30H41O4S3 
561.2167, found 561.2177. 
  
Bis((5-mercaptomethyl-2,2-dimethyl-1,3-dioxan-5-yl)methyl)sulfane (3.19)  
 A 1L 3-neck flask equipped with a stir bar, dry ice condenser, thermometer, and 
two gas inlets was charged with thioether 3.18 (8.92 g, 15.8 mmol) and THF (150 mL) 
under nitrogen and cooled in a dry ice/acetone bath. Anhydrous ammonia was then 




for ammonia was then removed and sodium metal (1.46 g, 4 equiv.) was added in small 
pieces against a gentle flow of nitrogen at a rate sufficient to maintain the temperature of 
the reaction mixture between -70 and -60°C. After addition was complete, the dark blue 
mixture was allowed to stir for 15 minutes and then quenched with ammonium chloride 
(8.5 g, 10 equiv). The open neck of the reaction flask was then sealed, the dry ice bath 
was removed, and the ammonia was carefully boiled off using a warm water bath. Note: 
the ammonia gas exiting the top of the condenser was collected with an ice-cooled 
mixture of 500 mL concentrated HCl and 2.5 L water to prevent release to the 
atmosphere. Sodium hydroxide solution (5% w/v, 130 mL, 10 equiv.) was then added, 
and the resulting mixture was diluted with water (200 mL), washed with MTBE (150 
mL), and neutralized with citric acid (12.2 g, 4 equiv.), causing the crude product to 
separate as a yellow oil. The mixture was extracted with MTBE (3 x 100 mL) and the 
combined extracts were dried with MgSO4, concentrated, and purified by column 
chromatography (hexane-MTBE) to give the product as a colorless oil. Yield 5.02 g (13.1 
mmol, 83%). 
1
H NMR (CDCl3)  1.31 (t,  J = 9.1 Hz, 2H), 1.40 (s, 6H), 1.42 (s, 6H), 
2.73 (d, J = 9.1 Hz, 4H), 2.74 (s, 4H), 3.70 (d, J = 11.7 Hz, 4H), 3.76 (d, J = 11.7 Hz, 
4H). 
13
C NMR (CDCl3)  23.2, 24.1, 27.2, 36.6, 37.7, 65.8, 65.9, 98.3. IR (neat) 2990, 
2938, 2863, 2556, 1451, 1419, 1371, 1254, 1195, 1153, 1119, 1065, 934, 832, 729, 521 
cm
–1
. EI-MS m/z 382 (60, [M]
+
), 309 (36), 207 (75), 149 (80), 117 (56), 99 (72), 87 (93), 
59 (100). EI-HRMS m/z calcd for [M]
+
 C16H30O4S3 382.1306, found 382.1299. 
 
4-(Bis(2-iodoethyl)amino)benzaldehyde (3.20) 
 To a solution of N-phenyldiethanolamine (17.36 g, 95.8 mmol) in DMF (33 mL) 
was added a cooled solution of phosphorus oxychloride (40 mL, 4.5 equiv.) in DMF (67 
mL, 9 equiv.) and the resulting mixture was stirred at 90°C for 4 hours. After cooling to 




solution of NaOH (70 g, 18 equiv.) in water (200 mL), and stirred for 1 hour at 0°C. The 
precipitated product was then collected by filtration and recrystallized from ethanol to 
give the intermediate 4-(bis(2-chloroethyl)amino)benzaldehyde as tan needles. Yield 




H NMR (CDCl3)  3.68 (t, J = 
6.9 Hz, 4H), 3.84 (t, J = 6.9 Hz, 4H), 6.75 (d, J = 9.0 Hz, 2H), 7.77 (d, J = 9.0 Hz, 2H), 
9.78 (s, 1H). 
13
C NMR (CDCl3)  40.0, 53.3, 111.3, 126.7, 132.3, 150.9, 190.1. IR (KBr 
pellet) 2964, 2746, 1668, 1592, 1560, 1521, 1405, 1361, 1285, 1167, 1140, 962, 819, 
750, 715, 605 cm
–1
. EI-MS m/z 245 (28, [M]
+
), 196 (100), 132 (34), 77 (27), 63 (35). EI-
HRMS m/z calcd for [M]
+
 C11H13Cl2NO 245.0374, found 245.0384. 
 A solution of 4-(bis(2-chloroethyl)amino)benzaldehyde (9.60 g, 39.0 mmol) and 
sodium iodide (17.5 g, 3 equiv.) in butanone (60 mL) was stirred at 65°C for 24 hours. 
The mixture was then allowed to cool, diluted with acetone (100 mL), stirred with 6 g 
activated carbon, filtered through Celite, and concentrated. The residue was taken up in 
dichloromethane (200 mL), filtered to remove salts, concentrated, and crystallized from 
methanol (300 mL) under stirring to give the product as a light green crystalline powder. 




H NMR (CDCl3) 
 3.25 (t, J = 8.0 Hz, 4H), 3.85 (t, J = 8.0 Hz, 4H), 6.70 (d, J = 8.9 Hz, 2H), 7.78 (d, J = 
8.9 Hz, 2H), 9.79 S, 1H). 
13
C NMR (CDCl3)  -0.1, 53.8, 111.1, 126.9, 132.4, 150.2, 
190.1. IR (KBr pellet) 2969, 2930, 1665, 1592, 1557, 1517, 1393, 1164, 816 622 cm
–1
. 
EI-MS m/z 429 (48, [M]
+
), 302 (42), 288 (100), 155 (52), 147 (42), 133 (44), 91 (32), 77 
(33). EI-HRMS m/z calcd for [M]
+
 C11H13I2NO 428.9087, found 428.9095. 
 
Macrocycle 3.21 
  Solutions of dithiol 3.19 (4.87 g, 12.7 mmol) and diiodide 3.20 (5.46 g, 12.7 
mmol) in DMF were added simultaneously by syringe pump to a stirred mixture of 




85°C over a period of 24 hours. The mixture was concentrated to dryness, and the residue 
was taken up in toluene (200 mL), filtered, and concentrated. The product was isolated by 
column chromatography (4:1 to 1:1; hexane/ethyl acetate) and recrystallized from 
methanol to give colorless crystals. Yield 5.12 g (9.21 mmol, 72%). Mp 197-199°C. 
1
H 
NMR (CDCl3)  1.41 (s, 6H), 1.43 (s, 6H), 2.78 (s, 4H), 2.84 (t, J = 6.9 Hz, 4H), 2.86 (s, 
4H), 3.69 (d, J = 11.8 Hz, 4H), 3.74 (d, J = 11.8 Hz, 4H), 3.79 (t, J = 6.9 Hz, 4H), 6.66 
(d, J = 8.9 Hz, 2H), 7.74 (d, J = 8.9 Hz, 2H), 9.75 (s, 1H). 
13
C NMR (CDCl3)  22.7, 
24.3, 29.9, 33.8, 35.9, 37.6, 52.4, 66.9, 98.5, 111.1, 125.6, 132.1, 151.2, 190.0. IR (KBr 
pellet) 2983, 2943, 1669, 1593, 1521, 1369, 1192, 1167, 1116, 846, 816 cm
–1
. EI-MS m/z 
555 (61, [M]
+
), 540 (46), 349 (33), 206 (60), 202 (92), 193 (53), 175 (58), 160 (100), 147 
(97), 133 (80), 117 (73), 99 (50), 85 (73). EI-HRMS m/z calcd for [M]
+
 C27H41NO5S3 
555.2147, found 555.2158. 
 
(2,2,5-Trimethyl-1,3-dioxan-5-yl)methyl 4-fluorobenzenesulfonate (3.24a) 
 A solution of 4-fluorobenzenesulfonyl chloride (4.84 g, 24.9 mmol) in acetonitrile 
(12 mL) was added to a stirred solution of 5-hydroxymethyl-2,2,5-trimethyl-1,3-
dioxane
42
 (3.23) (5.98 g, 37.3 mmol) in pyridine (20 mL, 10 equiv.). After stirring 
overnight, the mixture was quenched with water (10 mL), diluted with methanol (100 
mL), and slowly diluted with crushed ice under rapid stirring until the product began to 
crystallize. The mixture was then stirred for 3 hours at room temperature followed by 1 
hour at 0°C. The product was collected by filtration and washed with water to give a 
colorless crystalline powder. Yield 6.90 g (21.7 mmol, 87%). Mp 64-65°C. 
1
H NMR 
(CDCl3)  0.82 (s, 3H), 1.22 (s, 3H), 1.38 (s, 3H), 3.52 (dt, J = 12.1, 1.0 Hz, 2H), 3.59 
(dt, J = 12.1, 1.0 Hz, 2H), 4.13 (s, 2H), 7.21-7.27 (m, 2H), 7.93-7.98 (m, 2H). 
13
C NMR 
(CDCl3)  17.1, 18.9, 28.0, 33.9, 65.5, 72.9, 98.1, 116.5 (d, JCF = 22.8 Hz), 130.8 (d, JCF 
= 9.6 Hz), 131.7 (d, JCF = 3.3 Hz), 165.7 (d, JCF = 256.5 Hz). 
19




103.26 (tt, J = 8.2, 5.0 Hz, 1F). IR (KBr pellet) 3434 (br), 2971, 2996, 2878, 1601, 1591, 
1494, 1371, 1360, 1187, 1157, 967, 863, 845, 675, 552 cm
–1
. EI-MS m/z 318 (100, [M–
CH3]
+
), 230(12), 159 (50), 95 (47), 83 (35), 71 (38), 59 (49). EI-HRMS m/z calcd for 
[M–CH3]
+
 C13H16FO5S 303.0702, found 303.0712. 
 
(2,2,5-Trimethyl-1,3-dioxan-5-yl)methyl 3,4-difluorobenzenesulfonate (3.24b) 
 Synthesized as described for 3.24a using 3.70 g (17.4 mmol) of 3,4-difluoro-
benzenesulfonyl chloride to give the product as a colorless crystalline powder. Yield 5.04 
g (15.0 mmol, 86%). Mp 54-55°C. 
1
H NMR (CDCl3)  0.82 (s, 3H), 1.24 (s, 3H), 1.38 (s, 
3H), 3.51 (dt, J = 12.1, 1.1 Hz, 2H), 3.60 (dt, J = 12.2, 1.1 Hz, 2H), 4.17 (s, 2H), 7.37 
(ddd, J = 9.5, 8.7, 7.4 Hz, 1H), 7.73 (dddd, J = 8.6, 3.9, 2.2, 1.5 Hz, 1H), 7.78 (ddd, J = 
9.3, 7.1, 2.2 Hz, 1H). 
19
F NMR (CDCl3)  –128.02 (dddd, J = 20.8, 9.7, 7.1, 4.6 Hz, 1F), 
–133.52 (dt, J = 20.4, 7.6 Hz, 1F). IR (KBr pellet) 3092, 2996, 2961, 2876, 1613, 1512, 
1374, 1363, 1279, 1210, 1183, 1088, 1078, 969, 962, 917, 852, 840, 680, 618, 582 cm
–1
. 
EI-MS m/z 336 (100, [M–CH3]
+
), 248 12), 177 (37), 113 (36), 85 (26), 71 (30), 59 (52). 
EI-HRMS m/z calcd for [M–CH3]
+
 C13H15F2O5S 321.0608, found 321.0605. 
 
(2,2,5-Trimethyl-1,3-dioxan-5-yl)methyl 3,4,5-trifluorobenzenesulfonate (3.24c) 
 3,4,5-trifluorobenzenesulfonyl chloride (2.34 g, 10.1 mmol) was added to a 
solution of 5-hydroxymethyl-2,2,5-trimethyl-1,3-dioxane
42
 (3.23) (1.8 g, 1.1 equiv.) and 
triethylamine (2.1 mL, 1.5 equiv.) in dichloromethane (10 mL) and the mixture was 
stirred for 4 hours at room temperature. The mixture was then quenched with water and 
extracted with MTBE (50 mL). The extract was washed with 1 M monosodium 
phosphate (2 x 25 mL), dried with MgSO4, and concentrated under reduced pressure. The 
residue was recrystallized from MTBE-hexane to give the product as a colorless 
crystalline powder. Yield 2.11 g (59%, 5.95 mmol). Mp 87-90°C. 
1




0.83 (s, 3H), 1.25 (s, 3H), 1.38 (s, 3H), 3.48 (dt, J = 12.3, 1.2 Hz, 2H), 3.60 (dt, J = 12.3, 
12. Hz, 2H), 4.21 (s, 2H), 7.61 (t, J = 6.3 Hz, 2H). 
19
F NMR (CDCl3)  –129.57 (dd, J = 
19.9, 6.4 Hz, 2F), –150.49 (tt, J = 19.9, 6.2 Hz, 1F). IR (KBr pellet) 3082, 2940, 2993, 
2882, 1609, 1526, 1441, 1368, 1328, 1180, 1087, 1049, 959, 922, 852, 827, 619, 517 cm
–
1
. EI-MS m/z 339 (100, [M–CH3]
+
), 266(12), 195 (30), 131 (31), 85 (24), 71 28), 59 (65). 
EI-HRMS m/z calcd for [M]
+
 C13H14F3O5S 339.0514, found 339.0520. 
 
Arylhydrazine 3.25a  
 A solution of 3.24a (1.96 g, 6.16 mmol) and hydrazine hydrate (1.2 mL, 4 equiv.) 
in DMSO (5 mL) was stirred under argon for 3 hours at 50°C. An additional 1.2 mL 
hydrazine hydrate and 5 mL DMSO were then added, and the mixture was stirred for an 
additional 3 hours at 50°C. The reaction mixture was then diluted with water until 
slightly turbid, stirred at 0°C until crystals appeared, diluted slowly with 170 mL water 
plus 20 mL methanol, and stirred at 0°C for 1 hour. The product was collected by 
filtration and washed with cold water to give an off-white crystalline powder. Yield 1.78 
g (5.39 mmol, 87%). Mp 115-116°C. 
1
H NMR (CDCl3)  0.82 (s, 3H), 1.26 (s, 3H), 1.38 
(s, 3H), 3.56 (s, 4H), 3.69 (s, (br), 2H), 4.04 (s, 2H), 5.73 (s, (br), 1H), 6.87 (d, J = 8.9 
Hz, 2H), 7.72 (d, J = 8.9 Hz, 2H). 
13
C NMR (CDCl3)  17.3, 19.6, 27.4, 33.9, 65.7, 72.1, 
98.0, 110.9, 123.4, 130.0, 155.0. IR (KBr pellet) 3330, 2993, 2960, 1632, 1594, 1382, 
1375, 1349, 1207, 1186, 1164, 1095, 1082, 975, 824, 810, 692, 568 cm
–1
. EI-MS m/z 330 
(29, [M]
+
), 315 (37), 188 (100), 171 (48), 107 (39), 106 (41). EI-HRMS m/z calcd for 
[M]
+
 C14H22N2O5S 330.1249, 330.1266. 
 
Arylhydrazine 3.25b 
 To a stirred solution of 3.24b (2.22 g, 6.60 mmol) in DMSO (10 mL) was added 




a cool water bath, then stirred overnight. The mixture was diluted 1:1 with an equal 
volume of water, stirred at 0°C, poured into 100 mL of ice water to induce crystallization, 
diluted with 60 mL methanol to redissolve amorphous material, and then slowly diluted 
with ice water to 220 mL under continuous stirring. The product was collected by 
filtration and washed with water to give an off-white crystalline powder. Yield 2.18 g 
(6.26 mmol, 95%). Mp 132-133°C. 
1
H NMR (CDCl3)  0.82 (s, 3H), 1.26 (s, 3H), 1.38 
(s, 3H), 3.55 (dt, J = 12.1, 1.1 Hz, 2H), 3.57 (dt, J = 12.1, 1.1 Hz, 2H), 3.69 (d (br), J = 
2.1 Hz, 2H), 4.07 (s, 2H), 5.88 (s (br), 1H), 7.27 (t, J = 8.3 Hz, 1H), 7.48 (dd, J = 11.1, 
2.0 Hz, 1H), 7.63 (ddt, J = 8.6, 2.0, 0.8 Hz, 1H). 
13
C NMR (CDCl3)  17.2, 19.3, 27.6, 
33.8, 65.6, 72.4, 98.0, 111.6 (d, JCF = 3.8 Hz), 114.4 (d, JCF = 21.1 Hz), 122.3 (d, JCF = 
6.7 Hz), 125.9 (d, JCF = 3.0 Hz), 143.8 (d, JCF = 9.6 Hz), 148.6 (d, JCF = 243.5 Hz). 
19
F 
NMR (CDCl3)  –135.37 (dddd, J = 11.1, 8.1, 3.1, 0.6 Hz, 1F). IR (KBr pellet) 3343, 
2988, 2883, 1635, 1605, 1522, 1375, 1363, 1349, 1202, 1163, 1087, 1000, 974, 912, 839, 
806, 677, 574 cm
–1
. EI-MS m/z 348 (32, [M]
+
), 333 (42), 290 (25), 260 (30), 206 (100), 
189 (40), 125 (40), 108 (33), 85 (34). EI-HRMS m/z calcd for [M]
+
 C14H21FN2O5S 
348.1155, found 348.1158. 
 
Arylhydrazine 3.25c 
 To a stirred solution of 3.24c (1.31 g, 3.70 mmol) in acetonitrile (5 mL) was 
added potassium carbonate (770 mg, 1.5 equiv.), followed by hydrazine hydrate (270 µL, 
1.5 equiv.) and the resulting biphasic mixture was stirred at room temperature overnight. 
The mixture was then poured into water (100 mL) and extracted with dichloromethane (3 
x 25 mL). The combined extracts were dried with Na2SO4 and concentrated under 
reduced pressure. The residue was crystallized from dichloromethane-EtOAc-hexane to 
give the product as a colorless crystalline powder. Yield 1.02 g (2.78 mmol, 75%). Mp 
112-115°C. 
1




12.1, 1.0 Hz, 2H), 3.59 (dt, J = 12.1, 1.0 Hz, 2H), 4.05 (d (br), J = 3.8 Hz, 2H), 4.14 (s, 
2H), 5.53 (s (br), 1H), 7.37-7.47 (m, 2H). 
19
F NMR (CDCl3)  –127.49 - –127.38 (m, 2F). 
IR (KBr pellet) 3369, 3303, 2992, 2874, 1613, 1512, 1437, 1365, 1302, 1207, 1178, 
1089, 1084, 1032, 970, 920, 837, 801, 606, 520 cm
–1
. EI-MS m/z 366 (27, [M]
+
), 308 
(28), 278 (30), 224 (100), 207 (23), 159 (26), 143 (50), 85 (38), 59 (38). EI-HRMS m/z 
calcd for [M]
+
 C14H20F2N2O5S 366.1061, found 366.1075. 
 
Chalcone 3.26 
  A solution of aldehyde 3.21 (2.04 g, 3.67 mmol), 4-cyanoacetophenone (543 mg, 
3.74 mmol) and pyrrolidine (0.6 mL, 2 equiv.) in 1:1 benzene-ethanol (15 mL) was 
stirred at 50°C for 2 days. The reaction mixture was then diluted with ethanol (15 mL), 
concentrated to 15 mL total volume, diluted with an additional ethanol (15 mL), and 
stirred at 0°C for 4 hours. The product was collected by filtration as a bright orange 
crystalline powder. Yield 2.30 g (92%). Mp 197-201°C. 
1
H NMR (CDCl3)  1.41 (s, 6H), 
1.43 (s, 6H), 2.78 (s, 4H), 2.84 (t, J = 6.9 Hz, 4H), 2.83 (s, 4H), 3.70 (d, J = 11.8 Hz, 4H), 
3.74 (d, J = 11.8 Hz, 4H), 3.76 (t, J = 7.9 Hz, 4H), 6.64 (d, J = 8.9 Hz, 2H), 7.25 (d, J = 
15.4 Hz, 1H), 7.54 (d, J = 8.9 Hz, 2H), 7.782 (d, J = 8.6 Hz, 2H), 7.784 (d, J = 15.4 Hz, 
1H), 8.05 (d, J = 8.5 Hz, 2H). 
13
C NMR (CDCl3)  22.7, 24.3, 30.0, 33.7, 35.9, 37.6, 
52.3, 66.8, 98.4, 111.7, 115.1, 116.0, 118.1, 122.5, 128.5, 131.0, 132.2, 142.2, 146.9, 
149.0, 188.7. IR (KBr pellet) 2988, 2939, 2229, 1650, 1571, 1517, 1343, 1213, 1173, 
1033, 810 cm
–1
. EI-MS m/z 682 (75, [M]
+
),320 (38), 287 (70), 274 (100), 261 (49), 117 
(47), 83 (47). EI-HRMS m/z calcd for [M]
+
 C36H46N2O5S3 682.2569, found 682.2592. 
 
Triarylpyrazoline 3.27a 
 A mixture of chalcone 3.26 (540 mg, 0.791 mmol), arylhydrazine 3.25a (392 mg, 




stirred in a sealed flask under argon at 90°C for 6 hours. After cooling to room 
temperature, the reaction mixture was diluted with 10 mL dichloromethane followed by 
10 mL xylenes and concentrated under reduced pressure. The residue was taken up in 
acetone (20 mL). 2,2-dimethoxypropane (2 mL) was added followed by p-toluenesulfonic 
acid monohydrate (600 mg, 4 equiv.), and the mixture was stirred for 30 minutes at room 
temperature. It was then made basic with 20% aqueous ammonia (1 mL), poured into 
water (140 mL) + brine (5 mL), and extracted with MTBE (3 x 25 mL). The combined 
extracts were dried with MgSO4, concentrated under reduced pressure, and subjected to 
sequential column chromatography with hexane-ethyl acetate (2:1) followed by benzene-
MTBE (7:1) to give the product as a yellow glassy solid. Yield 462 mg (0.464 mmol, 
59%). 
1
H NMR (CDCl3)  0.81 (s, 3H), 1.22 (s, 3H), 1.37 (s, 3H), 1.39 (s, 6H), 1.42 (s, 
6H), 2.76 (s, 4H), 2.77 (t, J = 7.5 Hz, 4H), 2.82 (s, 4H), 3.18 (dd, J = 17.4, 5.7 Hz, 1H), 
3.55 (s, 4H), 3.64 (t, J = 7.2 Hz, 4H), 3.68 (d, J = 11.8 Hz, 4H), 3.73 (d, J = 11.8 Hz, 4H), 
3.84 (dd, J = 17.2, 12.2 Hz, 1H), 4.03 (s, 2H), 5.35 (dd, J = 12.2, 5.7 Hz, 1H), 6.55 (d, J = 
8.9 Hz, 2H), 7.06 (d, J = 8.9 Hz, 2H), 7.16 (d, J = 9.0 Hz, 2H), 7.67 (d, J = 8.7 Hz, 2H), 
7.69 (d, J = 9.0 Hz, 2H), 7.81 (d, J = 8.7 Hz, 2H). 
13
C NMR (CDCl3)  17.3, 19.6, 22.9, 
24.3, 27.5, 30.1, 33.7, 33.9, 36.1, 37.8, 43.1, 52.4, 63.5, 65.6, 65.7, 67.0, 72.1, 98.0, 98.5, 
112.0, 112.3, 113.0, 118.6, 124.4, 126.3, 126.8, 127.8, 129.5, 132.3, 136.3, 146.5, 147.4, 
147.6. IR (KBr pellet) 2990, 2937, 2866, 2225, 1611, 1594, 1519, 1500, 1372, 1354, 





  A mixture of chalcone 3.26 (610 mg, 0.893 mmol), arylhydrazine 3.25b (342 mg, 
0.982 mmol, 1.1 equiv.), pyridinium p-toluenesulfonate (220 mg, 1 equiv.) and pyridine 
(1.8 mL) was stirred under argon at 80°C for 16 hours. A further 156 mg (0.448 mmol, 




and then at 100°C for 4 hours. The mixture was worked up analogously to 3.27a to give 
the product as a yellow glassy solid. Yield 327 mg (0.323 mmol, 36%). 
1
H NMR (CDCl3) 
 0.78 (s, 3H), 1.24 (s, 3H), 1.38 (s, 3H), 1.39 (s, 6H), 1.42 (s, 6H), 2.74 (t, J = 7.3 Hz, 
4H), 2.75 (s, 4H), 2.79 (s, 4H), 3.26 (dd, J = 17.2, 3.7 Hz, 1H), 3.53-3.61 (m, 8H), 3.67 
(d, J = 11.8 Hz, 4H), 3.72 (d, J = 11.8 Hz, 4H), 3.78 (dd, J = 17.2, 11.8 Hz, 1H), 4.08 (s, 
2H), 5.74 (dt, J = 11.7, 3.7 Hz, 1H), 6.44 (d, J = 8.9 Hz, 2H), 6.97 (d, J = 8.7 Hz, 2H), 
7.42 (dd, J = 12.2, 2.0 Hz, 1H), 7.57 (dd, J = 8.7, 2.0 Hz, 1H), 7.69 (d, J = 8.6 Hz, 2H), 
7.79 (t, J = 8.1 Hz, 1H), 7.84 (d, J = 8.6 Hz, 2H). 
13
C NMR (CDCl3)  17.1, 19.3, 22.9, 
24.3, 27.7, 30.1, 33.5, 33.9, 36.0, 37.7, 42.7, 52.3, 65.50, 65.55, 65.59, 66.9, 72.6, 98.0, 
98.5, 111.8, 112.2, 116.7 (d, JCF = 16.7 Hz), 118.6, 118.8 (d, JCF = 3.8 Hz), 125.0 (d, JCF 
= 2.5 Hz), 126.0 (d, JCF = 6.6 Hz), 126.4, 126.8, 128.3, 132.4, 136.2, 137.0 (d, JCF = 8.6 
Hz), 146.4, 148.8 (d, JCF = 248.8 Hz), 148.5. 
19
F NMR (CDCl3)  –122.99 (ddd, J = 11.9, 
7.9, 3.8 Hz, 1F). IR (KBr pellet) 2990, 2938, 2866, 2226, 1602, 1519, 1372, 1254, 1174, 





  A mixture of chalcone 3.26 (359 mg, 0.526 mmol), arylhydrazine 3.25c (269 mg, 
0.734 mmol, 1.4 equiv.), pyridinium p-toluenesulfonate (203 mg, 1.5 equiv.) and pyridine 
(1.3 mL) was stirred under argon at 90°C for 16 hours. A further 95 mg (0.26 mmol, 0.5 
equiv.) of 3.25c were added, and the mixture was stirred for 100°C for 8 hours. The 
reaction mixture was worked up analogously to 3.27a to give the product as a pale yellow 
glassy solid. Yield 51 mg (0.049 mmol, 9%). 
1
H NMR (CDCl3)  0.78 (s, 3H), 1.27 (s, 
3H), 1.387 (s, 3H), 1.391 (s, 6H), 1.42 (s, 6H), 2.73-2.75 (m, 8H), 2.80 (s, 4H), 3.25 (dd, 
J = 17.1, 6.3 Hz, 1H), 3.50-3.62 (m, 8H), 3.66-3.76 (m, 9H), 4.13 (2H), 5.63 (dd, J = 




2H), 7.67 (d, J = 8.2 Hz, 2H), 7.78 (d, J = 8.7 Hz, 2H). 
19
F NMR (CDCl3)  –115.24 (d, J 
= 7.4 Hz, 2F).  
 
Probe 3.3a (CTAP-2) 
  Intermediate 3.27a (332 mg, 0.333 mmol) was dissolved in a mixture of 90% 
TFA and 10% H2O (w/w, 10 mL) and stirred for 12 minutes at room temperature after 
complete dissolution. The reaction mixture was then diluted with H2O (5 mL), stirred for 
an additional 12 minutes, poured into H2O (75 mL), rinsed in completely with methanol 
(10 mL), cooled by adding crushed ice, and made basic with 20% aqueous ammonia (14 
mL). The resulting suspension was stirred for 30 minutes at 0°C and the intermediate was 
then collected by filtration, washed with water, and dried under vacuum to give a yellow 
powder (281 mg). This product was then dissolved in dry DMSO (0.5 mL) under argon, 
and the resulting viscous solution was diluted with dry THF (3 mL) followed by dry tert-
butanol (3 mL) under rapid stirring. Potassium tert-butoxide (3.8 mL of a freshly 
prepared 1M solution in THF, 12 equiv.) was  added dropwise. The mixture was stirred 
for 20 minutes at room temperature, then quenched with acetic acid (275 µL) and diluted 
with dichloromethane (10 mL). The resulting yellow fluorescent precipitate was filtered 
off, dried under argon flow, and dissolved in water (10 mL). The solution was acidified 
with 1 M HCl (5 mL), and the resulting yellow precipitate was collected and crystallized 
from methanol to give the zwitterionic acid form of the product as a yellow crystalline 
powder. Yield 156 mg (0.202 mmol, 61%) mp > 200°C (decomposes). An analytical 
sample of the ammonium salt was obtained by dissolving the acid form in dilute aqueous 
ammonia and subjecting the resulting solution to reversed phase HPLC to give the 
product as a yellow glassy solid after evaporation. HPLC tr = 15.2 min (gradient 0-20 min 
30%-37% MeCN/0.1% aqueous NH4HCO3). 
1
H NMR (CD3OD)  2.58 (s, 4H), 2.59 (s, 




Hz, 4H), 3.76 (dd, J = 17.5, 12.3 Hz, 1H), 5.36 (dd, J = 12.3, 6.0 Hz, 1H), 6.48 (d, J = 8.9 
Hz, 2H), 6.98 (d, J = 8.8 Hz, 2H), 7.10 (d, J = 8.9 Hz, 2H), 7.60 (d, J = 8.9 Hz, 2H), 7.71 
(d, J = 8.7 Hz, 2H), 7.84 (d, J = 8.7 Hz, 2H). 
13
C NMR (CD3OD, c = 56 mM)  31.2, 
33.5, 35.5, 43.7, 45.9, 53.3, 64.5, 65.1, 112.2, 113.3, 114.0, 119.9, 127.4, 128.0, 128.2, 
130.0, 133.5, 136.6, 138.5, 146.6, 147.7 (Note: the last resonance corresponds to 
isochronous shift of two carbon atoms, at a concentration of 22 mM an additional 
resonance appears at 147.8 ppm). IR (KBr pellet) 2912, 2224, 1595, 1518, 1498, 1394, 
1180, 1121, 1027, 823, 742, 635, 558 cm
–1
. ESI-HRMS m/z calcd for [M]
–
 C36H43N4O7S4 
771.2015, found 771.2019. 
 
Probes 3.3b and 3.3c 
 The ammonium salts were prepared analogously to 3.3a except that the mixed 
precipitate obtained after quenching with acetic acid was dissolved water and directly 
purified by rp-HPLC without isolation of the acid forms. No attempt was made to 
quantitatively isolate the products from the reaction mixtures, so the isolated yields 
shown do not represent the true chemical yields. 
 Probe 3.3b: Yellow glassy solid. Isolated yield 10 mg (0.0126 mmol, 50%). 
HPLC tr = 17.3 min (gradient 0-20 min 30%-37% MeCN/0.1% aqueous NH4HCO3). 
1
H 
NMR (CD3OD)  2.57 (s, 4H), 2.58 (s, 4H), 2.67 (t, J = 6.9 Hz, 4H), 3.23 (dd, J = 17.3, 
4.1 Hz, 1H), 3.48 (s, 8H), 3.58 (t, J = 7.0 Hz, 4H), 3.77 (dd, J = 17.3, 11.8 Hz, 1H), 5.66 
(dt, 11.8, 3.8 Hz, 1H), 6.40 (d, J = 8.9 Hz, 2H), 6.94 (d, J = 8.7 Hz, 2H), 7.33 (dd, J = 
12.6, 1.9 Hz, 1H), 7.49 (dd, J = 8.5, 1.9 Hz, 1H), 7.65 (t, J = 16.6 Hz, 1H), 7.74 (d, J = 
8.7 Hz, 2H), 7.91 (d, J = 8.7 Hz, 2H). 
19
F NMR (CD3OD)  –122.8 (m, 1F). IR (KBr 
pellet) 2912, 2225, 1605, 1518, 1417, 1185, 1096, 1034, 816, 701, 610, 558 cm
–1
. ESI-
HRMS m/z calcd for [M]
–




 Probe 3.3c: Pale yellow glassy solid. Isolated yield 17 mg (0.021 mmol, 42%). 
HPLC tr = 18.4 min (gradient 0-20 min 30%-37% MeCN/0.1% aqueous NH4HCO3). 
1
H 
NMR (CD3OD)  2.59 (s, 4H), 2.60 (s, 4H), 2.71 (t, J = 6.9 Hz, 4H), 3.27 (dd, J = 17.2, 
7.7 Hz, 1H), 3.50 (s, 8H), 3.62 (t, J = 7.2 Hz, 4H), 3.74 (dd, J = 17.2, 11.9 Hz, 1H), 5.47 
(dd, J = 11.9, 7.7 Hz, 1H), 6.48 (d, J = 8.9 Hz, 2H), 7.08 (d, J = 8.7 Hz, 2H), 7.27 (d, J = 
8.6 Hz, 2H), 7.73 (d, J = 8.7 Hz, 2H), 7.86 (d, J = 8.7 Hz, 2H). 
19
F NMR (CD3OD)  –
116.7 (d, J = 8.4 Hz, 2F). IR (KBr pellet) 2915, 2226, 1608, 1520, 1422, 1425, 1185, 
1093, 1044, 840, 815, 643, 557 cm
–1
. ESI-HRMS m/z calcd for [M]
–
 C36H41F2N4O7S4 
807.1826, found 807.1828. 
 
(3-Nitrophenyl)methanethiol (3.30) 
 3-Nitrobenzyl chloride (18.0 g, 10.5 mmol) and potassium ethyl xanthate (20.2 g, 
1.2 equiv.) were stirred together in DMSO (200 mL) for 30 minutes. The mixture was 
diluted with water (500 mL) and extracted with MTBE (300 mL). The extract was 
washed with water (2 x 300 mL) followed by brine (30 mL), dried with MgSO4, and 
concentrated under reduced pressure to give the intermediate S-3-nitrobenzyl-O-
ethylxanthate as a yellow oil. Yield 26.7 g (10.4 mmol, 99%). 
1
H NMR (CDCl3)  1.43 
(t, J = 7.1 Hz, 3H), 4.44 (s, 2H), 4.66 (q, J = 7.1 Hz, 2H), 7.50 (t, J = 8.0 Hz, 1H), 7.70 
(d, J = 7.7 Hz, 1H), 8.12 (ddd, J = 8.2, 2.3, 1.0 Hz, 1H), 8.23 (t, J = 1.8 Hz, 1H). 
13
C 
NMR (CDCl3)  13.7, 39.2, 70.5, 122.5, 123.9, 129.4, 135.1, 138.6, 148.2, 212.6. IR 
(neat) 2982, 1529, 1224, 1111, 1047, 811, 722, 680 cm
–1
. EI-MS m/z 257 (76, [M]
+
), 169 
(51), 152 (85), 136 (100), 121 (65), 90 (78), 77 (47), 63 (40). EI-HRMS m/z calcd for 
[M]
+
 C10H11NO3S2 257.0180, found 257.0177. 
  A solution of the above xanthate ester (11.55 g, 44.9 mmol) in DMSO (20 mL) 
was added to a cooled solution of ethylenediamine (4.8 mL, 1.6 equiv.) and concentrated 




minutes, then diluted with 1 M HCl (100 mL) followed by water (300 mL), and extracted 
with MTBE (200 mL). The organic layer was extracted with 5% aqueous NaOH (3 x 50 
mL) and the combined aqueous extracts were immediately acidified with 30 mL of 37% 
HCl. The resulting emulsion was extracted with dichloromethane (2 x 30 mL) and the 
combined organic phases were dried with MgSO4, stirred with 2 g silica gel, filtered, and 
concentrated under reduced pressure to give the product as a pale yellow oil. Yield 6.71 g 
(39.7 mmol, 88%). 
1
H NMR (CDCl3)  1.87 (t, J = 7.9 Hz, 1H), 3.84 (d, J = 7.9 Hz, 2H), 
7.51 (t, J = 7.9 Hz, 1H), 7.66-7.69 (m, 1H), 8.11 (ddd, J = 8.2, 2.2, 1.0 Hz, 1H), 8.21 (tt, J 
= 1.8, 0.4 Hz, 1H). 
13
C NMR (CDCl3)  28.3, 122.1, 123.0, 129.6, 134.2, 143.1, 148.4. IR 
(neat) 3069, 2031, 1525, 1351, 810, 739, 701, 680, 667 cm
–1
. EI-MS m/z 169 (56, [M]
+
), 
136 (100, 121 (22), 90 (52), 78 (20), 63 (23). EI-HRMS m/z calcd for [M]
+
 C7H7NO2S 
169.0197, found 169.0203. 
 
(3-Nitrophenyl)methanesulfonyl chloride (3.29) 
 A round bottom flask containing a magnetic stir bar was charged with thiol 3.30 
(6.18 g, 36.5 mmol), dichloromethane (75 mL), and concentrated HCl (60 mL, 20 
equiv.), then fitted with a reflux condenser topped with a pressure-equalizing addition 
funnel containing 30% aqueous hydrogen peroxide (22 mL, 6 equiv.). The first 5 mL of 
H2O2 solution were added, and the mixture was stirred rapidly without external heat until 
reflux commenced. The remaining H2O2 was then added in 2 mL portions at a rate 
sufficient to maintain gentle reflux. After the mixture had cooled, the green organic layer 
was separated, carefully decolorized with aqueous Na2SO3 (exothermic), dried with 
MgSO4, and concentrated under reduced pressure. The residue was recrystallized from 
benzene-cyclohexane to give the product as colorless crystals. Yield 6.60 g (28.0 mmol, 




H NMR (CDCl3)  4.96 (s, 2H), 7.69 (td, J = 






C NMR (CDCl3)  69.3, 125.1, 126.2, 128.2, 130.4, 137.2, 148.5. IR (film 
from CDCl3) 3082, 2992, 2930, 1523, 1359, 1265, 1180, 1167, 1141, 907, 877, 816, 810, 
754, 684, 672, 535, 509 cm
–1
. EI-MS m/z 237 (1), 235 (2, [M]
+
), 136 (100), 90 (48), 64 
(23). EI-HRMS m/z calcd for [M]
+
 C7H6ClNO4S 234.9706, found 234.9707. 
 
(2,2,5-trimethyl-1,3-dioxan-5-yl)methyl (3-nitrophenyl)methanesulfonate (3.31) 
  A solution of sulfonyl chloride 3.29 (5.00 g, 21.2 mmol) in acetonitrile (20 mL) 
was added to a solution of 5-hydroxymethyl-2,2,5-trimethyl-1,3-dioxane
42
 (3.23) (4.07 g, 
25.4 mmol) in pyridine (10.4 mL, 10 equiv.) The resulting mixture was stirred overnight, 
then diluted with water (300 mL) and extracted with toluene (3 x 100 mL). The combined 
extracts were washed with water (100 mL), dried with MgSO4, and concentrated under 
reduced pressure. The residue was recrystallized from benzene-cyclohexane to give the 
product as small colorless needles. Yield 7.00 g (19.5 mmol, 92%). Mp 102-103°C. 
1
H 
NMR (CDCl3, 400 MHz)  1.32 (s, 3H), 1.39 (s, 3H), 1.43 (s, 3H), 3.54 (d, J = 10.0 Hz, 
2H), 3.64 (d, J = 10.0 Hz, 2H), 4.32 (s, 2H), 4.49 (s, 2H), 7.62 (t, J = 7.9 Hz, 1H), 7.81 
(dtd, J = 7.7, 1.0, 0.4 Hz, 1H), 8.27 (ddd, J = 8.2, 2.2, 1.0 Hz, 1H), 8.32 (t, J = 1.8 Hz, 
1H). 
13
C NMR (CDCl3, 100 MHz)  17.0, 18.8, 28.3, 34.1, 55.2, 65.5, 73.4, 98.3, 124.0, 
125.6, 129.9, 130.0, 136.6, 148.4. IR (KBr) 3447 (br), 2995, 2960, 2879, 1532, 1352, 
1207, 1175, 1180, 1088, 962, 909, 813, 731, 691, 559 cm
–1
. EI-MS m/z 359 (1, [M]
+
), 
344 (100), 329 (12), 187 (20), 136 (97), 120 (15), 106 (68), 90 (51), 59 (62). EI-HRMS 
m/z calcd for [M]
+
 C15H21NO7S 359.1039, found 359.1021. 
 
(2,2,5-trimethyl-1,3-dioxan-5-yl)methyl (3-aminophenyl)methanesulfonate (3.28) 
 To a solution of 3.31 (6.67 g, 18.6 mmol), ammonium acetate (25.4 g, 18 equiv.), 
and acetic acid (2.2 mL, 2 equiv.) in methanol (220 mL) was added  zinc dust (7.3 g, 6 




The mixture was then filtered, concentrated under reduced pressure, diluted with water 
(80 mL) and extracted with dichloromethane (2 x 80 mL). The combined extracts were 
washed with 0.2 M tetrasodium EDTA solution (100 mL), dried with MgSO4, and 
concentrated under reduced pressure. The residue was crystallized from MTBE-hexane to 
give the product as a colorless crystalline powder. Yield 5.16 g (15.7 mmol, 84%). Mp 
72-73°C.
1
H NMR (CDCl3, 400 MHz)  0.82 (s, 3H), 1.41 (s, 3H), 1.43 (s, 3H), 3.57 (d, J 
= 11.5 Hz, 2H), 3.61 (d, J = 11.5 Hz, 2H), 3.76 (s (br), 2H), 4.22 (s, 2H), 4.28 (s, 2H), 
6.66-6.68 (m, 1H), 6.76-6.78 (m, 2H), 7.15 (t, J = 8.0 Hz, 1H). 
13
C NMR (CDCl3, 100 
MHz)  17.2, 19.3, 27.9, 34.0, 56.1, 65.6, 73.1, 98.2, 115.6, 116.9, 120.6, 128.6, 129.8, 
147.0. IR (KBr) 3462, 3435, 3360, 2988, 2872, 1624, 1465, 1351, 1266, 1184, 1145, 
1084, 1032, 1001, 968, 823, 795, 701, 636 517 cm
–1
. EI-MS m/z 329 (31, [M]
+
), 314 
(17), 187 (37), 106 (100), 77 (17), 59 (19). EI-HRMS m/z calcd for [M]
+
 C15H23NO5S 
329.1297, found 329.1299. 
 
Triarylpyrazoline 3.32 
 Amine  3.28 (808 mg, 2.43 mmol) was stirred in dichloromethane (6 mL), and 
isoamyl nitrite (330 µL, 1 equiv.) was added dropwise. After 1 hour, the reaction mixture 
was concentrated under reduced pressure, redissolved in toluene, and concentrated again. 
The resulting material was taken up in methanol (12 mL) and ammonium acetate (3.7 g, 
20 equiv.), acetic acid (280 µL, 2 equiv.) and zinc dust (1.6 g, 10 equiv.) were added 
sequentially with rapid stirring. After 15 minutes, the reaction mixture was diluted with 
methanol, filtered, concentrated under reduced pressure, diluted with water, and extracted 
with dichloromethane (3 x 20 mL). The combined extracts were washed with tetrasodium 
EDTA solution, dried with Na2SO4, and concentrated under reduced pressure. The 
residue was fractioned by column chromatography (dichloromethane-MTBE) to give the 




  A mixture of the above crude arylhydrazine (145 mg, approx. 0.4 mmol), 
chalcone 3.26 (143 mg, 0.209 mmol), and pyridinium p-toluenesulfonate (104 mg, 2 
equiv.) in pyridine (0.7 mL) was stirred for 16 hours at 60°C and then worked up 
analogously to 3.27a to give the product as a yellow, highly fluorescent glassy solid. 
Yield 110 mg (0.109 mmol, 52%). 
1
H NMR (CDCl3, 400 MHz)  0.81 (s, 3H), 1.45 (s, 
3H), 1.39 (s, 6H), 1.41 (s, 3H), 1.42 (s, 6H), 2.76 (s, 4H), 2.77 (t, J = 6.9 Hz, 4H), 2.82 (s, 
4H), 3.10 (dd, J = 17.1, 6.4 Hz, 1H), 3.56 (d, J = 10.0 Hz, 2H), 3.59 (d, J = 10.0 Hz, 2H), 
3.63 (t, J = 7.3 Hz, 4H), 3.68 (d, J = 11.9 Hz, 4H), 3.73 (d, J = 11.9 Hz, 4H), 3.76 (dd, J 
= 12.4, 17.1 Hz, 1H), 4.17 (d, J = 9.6 Hz, 1H), 4.20 (d, J = 9.6 Hz, 1H), 4.29 (d, J = 14.0 
Hz, 1H), 4.33 (d, J = 14.0 Hz, 1H), 5.30 (dd, J = 12.4, 6.3 Hz, 1H), 6.54 (d, J = 8.9 Hz, 
2H), 6.86 (d, J = 8.0 Hz, 1H), 6.96 (dd, J = 8.3, 1.6 Hz, 1H), 7.09 (d, J = 8.9 Hz, 2H), 
7.17 (t, J = 8.0 Hz, 1H), 7.31 (t, J = 1.8 Hz, 1H), 7.63 (d, J = 8.7 Hz, 2H), 7.76 (d, J = 8.7 
Hz, 2H). 
13
C NMR (CDCl3, 100 MHz)  17.2, 19.6, 22.9, 24.3, 27.6, 30.2, 33.7, 34.0, 
36.1, 37.8, 42.9, 52.4, 56.7, 63.9, 65.59, 65.63, 67.0, 73.1, 98.1, 98.5, 111.1, 112.3, 113.9, 
115.9, 118.9, 121.7, 125.9, 127.0, 128.4, 128.9, 129.4, 132.2, 137.0, 144.1, 144.9, 146.2. 
IR (KBr pellet) 2990, 2938, 2866, 2224, 1602, 1571, 1519, 1451, 1372, 1256, 1190, 





 This compound was prepared from intermediate 3.32 (25.2 mg, 28 µmol) using 
same method as for 3.3b-c. Yellow-orange glassy solid. Isolated yield 13.5 mg (0.017 
mmol, 47%). HPLC tr  = 16.0 min (gradient 0-20 min 30%-37% MeCN/0.1% aqueous 
NH4HCO3). 
1
H NMR (CD3OD, 400 MHz)  2.59 (s, 4H), 2.60 (s, 4H), 2.72 (t, J = 7.0 
Hz, 4H), 3.03 (dd, J = 17.3, 6.6 Hz, 1H), 3.50 (s, 8H), 3.64 (t, J = 7.0 Hz), 3.77 (dd, J = 
17.3, 12.5 Hz, 1H), 3.93 (d, J = 13.5 Hz, 1H), 3.98 (d, J = 13.5 Hz, 1H), 5.35 (dd, J = 




8.3, 2.3, 0.8 Hz, 1H), 7.05 (t, J = 7.9 Hz, 1H), 7.07 (d, J = 8.8 Hz, 2H), 7.36 (d, J = 1.8 
Hz, 1H), 7.69 (d, J = 8.7 Hz, 2H), 7.85 (d, J = 8.7 Hz, 2H). 
13
C NMR (CD3OD, 100 
MHz)  32.1, 34.4, 36.3, 44.5, 46.8, 54.2, 59.7, 65.3, 66.4, 112.5, 114.2, 114.6, 118.3, 
120.8, 123.9, 127.9, 129.1, 130.3, 131.8, 134.3, 135.9, 139.9, 146.2, 146.8, 148.6. IR 
(KBr pellet) 2918, 2224, 1600, 1518, 1488, 1393, 1184, 1134, 1039, 701, 569 cm
–1
. ESI-
HRMS m/z calcd for [M]
–
 C37H45N4O7S4 785.2171, found 785.2187. 
 
3.11.2. Absorption and fluorescence spectroscopy 
General 
 UV-vis absorption spectra were acquired at 22°C with a Varian Cary Bio50 
spectrophotometer with constant temperature accessory. Fluorescence spectra were 
recorded with a PTI fluorimeter. The fluorescence spectra were corrected for the spectral 
response of the detection system and for the spectral irradiance of the excitation source 
(via a calibrated photodiode). The path length was 1 cm for absorbance and fluorescence 
spectra and 10 cm for absorbance measurements used in quantum yield determination. 
 
Absorption and emission spectra 
 The normalized absorption (blue traces) and emission spectra (red traces) of 
compounds 3.3a-d in aqueous solution (10 mM MOPS/K
+
, pH 7.2) are shown in Figure 
3.12. Emission spectra were monitored in the presence of excess Cu(I) for maximizing 
the signal/noise ratio. No discernable shifts in emission wavelength were observed upon 
Cu(I) addition for any of the probes. The beige area indicates the tunable range of the 






Figure 3.12: Normalized absorption and emission spectra of 3.3a-d 
 
Fluorescence quantum yields, contrast ratios, and reversibility of response 
 Quantum yields and fluorescence enhancement factors (contrast ratios) were 
determined in 10 mM pH 7.2 MOPS buffer, which was filtered through a 0.45 µM 
membrane filter to prevent interference from dust particles or fibers. For quantum yield 
determination, excitation was at 380 nm and four data points with absorbances between 
0.05 and 0.5 (l = 10 cm) were used for each compound. The probes were saturated with 
Cu(I) by titration with 250 µM aqueous copper(II) sulfate in the presence of 20 µM 
sodium ascorbate as a reducing agent. The quantum yields of the copper saturated forms 
were determined from the slope of the integrated fluorescence emission from 390-700 nm 
versus absorbance at 380 nm using norharmane in 0.1 N H2SO4 (Φf = 0.58)
45
 as a 
standard. To reduce errors due to the much lower signal-to-noise ratios of the emission 
spectra of the free probes, the raw spectra were converted to a wavenumber scale, fitted 
to a Gaussian function, transformed back to a wavelength scale, and integrated over the 
acquired spectral range. Fluorescence enhancement factors were determined as the ratio 




concentration of the Cu(I)-saturated and free probes. For probes 3.3a (CTAP-2) and 3.3d, 
the reversibility of the fluorescence response was confirmed at each absorbance point by 
adding an excess (10 µM) of  the non-selective transition metal chelating agent tetrakis(2-
pyridylmethyl)ethylenediamine (TPEN) to the copper saturated probe solutions to 
remove Cu(I). For both compounds, the fluorescence intensity after addition of TPEN 
was equal to that of the free probe within experimental error. 
 
Mole ratio titration of CTAP-2 with Cu(I) (Figure 3.5) 
 A magnetically stirred solution of CTAP-2 (4.5 µM, 3 mL) in deoxygenated 
MOPS/K
+
 buffer (10 mM, pH 7.2) was titrated with 0.6 µL aliquots of 2.5 mM 
Cu(MeCN)4PF6 in acetonitrile to provide a final Cu(I) concentration of 0.5 µM  per 
aliquot. Each aliquot was introduced below the surface of the solution, and the 
fluorescence response (λexc = 380 nm, λem = 498-518 nm) was recorded after a 1 minute 
delay to allow for thorough mixing. 
 
Analyte selectivity of CTAP-2 (Figure 3.6) 
 A single 4.5 μM solution (100 mL) of CTAP-2 in MOPS buffer (10 mM, pH 7.2) 
was prepared and the fluorescence spectrum of a 3 mL aliquot of the solution was 
recorded over the range of 410-700 nm with excitation at 380 nm. Each cation tested was 
then added as an aqueous stock solution (5 μL) to provide the indicated final 








; 10 µM for others) and the solution 
was thoroughly mixed by inversion. The fluorescence response was measured after a 1 
minute equilibration period. Cu(I) was then added as a 2.5 mM stock solution of 
[Cu(MeCN)4]PF6 in acetonitrile (6 μL) to provide a final Cu(I) concentration of 5 μM, 
the solution was quickly mixed, and the fluorescence response was measured after a 




integrated over the range of 498-518 nm (λmax ± 10 nm) to maximize signal to noise ratio, 
and none of the analytes other than Cu(I) produced a significant fluorescence 
enhancement outside of this range. The cations tested were supplied in the following 
forms: Mg(II), Ca(II), Co(II), and Ni(II) were provided as nitrates, Na
+
 was provided as 
NaClO4, and Mn(II), Fe(II), Cu(II) and Zn(II) were provided as sulfates. Chloride was 
supplied as KCl. 
 
Absorbance and fluorescence versus concentration of CTAP-2-Cu(I) (Figure 3.7) 
 An aliquot of CTAP-2 ammonium salt stock solution (150 μM in H2O) was added 
to a 1 cm cuvette containing 3 mL MOPS buffer (10 mM, pH 7.20) under rapid stirring, 
followed quickly by an aliquot of Cu(I) stock solution (1 mM [Cu(MeCN)4]PF6 in 
acetonitrile) sufficient to provide 1.3 molar equivalents of Cu(I). After 1 minute of 
stirring, the fluorescence spectrum was acquired with excitation at 380 nm and integrated 
over the emission range of 498-518 nm, and the UV absorbance was measured at 380 nm. 
This process was repeated using the same solution to provide increasing concentrations of 
CTAP-2-Cu(I) up to 5 μM. 
  
Absorbance versus concentration of free CTAP-2 (Figure 3.8) 
Experimental procedure 
 Aliquots of a 2.0 mM stock solution of CTAP-2 ammonium salt in water were 
sequentially added to 28.2 mL of MOPS/K
+
 buffer (10 mM, pH 7.20) in a 10 cm path 
length cuvette to provide CTAP-2 concentrations from 1 to 10 µM in 1 µM steps. 
Aliquots of the same stock solution were added to 1.5 mL of MOPS/K
+
 buffer in a 0.5 cm 
path length cuvette to provide concentrations from 10 to 100 µM in 10 µM steps. The 
absorbance at 396 nm was recorded at each concentration and the results were divided by 





 The nonlinear data obtained in the above experiment were analyzed assuming a 
simple dimerization equilibrium, where L represents monomeric CTAP-2 and L2 
represents the dimer (Equation 3.2): 
 
 2 L    L2 (3.2) 
 
The dimerization equilibrium constant, K, is given by Equation 3.3, where species given 
in brackets represent concentrations: 
 
  =  
    
    
 (3.3) 
 
By mass balance, the dimer concentration, monomer concentration, and total CTAP-2 
concentration [Ltot] are related by Equation 3.4: 
 
       =    +        (3.4) 
 
The total absorbance of a solution containing L and L2 but no other colored species is 
given by Equation 3.5, where A is the absorbance,    and     are the respective molar 
absorptivities of the monomer and dimer at the wavelength of measurement, and b is the 
optical path length. 
 
  =       +          (3.5) 
Solving Equations 3.3 and 3.4 for [L] and [L2] and substituting the results into Equation 
3.5 gives Equation 3.6, which relates the absorbance to the dimerization equilibrium 








(   (√ +         −  ) +    (4       − √ +         +  )) (3.6) 
 
The absorbance versus concentration data were fitted over the entire concentration range 
using Equation 3.6 with a monomer molar absorptivity (  ) of 2.91 x 10
4
, which was 
obtained from a linear fit over the 0-5 µM range, to give log K = 3.98 ± 0.06 and     = 
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DECONSTRUCTING THE PERFORMANCE CEILING FOR CTAP-2 
AND RELATED PROBES: THE IMPORTANCE OF COPPER-





4.1. Introduction: Incomplete fluorescence recovery in PET-based Cu(I)-probes 
limits contrast ratio and quantum yield 
 The previous chapter describes the development of CTAP-2,
1
 a water-soluble, 
high contrast fluorescence turn-on probe for Cu(I) based on a photoinduced electron 
transfer (PET) switching mechanism. With a contrast ratio of 65, CTAP-2 represents a 
significant improvement over the first generation aqueous Cu(I)-probe CTAP-1,
2
 which 
gave only a 4.6 fold fluorescence enhancement upon Cu(I)-saturation. The fluorescence 
quantum yield of Cu(I)-saturated CTAP-2, however, remains relatively low at 8.3%, 
which is only a third of the 25% quantum yield observed upon protonation of the N-
arylthiazacrown PET donor. Similar behavior was previously noted for the forerunners of 
CTAP-2, the N-arylthiazacrown-based methanolic Cu(I)-probes described in Chapter 2. 
For example, probe 2.3d, which provided the highest contrast ratio of 50, gave a 
fluorescence quantum yield of only 7% upon saturation with Cu(I), corresponding to a 
recovery of only 18% of the fluorescence output available upon complete PET inhibition 
by protonation of the thiazacrown nitrogen.
3
 Fluorescence recovery can be improved by 
lowering the PET driving force, but a moderate increase in the fluorescence quantum 




more electron-rich triarylpyrazoline 2.4b gave a quantum yield of 15% upon saturation 
with Cu(I), corresponding to 28% fluorescence recovery, but the contrast ratio was 
reduced to only 21. The low fluorescence recovery was shown to be due to incomplete 
Cu(I)-N coordination and concomitant coordination of a solvent molecule to the resulting 
vacancy at the Cu(I) center, resulting in rapidly equilibrating ternary complexes with 




 Although CTAP-2 offers a slightly better combination of contrast ratio and 
quantum yield than the methanolic Cu(I)-probes described above, its fluorescence 
recovery remains low at 33%, implying that its performance is likely limited by a similar 
mechanism. Additionally, the 25% fluorescence quantum yield of protonated CTAP-2 is 
only about half that typically shown by cyano-substituted triarylpyrazolines lacking a 
PET quencher,
4-6
 suggesting that an additional fluorescence quenching mechanism limits 
the intrinsic quantum yield of the CTAP-2 fluorophore in aqueous solution. The work 
presented in this chapter,
7
 which began as an attempt to improve upon the performance of 
CTAP-2 by incorporating a new ligand design strategy recently demonstrated in 
methanolic solution,
6
 ultimately shed light on the causes of both the incomplete 
fluorescence recovery and the low intrinsic fluorophore quantum yield observed for 
CTAP-2 and related triarylpyrazoline-based aqueous Cu(I)-probes. 
 
4.2. Background: Integrating the aryl ring of the PET donor into the ligand 
backbone improves fluorescence contrast and quantum yield in methanolic Cu(I)-
probes 
 During the development of CTAP-2, a parallel effort was underway in the Fahrni 
laboratory to improve the performance of methanolic Cu(I)-probes by addressing the 
problem of ternary complex formation
4




derivatives described in Chapter 2. This project,
6
 which served as a basis for the probe 
design described in this chapter, is summarized below (Section 4.2). 
 
4.2.1. A Revised ligand design to alleviate steric crowding in the Cu(I)-complex and 
provide an improved switching potential 
 Computational modeling of the Cu(I)-complexes of ligand 2.2, the N-aryl 
thiazacrown Cu(I)-receptor/PET donor of the probes described in Chapter 2, revealed that 
at least part of the driving force for Cu-N bond dissociation and ternary complex 
formation is due to steric clashes between the ortho-hydrogen atoms of the aromatic ring 
and the ligand backbone.
4,6
 Integration of the aromatic ring of the PET donor into the 
ligand backbone (ligand 4.1) was expected to alleviate these unfavorable steric 




Scheme 4.1: Fusing the PET-donor aryl ring with the ligand backbone to remove 
the steric driving force for ternary complex formation. Adapted  from a similar 






 In addition to inhibiting ternary complex formation, the new design was expected 
to provide a synergistic conformational and electronic switching effect: binding of Cu(I) 
to the ligand should induce a conformational change that rotates the NH unit out of the 
plane of the aromatic ring, thus resulting in reduced π-donation and therefore greater 
inhibition of PET than would be provided by the Cu-N interaction alone.
6
 The switch 
from macrocyclic to linear topology was purely for synthetic accessibility; this change 




4.2.2. Integration of the PET donor aryl ring with the ligand backbone markedly 
improves probe performance 
 The new ligand design 4.1 was combined with the tunable triarylpyrazoline 
fluorophore platform previously utilized in methanolic Cu(I)-probe series 2.4b-f (Chapter 





Figure 4.1: Methanolic Cu(I)-probes based on an integrated arylamine ligand design.
6
 For 






 As shown in Table 4.1, a side-by-side comparison of probes differing in ligand 
design but with equivalent triarylpyrazoline fluorophores, substitution of  the integrated 
arylamine ligand design 4.1 (probes 4.2b-f) for the original N-arylthiazacrown design 2.2 
(probes 2.4b-f) results in  markedly higher fluorescence quantum yields upon Cu(I) 
saturation for all derivatives. The fluorescence quantum yields in the absence of Cu(I) are 
similar for the two probe series, resulting in substantially higher fluorescence contrast 
ratios for the integrated arylamine ligand design (series 4.2). 
 
 
Table 4.1: Comparison of probe series 4.2 to the analogous series 2.4 
Probe Φf Free Φf Cu(I)
a  𝑓 
b Probe Φf Free Φf Cu(I)
a  𝑓 
b 
2.4b 0.007 0.15 21 4.2b 0.017 0.57 34 
2.4c 0.003 0.095 29 4.2c 0.007 0.54 74 
2.4d 0.002 0.048 20 4.2d 0.002 0.49 210 
2.4e 0.001 0.020 20 4.2e 0.001 0.24 160 
2.4f <0.001 0.020 n.d. 4.2f <0.001 0.21 n.d. 
a
 Probes were saturated with Cu(I) provided as Cu(MeCN)4PF6. 
b
Fluorescence enhancement 
factor (contrast ratio) given as the ratio of the fluorescence quantum yield of the Cu(I) saturated 
probe to that of the free probe. Data from references 4 and 6. 
 
 
 Since probe series 2.4 and 4.2 share a common set of fluorophore moieties, the 
substantially greater fluorescence quantum yields upon Cu(I)-saturation for series 4.2 
versus series 2.4 correspond to greater recovery of the intrinsic fluorophore quantum 
yield upon binding of Cu(I). As the low fluorescence recovery of the series 2.4 probes 
was found to be due to incomplete Cu(I)-N coordination with ternary complex 
formation,
4
 the greatly improved fluorescence recovery for series 4.2 suggests that the 




observed with ligand 2.2 (see Scheme 4.1). Accordingly, the fluorescence decay profile 
of the contrast-optimized probe 4.2d upon saturation with Cu(I) that fit well to a 
monoexponential model, which is consistent with a uniform emitter as opposed to the 
multiple coordination species apparent in the multiexponential fluorescence decay 
profiles of probe 2.4b. Furthermore, the X-ray crystal structure of the complex [4.1-
Cu(I)]PF6, which was crystallized from methanol, revealed only a binary comlex with a 
direct Cu-N bond.
6
 Therefore, it appears that the integrated arylamine ligand design 
strategy improves the fluorescence quantum yield and contrast ratio of PET-based 
methanolic Cu(I)-probes by suppressing the Cu-N bond dissociation and ternary complex 
formation that occur with the earlier N-arylthiazacrown ligand design. 
 
4.3. Combining an integrated arylamine ligand architecture with the balanced 
soulbilization strategy of CTAP-2 
 As noted in the introduction, the performance of CTAP-2 is presumably limited 
by incomplete Cu(I)-N coordination and ternary complex formation analogous to that 
observed for N-arylthiazacrown-based methanolic Cu(I) probe series 2.4. Since this effect 
can be abrogated in methanolic solution by integrating the arylamine PET donor into the 
ligand backbone, an analog of CTAP-2 incorporating this ligand design strategy may 
provide substantially higher contrast ratio and quantum yield in aqueous solution than 
CTAP-2 itself, despite the apparently low intrinsic quantum yield of the CTAP-2 
fluorophore. For example, the contrast-optimized methanolic Cu(I)-probe 4.2d gave a 
fluorescence quantum yield of 0.49 upon saturation with Cu(I) versus 0.64 for the 
corresponding triarylpyrazoline bearing an unsubstituted 5-aryl ring, corresponding to a 
fluorescence recovery of 77%. An equivalent fluorescence recovery for CTAP -2, 
assuming a value of 0.25 for the intrinsic fluorophore quantum yield, would more than 




change in quantum yield for the free probe, this would give a corresponding increase in 
contrast ratio from 65 to 149.  
 Combining the integrated arylamine ligand architecture of the ultra-high contrast 
methanolic Cu(I) probe 4.2d with the hydroxylated ligand/sulfonated fluorophore 




Figure 4.2: Conception of aqueous Cu(I)-probe 4.3 
 
 
 As shown in the above figure, the macrocyclic ligand topology of CTAP-2 was 
retained for 4.3 even though 4.2d has an acyclic ligand for easier synthetic accessibility. 
It was thought that the reduced conformational flexibility of a macrocyclic ligand would 
result in better resistance toward ternary complex formation, particularly against 
relatively strong monodentate ligands such as thiols, which are ubiquitous in biological 
environments.  




4.4.1. Construction of the ligand framework 
 The macrocyclic ligand framework of probe 4.3 was rendered synthetically 
accessible by combining the thietane ring-opening strategy developed for CTAP-2 with a 
recently introduced low-valent titanium-based method that, in contrast to standard 
dissolving-metal reduction, cleaves benzyl thioethers with high selectivity over 
thiophenol ethers.
9
 As shown in Scheme 4.1, ring opening of thietane 3.15 with benzyl 
chloride in the presence of sodium iodide gave neopentyl iodide 4.4, which proved 
sufficiently reactive to cleanly alkylate the acidic NH unit of benzothiazolin-2-one upon 
deprotonation in DMSO solution. The resulting intermediate was converted directly to 
the corresponding thiophenolate with sodium hydroxide, which was subsequently 
alkylated with a second equivalent of iodide 4.4. This three-step, one pot synthesis 
furnished the bis(benzyl thioether) 4.5 in 75% yield. Thioether 4.5 was cleaved to the 
corresponding dithiol 4.6 by the titanium-catalyzed method of Akao et al,
9
 and 4.6 was 
cyclized with 1,3-diiodopropane under Kellogg conditions
10







Scheme 4.2: Synthesis of the integrated arylamine-thiazacrown ligand framework 
 
4.4.2. Assembly of the triarylpyrazoline fluorophore 
 To construct the triarylpyrazoline fluorophore, a carbon-based substituent such as 
an aldehyde must first be introduced para to the NH moiety of intermediate 4.7. As 
shown in Scheme 4.2, this was accomplished by a two step Bouveault-type formylation: 
Amine 4.7 was selectively brominated at the para-position without oxidizing the sensitive 
aliphatic thioethers using 2,4,4,6-tetrabromocyclohexadienone under anhydrous 
conditions, and the resulting bromide 4.8 was subjected to metal-halogen exchange 
followed by addition of dimethylformamide and aqueous workup to decompose the 




facile for aryl bromides even at low temperature, 4.8 was unreactive toward exchange 
with n-butyllithium at -78°C, presumably due to the strong electron-donating effect of the 
deprotonated secondary amine. Simply increasing the reaction temperature would likely 
result in N-alkylation of the deprotonated amine by the byproduct n-butyl bromide, so the 
metal-halogen exchange was instead carried out using the more reactive t-BuLi after 
initial deprotonation of the NH unit by n-BuLi. Addition of DMF followed by aqueous 
workup gave aldehyde 4.9 in 91% yield after recrystallization. To the knowledge of the 
author, this is the first published example of the Bouveault-type para-formylation of a 
secondary n-alkylarylamine.  
 Aldehyde 4.9 was condensed with 4-cyanoacetophenone to form chalcone 4.10, 
the immediate precursor to the triarylpyrazoline fluorophore. In contrast to 3.26, the 
chalcone precursor of CTAP-2 (Chapter 3), 4.10 did not spontaneously crystallize from 
the ethanolic reaction mixture, allowing extensive side-product formation and providing 
the desired product in only 48% yield after chromatographic purification. In a second run, 
a small aliquot of the reaction mixture was removed early in the reaction and the impure 
chalcone crystallized from hexane-dichloromethane. The remainder of the reaction 
mixture was seeded with this crystalline material, causing in situ crystallization of the 
product. After the reaction proceeded to completion, sufficiently pure chalcone 4.10 was 
obtained in 91% yield by simple filtration from the reaction mixture. 
 In contrast to the case of CTAP-2, fluorinated analogs of 4.3 were not desired for 
the initial stages of characterization. Therefore, the sulfonate protective group strategy 
developed for CTAP-2 was bypassed by condensing the chalcone with commercially 
available 4-hydrazinobenzenesulfonic acid in one pot following hydrolysis of the 
acetonide moieties to directly produce the triarylpyrazoline sulfonic acid 4.3, which was 
isolated as its ammonium salt by HPLC in 82% yield (Scheme 4.2). Remarkably, the 
final product 4.3 was obtained in 21% overall yield from the simple thietane 3.15 over 






Scheme 4.3: Synthesis of Cu(I)-probe 4.3 from ligand precursor 4.7 
 
4.5. Cu(I) binding stoichiometry, analyte selectivity, and fluorescence response to 
Cu(I) and acidification 
 
 Similarly to CTAP-2, the ammonium salt of probe 4.3 was found to dissolve 
rapidly in pure water to millimolar concentrations. At micromolar concentrations in 
MOPS/K
+
 buffer (10 mM, pH 7.2), 4.3 gave a strong fluorescence turn-on response to 
Cu(I), saturating sharply at 1 molar equivalent under deoxygenated conditions and giving 






Figure 4.3: Titration of probe 4.3 with Cu(I) provided by in situ reduction of CuSO4 with 
ascorbate. Inset: Fluorescence intensity at 506 nm versus amount of Cu(I) added. Probe 
concentration 4.6 µM. 
 
 The response of 4.3 proved highly selective for Cu(I) over all other cations tested, 
including Cu(II) and Hg(II), and identical fluorescence enhancements were obtained 
whether Cu(I) was provided directly as Cu(MeCN)4PF6 or by in situ reduction of Cu(II) 






Figure 4.4: Analyte selectivity of probe 4.3 (4.6 µM in MOPS buffer). *10 µM 
Cu(MeCN)4PF6. **10 µM CuSO4 + 150 µM sodium ascorbate. 
 
 
 Contrary to our expectations, the fluorescence quantum yield (0.074) and contrast 
ratio (57) of 4.3 upon saturation with Cu(I) do not represent an improvement over CTAP-
2, which gave a fluorescence quantum yield and contrast ratio of 0.083 and 65, 
respectively. The response of 4.3 to acidification is also surprisingly weak, reaching a 
maximum fluorescence quantum yield of only 0.070 at 100 mM HCl versus 0.25 at 5 mM 
HCl for CTAP-2. While such behavior is desirable in that it decreases the susceptibility 
of the probe to interference from pH changes, it challenges our previous assumptions 
about the intrinsic fluorophore quantum yield; calculating the fluorescence recovery upon 
Cu(I)-binding for probe 4.3 as for CTAP-2 --using the fluorescence quantum yield under 
acidic conditions as the reference point-- gives an impossible value of 106%. Clearly, a 
previously unrecognized fluorescence quenching mechanism is involved for probe 4.3 





4.6. Investigating the intrinsic fluorophore quantum yield and effects of acidification 
4.6.1. A pH-independent analog of the protonated Cu(I)-probes 
 To gauge the intrinsic fluorescence quantum yield of the common fluorophore 
moiety of CTAP-2 and 4.3 in neutral aqueous solution, we devised reference 
triarylpyrazoline 4.11, in which the amine moiety of the 5-aryl ring is replaced with a 
cationic trimethylammonium group, permanently deactivating the 5-aryl ring toward 
oxidative electron transfer and exerting an electron-withdrawing effect comparable to a 
protonated amine at any pH. As shown in Scheme 4.3, pyrazoline 4.11 was prepared by 
quaternization of the dimethylamino-substituted chalcone 4.12 with methyl triflate to 
give chalcone 4.13, which was subsequently condensed with 4-hydrazinobenzenesulfonic 
acid to give the desired triarylpyrazoline. Unexpectedly, this reaction initially halted at 
the chalcone hydrazone stage, and a change of solvent and temperature was required to 
achieve cyclization to the pyrazoline. Nevertheless, the zwitterionic product was readily 






Scheme 4.4: Synthesis of the zwitterionic reference fluorophore 4.11 
 
 In neutral aqueous solution (10 mM MOPS/K
+
, pH 7.2), reference compound 4.11 
showed very similar fluorescence properties to protonated CTAP-2 in 5 mM HCl: The 
absorption and emission maxima are nearly identical (see table 4.2) and the observed 
fluorescence quantum yield of 0.28 for compound 4.11 is only slightly higher than the 
value of 0.25 previously recorded for protonated CTAP-2. Consistent with this 
observation, the quantum yield of 4.11 was reduced by only 4% in 5 mM HCl versus 
neutral solution. In 100 mM HCl, however, the fluorescence quantum yield of 4.11 
decreased by half to 0.14. No such decrease was observed in 100 mM KCl, confirming 
that the effect is mediated by the hydronium ion and is not due to the increase in ionic 




in the ground state at pH 1 might be reasonably expected, the absorption spectra of 4.11 
in 100 mM HCl and 100 mM KCl are superimposable, as are those in 1 M HCl and 1M 
KCl, suggesting that the observed fluorescence quenching by acid is due to an excited 
state proton transfer (ESPT) process and not to ground state protonation. Furthermore, the 
normalized emission spectra in neutral buffer and 100 mM HCl are superimposable, 
indicating that the species produced by ESPT is nonemissive.  
 











394 506 0.0014 
Buffer + Cu(I) 388 506 0.074
c 



















387 511 0.28 
5 mM HCl 387 511 0.27 
100 mM HCl 387 511 0.14 
a
 10 mM MOPS/K
+
 pH 7.2. 
b
 Identical values were observed in 
unbuffered H2O. 
c
 The ratio of Φf (free)/ Φf (Cu(I)) is slightly less 
than the observed contrast ratio at 380 nm excitation due to a small 
shift in the absorption spectra upon Cu(I) complexation. 
d
 The 
original value of 508 nm reported for the emission maximum of 
CTAP-2
1
 is due to a slight error in emission monochromator 
calibration. The fluorescence quantum yields are not affected. 
 
4.6.2. Analyzing the response of probe 4.3 to acidification 
 Armed with new knowledge regarding the direct effects of acidification on the 




detail. In contrast to reference compound 4.11, probe 4.3 showed a significant shift in the 
absorption spectrum upon acidification, with the absorption maximum changing from 
394 nm in 1 M KCl to 388 nm in 1M HCl. As a similar shift from 396 to 388 nm is 
observed upon protonation of CTAP-2 with 5 mM HCl, these shifts presumably 
correspond to protonation of the arylamine Cu(I)-ligand. In 100 mM HCl, probe 4.3 gave 
an absorption maximum of 391 nm, exactly halfway between the values observed in 1 M 
HCl and neutral solution, suggesting a pKa near 1 for protonation of the arylamine 
moiety. This remarkably low pKa was confirmed by Pritha Bagchi by nonlinear least-
squares fitting of a series of absorption spectra acquired in aqueous HCl-KCl mixtures of 
varying [H
+
] but constant ionic strength using the SpecFit software package,
11
 which 
yielded an extrapolated pKa value of 1.0 at 0.1 M ionic background.  
 Together with the observed fluorescence quenching of reference compound 4.11 
under acidic conditions, the surprisingly low arylamine pKa of probe 4.3 fully explains 
the unexpectedly low fluorescence quantum yield observed in acidic solution: Relatively 
large acid concentrations are required to protonate the PET donor arylamine moiety to a 
significant extent, but high acid concentrations also directly quench the pyrazoline 
fluorophore by ESPT. At 100 mM HCl, only half of 4.3 is in the protonated form, and the 
fluorescence quantum yield is further reduced by half due to ESPT, thus bringing the 
quantum yield down from 0.28 (the value for reference compound 4.11 in neutral 
solution) to the observed value of 0.070. Taking the fluorescence quantum yield of 4.11 
in neutral solution as the intrinsic fluorophore quantum yield, the fluorescence recovery 
of probe 4.3 upon Cu(I)-coordination is 26%, and that of CTAP-2 is 30%. 
 
4.7. Reduced Cu(I)-binding affinity: a manifestation of poor Cu-N coordination? 
 The slightly lower fluorescence recovery upon Cu(I)-saturation of 4.3 compared 




despite the integrated arylamine ligand design. This behavior is consistent, however, with 
the very low pKa of the arylamine nitrogen of probe 4.3, which is nearly 1000-fold less 
basic than that of CTAP-2 (pKa 3.97).
1
 Such a feebly basic amine nitrogen donor would 
be expected to coordinate only weakly, if at all, to the Cu(I) center. Inadequate donor 
strength of the arylamine nitrogen, however, would likely manifest not only in an 
attenuated fluorescence response but also in a reduced Cu(I)-binding affinity for probe 
4.3 compared to related ligands.  
 Initially, we attempted to determine the Cu(I)-binding affinity of 4.3 as previously 
described for CTAP-2 using the Cu(II)-binding affinity and the ligand-bound 
Cu(II)/Cu(I) redox potential (Section 3.7.3). Attempts to determine the Cu(II) affinity of 
4.3, however, were complicated by a slow redox reaction between Cu(II) and the probe 
itself. In the presence of 10 µM (2 molar equivalents) of Cu(II), the fluorescence output 
of 4.3 slowly increased with time, reaching an emission enhancement of 6-fold after 30 





 = 15.4 at pH 7.2) reduced the fluorescence output by 
more than 60% within 1 minute. This indicates that the time-dependent fluorescence 
enhancement observed with Cu(II) is largely mediated by reduction  to probe-bound 
Cu(I), presumably with the free probe serving as the electron source. A similar behavior 
was previously observed for 4.2d in methanolic solution.
6
 
 In addition to the difficulty in determining the Cu(II) binding affinity, the 
electrochemical behavior of the 4.3-Cu(I) complex was also unsuitable for affinity 
determination: Cyclic voltammetry experiments conducted by Pritha Bagchi revealed a 
one-electron process with a peak separation of 266 mV and a formal potential of 0.480 V 
vs. SHE for Cu(I)-saturated 4.3 at pH 5 (50 mV/s scan rate). Such a large peak separation 
indicates that substantial structural changes occur following oxidation of the Cu(I) 
complex or reduction of the Cu(II) complex, and the resulting formal potential is not 






 Instead, the Cu(I) affinity of 4.3 was determined by Pritha Bagchi via direct 
fluorescence-monitored titration using acetonitrile as a competing Cu(I) ligand.
2,12,13
 This 
gave a uniform value of log K
Cu(I)
 = 9.72 ± 0.03 at pH 7.2 for probe 4.3 whether the 
titration was conducted by varying the concentration of Cu(I) in the presence of a 
constant concentration of acetonitrile or vice versa. This binding affinity is nearly120 









 Although the 
reduced Cu(I)-binding affinity of 4.3 compared to these ligands may perhaps be 
attributable to other factors, it would certainly be consistent with an unusually low donor 
ability of the arylamine nitrogen in 4.3 toward Cu(I), which in turn is consistent with the 
unusually low pKa. 
 
4.8. Fluorescence recovery  limited by incomplete Cu(I)-N coordination: Evidence 
from fluorescence decay profiles 
 Previously, the Fahrni et al. demonstrated that the incomplete Cu(I)-N 
coordination and concomitant ternary complex formation  responsible for the low 
fluorescence recovery of methanolic Cu(I) probes such as 2.4b can be detected by 
picoseconds time-resolved fluorescence spectroscopy; each of the rapidly equilibrating 
coordination species has a distinct fluorescence lifetime, resulting in a multiexponential 
fluorescence decay profile which can be resolved into separate components. To gain 
further insight into the mechanism responsible for incomplete fluorescence recovery of 
4.3 and CTAP-2, we applied the same technique to these aqueous Cu(I)-probes. As 
shown in Figure 4.5, both CTAP-2 and 4.3 gave multiexponential fluorescence decay 
profiles upon saturation with Cu(I), which appear as curved traces when plotted on a 
logarithmic y-axis. Reference compound 4.11, by contrast, gave a cleanly 





Figure 4.5: Fluorescence decay profiles of 4.3-Cu(I), CTAP-2-Cu(I), and 4.11 in aqueous 
buffer. 
 
 The decay profiles of both CTAP-2-Cu(I) and 4.3-Cu(I) fit well to a biexponential 
model with components of 0.82 ns (67%) and 1.36 ns (33%) for CTAP-2 and similar 
components of 0.72 ns (93%) and 1.44 ns (7%) for 4.3. Interestingly, the minor, longer-
lived species detected in the decay profile of 4.3-Cu(I) recovers 70% of the fluorescence 
lifetime of reference compound 4.11. This is comparable to the ultra-high contrast 
methanolic Cu(I)-probe 4.2d (Section 4.2), which recovered 76% of the fluorescence 
lifetime of the corresponding triarylpyrazoline lacking a PET quencher (lifetimes 2.80 vs. 
3.70 ns).
15
 The substantially shorter lifetime of the predominant component, however, 
indicates that this species is substantially quenched by residual PET from the arylamine 
donor, suggesting little or no direct Cu(I)-N bonding interaction. As the Cu(I)-complexes 
of both CTAP-2 and 4.3 give biexponential fluorescence decay profiles with a 
predominant short lived component, it is evident that the fluorescence recoveries of both 





4.9. Uncovering the cause of the low intrinsic fluorophore quantum yield 
4.9.1. Suspected fluorescence quenching pathways 
 The 2.07 ns fluorescence lifetime observed for compound 4.11 in aqueous buffer 
is significantly shorter than those previously observed for triarylpyrazolines in methanol 
or acetonitrile, which are typically 3-4 ns for cyano-substituted derivatives. [REF] 
Consistent with a high nonradiative deactivation rate, the fluorescence quantum yield is 
correspondingly low at 0.28 compared to 0.4-0.7 for comparable triarylpyrazolines in 
polar organic solvents. Organic fluorophores quite commonly show a reduced 
fluorescence quantum yield in aqueous solution due to aggregation, but the fluorescence 
versus absorbance profile of 4.11 used in quantum yield determination (Figure 4.6) shows 
good linearity over a four-fold concentration range from 0.4 to 1.6 µM, indicating that the 
fluorescence quantum yield is independent of concentration and therefore that a 




Figure 4.6: Fluorescence versus absorbance profile for triarylpyrazoline 4.11 in aqueous 
solution (10 mM MOPS, pH 7.2). 
y = 95.715x 
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 Another potential cause of the low fluorescence quantum yield and short lifetime 
could be an efficient internal conversion process involving the sulfonate moiety or its 
hydrogen-bonded solvation shell, and it is common for fluorophores to suffer a slight 
reduction in quantum yield upon sulfonation;
16
 however, the 62% fluorescence quantum 
yield in acidic aqueous solution shown by triarylpyrazoline 3.3c, a difluorinated analog of 
CTAP-2 (Chapter 3), speaks against the sulfonate moiety itself as the cause of the low 
fluorescence quantum yield of 4.11. 
 A third possible explanation for the low fluorescence quantum yield of 4.11 is 
donor-excited PET, in which an electron is transferred from the excited fluorophore to an 
electron acceptor, in this case the 5-aryl ring. In simplified terms, the transferred electron 
can be considered to originate from the molecular orbital corresponding to the LUMO of 
the ground-state fluorophore. Striking evidence for such an effect is apparent in the 
fluorescence quantum yields of a series of triarylpyrazolines investigated by Rivett et 
al.
17,18
 As shown in Figure 4.7, placement of strongly electron-withdrawing substituents 
such as cyano-, methanesulfonyl-, or carboxymethyl- on the 5-aryl ring results in 
dramatic fluorescence quenching when the 3-aryl ring is unsubstituted. The presence of a 
strong electron-withdrawing group on the 3-aryl ring, which should significantly lower 
the LUMO energy of the fluorophore, suppresses this quenching effect almost 
completely, while an electron-withdrawing group on the 1-aryl ring alone, which should 
primarily lower the HOMO energy, is ineffective. While the original reports offer no 
explanation for this behavior, it is certainly consistent with donor-excited PET with the 5-





Figure 4.7: Relative fluorescence quantum yields of triarylpyrazolines bearing electron-





 If donor-excited PET to the cationic 5-aryl ring were the primary factor 
responsible for the low fluorescence quantum yield of triarylpyrazolines such as 4.11 and 
protonated CTAP-2, then a similar quenching effect might also be expected for related 
compounds containing fluoro-substituents rather than the sulfonate moiety such as 2.4b-
H+, but this is not observed. It seems reasonable, however, that direct attachment of the 
anionic sulfonate group to the fluorophore might facilitate donor-excited PET via a field 
effect. Furthermore, Cody et al. previously observed evidence of donor-excited PET upon 
protonation of pyrazolines bearing a 5-aryl dimethylamino group and an unsubstituted 3-
aryl ring,
5
 indicating that a substituted arylammonium ion is a viable electron acceptor. 
 Due to the cationic 5-aryl ring and anionic fluorophore, donor-excited PET in 
triarylpyrazoline 4.11 would likely result in a net decrease in charge separation, and if 
this is the case then the fluorescence quantum yield should actually be higher in water 
than in a less polar solvent. Contrary to this notion, changing the solvent from water to 
methanol dramatically increased the quantum yield of 4.11 from 0.28 to 0.58. The 




improvement in quantum yield is primarily due to a large decrease in knr, although a small 
increase in kr also occurs (Table 4.3). Furthermore, the fluorescence lifetime and quantum 
yield of 4.11 in methanol are quite comparable to those of other cyano-substituted 
triarylpyrazolines previously reported, indicating that the low quantum yield observed in 
aqueous solution is due to a solvent effect rather than an inherent property of the 
compound.  
 
4.9.2. ESPT in neutral solution revealed by solvent isotope effects 
 Given the fluorescence quenching by ESPT apparent for 4.11 under acidic 
conditions, a likely explanation for the substantially increased nonradiative deactivation 
rate of 4.11 in aqueous solution would be a second ESPT pathway with H2O itself as the 
proton donor. Addition of 0.1 M NaOH had no effect on the fluorescence spectrum or 
quantum yield of 4.11, indicating that any excited state protonation that occurs must be 
irreversible and kinetically controlled. Consistent with a fluorescence quenching 
mechanism involving a rate-limiting proton transfer from the solvent, the fluorescence 
quantum yield of 4.11 showed a substantial solvent deuterium isotope effect, increasing 
1.7-fold from 0.28 to 0.48 when the solvent was changed from H2O to D2O with no effect 
on the absorption or normalized emission spectrum. The fluorescence lifetime increased 
proportionally from 2.07 to 3.56 ns, indicating that the improvement in quantum yield is 
due solely to a decrease in the nonradiative deactivation rate knr while kr remains 
constant. Notably, the fluorescence lifetime and knr values obtained in D2O are similar to 




























387 511 0.28 2.07 1.35 3.48 
D2O
a 
387 511 0.48 3.56 1.35 1.46 
CH3OH
a 
390 496 0.58 3.58 1.62 1.17 
a
 Air-saturated conditions. 
b
 Deoxygenation had a negligible effect on the 
fluorescence lifetime. 
c
 kr =  Φf/τf. 
d
 knr = (1− Φf)/ τf. 
e
 The third digit is not 
significant but is included to show the level of internal consistency. 
 
 While the above effects have been interpreted as evidence of ESPT, a substantial 
increase in fluorescence quantum yield in D2O versus H2O sometimes occurs for 
fluorophores which engage in hydrogen bonding with the solvent but have no obvious 
sites for excited-state protonation or deprotonation, such as 5-dimethylaminonaphthalene-
1-sulfonate.  In these cases, the increased nonradiative deactivation rate in H2O is 
presumably due to an internal conversion mechanism involving transfer of energy to the 
high frequency O-H stretching vibrations of the solvent.
19
 The similarly low knr values of 
4.11 in D2O versus CH3OH, however, indicate that the mere presence of a solvent O-H 
stretch does not explain the fast nonradiative deactivation rate observed in H2O. ESPT 
appears a more likely explanation, as remarkably similar decreases in knr in either D2O or 
CH3OH versus H2O have been previously reported for several indole derivatives known 
to undergo fluorescence quenching by excited state protonation at C2 or C3 of the indole 
ring.
20
 Furthermore, comparable solvent isotope effects on fluorescence quantum yield 
and lifetime have been previously observed in methanolic solution for 1,3,5-
triarylpyrazolines lacking the strongly electron-withdrawing 3-aryl cyano-group and 1-
aryl sulfonate moiety. These effects, which were completely absent in aprotic solvents 
such as benzene or acetonitrile, were attributed to excited-state protonation, and were 
enhanced by electron-donating substituents but diminished by electron-withdrawing 
substituents on the 1-aryl ring.
21




CTAP-2 series probes 3.3a-d, where the fluorescence quantum yields of the probes under 
acidic conditions rose dramatically as electron-withdrawing substituents were added to 
the 1-aryl ring (Chapter 3, Table 3.2). 
 
4.10. The Relative importance of ESPT versus residual PET in the fluorescence 
quantum yield of Cu(I)-probes 
 Based on the data presented in this chapter, the fluorescence quantum yields upon 
Cu(I)-saturation of 4.3 and CTAP-2 are limited both by incomplete fluorescence 
recovery, which is apparently due to inadequate Cu(I)-N coordination resulting in 
residual PET, and a low intrinsic fluorophore quantum yield, which appears to be due to 
excited-state protonation of the fluorophore in aqueous solution. The relative importance 
of these two factors is determined by the contribution of each to the overall nonradiative 
deactivation rate constant knr. For 4.3 and CTAP-2, which exhibit a biexponential 
fluorescence decay rather than a single τf value, a combined knr can be calculated based 
on the natural decay lifetime, which is the average of the two lifetime components (τn) 
weighted by the fractional contribution (fn) of each component (Table 4.4). 
 





































1.141 0.089 0.84 8.6 
a
 Deoxygenated 10 mM MOPS/K
+
, pH 7.2. 
b









 Goodness-of-fit parameter for 
biexponential fit. 
d






 The contribution of ESPT to the overall value of knr can be estimated from the 
difference in knr for compound 4.11 in H2O versus D2O. Although quenching by an 
analogous mechanism may occur to a small extent even in D2O, the knr value for 4.11 in 
this solvent is within the range observed for related triarylpyrazolines in acetonitrile 
solution,
5
 where ESPT cannot occur, thus indicating that the contribution of such a 
pathway to knr should be relatively small. Subtracting knr(D2O) from knr(H2O) gives an 




 for compound 4.11, 
which is rather small compared to the overall effective knr values for the Cu(I)-probes 
(Table 4.4).  
 Assuming that the rate constants for ESPT and all other nonradiative deactivation 
pathways except for PET are similar for 4.11, 4.3-Cu(I), and CTAP-2-Cu(I), the effective 
rate constants of residual PET for the Cu(I)-probes can be estimated by subtracting the knr 
value of 4.11 in H2O from the overall knr of each probe. For 4.3-Cu(I), this yields an 




, more than four-fold larger than the estimated kESPT, indicating 
that residual PET is the more important limiting factor for the fluorescence quantum yield 
of this probe. The same applies for CTAP-2-Cu(I), for which we estimate an effective 




.  To check the validity of these conclusions, we 
predicted the fluorescence quantum yield of 4.3-Cu(I) in the absence of ESPT, then 














 in D2O. Assuming the same kr as in H2O, the predicted quantum yield is Φf = kr/(kr 
+ knr) = 0.088, which is in excellent agreement with the experimentally determined value 
of 0.089. The striking accuracy of this quantum yield prediction is partially coincidental 
given the less exact agreement in kr and knr (Table 4.3), but the results nevertheless 
substantiate the conclusion that residual PET is the major process limiting the quantum 
yield of low fluorescence recovery Cu(I)-probes such as 4.3 and CTAP-2, while ESPT 




however, should become more important at higher degrees of PET inhibition. This is 
demonstrated by compound 4.11, in which acceptor-excited PET is presumably 
abolished. In this case, elimination of the ESPT pathway results in a 70% improvement in 
fluorescence quantum yield from 0.28 to 0.48, and a comparable effect would be 
expected for a triarylpyrazoline-based probe that achieves nearly complete inhibition of 
PET upon Cu(I)-coordination. Furthermore, elimination of ESPT would improve the 
fluorescence contrast ratio almost in proportion to the quantum yield of the Cu(I)-bound 
probe, because the quantum yield of the free probe should be little affected by ESPT 
given the much larger rate of PET in the absence of analyte. Therefore, if the degree of 
PET inhibition upon Cu(I)-binding can be significantly improved in future aqueous 
Cu(I)-probes, simultaneous suppression of the ESPT pathway will give a synergistic 
improvement in contrast ratio and quantum yield. 
 
4.11. Conclusions 
 In an effort to improve upon the fluorescence sensing performance offered by our 
recently developed aqueous Cu(I) probe CTAP-2 (Chapter 3), we combined the balanced 
aqueous solubilization strategy and macrocyclic ligand topology of this probe with a new 
design principle entailing integration of the PET donor aryl ring into the ligand backbone. 
Based on previous results obtained in methanolic solution, we expected the new ligand 
design to give a substantial improvement in fluorescence contrast ratio and quantum yield 
upon Cu(I)-saturation by enforcing complete coordination of the PET donor nitrogen to 
the Cu(I)-center.  While the new probe 4.3 gave a strong fluorescence turn-on response 
with high selectivity for Cu(I), it did not exceed CTAP-2 in contrast ratio or quantum 
yield. To gain insight into the factors limiting the performance of these Cu(I) probes, we 
conducted more detailed studies with probe 4.3, CTAP-2 and reference fluorophore 4.11. 




CTAP-2 to Cu(I): residual PET due to incomplete Cu-N coordination limits fluorescence 
recovery upon Cu(I) binding, and fluorescence quenching by excited-state protonation 
hinders the intrinsic fluorophore quantum yield even in neutral aqueous solution. The 
former effect, which was suspected for CTAP-2 based on previous studies in methanolic 
solution,
4
 was confirmed for both probes by fluorescence decay analysis.  The latter, 
which was discovered through solvent isotope effects on the fluorescence quantum yield 
and lifetime of reference fluorophore 4.11, was initially unexpected but later found to 




 Although the reduction in fluorescence quantum yield due to ESPT is relatively 
minor compared to the effect of residual PET for the current Cu(I)-probes CTAP-2 and 
4.3, the ESPT pathway will become increasingly important at higher degrees of PET 
inhibition. As essentially complete PET inhibition upon Cu(I)-binding has already been 
demonstrated  in methanol,
15
 the ESPT pathway will likely be a critical consideration for 
the design of triarylpyrazoline-based aqueous Cu(I)-probes once a ligand design is found 
that more effectively enforces Cu(I)-N coordination in aqueous solution. 
  
4.12. Experimental section 
 The experimental work carried out by the author is described below. Details 
regarding determination of the pKa, Cu(I)-binding affinity, and electrochemical behavior 









 Materials and reagents: 2,4,4,6-tetrabromocyclohexadienone was purchased from 
Alfa Aesar and the purity was determined via 
1
H NMR (CDCl3) shortly before use 
(impurity is 2,4,6-tribromophenol). Diglyme (diethylene glycol dimethyl ether) was 
distilled from sodium-benzophenone and stored under argon. Dry diethyl ether and dry 
DMF (EMD DriSolv® grade) were used as received. Other solvents and reagents were 
purchased from standard commercial sources and used as received. The synthesis of 
thietane 3.15 and CTAP-2 are described in Chapter 3. NMR: Spectra were recorded at 
400 MHz (
1
H, ppm vs. internal TMS), 376 MHz (
19
F, ppm vs. internal CCl3F), and 100 
MHz (
13
C, ppm vs. TMS, referenced to CDCl3 (77 ppm) or CD3OD (49 ppm) chemical 
shifts). Spectra were recorded at ambient temperature (20-23°C) unless stated otherwise. 
For 
1
H spectra, the abbreviation “ad” denotes an apparent doublet with additional 
partially resolved coupling (AA’XX’ spin system). In the 
13
C spectra, isochronous 
chemical shifts for nonequivalent carbon nuclei were observed for 4.3, 4.6, and 4.7. The 
coincident peaks were identified via integration, and the number of carbon nuclei 
represented by each peak is given in parentheses. 
 
5-((benzylthio)methyl)-5-(iodomethyl)-2,2-dimethyl-1,3-dioxane (4.4)  
 A mixture of thietane 3.15 (8.19 g, 47 mmol), benzyl chloride (5.62 mL 48.9 
mmol), NaI (10.6 g, 70.5 mmol), Na2CO3 (1g), and CH3CN (20 mL) was stirred for 10 d 
in the dark. The resulting yellow mixture was stirred with aqueous Na2SO3 until 
colorless, diluted with water (200 mL), and extracted with MTBE (200 mL). The extract 
was washed with water (200 mL) followed by brine (20 mL), dried with MgSO4, and 
concentrated. The yellow residue was taken up in dichloromethane (100 mL), stirred with 
silica gel (5g), filtered, and concentrated to give the product as a colorless oil which was 
used without further purification. Yield 18.1 g (98%). 
1
H NMR (CDCl3) δ 1.38 (s, 3H), 
1.39 (s, 3H), 2.60 (s, 2H), 3.39 (s, 2H) 3.68 (d, J = 11.6 Hz, 2H), 3.72 (d, J = 11.6 Hz, 
2H), 3.76 (s, 2H), 7.22-7.30 (m, 5H). 
13




37.9, 66.3, 76.7, 98.6, 127.1, 128.5, 129.0, 138.0. EI-MS m/z 392 (27, [M]
+
), 334 (68), 91 
(100). EI-HRMS m/z calcd for [M]
+
 C15H21IO2S 392.0307, found 392.0303. 
 
Dibenzyl thioether intermediate 4.5  
 A mixture of iodide 4.4 (8.13 g, 20.7 mmol), benzothiazolin-2-one (3.13 g, 20.7 
mmol), Cs2CO3 (8.1 g, 25 mmol) and DMSO (9 mL) was stirred under argon overnight at 
80°C. The mixture was diluted with 30 mL DMSO, and 20% w/v aq. NaOH (16.6 mL, 83 
mmol) was slowly injected. A further 28 mL of DMSO was added simultaneously with 
NaOH as needed to prevent separation of the intermediate from the reaction mixture. 
After 35 min, acetic acid (1.42 mL, 25 mmol) was added to destroy excess NaOH, and a 
further 20.7 mmol of 4.4 was added as a solution in DMSO (11 mL). After 30 min, the 
mixture was allowed to cool, poured into water (300 mL) and extracted with MTBE (250 
mL). The extract was washed with water + brine (2 x (250 mL + 10 mL)), dried with 
MgSO4, and concentrated. The residue was purified by column chromatography 
(hexanes-MTBE) to give the product as a yellow oil. Yield 10.2 g (75%). 
1
H NMR 
(CDCl3) δ 1.36 (s, 3H), 1.40 (s, 3H), 1.44 (s, 3H), 2.57 (s, 2H), 2.72 (s, 2H), 2.85 (s, 2H), 
3.35 (d, J = 6.6 Hz, 2H), 3.66 (s, 2H), 3.69-3.75 (m, 10H), 5.22 (t, J = 6.7 Hz, 1H), 6.61 
(td, J = 7.5, 1.2 Hz, 1H), 6.77 (dd, J = 8.3, 1.0 Hz, 1H), 7.19 (ddd, J = 8.6, 7.5, 1.6 Hz, 
1H), 7.21-7.27 (m, 10H), 7.39 (dd, J = 7.6, 1.6 Hz, 1H). 
13
C NMR (CDCl3) δ 22.5, 22.7, 
24.7, 25.0, 34.7, 34.8, 37.8, 38.0, 38.3, 38.4, 38.8, 45.9, 65.4, 66.2, 98.3, 98.4, 110.4, 
117.0, 117.7, 127.0, 127.1, 128.4, 128.5, 128.9, 129.0, 130.2, 135.8, 137.9, 138.2, 149.4. 
MALDI-HRMS (matrix: dithranol) m/z calcd for [M+H]
+
 C36H48NO4S3 654.2745 found 
654.2767. 
 
Dithiol 4.6  
 An oven-dried 250 mL three-necked rb flask equipped with a gas inlet, 




(10.1 g, 15.4 mmol) in benzene (20 mL). The solution was concentrated under a stream 
of argon at 80°C, and diglyme (62 mL) was added. The mixture was stirred in an ice 
bath, and dibutylmagnesium solution (1 M in heptane, 62 mL) was added at a rate such 
that the temperature did not rise above 15°C. The Ar flow rate was then increased, the 
rubber septum was removed, solid Cp2TiCl2 (384 mg, 1.54 mmol) was added, and the 
septum was quickly replaced. The ice bath was removed after 5 min, and after 30 min the 
reaction was quenched with methanol (10 mL).  The mixture was treated with citrate 
buffer (0.5 M trisodium citrate, 0.5 M citric acid, 120 mL), diluted with water (200 mL), 
and extracted with MTBE (250 mL). The organic layer was back-extracted with 5% aq. 
NaOH + methanol (3 x (60 mL + 10 mL)). The combined aqueous extracts were washed 
with hexanes (200 mL), acidified with citrate buffer (100 mL) + 1 M HCl (180 mL), and 
the resulting emulsion was extracted with 1:1 MTBE-toluene (300 mL). The extract was 
washed with water (3 x 500 mL), dried with MgSO4, and concentrated to give the product 
as a pale pink oil. Yield 6.82 g (93%).  
1
H NMR (CDCl3) δ 1.16 (t, J = 9.2 Hz, 1H), 1.35 
(t, J = 8.8 Hz, 1H), 1.38 (s, 3H), 1.39 (s, 3H), 1.43 (s, 3H), 1.47 (s, 3H), 2.74 (d, J = 8.8 
Hz, 2H), 2.80 (d, J = 9.2 Hz, 2H), 3.35 (d, J = 6.4 Hz, 2H), 3.70 (d, J = 11.8 Hz, 2H), 
3.75 (d, J = 11.8 Hz, 2H), 3.78 (s, 4H), 5.16 (t, J = 6.4 Hz, 1H), 6.65 (td, J = 7.5, 1.2 Hz, 
1H), 6.79 (dd, J = 8.3, 1.1 Hz, 1H), 7.22 (ddd, J = 8.5, 7.5, 1.6 Hz, 1H), 7.43 (dd, J = 7.6, 
1.6 Hz, 1H). 
13
C NMR (CDCl3) δ 22.5, 23.2, 24.2, 24.7, 27.2 (2C), 37.6, 37.90, 37.92, 
45.2, 65.1, 66.0, 98.4, 98.6, 110.5, 117.4, 117.6, 130.5, 136.0, 149.3. EI-MS m/z 473 
([M]
+
, 100), 458 (25), 312 (48), 254 (49), 137 (30), 136 (64), 87 (21). ). EI-HRMS m/z 
calcd for [M]
+
 C22H35NO4S3 473.1728, found 473.1731. 
 
Macrocycle 4.7  
 Solutions of dithiol 4.6 (6.81 g, 14.4 mmol) and 1,3-diiodopropane (4.25 g, 14.4 
mmol) in DMF (each 23 mL total volume) were added via a syringe pump over 18 h to a 




(internal temperature). After cooling, the liquid phase was decanted, and the solid was 
washed with warm xylenes (3 x 100 mL). The combined liquid phases were concentrated 
to dryness, and the residue was stirred in toluene (250 mL). After 10 min, the mixture 
was filtered through Celite and concentrated to dryness. The residue was purified by 
column chromatography (hexane-MTBE), and crystallized from boiling cyclohexane (20 
mL) by addition of hexanes (25 mL) under stirring to give the product as a colorless 
crystalline powder. Yield 4.91 g (66%).  Mp 123-123.5 °C 
1
H NMR (CDCl3) δ 1.41 (s, 
3H), 1.45 (s, 3H), 1.48 (s, 3H), 1.95 (p, J = 6.6 Hz, 2H), 2.66 (s, 2H), 2.77 (t, J = 6.6 Hz, 
2H), 2.82 (t, J = 6.7 Hz, 2H), 2.85 (s, 2H), 2.94 (s, 2H), 3.52 (d, J = 7.0 Hz, 2H), 3.67 (d, 
J = 11.9 Hz, 2H), 3.73 (d, J = 11.4 Hz, 2H), 3.75 (s, 4H), 5.58 (t, J = 7.0 Hz, 1H), 6.62 
(td, J = 7.4, 1.2 Hz, 1H), 6.89 (dd, J = 8.3, 1.1 Hz, 1H), 7.20 (ddd, J = 8.5, 7.5, 1.6 Hz, 
1H), 7.42 (dd, J = 7.6, 1.6 Hz, 1H). 
13
C NMR (CDCl3) δ 20.9, 22.7, 24.6, 26.6, 27.8, 
31.4, 31.8, 34.9 (2C), 37.8, 38.5, 39.7, 44.8, 65.8, 66.7, 98.4, 98.5, 110.7, 117.0, 117.1, 
130.4, 136.2, 150.2. EI-MS m/z 513 ([M]
+
, 100), 498 (27), 220 (18), 150 (33), 137 (80), 
136 (74), 83 (18). EI-HRMS m/z calcd for [M]
+
 C25H39NO4S3 513.2041, found 513.2042. 
 
Bromide 4.8  
 Macrocycle 4.7 (3.43 g, 6.68 mmol) was dissolved in CH2Cl2 (25 mL, dried over 
4Å ms) in a 50 mL three-necked flask equipped with a gas inlet, thermometer, and stir 
bar. The mixture was cooled in an ice bath under Ar, and solid 2,4,4,6-
tetrabromocyclohexadienone (4.10 g of 80% pure material, 8.0 mmol) was added in small 
portions against a gentle argon current at 0-10°C.  After 10 minutes, the reaction was 
quenched with a solution of Na2SO3 (1.7 g, 13 mmol) and 20% aq. NH3 (1.2 mL, 13 
mmol) in H2O (20 mL), then diluted with MTBE (100 mL). The aqueous layer was 
removed, and the organic layer was washed with water + 5% aq. NaOH (3 x (100 mL + 
10 mL)), dried with Na2SO4, and concentrated. The residue was taken up in boiling 




the product as a colorless crystalline powder. Yield 2.78 g (72%). Mp 121-122.5°C. 
1
H 
NMR (CDCl3) δ 1.41 (s, 3H), 1.43 (s, 3H), 1.45 (s, 3H), 1.47 (s, 3H), 1.95 (p, J = 6.6 Hz, 
2H), 2.60 (s, 2H), 2.77 (t, J = 6.5 Hz, 2H), 2.81 (t, J = 6.7 Hz, 2H), 2.83 (s, 2H), 2.94 (s, 
2H), 3.52 (d, J = 7.0 Hz, 2H), 3.62 (d, J = 12.1 Hz, 2H), 3.71 (d, J = 12.1 Hz, 2H), 3.74 
(s, 4H), 5.60 (t, J = 7.0 Hz, 1H), 6.81 (d, J = 8.8 Hz, 1H), 7.27 (dd, J = 8.8, 2.4 Hz, 1H), 
2.53 (d, J = 2.4 Hz, 1H). 
13
C NMR (CDCl3) δ 20.4, 20.8, 24.4, 27.0, 27.6, 31.3, 31.9, 
34.9, 35.0, 37.7, 38.5, 39.7, 44.7, 65.7, 66.7, 98.5, 98.6, 107.6, 112.2, 118.6, 133.0, 137.9, 
149.3. EI-MS m/z 593 (100), 591 ([M]
+
, 92), 578 (14), 576 (13), 217 (50), 215 (50), 214 
(40), 83 (39). EI-HRMS m/z calcd for [M]
+
C25H38NO4S3Br 591.1146, found 591.1145. 
 
Aldehyde 4.9  
 Bromide 4.8 (2.59 g, 4.37 mmol) was added to an oven-dried two-necked flask 
equipped with a thermometer and magnetic stir bar, and the flask was sealed with a 
rubber septum and flushed with argon. Dry Et2O (48 mL) was added, and the mixture 
was stirred until the bromide completely dissolved, then cooled in a dry ice-acetone bath. 
n-Butyllithium solution (2.5 M in hexanes, 3.5 mL, 8.7 mmol) was added dropwise at a 
rate such that the temperature did not exceed -60°C. tert-Butyllithium solution (1.6 M in 
pentane, 8.2 mL, 13 mmol; Caution: highly pyrophoric) was then added likewise. After 
30 minutes, dry DMF (2.7 mL, 35 mmol) was added, the dry ice bath was removed, and 
the reaction was quenched with methanol (5 mL) once the internal temperature reached -
30 °C. The mixture was then partitioned between toluene (70 mL) and water (70 mL). 
The aqueous layer was removed, and the organic layer was washed with water (3 x 70 
mL) followed by brine (10 mL), dried with MgSO4, stirred with silica gel (5 g) and 
filtered. The drying agent and silica were washed with MTBE, and the combined filtrates 
were concentrated under reduced pressure to give a brown oil. This material crystallized 
from boiling cyclohexane-ethyl acetate (30 mL + 5 mL), and the colorless crystalline 






NMR (CDCl3) δ 1.42 (s, 3H), 1.43 (s, 3H), 1.46 (s, 3H), 1.50 (s, 3H), 1.97 (p, J = 6.4 Hz, 
2H), 2.58 (s, 2H), 2.81-2.86 (m, 6H), 2.93 (s, 2H), 3.60 (d, J = 12.2 Hz, 2H), 3.70-3.74 
(m, 4H), 3.76 (s, 4H), 6.44 (t, J = 7.0 Hz, 1H), 7.02 (d, J = 8.6 Hz, 1H), 7.71 (dd, J = 8.6, 
2.0 Hz, 1H), 7.98 (d, J = 2.0 Hz, 1H), 9.69 (s, 1H). 
13
C NMR (CDCl3) δ 19.8, 22.6, 24.6, 
27.1, 27.6, 31.1, 32.2, 34.8, 35.0, 37.6, 38.7, 39.7, 43.8, 65.6, 66.7, 98.5, 98.6, 109.6, 
116.9, 126.3, 133.4, 138.8, 154.8, 189.5. EI-MS m/z 541 ([M]
+
, 100), 526 (16), 178 (18), 
165 (87), 164 (53), 83 (29).  EI-HRMS m/z calcd for [M]
+
 C26H39NO5S3 541.1990, found 
541.1996. 
 
Chalcone 4.10  
 Aldehyde 4.9 (523 mg, 965 µmol) and 4-cyanoacetophenone (147 mg, 1.01 
mmol) were dissolved in ethanol (5 mL) + MTBE (2.5 mL) at 63°C (bath temperature). 
Pyrrolidine (160 µL, 1.9 mmol) was added, and the flask was sealed with a Teflon 
stopper. After 2 hours, a 150 µL aliquot of the reaction mixture was transferred to a glass 
vial, concentrated to dryness, and crystallized from CH2Cl2-hexanes (0.3 mL each). The 
crystal slurry was concentrated to dryness, taken up in MTBE, and added back to the 
reaction mixture, which rapidly transformed from a deep red solution to an orange 
crystalline slurry. The mixture was stirred for 1 h at 63°C, then for 36 h at 45-50°C.  
After cooling slowly to 4°C, the product was collected by filtration, washed with cold 
ethanol, and dried to give the product as an orange crystalline powder. Yield 588 mg 
(91%). Mp 148-151°C. 
1
H NMR (CDCl3) δ 1.43 (s, 6H), 1.46 (s, 3H), 1.51 (s, 3H), 1.97 
(p, J = 6.4 Hz, 2H), 2.58 (s, 2H), 2.81-2.86 (m, 6H), 2.98 (s, 2H), 3.62 (d, J = 12.1 Hz, 
2H), 3.69-3.74 (m, 4H), 3.77 (s, 4H), 6.27 (t, J = 7.1 Hz, 1H), 7.00 (d, J = 8.7 Hz, 1H), 
7.26 (d, J = 15.4 Hz, 1H), 7.54 (dd, J = 8.7, 2.1 Hz, 1H), 7.74 (d, J = 15.4 Hz, 1H), 7.77-
7.80 (m, 3H), 8.05-8.08 (m, 2H). 
13
C NMR (CDCl3) δ 19.8, 23.4, 23.9, 27.1, 27.7, 31.3, 
32.2, 35.0, 35.2, 37.7, 38.8, 39.7, 44.0, 65.6, 66.8, 98.6, 98.7, 110.5, 115.4, 116.3, 117.1, 






, 100), 653 (10), 305 (18), 292 (75), 291 (52), 130 (17), 83 (20). EI-HRMS m/z 
calcd for [M]
+
 C35H44N2O5S3 668.2412, found 668.2413. 
 
Triarylpyrazoline 4.3 ammonium salt  
 A mixture of chalcone 4.10 (56.7 mg, 85 µmol), methanol (3 mL), and 1 M aq. 
HCl 68 µL) was boiled under stirring in a 90°C bath until the starting material dissolved 
completely (10 min). Water (0.8 mL) was then added, and the mixture was concentrated 
to ca. 1 mL. Ethanol (3 mL) was added, and the mixture was concentrated to dryness. 
Water (1 mL), ethanol (1.2 mL), 4-hydrazinobenzenesulfonic acid hemihydrate (25 mg, 
130 µmol) and pyridine (16 µL, 200 µmol) were added.  The reaction vessel was flushed 
with Ar, sealed, and stirred at 90°C for 16 h. The mixture was allowed to cool, then 
concentrated to dryness under a stream of Ar in a 35°C bath. The residue was completely 
dissolved in aq. NH4HCO3 (34 mg, 420 µmol, 3 mL), concentrated to dryness, 
redissolved in 4 mL water, and subjected to RP-HPLC to give the product as a yellow 
glassy solid after redissolution in methanol to decompose NH4HCO3 followed by drying 
under high vacuum. Yield 50.4 mg (82%). HPLC tr = 16.8 min. (gradient 0-20 min., 28% 
to 35% MeCN / 0.5% aq. NH4HCO3 at 4 mL/min, 30 x 1 cm C18 column). 
1
H NMR 
(CD3OD, 25°C) δ 1.83 (p, J = 6.9 Hz, 2H), 2.54 (t, J = 6.8 Hz, 2H), 2.57 (overlapping t, J 
≈ 7 Hz), 2.60 (s, 2H), 2.75 (s, 2H), 2.87 (d, J = 12.5 Hz, 1H), 2.92 (d, J = 12.5 Hz, 1H), 
3.10 (dd, J = 17.4, 6.2 Hz, 1H), 3.18 (s, 2H) 3.47 (d, J = 11.1 Hz, 1H), 3.51 (d, J = 11.1 
Hz, 1H), 3.53-3.56 (m, 6H), 3.80 (dd, J = 17.4, 12.3 Hz, 1H), 5.37 (dd, J = 12.3, 6.2 Hz, 
1H), 6.66 (d, J = 8.6 Hz, 1H), 6.97 (dd, J = 8.5, 2.2 Hz, 1H), 7.10 (ad, J = 9.0 Hz, 2H), 
7.27 (d, J = 2.2 Hz, 1H), 7.62 (ad, J = 9.0 Hz, 2H), 7.70 (ad, J = 8.7 Hz, 2H), 7.86 (ad, J 
= 8.7 Hz, 2H). 
13
C NMR (CD3OD) δ 30.0, 32.1, 32.4, 33.9, 34.9, 40.1, 43.6, 45.9, 46.0, 
46.4, 65.0 (br, 2C), 65.06, 65.12, 65.16, 111.7, 112.3, 114.1, 119.8, 120.9, 127.4, 127.9, 
128.0, 130.7, 133.5 (3C, 2 equivalent, 1 coincident) 136.7, 138.5, 146.6, 147.8, 150.1. 
ESI-HRMS m/z calcd for [M]
-








 p-Dimethylaminobenzaldehyde (744 mg, 4.99 mmol) and 4-acetylbenzonitrile 
(742 mg, 5.11 mmol) were stirred in ethanol (5 mL) until completely dissolved. 
Pyrrolidine (209 µL, 2.5 mmol) was added, and the mixture was stirred rapidly for ~ 20 
min. until a red precipitate began to form then stirred slowly overnight. After 14 hours, 
the mixture was diluted with ethanol (7 mL) and cooled to 0°C, and the product was 
collected by filtration, washed with cold ethanol, and dried. Yield 1.24 g (90%). 
1
H NMR 




Chalcone triflate 4.13  
 Chalcone 4.12 (655 mg, 2.37 mmol) was completely dissolved in CH2Cl2, (10 
mL) and methyl triflate (402 µL, 3.56 mmol) was added dropwise to the stirred solution. 
After 20 h, the precipitated product was collected by filtration, washed with CH2Cl2 
followed by diethyl ether, and dried under vacuum to give the product as an off-white 
crystalline powder. Yield 964 mg (92%).  Mp 224-225°C. 
1
H NMR (DMSO-d6) δ 3.66 (s, 
9H), 7.85 (d, J = 15.7 Hz, 1H), 8.05-8.13 (m, 5H), 8.19 (ad, J = 9.1 Hz, 2H), 8.33 (ad, J = 
8.6 Hz, 2H). 
19
F NMR (DMSO-d6) δ –77.3 (s, 3F). ESI-HRMS m/z calcd for [M]
+
 
C19H19ON2 291.1492, found 291.1484.  
 
Triarylpyrazoline 4.11 
  Chalcone 4.13 (490 mg, 1.11 mol), 4-hydrazinobenzenesulfonic acid hemi-
hydrate (241 mg, 1.22 mmol), pyridine (136 µL, 1.67 mmol) and methanol (4 mL) were 
stirred overnight in a sealed vessel under Ar at 75°C. After cooling, the mixture was 
diluted with water + 20% aqueous ammonia (4 mL + 0.15 mL) and stirred for 1 h at 0°C. 
A yellow powder (390 mg) was collected by filtration and determined by 
1
H NMR 




acid (3 mL) + water (1 mL) for 3 hours at 100°C under Ar. After cooling, the reaction 
mixture was diluted with CH3CN under rapid stirring, and the resulting yellow crystalline 
powder was collected by filtration, washed with MeOH, and dried under vacuum to give 
11 as a fine orange powder. Yield 220 mg (43% overall). To prepare an analytical 
sample, the product was dissolved in a minimum volume of 2,2,2-trifluoroethanol, 
filtered through a tight cotton plug, and diluted 10-fold with water to give yellow needles 
after standing overnight. The needles crumbled to a fine orange powder upon drying. Mp 








H NMR (2 M LiCl in 
CD3OD, 35°C) δ 3.17 (dd, J = 17.6, 5.8 Hz, 1H), 3.73 (s, 9H), 4.05 (dd, J = 17.6, 12.4 
Hz, 1H), 5.78 (dd, J = 12.4, 5.8 Hz), 7.09 (ad, J = 8.9 Hz, 2H), 7.57 (ad, J = 9.1 Hz, 2H), 
7.61 (ad, J = 8.9 Hz, 2H), 7.77 (ad, J = 8.5 Hz, 2H), 7.94 (ad, J = 8.5 Hz, 2H), 8.02 (ad, J 
= 9.1 Hz). ESI-HRMS m/z calcd for [M+H]
+
 C25H25O3N4S 461.1642, found 461.1636. 
 
4.12.2. Steady-state absorption and fluorescence spectroscopy 
 Sample solutions were filtered through 0.45 m nylon membrane filters to 
remove interfering dust particles or fibers. UV-vis absorption spectra were recorded at 22 
°C using a Varian Cary Bio50 UV-vis spectrometer with constant-temperature accessory. 
Steady-state emission and excitation spectra were recorded with a PTI fluorimeter at 
ambient temperature (22 ± 2°C). Path lengths were 1 cm with a cell volume of 3.0 mL. 
The fluorescence spectra have been corrected for the spectral response of the detection 
system (emission correction file provided by instrument manufacturer) and for the 
spectral irradiance of the excitation channel (via a calibrated photodiode). The mole-ratio 
titration with Cu(I) was carried out by addition of aqueous copper (II) sulfate stock 
solution to a  4.6 M working solution of probe 4.3 under argon in deoxygenated MOPS-
K
+
 buffer containing 100 µM sodium ascorbate as a reducing agent. The fluorescence 




methanol were determined at 380 nm excitation using norharmane in 0.1 N H2SO4 as the 
fluorescence standard (f = 0.58)
23
 with a 10 cm path length for absorbance 
measurements to provide high accuracy.  Other fluorescence quantum yields were 
subsequently determined using 4.11 in MOPS buffer as the fluorescence standard with 1 
cm path lengths for both absorption (380 nm) and fluorescence measurements. 
 
4.12.3. Analyte selectivity of probe 4.3 
 A 4.6 µM solution (100 mL) of 4.3 in 10 mM pH 7.2 MOPS buffer was prepared 
and the fluorescence spectrum was recorded over the emission range 400 to 700 nm with 
380 nm excitation. Each cation tested was added to a 3 mL aliquot of the probe solution. 
The solution was mixed thoroughly, and the fluorescence spectrum was recorded after a 1 
minute equilibration period. Emission spectra were integrated over the range of 486-526 
nm, and the resulting intensities were divided by that of the free probe. Metal cations 
were supplied as aqueous stock solutions of the following salts: Mg(II), Ca(II), Co(II), 
and Ni(II) as nitrates, Na
+
 as NaClO4, Cd(II) as CdCl2, Hg(II) as Hg(OAc)2, and Mn(II), 
Fe(II), Cu(II) and Zn(II) as sulfates. Cu
I
(MeCN)4PF6 was supplied as a 2.5 mM stock 
solution in MeCN. To avoid aerial oxidation, Fe(II) stock solution was prepared 
immediately before use. 
 
4.12.4. Time-resolved fluorescence spectroscopy 
 Fluorescence decay data of 4.3-Cu(I) (5 µM), CTAP-2-Cu(I) (5 µM), and 4.11 (2 
µM) were acquired at the respective emission maxima using a single photon counting 
spectrometer (Edinburgh Instruments, LifeSpec Series) equipped with a pulsed laser 
diode as the excitation source (372 nm, FWHM = 80 ps, 10 MHz repetition rate, 1024 




prepared based on steady-state fluorescence titrations as described above, and the steady 
state spectrum was checked after each decay measurement to confirm stability of the 
solution. Probe 4.3-Cu(I) solutions were found to be unstable in air saturated solution, so 
the fluorescence decay profiles of both probe-Cu(I) complexes were subsequently 
acquired under deoxygenated conditions. To ensure a relevant comparison, the 
fluorescence decay of 4.11 in H2O was measured under both air-saturated and 
deoxygenated conditions, and the two fluorescence lifetimes were the same within 
experimental error (2.07 and 2.09 ns, respectively). The time decay data were analyzed 
by non-linear least squares fitting with deconvolution of the instrumental response 
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RAISING THE BAR: IMPROVING THE MAXIMUM 
FLUORESCENCE CONTRAST RATIO AND QUANTUM YIELD 
AVAILABLE FOR AQUEOUS COPPER(I) PROBES BY 





5.1. Introduction:  
 In the previous chapter, we attempted to improve upon the fluorescence contrast 
ratio and quantum yield offered by our aqueous Cu(I)-probe CTAP-2
1
 using a new ligand 
design strategy previously demonstrated to improve these parameters in methanolic 
Cu(I)-probes.
2
 This entailed fusion of the PET donor aryl ring to the Cu(I)-ligand 
backbone while retaining all other design features of CTAP-2, including the sulfonated 
triarylpyrazoline fluorophore, the macrocyclic ligand topology, and two geminal pairs of 
hydroxymethyl groups attached to the three-carbon bridges of the ligand structure. While 
the new design (probe 4.3) did not yield the expected improvements in contrast ratio and 
quantum yield, it did provide a strong and highly selective fluorescence turn-on response 
to Cu(I) with a reduced pH sensitivity compared to CTAP-2. More importantly, we 
uncovered the primary factors limiting the fluorescence response of CTAP-2 and 4.3 to 
Cu(I) in aqueous solution, which are incomplete Cu-N coordination resulting in residual 
PET in the probe-Cu(I) complex and fluorescence quenching by excited-state proton 
transfer (ESPT).
3
 In this chapter, both of these issues are addressed by iterative 




improvement in both the fluorescence contrast ratio and quantum yield available from 
aqueous Cu(I)-probes. 
 
5.2. Improving the intrinsic fluorophore quantum yield in aqueous solution 
5.2.1. Suppression of ESPT by electron-withdrawing substituents 
   As discussed in Chapter 4, the intrinsic fluorescence quantum yield of the 
CTAP-2 fluorophore is significantly limited by ESPT in neutral aqueous solution. This 
was shown for the trimethylammonium analog 4.11 by substantial solvent deuterium 
isotope effects on the fluorescence quantum yield and lifetime, which both increased by 
over 70% in D2O versus H2O solution.
3
 Although the ESPT pathway appears to be 
suppressed for 4.11 in methanol, triarylpyrazolines lacking strong electron-withdrawing 
groups do show strong solvent isotope effects in methanolic solution, and the magnitude 
of the effect is significantly influenced by the electron-donating or withdrawing character 
of substituents on the 1-aryl ring.
4
 For example, the parent 1,3,5-triphenylpyrazoline 
shows an increase in fluorescence quantum yield of 1.31-fold in CH3OD vs. CH3OH, but 
the effect increases to 1.71-fold when an amino-group is placed at the para-position of the 
1-aryl ring. By contrast, the effect is reduced to 1.13-fold by a cyano-group and 1.06-fold 
by a nitro-group at the same position. The substitution pattern of the 3-aryl ring appears 
to be less important, as a para-amino group on this ring increases the solvent isotope 
effect only slightly to 1.46-fold.
4
 
 Interestingly, the above data mirror trends in the fluorescence quantum yields of 
1,3,5-triarylpyrazolines reported earlier by Rivett et al, who noted that the quantum 
yields in methanolic solution are increased by electron-withdrawing substituents and 
strongly diminished by electron-donating substituents on the 1-aryl ring, while no such 
effect is observed in cyclohexane solution.
5




these para-substituted triarylpyrazolines in Table 5.1, the effects on fluorescence 
quantum yield correlate with the Hammett constants (σp) of the 1-aryl substituents, with 
stronger electron-withdrawing groups giving greater improvements in fluorescence 
quantum yield, while substituents on the 3-aryl ring exert a similar but substantially 
weaker effect. 
 
Table 5.1: Relative Fluorescence quantum yield versus Hammett substituent constant for 










OMe -0.27 <0.05 0.39 
H 0 0.46 0.46 
Cl 0.23 0.52 0.51 
CN 0.66 0.91 0.66 
SO2Me 0.72 1.00 0.85 
a




Relative fluorescence quantum 




 Based on the data presented above, the adverse effect of ESPT on the 
fluorescence quantum yields of 1,3,5-triarylpyrazolines in methanolic solution can be 
abolished by substitution of the 1-aryl ring with sufficiently powerful electron-
withdrawing groups. It appears that this effect can also be harnessed in aqueous solution 
given the high fluorescence quantum yield (0.62) of the difluorinated CTAP-2 analog 
3.3c under acidic conditions (Chapter 3). Increasing the electron-withdrawing power of 
the 1-aryl ring, however, also results in a blue shift in absorption and emission 
wavelengths, which corresponds to a higher excited-state energy and thus a greater PET 
driving force. For Cu(I)-probes, the benefit of ESPT inhibition may be overpowered by a 
large increase in PET driving force if the 1-aryl ring is too electron-deficient, as 




5.2.2. A sulfonamide-substituted triarylpyrazoline fluorophore with high 
fluorescence quantum yield in aqueous solution 
5.2.2.1. Fluorophore design 
 Considering that the CTAP-2 fluorophore suffers from significant ESPT-mediated 
quenching while its difluorinated analog 3.3c gives an excessive PET driving force, the 
monofluorinated derivative 3.3b might be expected to provide an ideal compromise in 
electron-withdrawing character of the 1-aryl ring. This compound, however, gave only a 
slight improvement over CTAP-2 for the fluorescence quantum yield in acidic solution 
(0.31 vs. 0.25) but a 2.5-fold reduction in quantum yield of the Cu(I)-saturated form 
(0.033 vs. 0.083). Therefore, we investigated an alternative set of electron-withdrawing 
substituents. 
 We had previously considered the use of sulfonamide moieties as electron-
withdrawing groups for water-soluble electronically tuned triarylpyrazoline fluorophores, 
particularly as an alternative to the 3-aryl cyano-substituent that would facilitate future 
design elaboration, such as conjugation to a protein or auxiliary fluorophore, via N-
alkylation. As indicated by the Hammett substituent constant σp of 0.65 for the 
dimethylaminosulfonyl (-SO2NMe2) group, the electron-withdrawing power of an S-
linked sulfonamide substituent is quite similar to that of a cyano-group (σp = 0.66) and 
significantly greater than that of a sulfonate moiety (σp = 0.36).
6
 Therefore, replacing the 
1-aryl sulfonate in addition to the 3-aryl cyano-group of the CTAP-2 fluorophore with 
sulfonamide moieties would be expected to reduce fluorescence quenching by ESPT. To 
maintain high aqueous solubility, the sulfonamide nitrogens can be functionalized with 
ionizable groups. For this purpose we chose ethanesulfonic acid units, thus permitting 
characterization over a large pH range while introducing minimal additional hydrophobic 
surface area. For initial evaluation of this fluorophore design, a 5-aryl dimethylamino-




concentrations, thus reducing the potential for interference from the acid-mediated ESPT 
quenching pathway (Chapter 4) during characterization. The chosen design (compound 
5.1) is shown in Figure 5.1. 
 
 




 The triarylpyrazoline core of 5.1 was assembled via an analogous route to the 
compounds described in Chapters 3 and 4: The sulfonamide-substituted arylhydrazine 5.2 
was prepared from 4-fluorobenzenesulfonyl chloride by reaction with aqueous 
methylamine followed by nucleophilic aromatic substitution with hydrazine. The 
sulfonamide-substituted acetophenone 5.3, also obtained by reaction of a commercially 
available sulfonyl chloride with methylamine, was subjected to pyrrolidine-catalyzed 
condensation with p-dimethylaminobenzaldehyde to give chalcone 5.4 followed by acid-










 As shown above, the secondary sulfonamide moieties of 5.5 were functionalized 
to give the sulfonyl fluoride intermediate 5.6 by base-catalyzed conjugate addition to the 
potent Michael acceptor ethenesulfonyl fluoride (ESF). Interestingly, no literature 
precedent could be found for this reaction, and ESF in the absence of base has in fact 
been employed to selectively functionalize other nucleophilic moieties in the presence of 
primary or secondary sulfonamides.
7
 The sulfonyl fluoride moieties were hydrolyzed to 
sulfonate anions using a triethylamine-water-acetonitrile mixture, which also gave 
moderate amounts of secondary sulfonamide side products, apparently by a competing 
base-catalyzed elimination reaction. Nevertheless, the desired triarylpyrazoline could be 
purified by HPLC using an ammonium bicarbonate-containing mobile phase, and was 
obtained in good yield as a mixed ammonium-triethylammonium salt. 
 
5.2.2.3. Characterization and evaluation 
 Triarylpyrazoline 5.1 was found to be freely soluble in water, giving very weak 
fluorescence at neutral pH and bright fluorescence upon acidification. In 1 mM HCl, 
where the dimethylamino-group is expected to be completely protonated, 5.1 gave a 
fluorescence quantum yield of 0.59, which is more than double that of protonated CTAP-
2 or its quaternary ammonium fluorophore analog 4.11, at the expense of only a small 

















387 491 2.87 0.006
c 
1 mM HCl 383 491 2.88 0.59 








CTAP-2 5 mM HCl 388 512 2.82 0.25 
3.3b 5 mM HCl 367 502 2.92 0.31 
3.3c 5 mM HCl
 
348 478 3.08 0.62 
a
 10 mM MOPS pH 7.2. 
b
 Estimated as the mean of the excitation and 
emission energies. 
c
 This value decreased to 0.002 upon addition of 10 mM 
NaOH. 
d
 Calculated from Φf in 1 mM HCl and the respective fluorescence 
lifetimes assuming no change in kr (see Table 5.3). 
 
 Notably, 5.1 has a longer wavelength absorption maximum and similar excited-
state energy compared to the monofluorinated CTAP-2 analog 3.3b, but the fluorescence 
quantum yield is substantially higher. Based on a computationally derived effective 
Hammett substituent constant of σc = 0.28 for an ortho-fluoro-substituent,8 the combined 
electron-withdrawing power of the 1-aryl -F and -SO3
-
 substituents of 3.3b (Σσ = 0.64) is 
expected to be similar to that of the 1-aryl sulfonamide substituent of 5.1 (σp = 0.65).   
Based on the above data and given the similar electron-withdrawing ability of cyano- and 
dialkylaminosulfonyl-groups, it appears that the sulfonamide moieties of 5.1 provide a 
greater fluorescence quantum yield in aqueous solution than a combination cyano, fluoro- 
and sulfonate substituents with comparable overall electron-withdrawing power. 
 





 While the arenesulfonamide compound 5.1 clearly provides a superior 
fluorescence quantum yield in aqueous solution compared to the arenesulfonate-based 
triarylpyrazoline fluorophore of CTAP-2 and 4.11, we questioned whether such a large 
effect could be fully explained by ESPT inhibition mediated by the greater electron-
withdrawing power of a sulfonamide versus a sulfonate substituent on the 1-aryl ring, 
especially given the lower quantum yield of the electronically similar triarylpyrazoline 
3.3c (see above). The 3-aryl cyano-group of the previous sulfonated triarylpyrazolines 
might itself serve as a proton acceptor in the excited state, an effect  previously noted for 
cyano-substituted donor-acceptor biphenyls.
9
 If this were the case, then the fluorescence 
quantum yield in aqueous solution might be improved without increasing the PET driving 
force simply by replacing the 3-aryl cyano-group with a comparably electron-
withdrawing sulfonamide substituent without modification of the 1-aryl ring. To test this 
possibility, we prepared reference compound 5.7, a direct analog of 4.11 containing a 











 Compared to 4.11, triarylpyrazoline 5.7 gave very similar spectral properties, with 
a slight blue shift in absorption and emission maxima from 387 and 511 nm to 381 and 
508 nm for 4.11 and 5.7, respectively. The fluorescence quantum yield in neutral aqueous 
solution was also nearly identical for the two compounds, increasing only from 0.28 to 
0.30. Therefore, it appears that the change from a cyano- to a sulfonamide substituent at 
the 3-aryl ring does not explain the greatly increased fluorescence quantum yield of 5.1. 
Furthermore the fluorescence quantum yield of 5.7 increased from 0.30 in H2O to 0.50 in 
D2O, demonstrating a nearly identical solvent isotope effect to that of 4.11 (1.67 vs. 
1.71), and implying that ESPT-mediated quenching is equally important for the two 
compounds. 
 To determine whether ESPT inhibition is indeed the primary factor responsible 
for the improved fluorescence quantum yield of sulfonamide-substituted triarylpyrazoline 
5.1 relative to the sulfonate 4.11, we measured the fluorescence decay profiles of 5.1 in 
acidified H2O and D2O by picosecond time-resolved fluorescence spectroscopy as 
previously described in Chapter 4 to determine the solvent isotope effect on the 









  As shown above, the difference in the fluorescence decay profile of 5.1 in D2O 
versus H2O is rather small. In fact, the fluorescence lifetime of 5.1 increased by only 19% 
from 3.38 ns in H2O to 3.99 ns in D2O (Table 5.3), which stands in marked contrast to the 
72% increase observed for 4.11. The fluorescence quantum increased proportionally to 
the lifetime, indicating that the isotopic composition of the solvent affects only the 
nonradiative deactivation rate constant knr and not the radiative deactivation rate constant 
kr. Estimating the rate constant of ESPT in H2O as kESPT =  knr(H2O) - knr (D2O) yields a 









 for 4.11. Additionally, kr is slightly higher for 5.1, but this effect is less 





Table 5.3: Fluorescence decay data for compound 5.1 versus 4.11 in H2O and D2O 
















 1 mM HCl in H2O 3.38 0.973 1.75 1.21 
5.1 5 mM HCl in H2O 3.13 1.08 1.75
e
 1.45 
 1 mM DCl in D2O 3.99 1.06 1.75 0.76 
4.11 
H2O 2.07 1.17 1.35 3.48 
D2O 3.36 1.03 1.35 1.46 
a
 Goodness-of-fit parameter. All fits include a risetime of 0.25-0.4 ns.
 b
 kr =  Φf/τf. 
c
 knr = (1− Φf)/ τf. 
d
 The third digit is not significant in absolute terms but is 






 Concluding from the above data, it appears that replacing the 1-aryl sulfonate of 
the CTAP-2 fluorophore by a more electron-withdrawing sulfonamide substituent 
produces a large increase in fluorescence quantum yield in aqueous solution due 
primarily to inhibition of ESPT in addition to a small contribution from an increased kr. 
 
5.3. Testing the new sulfonamide-based fluorophore with an existing Cu(I)-ligand 
design 
5.3.1. Probe design 
 While the bis-sulfonamide fluorophore of 5.1 provides a substantially larger 
fluorescence quantum yield than the CTAP-2 fluorophore in the absence of PET 
quenching, its utility for Cu(I) probes will depend on the PET driving force it provides 
with the available Cu(I)-ligand-PET donor designs. As discussed in the previous section, 
the fluorophore of 5.1 is expected to be electronically similar to that of the 
monofluorinated CTAP-2 analog 3.3b, and is therefore likely to provide a somewhat 




with the same Cu(I)-ligand moiety. The difference in PET driving force between the two 
fluorophore designs cannot be estimated directly from the Rehm-Weller equation 
(Chapter 2), because the reduction potentials of 1,3,5-triarylpyrazolines are typically well 
outside of the accessible window in aqueous solution. Therefore, before optimizing the 
ligand design, we gauged the PET driving force of the new bis-sulfonamide fluorophore 
by combining it with the integrated arylamine thiazacrown ligand of the CTAP-2 analog 
4.3 (Chapter 4), allowing a side-by-side comparison of the two fluorophore designs with 




Figure 5.4: Structures of Cu(I)-probes 4.3 and 5.8 
 
5.3.2. Synthesis 
 Probe 5.8 was synthesized analogously to 5.1 using the previously prepared 




5.9, which was converted to triarylpyrazoline 5.10 in good yield using a one-pot 
procedure involving cleavage of the acetonide moieties, acid-catalyzed condensation with 
arylhydrazine 5.2 in methanolic solution, and re-acetalization with 2,2-
dimethoxypropane. In the initial acetonide cleavage step, the volatile byproducts are 
evaporated under a stream of inert gas before addition of the arylhydrazine, thus 
preventing its conversion to the corresponding acetone hydrazone and providing a shorter 
reaction time and higher yield than the two-step method previously employed for the 
CTAP-2 series.   
 The sulfonamide NH moieties of triarylpyrazoline 5.10 were readily 
functionalized with ESF under basic conditions without significant alkylation of the 
arylamine NH. Notably, this chemoselectivity is exactly opposite to that previously 
reported in the literature for an arylamine-sulfonamide substrate heated with ESF in DMF 
solution.
7
 Furthermore, the sulfonyl fluoride moiety itself is unreactive toward 
sulfonamide formation with arylamines even at elevated temperatures,
7
 and thus should 
be compatible with a wide variety of secondary amine Cu(I)-ligand designs. The sulfonyl 
fluoride 5.11 was hydrolyzed by a one-pot, two-step procedure involving addition of 
aqueous HCl to a solution of the substrate in acetonitrile to hydrolyze the acetonide 
moieties followed by addition of excess triethylamine to promote sulfonyl fluoride 
hydrolysis, which furnished the desired product 5.8 in moderate yield as the ammonium 









5.3.3. Characterization and evaluation 
 Probe 5.8 was found to be freely soluble in water as expected and has very similar 
spectral properties to its fluorophore analog 5.1. In neutral aqueous buffer (10 mM 
MOPS, pH 7.2), 5.8 gave an absorption maximum identical to that of 5.1 at 387 nm. 
Upon saturation with Cu(I), 5.8 gave a 30-fold fluorescence turn-on response with an 
emission maximum of 497 nm, but reached a peak fluorescence quantum yield of only 
0.03.  This is substantially lower than the value of 0.074 observed for probe 4.3, which is 
indicative of a stronger PET driving force for the bis-sulfonamide fluorophore. Notably, 
the fluorescence quantum yield upon Cu(I)-saturation of 5.8 is similar to the value of  
monofluorinated CTAP-2 analog 3.3b (0.033), suggesting that the PET driving force is 
similar for these two compounds as expected based on the electronic similarity of the 
fluorophores. In fact, the proportional decrease in quantum yield for 5.8 versus 4.3 is the 
same as for 3.3b versus CTAP-2. 
 Based on the above data, the increase in PET driving force for the new 
sulfonamide-based fluorophore versus the previous sulfonate-based platform is 
significant but appears to be comparable to the addition of a single fluoro-substituent to 
the 1-aryl ring. An increase of this size should not be insurmountable through better 
ligand design; in fact, the value of initial PET driving force (−ΔG
0
et) required for 
maximum contrast ratio actually increases for a ligand providing a greater increase in 
donor potential upon Cu(I)-binding, as exemplified by the additional fluoro-substituent 
required for optimum contrast ratio in probe 4.2d versus its N-arylthiazacrown forerunner 
2.4c (See Chapter 4, Table 4.1). 
2,10
 Therefore, bis-sulfonamide fluorophore design 
should provide a suitable platform for optimization of the Cu(I)-ligand structure. 
 





5.4.1. Probe design 
 There are several possible explanations for the apparent low degree of Cu-N 
coordination
3
 and poor fluorescence recovery observed for the integrated arylamine-
thiazacrown ligand of 4.3 and 5.8, including  reduced basicity of the arylamine nitrogen 
due to an inductive effect of the nearby hydroxymethyl groups, participation of one of the 
OH-groups as a donor toward Cu(I) in place of the arylamine nitrogen, or geometric 
constraints imposed by the sterics of the highly substituted and relatively rigid benzo-
fused thiazacrown structure. To investigate the latter possibility, we designed probe 5.12, 
in which the trimethylene bridge connecting the two aliphatic thioethers of 5.8 has been 
replaced by two methyl groups, giving a closer analog to the ultra high-contrast 
methanolic Cu(I)-probe
2
 4.2d. The structures of 5.12 and also 4.2d for comparison are 










 As shown in Scheme 5.3, The Cu(I)-ligand moiety of 5.12 was prepared as its 
protected aldehyde derivative 5.13 by a similar route as for its macrocyclic analog 4.9 
(Chapter 4), except that the aldehyde moiety was introduced at the beginning of the 
synthesis via the previously described
11
 benzothiazolinone aldehyde 5.14. This 
compound was N-alkylated with neopentyl iodide derivative 5.15, which itself was 
prepared from the thietane intermediate 3.15 previously utilized in the synthesis of 
CTAP-2. The resulting product 5.16  was treated with aqueous sodium hydroxide in hot 
DMSO solution to cleave the thiocarbamate moiety, and the resulting thiolate was 
alkylated in situ with iodide 5.15 to give aldehyde 5.13. This aldehyde was condensed 
with acetophenone derivative 5.3 to produce chalcone 5.17, which was subsequently 
converted to triarylpyrazoline 5.18, sulfonyl fluoride 5.19, and finally to probe 5.12 using 
the methodology established for probe 5.8. The final product was isolated by HPLC as its 
ammonium salt; the low isolated yield is due to difficulty in isolation and does not reflect 










5.4.3. Characterization and evaluation 
 Probe 5.12 dissolves rapidly in water and gives an absorption maximum identical 
to that of its macrocyclic congener 5.8 at 387 nm in neutral buffer. The fluorescence 
emission maximum upon addition of Cu(I) is also identical at 487 nm, but the intensity of 
the fluorescence response to Cu(I) is dramatically improved, reaching a contrast ratio of 
100 and a fluorescence quantum yield of approximately 0.11. This represents the first 
actual performance improvement over CTAP-2 in aqueous solution. Given that the 
structures of 5.8 and 5.12 differ only by a single carbon atom at a site far removed from 
the fluorophore and PET donor, the more than three-fold improvement in fluorescence 
quantum yield and contrast ratio for 5.12 versus 5.8 provides a striking demonstration of 
the importance of cation binding mode for achieving a high-contrast response in PET-
based fluorescence turn-on probes. Interestingly, 5.12 is also more responsive to 
acidification than its macrocyclic analog, reaching maximum fluorescence intensity at 
only 40 mM HCl versus 100 mM HCl for 5.8. This difference is surprising given the 
identical fluorophore and PET donor structure of these compounds, and suggests that the 
pKa of the arylamine moiety in 5.8 is somehow influenced by the steric constraints of the 
macrocyclic ligand. 
  Although 5.12 gave a substantial improvement in performance relative to 
previous water-soluble Cu(I)-probes, the fluorescence decay profile upon saturation with 
Cu(I) is clearly multiexponential (Figure 5.6), suggesting that Cu-N coordination is 
incomplete even for this probe. The decay could could be fit to a biexponential model 
with components of 0.88 ns (62%) and 1.52 ns (38%) or to a triexponential model with 
components of 1.56 ns (32%), 0.93 ns (67%), and 0.25 ns (1%) (χ
2





Figure 5.6: Fluorescence decay profile of Cu(I)-saturated 5.12. 
 
 
5.5. Removing a geminal pair of hydroxymethyl groups to reduce steric congestion 
in the Cu(I)-complex 
5.5.1. Probe design 
 The large improvement in fluorescence contrast ratio and quantum yield obtained 
simply by opening the macrocyclic ring of probe 5.8 to give 5.12 suggests that the low 
Cu-N coordination apparent for the tetrahydroxylated thiazacrown ligand design of 4.3 
and 5.8 is primarily due to steric effects. While the open-chain ligand design of 5.12 
substantially improves the fluorescence response to Cu(I), this probe nevertheless gives a 
multiexponential fluorescence decay profile and does not achieve a fluorescence recovery 
comparable to that of the methanolic Cu(I)-probe 4.2d, which gave a monoexponential 
decay profile.
2
 Since the most substantial difference in ligand architecture between 4.2d 




bridges of the ligand backbone, a likely contributing factor to the apparently lower degree 
of Cu-N coordination for 5.12 is that steric strain imposed by one or both pairs of 
hydroxymethyl groups disfavors direct Cu-N coordination. In fact, inspection of the 
crystal structure
2
 of the related ligand 4.1-Cu(I) complex, which contains a direct Cu-N 
bond,  indicates that hydroxymethylation of the middle CH2 of the S-S bridge will likely 
result in steric clashes with the aromatic ring reminiscent of those suspected for the 
earlier N-arylthiazacrown Cu(I)-ligand design. Removal of both pairs of hydroxymethyl 
groups would leave a strongly amphiphilic, detergent-like structure, so we elected to 
remove only the hydroxymethyl groups of the S-S bridge of probe 5.12 to give design 










 Probe 5.20 was obtained by a similar route as for 5.12 except that the aldehyde 
functionality was introduced after assembly of the complete Cu(I)-ligand framework. 
This route was chosen due to the relatively low yield observed for the hydrolysis-
alkylation step in the presence of an aldehyde group during the synthesis of 5.12. As 
shown in Scheme 5.4, the synthesis instead began with the brominated benzothiazolinone 
5.21. N-alkylation with iodide 5.15 gave intermediate 5.22, which was converted in high 
yield to the brominated ligand precursor 5.23 by the one pot hydrolysis-alkylation 
procedure. Bromide 5.23 was converted to aldehyde 5.24 in good yield using the metal-
halogen exchange-based procedure originally developed for aldehyde 4.9 (Chapter 4), 
except that a solvent change from diethyl ether to THF was required to increase the 
solubility of the lithiated intermediates. Aldehyde 5.24 was converted sequentially to 
chalcone 5.25, triarylpyrazoline 5.26, and sulfonyl fluoride 5.27 using the same 
methodology as in the syntheses of probes 5.8 and 5.12.  
 To avoid the elimination side reactions encountered in the synthesis 5.8 and 5.12 
and difficult HPLC purification of the triethylamine-containing product mixture, we 
sought a different procedure for the final sulfonyl fluoride hydrolysis step. Interestingly, 
pyridine, which is often used to promote substitution reactions of sulfonyl chlorides and 
might be expected to serve as a nucleophilic catalyst, was found to be practically inert 
toward the sulfonyl fluoride moieties of intermediate 5.6, which remained almost 
completely intact after stirring overnight in a solution of 10% water in pyridine! In 
marked contrast, sodium hydroxide in a methanol-THF-water mixture (63:32:5) was 
highly effective, cleaving the sulfonyl fluoride moieties completely in only 120 minutes, 
and only trace amounts of elimination side products were apparent by TLC. This method, 
combined with an initial acidic hydrolysis step, was applied to sulfonyl fluoride 5.27, 
furnishing probe 5.20 in 75% yield as the ammonium salt after HPLC purification. The 












5.5.3. Characterization and evaluation 
 Despite the removal of two hydroxyl groups, probe 5.20 dissolves directly in 
water to millimolar concentrations; however, the resulting solution foams readily, 
indicating a surfactant effect not apparent for the tetrahydroxylated probes 5.8 and 5.12. 
Nevertheless, at the low micromolar concentrations used for characterization of its 
fluorescence properties, 5.20 gave no spectral evidence of increased aggregation, yielding 





Figure 5.8: Normalized absorption spectra of probes 5.20 and 5.12 at a concentration of 
1.25 µM (approximate) 
 
 
 Upon saturation with Cu(I), 5.20 gave a strong fluorescence turn-on response with 
an emission maximum identical to those of 5.8 and 5.12 at 487 nm and a contrast ratio 
near 160. A single-point fluorescence quantum yield measurement yielded an 



























is consistent with the observed increase in contrast ratio. A more rigorous four-point 
measurement as described in Chapter 4 yielded a slightly lower quantum yield of 0.14 for 
5.20-Cu(I) after correction for a small shift in the absorption spectrum upon Cu(I) 
binding; the observed shift in absorption maximum from 387 to 381 nm is similar in 
magnitude to that observed for CTAP-2 and 4.3 (Chapter 4). 
 While the 160-fold fluorescence enhancement achieved by aqueous Cu(I) probe 
5.20 approaches the maximum contrast ratio of 220 reached by related Cu(I)-probes in 
methanolic solution,
2
 the fluorescence quantum yield of 0.14 is much lower than the 
value of 0.49 observed for the contrast-optimized methanolic Cu(I)-probe 4.2d and 
corresponds to a fluorescence recovery of only 24% versus reference fluorophore 5.1. 
Furthermore, the fluorescence decay profile (Figure 5.9) of Cu(I)-saturated 5.20 is 
obviously multiexponential, indicating that multiple coordination species providing 
significantly different degrees of PET inhibition are present even after removal of the 
hydroxymethyl moieties from the S-S bridge of the ligand moiety. The fluorescence 
decay of 5.20-Cu(I) fit well to a biexponential model (Figure 5.9, blue trace), with decay 
components of 1.64 ns (21%) and 0.87 ns (79%) and a risetime of 0.26 ns (
2







Figure 5.9: Fluorescence decay profile of Cu(I)-saturated 5.20 
 
 The fluorescence decay profile of 5.20-Cu(I) is surprisingly similar to that of 
5.12-Cu(I), which is seemingly at odds with the substantially higher quantum yield and 
contrast ratio upon Cu(I)-saturation observed for 5.20. In fact, the respective fits actually 
show a decreased fractional contribution of the longer-lived decay component for 5.20 
versus 5.12 (21% versus 32-38%), which would seem to imply a lower degree of Cu-N 
coordination. These fractional contributions, however, are not necessarily an accurate 
reflection of the actual species distribution in the sample, as significantly different fits 
providing similar χ
2
 values can sometimes be found for a given multiexponential decay 
profile, especially when two decay components are relatively closely spaced as for 5.12. 
Furthermore, the risetime observed for both 5.1-H
+
 and 5.20-Cu(I) was not found for 
5.12-Cu(I), which instead yielded a low amplitude, short-lived decay component of 0.25 
ns in the triexponential fit, suggesting that the true abundance of the fast-decaying species 





5.6. Improving the fluorescence quantum yield by decreasing the PET driving force 
5.6.1. Rationale for decreasing the PET driving force 
 As discussed in the previous section, probe 5.20 achieves an excellent contrast 
ratio approaching that of the optimized methanolic Cu(I)-probe
2
 4.2d, but the quantum 
yield upon Cu(I)-saturation remains relatively low at 0.14, corresponding to a 
fluorescence recovery of only 24%.  Fluorescence decay analysis appears to implicate the 
ligand design as the cause of low fluorescence recovery, as the obviously 
multiexponential decay profile of 5.20-Cu(I) presumably corresponds to the presence of 
multiple coordination species in contrast to the monoexponential fluorescence decay of 
4.2d-Cu(I).
2
 A re-examination of unpublished data, however, revealed that the 
fluorescence decay profile upon Cu(I)-saturation of 4.2e, an analog of 4.2d with an 
additional ortho-fluoro-substituent on the pyrazoline 1-aryl ring and therefore a higher 
PET driving force, is actually multiexponential as well. Given that the 5-aryl ring 
comprising the ligand moiety is only weakly electronically coupled to the 1-aryl ring, it 
appears unlikely that a single additional 1-aryl fluoro-substituent would have a significant 
effect on Cu(I)-coordination. It is therefore probable that multiple coordination species 
actually exist for 4.2d-Cu(I) as well, but the difference in fluorescence lifetime between 
these species is not large enough to be easily resolved from the decay profile. Such an 
outcome would be expected if the PET rate constant for each species is small compared 
to the intrinsic excited-state deactivation rate constant k0 of the fluorophore, as in this 
case PET is not the major factor determining the fluorescence lifetime.  
 Based on the above reasoning, the obviously multiexponential decay profile of 
5.20-Cu(I) does not necessarily indicate that the ligand design is less effective than that 
of 4.2d and may instead be an indication of a higher than optimal PET driving force. In 
fact, the contrast ratio of 160 provided by 5.20 is equal to that of the over-tuned probe 
4.2e, which has an estimated PET driving force (–ΔG
0






 Therefore, an analog of 5.20 with a moderately decreased PET driving force might 
give an even higher contrast ratio as well as a higher fluorescence quantum yield upon 
Cu(I)-saturation. 
 
5.6.2. Reducing electron-withdrawing power at the 3-aryl ring by transposing the 
sulfonamide substituent 
 While previous efforts to tune the PET driving force of triarylpyrazoline-based 
Cu(I)-probes have focused on modification of the 1-aryl ring, it now appears that a large 
degree of electron-withdrawing character at this ring is required to achieve a high 
fluorescence quantum yield in aqueous solution through inhibition of ESPT. As discussed 
in Section 5.2, however, the degree of ESPT-mediated fluorescence quenching appears to 
be significantly less sensitive to the nature of the 3-aryl ring. Since electron-withdrawing 
substituents at either ring yield a comparable increase in PET driving force,
8,12
 it should 
be possible to create a Cu(I)-probe with significantly reduced PET driving force but 
similar intrinsic fluorophore quantum yield compared to 5.20 by decreasing the electron-
withdrawing power at the 3-aryl ring while retaining the 1-aryl sulfonamide substituent.  
To significantly reduce the electron-withdrawing power without sacrificing the 
hydrophilic character and ease of functionalization provided by the sulfonamide moiety, 
we realized that the SO2 and NR groups of the original N-methylarenesulfonamide design 
can simply be transposed to an N-arylmethanesulfonamide. The effect of this subtle 
modification should be quite substantial given the reported Hammett substituent 
constants of σp = 0.65 for -SO2NMe2 versus 0.24 for N(Me)SO2Me.
6
 To avoid possibly 
facilitating ESPT or donor-excited PET by introducing a π-donor in conjugation with the 
imine nitrogen of the pyrazoline core, the attachment point can also be moved from the 
para- to the meta-position of the 3-aryl ring with little expected change to the electron-
withdrawing power (σm = 0.21 for N(Me)SO2Me
6




probe 5.20 and its reference fluorophore 5.1 yields probe design 5.28 and reference 




Figure 5.10: Structures of Cu(I)-probe 5.28 and reference triarylpyrazoline 5.29 
 
 
5.6.3. Synthesis and characterization of the N-arylmethanesulfonamide reference 
fluorophore 
 Before preparing Cu(I)-probe 5.28, we first synthesized and characterized the 
reference compound 5.29 to ensure that the new fluorophore design achieves a sufficient 
fluorescence quantum yield in aqueous solution. As shown in Scheme 5.5, the synthesis 
proceeded similarly to that of the isomeric reference pyrazoline 5.1 up to the stage of the 
sulfonyl fluoride. The acetophenone derivative 5.30, prepared from commercially 
available 3-aminoacetophenone and methanesulfonyl chloride, was condensed with 4-




with arylhydrazine 5.2 to give triarylpyrazoline 5.32. This mixed secondary sulfonamide 
readily underwent base-catalyzed conjugate addition to ESF to give the bis(sulfonyl 
fluoride) 5.33. Interestingly, the first addition step proceeded more rapidly than expected 
and was complete within 30 minutes, while the second addition required several hours to 
approach completion as usual. This difference in reactivity is presumably due to greater 
acidity of the N-arylsulfonamide NH compared to that of an N-alkylsulfonamide. If this 
is the case, the N-arylsulfonamide should also be a better leaving group, and the reverse 
of the conjugate addition, E1cB-type elimination, may also proceed more rapidly, thus 
exacerbating the elimination side reactions previously encountered in the subsequent 
sulfonyl fluoride hydrolysis step. Given this possibility, we tested the ESF adduct of 
chalcone 5.31 as a simpler model substrate for sulfonyl fluoride hydrolysis before 
attempting the conversion with triarylpyrazoline sulfonyl fluoride 5.33. Chalcone 5.31 
reacted rapidly with ESF in the presence of triethylamine, giving clean conversion to a 
single product in minutes. When the resulting adduct was subjected to the conditions 
previously employed for efficient hydrolysis of the triarylpyrazoline sulfonyl fluoride 
5.27 (Scheme 5.4), it underwent rapid elimination, returning the secondary sulfonamide 
5.31 as the chief product by TLC. By contrast, treatment with an acetonitrile-water 
solution of DABCO (1,4-diazabicyclo[2,2,2]octane), a tertiary amine reported to be even 
more nucleophilic than 4-dimethylaminopyridine,
13
  gave roughly equal amounts of 5.31 
and a highly polar product consistent with a sulfonate salt. A solution containing equal 
parts of DABCO and its bicarbonate salt in 2:1 water-THF gave still better results, 
producing primarily the salt product with only a trace of 5.31. Application of similar 
conditions to sulfonyl fluoride 5.33 gave the desired reference pyrazoline 5.29 as its 
ammonium salt after HPLC purification, although the yield of purified product is low due 










 Triarylpyrazoline 5.29 dissolves readily in water similar to its isomer 5.1. In 1 
mM aqueous HCl, the absorption and emission maxima (364 and 463 nm, respectively) 
of 5.29 are significantly blue-shifted relative to those of 5.1 under the same conditions, 
corresponding to a substantial increase in estimated excited-state energy from 2.88 to 
3.04 eV. While such an increase in ΔE00 would appear to increase the PET driving force 
according to the Rehm-Weller equation (Chapter 2), previous data for 1,3,5-
triarylpyrazolines in acetonitrile solution indicate that the increase in excited-state energy 
upon removal of electron-withdrawing groups from the 3-aryl ring is more than offset by 
a concomitant decrease in E(A/A
-
), yielding a net decrease in the PET driving force (–
ΔGet) of similar magnitude to the observed increase in ΔE00.
8,12,14
 
 Compound 5.29  gave an outstanding fluorescence quantum yield of 0.68 in 1 
mM aqueous HCl, which is even higher than the value of 0.59 observed for 5.1 and 
compares favorably to previously reported fluorescence quantum yields for 
triarylpyrazolines in organic solvents,
8,10,12,14
 including those in the aprotic solvent 
acetonitrile. The fluorescence lifetime of 5.29 in 1 mM HCl is also somewhat greater than 
that of 5.1 at 3.84 versus 3.38 ns, indicating that the improvement in fluorescence 














 Based on its observed properties, it appears that the N-arylmethanesulfonamide 
triarylpyrazoline fluorophore of 5.29 is well suited for fluorescent probe design and will 
most likely yield a decreased PET driving force as well as a higher intrinsic fluorescence 
quantum yield in aqueous solution compared to its bis(arenesulfonamide) isomer 5.1. 
Therefore, we proceeded to Cu(I) probe 5.28 as described in the next section. 
 





 Cu(I)-probe 5.28 was  prepared by a combination of the methodologies developed 
for related compounds throughout this chapter as shown in Scheme 5.6. Aldehyde 5.24, 
the common precursor to probe 5.20, was condensed with acetophenone derivative 5.30 
to give chalcone 5.34, which was subsequently converted to triarylpyrazoline 5.35 and 









 The final conversion to probe 5.28 was achieved by a brief acidic hydrolysis step 
in a methanol-THF-water mixture to free the hydroxyl groups followed by addition of 
excess DABCO to cleave the sulfonyl fluoride moieties to sulfonates, and the desired 
product was isolated as the ammonium salt by HPLC in good yield. 
 
5.6.4.2. Characterization 
 Probe 5.28 dissolves readily in water and exhibits spectral properties similar to 
those of reference compound 5.29, with an absorption maximum of 387 nm in neutral 
buffer.  Upon saturation with Cu(I), 5.28 gave a powerful fluorescence turn-on response 
(Figure 5.11), reaching a contrast ratio of 180 with a fluorescence quantum yield of 0.41, 
which is approximately three-fold higher than that of the isomeric Cu(I)-probe 5.20 
(0.14) and almost five-fold higher than that of CTAP-2 (0.083). Notably, such a result 
would not have been possible regardless of the ligand structure using the original 
sulfonated fluorophore design of CTAP-2, probe 4.3, and reference compound 4.11, as 
studies with the latter demonstrated that the quantum yield is limited to less than 30% in 









Figure 5.11: Emission spectra of probe 5.28 (1.2 µM) in pH 7.2 MOPS buffer before and 
after addition of Cu(I) (generaged by in-situ reduction of 2.5 µM Cu(II) with 100 µM 
ascorbate). Note: Buffer contains 1 µM of the tripodal chelator 6.1 (Chapter 6) to 
suppress background copper contamination. The fluorescence response was fully 
reversible by addition of a further 4 µM of 6.1. 
 
 
 To reassess the PET switching performance provided by the ligand design shared 
by 5.20 and 5.28, we measured the fluorescence decay profile of 5.28-Cu(I). Based on the 
reasoning described in Section 5.6.1, if all major coordination modes of the ligand-Cu(I) 
complex provide a substantial increase in donor potential versus the free ligand, then at 
lower PET driving force the differences in fluorescence lifetime between the various 
coordination species should decrease, potentially resulting in a decay profile that appears 
monoexponential. 
 The observed decay profile (Figure 5.12) indeed shows this effect. In dramatic 
contrast to the decay profile of 5.20-Cu(I), the deviation from linearity on a logarithmic 































component of 2.48 ns (blue trace) yielding a reasonable χ
2
 value of 1.59. For comparison, 
the optimized methanolic Cu(I)-probe 4.2d gave χ
2
 = 1.32 for a monoexponential fit by 
the same procedure.
2
  A biexponential fit (red trace) with components of 2.27 ns (85%) 
and 3.68 ns (15%) gave an improved χ
2
 of 1.06, although the difference between the two 




Figure 5.12: Fluorescence decay profiles of probe 5.28 and reference compound 5.29 
 
The decay profile of reference compound 5.29 in 1 mM HCl and its monoexponential fit 
(τf = 3.86 ns, green trace) are also shown for comparison. All three fits include a risetime 
component of 0.19-0.32 ns. 
 Given the very high contrast ratio achieved by probe 5.28 and the fact that even 
the shorter component in the biexponential decay fit recovers more than half of the 
fluorescence lifetime of the reference fluorophore 5.29-H
+
, it appears that the Cu(I)-




switch despite the presence of multiple coordination species. In fact, it is possible that the 
shorter-lived species is not a ternary complex with solvent as observed for N-
arylthiazacrown-based probes
10
 but simply a different coordination isomer of the binary 
complex presumably responsible for the longer decay component. Either way, both the 
contrast ratio and fluorescence quantum yield provided by 5.28 rival those of the best 
methanolic Cu(I)-probe 4.2d, and further modifications to the ligand design are 
unnecessary with respect to these parameters. 
 
5.7. Review and Conclusions 
 Taking into account the ESPT-mediated fluorescence quenching pathway 
previously determined to limit the fluorescence quantum yield achievable with the 
CTAP-2 fluorophore design in aqueous solution, we developed a new fluorophore design 
containing sulfonamide substituents as electron-withdrawing groups. Based on previous 
evidence that a similar excited-state protonation pathway operating in methanolic 
solution is highly sensitive to the electron-donating or electron-withdrawing power of 
substituents on the triarylpyrazoline 1-aryl ring, we expected that replacement of the 1-
aryl sulfonate moiety of CTAP-2 with a more strongly electron-withdrawing sulfonamide 
substituent may suppress ESPT-mediated quenching in aqueous solution. Consistent with 
suppression of ESPT, the new fluorophore design exhibited more than double the 
fluorescence quantum yield of protonated CTAP-2 or its fluorophore analog 4.11, as well 
as a substantially reduced solvent isotope effect on the fluorescence lifetime versus the 
latter. Combining the sulfonamide-based fluorophore with a previously investigated 
Cu(I)-ligand moiety, however, resulted in a decreased fluorescence quantum yield upon 
Cu(I)-saturation relative to the original fluorophore architecture, presumably due to an 
increased PET driving force. Subsequent modifications to the ligand design lead to probe 




quantum yield upon Cu(I)-saturation remained relatively low at 14% and the fluorescence 
decay profile was obviously multiexponential. Based on previous observations with 
methanolic Cu(I)-probes, the behavior of 5.20 is consistent with an excessive PET 
driving force. To decrease the PET driving force while maintaining resistance to ESPT in 
aqueous solution, the 1-aryl sulfonamide substituent was left unmodified while the 3-aryl 
substituent was isomerized from a strongly electron-withdrawing N-methyl-
arenesulfonamide at the para-position to a weakly electron-withdrawing N-aryl-
methanesulfonamide at the meta-position (probe 5.28). This subtle modification resulted 
in a nearly three-fold increase in fluorescence quantum yield upon Cu(I)-saturation to 
41% and a further improvement in contrast ratio to 180, rivaling the best performing 
methanolic Cu(I) probes, yet 5.28 dissolves directly in water as easily as CTAP-2. While 
the binding affinity and selectivity of 5.28 remain to be determined, it is unlikely that 
these parameters will differ dramatically from those observed for CTAP-2 and 4.3 given 
the surprisingly small differences in coordination behavior previously reported for acyclic 
versus macrocyclic polythioethers.
15,16
 Disregarding the earlier reported Cu(I)-probe 
CS3,
17
 which was demonstrated to form a colloidal precipitate at micromolar 
concentrations,
1
 the challenge of obtaining bright, high-contrast fluorescence turn-on 
response to Cu(I) in aqueous solution has at last been met. 
 
5.8. Experimental section 
Absorption, steady-state fluorescence, and time-resolved fluorescence 
spectroscopy were conducted as described in the experimental section of Chapter 5. 











 (5.14) were prepared as previously described. The synthesis of thietane 
3.15 is described in Chapter 3, and that of aldehyde 4.9 is described in Chapter 4.  NMR: 
Spectra were recorded at 400 MHz (
1
H, ppm vs. internal TMS, referenced directly or 
indirectly via the known residual proton signal of the solvent
18
), 376 MHz (
19
F, ppm vs. 
internal CCl3F), and 100 MHz (
13
C, ppm vs. TMS, referenced to CDCl3 (77 ppm) or 
CD3OD (49 ppm) chemical shifts). Spectra were recorded at ambient temperature (20-
23°C) unless stated otherwise. For
 1
H spectra, the abbreviation “ad” denotes an apparent 
doublet with additional partially resolved coupling (AA’XX’ or AA’MM’ spin system); 
only the largest (first order) coupling constant is given for these systems. In cases where 
the product as isolated contained a substantial amount of solvent, the solvent content was 
calculated from the initial 
1
H NMR integrals and a second 
1
H NMR spectrum was 
acquired after removal of solvent by repeated dissolution in CDCl3 followed by 
concentration to dryness. MS: Spectra were acquired by the Georgia Tech Mass 
Spectrometry Facility. Column chromatography: Flash chromatography on Sorbent 
Technologies general purpose silica gel (60 Å pore size, 250 mesh).  
 
Arylhydrazine 5.2 
 A solution of 4-fluorobenzenesulfonyl chloride (8.49 g, 43.6 mmol) in DCM (60 
mL) was cooled in an ice bath and methylamine solution (7 ml, 40% aqueous, d = 0.9 
g/mL, 4 equiv.) was added slowly under stirring. Gentle boiling occurred, and the ice 
bath was removed once this had subsided. After 15 minutes, the mixture was diluted with 
crushed ice and carefully acidified with concentrated HCl (10 mL). The organic layer was 
separated, and the aqueous layer was extracted with DCM (2 x 20 mL). The combined 
organic layers were dried with Na2SO4 and concentrated. The residue was transferred to a 




hydrazine (4.1 mL, 3.0 equiv.) was added. The reaction vessel was vented to an oil 
bubbler, and the mixture was stirred at 50°C overnight. A further 2 mL (1.5 equiv.) of 
hydrazine were added, and the mixture was stirred at 60°C for 24 hours. After cooling, 
the mixture was slowly diluted with cold water (100 mL), and the resulting precipitate 
was collected by filtration, washed with cold water, and recrystallized from ethanol to 
give the product as colorless needles. Yield 7.54 g (37.5 mmol, 86%). Mp 140-141°C 
(lit.
19
 mp 137°C) 
1
H NMR (DMSO-d6) δ 2.32 (d, J = 5.2 Hz, 3H), 4.19 (br. s, 2H), 6.82 
(ad, J = 8.9 Hz, 2H), 6.94 (q, J = 5.2 Hz, 1H), 7.45 (ad, J = 8.9 Hz, 2H), 7.54 (br. s, 1H). 
13
C NMR (DMSO-d6) δ 28.7, 110.0, 124.5, 128.3, 155.2. EI-MS m/z 201 ([M]
+
, 100), 




 A solution of 4-acetylbenzenesulfonyl chloride (4.52 g, 20.7 mmol) in DCM (45 
mL) was cooled in an ice bath, and methylamine solution (7 ml, 40% aqueous, d = 0.9 
g/mL, 4 equiv.) was added slowly under rapid stirring. After 20 minutes, the solution was 
acidified with aqueous HCl, and the organic layer was separated. The aqueous layer was 
extracted with DCM (2 x 15 mL), and the combined organic layers were dried with 
MgSO4 and concentrated. The residue was recrystallized from boiling ethyl acetate-
cyclohexane under slow stirring to give the product as a colorless crystalline powder. 
Yield 4.09 g (19.2 mmol, 93%). 
1
H NMR (CDCl3) δ 2.67 (s, 3H), 2.69 (d, J = 5.3 Hz, 
3H), 4.92 (br, q, J = 5.2 Hz, 1H), 7.95-7.98 (m, 2H), 8.08-8.11 (m, 2H). 
13
C NMR 
(CDCl3) δ 26.9, 29.3, 127.4, 128.9, 140.0, 142.7, 196.9. EI-MS m/z 213 ([M]
+
, 55), 198 







Acetophenone 5.3 (480 mg, 2.25 mmol) and 4-dimethylaminobenzaldehyde (320 mg, 
2.14 mmol) were stirred in ethanol (4 mL) at 50°C until completely dissolved, and 
pyrrolidine (180 µL, 2.14 mmol) was then added. After 1 hour, the deep red solution was 
cooled under rapid stirring to initiate crystallization of the product, and the resulting 
orange slurry was stirred overnight at 50°C. After cooling, the product was collected by 
filtration, washed with cold ethanol, and dried by suction and then under vacuum to give 
an orange crystalline powder. Yield 583 mg (1.69 mmol, 79%). Mp 153-154°C. 
1
H NMR 
(CDCl3) δ 2.70 (s, 3H), 3.05 (s, 6H), 4.88 (br, s, 1H), 6.68 (ad, J = 9.0 Hz, 2H), 7.26 (d, J 
= 15.4 Hz, 1H), 7.55 (ad, J = 8.9 Hz, 2H), 7.79 (d, J = 15.4 Hz, 1H), 7.97 (ad, J = 8.6 Hz, 
2H), 8.08 (ad, J = 8.6 Hz, 2H). 
13
C NMR (CDCl3) δ 29.3, 40.0, 111.8, 116.0, 122.0, 
127.3, 128.8, 130.8, 141.6, 142.6, 147.5, 152.4, 189.5. EI-MS m/z 344 ([M]
+
, 100), 343 
(25), 250 (24), 174 (33). 
 
Triarylpyrazoline 5.5 
 A mixture of chalcone 5.4 (393 mg, 1.14 mmol), arylhydrazine 5.2 (321 mg, 1.4 
equiv.), PPTS (400 mg, 1.4 equiv.) and methanol (4 mL) was stirred under argon in a 
sealed vessel at 90°C for 3 hours. The mixture was poured into water (50 mL) and an 
attempt was made to extract the product with toluene (50 mL). A large amount of 
insoluble material remained so MTBE (25 mL) and dichloromethane (25 mL) were 
added, resulting two clear liquid phases after agitation and settling. The organic layer 
(top) was separated, dried with Na2SO4, and concentrated. The residue was subjected to 
column chromatography (DCM-MTBE) to give the product as a yellow glassy solid 
containing 0.6 molar equiv. of MTBE by 
1
H NMR. Crystallization from DCM-hexane 
under stirring gave a yellow-green, strongly fluorescent crystalline powder. Yield 501 mg 
(0.949 mmol, 83%) Mp ~155°C (dec.). 
1
H NMR (CDCl3) δ 2.59 (d, J = 5.4 Hz, 3H), 2.66 
(d, J = 5.4 Hz, 3H), 2.92 (s, 6H), 3.19 (dd, J = 17.3, 6.0 Hz, 1H), 3.84 (dd, J = 17.3, 12.3 




1H), 6.66 (ad, J = 8.8 Hz, 2H), 7.09 (ad, J = 8.8 Hz, 2H), 7.16 (ad, J = 9.0 Hz, 2H), 7.63 
(ad, J = 9.0 Hz, 2H), 7.83-7.88 (m, 4H). 
13
C NMR (CDCl3) δ 29.27, 29.29, 40.4, 43.3, 
63.7, 112.9, 113.0, 126.3, 126.5, 127.5, 127.6, 128.0, 128.7, 136.4, 138.5, 146.9, 147.4, 
150.2. 
 
Sulfonyl fluoride 5.6 
 Triarylpyrazoline 5.5 (102 mg, 193 µmol) and triethylamine (54 µL, 2 equiv.) 
were stirred in dry DCM (4 mL) under argon. Ethenesulfonyl fluoride (48 µL, d = 1.32 
g/mL, 3.0 equiv.) was added. TLC (10:1 DCM-MTBE) indicated almost complete 
consumption of the starting material (Rf  0.2) after 8 minutes and formation of two 
products (Rf  0.5 and 0.8). The latter is the desired product and the former is presumably 
the mono-N-alkylated intermediate. After 4 hours, the starting material was completely 
consumed but the intermediate remained. After 18 hours the reaction had progressed very 
little since the 4 hour point, so a further 3 equiv. of ESF were added. After 10 minutes, 
the intermediate at  Rf  0.5 had been completely consumed. The mixture was diluted with 
toluene (3 mL) and evaporated to dryness under a stream of argon in a 40°C bath. The 
residue was subjected to column chromatography (2:1 DCM-hexanes with a gradient 
from 0 to 3.3% MTBE) to give the product as a yellow glassy solid containing 0.74 molar 
equiv. (8 mass%) of MTBE calculated from the 
1
H NMR integrals. Yield 117 mg raw 
(108 mg corrected for solvent content, 145 µmol, 75%). 
1
H NMR (CDCl3) δ 2.80 (s, 3H), 
2.89 (s, 3H), 2.94 (s, 6H), 3.21 (dd, J = 17.4, 6.0 Hz, 1H), 3.47-3.51 (m, 2H), 3.55-3.59 
(m, 2H), 3.69-3.79 (m, 4H), 3.87 (dd, J = 17.4, 12.3 Hz, 1H), 5.37 (dd, J = 12.3, 6.0 Hz, 
1H), 6.68 (ad, J = 8.9 Hz, 2H), 7.10 (ad, J = 8.8 Hz, 2H), 7.19 (ad, J = 9.0 Hz, 2H), 7.59 
(ad, J = 9.1 Hz, 2H), 7.83 (ad, J = 8.7 Hz, 2H), 7.90 (ad, J = 8.7 Hz, 2H). 
19
F NMR 
(CDCl3) δ 56.3 (t, J = 4.8 Hz, 1F), 56.6 (t, J = 4.7 Hz, 1F). ESI
+
-HRMS calcd for [M+H]
+
 
C29H36O8N5F2S4 748.1409, found 748.1405. 




Sulfonyl fluoride 5.6 (74 mg of material containing 8% MTBE, 91 µmol) was 
stirred in 1 mL of a mixture containing acetonitrile (45%), triethylamine (45%) and water 
(10 %). After 10 min, TLC (10:1 DCM-MTBE) indicated a mixture of the starting 
material (Rf 0.8), a small amount of single-elimination product (Rf 0.5) and a trace of 
double elimination product (Rf 0.2, identical to triarylpyrazoline 5.5), as well as 
hydrolysis products (Rf ≈0). After stirring overnight, only the hydrolysis products and 
double-elimination product remained. The mixture was concentrated to dryness under a 
stream of argon, and the residue was taken up in methanol (2 mL) + concentrated 
ammonia (~100 µL) and concentrated again. The residue was dissolved in water (2 mL), 
and the product was isolated by RP-HPLC using a gradient of 25-33% CH3CN in 0.1% 
aqueous NH4HCO3 to give a yellow glassy solid after repeated evaporation with 
methanol and vacuum drying. The 
1
H NMR spectrum of this material is consistent with a 
mixed ammonium-triethylammonium salt containing 44 mol% Et3NH
+
, corresponding to 
a formula weight of 815 g/mol. Yield 74 mg (71 µmol, 78%). 
1
H NMR (CD3OD) δ 1.30 
(t, J = 7.3 Hz, 4H (0.44 Et3NH
+
)) 2.72 (s, 3H), 2.83 (s, 3H), 2.90 (s, 6H), 2.98-3.04 (m, 
4H), 3.19 (dd, J ≈ 17.7, 5.8 Hz, 1H, partly obscured by subsequent signal), 3.20 (q, J = 
7.3 Hz, 2.6H (0.44 Et3NH
+
)), 3.34-3.43 (m, 2H), 3.47-3.51 (m, 2H), 3.95 (dd, J = 17.6, 
12.2 Hz, 1H), 5.48 (dd, J = 12.2, 5.8 Hz, 1H), 6.76 (ad, J = 8.8 Hz, 2H), 7.13 (ad J = 8.8 
Hz, 2H), 7.23 (ad, J = 9.0 Hz, 2H), 7.58 (ad, J = 9.0 Hz, 2H), 7.86 (ad, J = 8.7 Hz, 2H), 
7.99 (ad, J = 8.7 Hz, 2H). ESI-HRMS m/z calcd for [M]
2-










 This compound was synthesized as described for chalcone 5.4 using N-(4-acetyl-
benzenesulfonyl) dimethylamine (304 mg, 1.34 mmol), p-dimethylaminobenzaldehyde 
(220 mg, 1.1 equiv.), and pyrrolidine (56 µL, 0.5 equiv.). Yield 360 mg (1.00 mmol, 
75%), orange crystalline powder. 
1
H NMR (CDCl3) δ 2.75 (s, 6H), 3.06 (s, 6H), 6.70 (ad, 
J = 9.0 Hz, 2H), 7.28 (d, J = 15.4 Hz, 1H), 7.76 (ad, J = 8.8 Hz, 2H), 7.81 (d, J = 15.4 
Hz, 1H), 7.88 (ad, J = 8.6 Hz, 2H), 8.11 (ad, J = 8.6 Hz, 2H). 
13
C NMR (CDCl3) δ 37.9, 
40.1, 111.7, 116.0, 122.0, 127.8, 128.7, 130.8, 138.2, 142.7, 147.4, 152.3, 189.5. EI-MS 
m/z 358 ([M]
+
, 100), 250 (40), 174 (32). EI-HRMS m/z calcd for [M]
+
 C19H22N2O3S 
358.1351, found 358.1345. 
 
Chalcone 5.38 
 Chalcone 5.37 (303 mg, 845 µmol) was dissolved in dry dichloromethane (5 mL) 
and methyl trifluoromethanesulfonate  (140 µL, 1.5 equiv.) was added. The solution was 
stirred rapidly until crystallization initiated and then stirred slowly overnight. The product 
was collected by filtration, washed with 1:1 dichloromethane-diethyl ether, and dried 




µmol, 96%). Mp 245-246°C. 
1
H NMR (DMSO-d6) δ 2.68 (s, 6H), 3.66 (s, 9H), 7.87 (d, J 
= 15.7 Hz, 1H), 7.95 (ad, J = 8.6 Hz, 2H), 8.08 (ad, J = 9.2 Hz, 2H), 8.12 (d, J = 15.7 Hz, 
1H), 8.20 (ad, J = 9.2 Hz, 2H), 8.40 (ad, J = 8.7 Hz, 2H). 
13
C NMR (DMSO-d6) δ 37.5, 
56.4, 121.1, 124.3, 127.9, 129.5, 130.3, 136.1, 138.6, 140.5, 142.5, 148.2, 186.6. Note: 
the 
13





C coupling, was not distinguished over baseline noise. ESI-HRMS m/z calcd 
for [M]
+
 C20H25N2O3S 373.1580, found 373.1572. 
 
Triarylpyrazoline 5.7  
 A mixture of chalcone 5.38 (232 mg, 444 µmol), 4-hydrazinobenzenesulfonic 
acid hemihydrate (114 mg, 1.3 equiv.), pyridine 47 µL, water (1.8 mL) and dioxane (0.6 
mL) was stirred under argon at 90°C. The solids dissolved within minutes give a clear 
red-orange solution which transformed to a canary-yellow slurry within two hours. A 
small sample of the solid material was removed and found to be poorly soluble in water 
and non-fluorescent in aqueous solution. Aqueous HCl (6 M, 96 µL, 1.3 equiv.) and 
dioxane (0.6 mL) were added, and the mixture was sealed under argon and stirred 
at100°C. After 26 minutes, the yellow solid had dissolved completely. The mixture was 
allowed to cool, diluted slowly with ethanol under rapid stirring to the point of permanent 
turbidity, and then diluted dropwise with water until clear. After 30 min., the product 
separated as a light yellow, strongly fluorescent crystalline powder. Yield 204 mg (376 
µmol, 85%) 
1
H NMR (3:1 D2O : CD3CN) δ 2.64 (s, 6H), 3.09 (dd, J = 17.7, 6.1 Hz, 1H), 
3.56 (s, 9H), 3.86 (dd, J = 17.7, 12.5 Hz, 1H), 5.51 (dd, J = 12.5, 6.1 Hz, 1H), 7.03 (ad, J 
= 8.9 Hz, 2H), 7.44 (ad, J = 9.1 Hz, 2H), 7.57 (ad, J = 8.9 Hz, 2H), 7.76-7.79 (m, 4H), 








 Aldehyde 4.9 (488 mg, 901 µmol) and acetophenone 5.3 (202 mg, 1.05 equiv.) 
were stirred in a mixture of ethanol (4.5 mL) and MTBE (2 mL) at 50°C until completely 
dissolved. Pyrrolidine (150 µL, 2 equiv.) was added, and the mixture was stirred for 2 
hours at 50°C then allowed to cool to rt, producing a red, gummy precipitate. After two 
days of stirring at rt, the mixture was stirred at 50°C for 3 hours and then poured into 
water (50 mL) + 1 M NaH2PO4 (10 mL). The resulting emulsion was extracted with 
MTBE, and the organic layer was dried with MgSO4, concentrated to dryness, and 
separated by column chromatography (2:1 DCM-hexanes + increasing MTBE) to give 
the product as an orange glassy solid. Yield 415 mg (63%). 
1
H NMR (CDCl3) δ 1.425 (s, 
3H), 1.428 (s, 3H), 1.46 (s, 3H), 1.51(s, 3H), 1.97 (p, J = 6.4 Hz, 2H), 2.59 (s, 2H), 2.71 
(d, J = 5.3 Hz, 3H), 2.81-2.86 (m, 6H), 2.97 (s, 2H), 3.60-3.80 (m, 10H), 4.60 (q, J = 5.3 
Hz, 1H), 6.26 (t, J = 7.1 Hz, 1H), 7.00 (d, J = 8.7 Hz, 1H), 7.28 (d, J = 15.5 Hz, 1H), 7.55 
(dd, J = 8.7, 2.1 Hz, 1H), 7.73 (d, J = 15.5 Hz, 1H), 7.80 (d, J = 2.1 Hz, 1H), 7.97 (ad, J = 
8.5 Hz, 2H), 8.10 (ad, J = 8.5 Hz, 2H). EI-MS m/z 736 ([M]
+
, 100), 360 (55), 265 (20), 
198 (15), 83 (19). EI-HRMS m/z calcd for C35H48N2O7S4 736.2344, found 736.2375. 
 
Triarylpyrazoline 5.10 
 Chalcone 5.9 (209 mg, 284 µmol) and PPTS (143 mg, 2 equiv.) were stirred in 
boiling methanol for 15 min. The mixture was concentrated to dryness under a stream of 
argon and the residue was dissolved in methanol (1.5 mL). Arylhydrazine 5.2 (86 mg, 1.5 
equiv.) was added, and the deep red solution was stirred in a sealed vessel under argon at 
90°C for 4 hours. The resulting brownish-yellow solution was allowed to cool and 
concentrated to dryness. The residue was dissolved in acetone (2 mL) and 2,2-
dimethoxypropane (2 mL) and p-TsOH • H2O (108 mg, 2 equiv.) were added. After 
stirring for 15 minutes, the reaction was quenched with triethylamine (240 µL, 6 equiv.), 




aqueous NaH2PO4 (10 mL). The aqueous layer was extracted with DCM (20 mL), and the 
combined organic layers were dried with Na2SO4 and concentrated to dryness. The 
residue was separated by column chromatography (DCM-MTBE) to give the product as a 
yellow glassy solid containing 0.65 molar equiv. (6 mass%) MTBE by 
1
H NMR. Yield 
182 mg (171 mg corrected for solvent content, 186 µmol, 66%). 
1
H NMR (CDCl3) δ 1.38 
(s, 3H), 1.40 (s, 3H), 1.43 (s, 3H), 1.44 (s, 3H), 1.94 (p, J = 6.4 Hz, 2H), 2.58 (s, 2H), 
2.61 (d, J = 5.4 Hz, 3H), 2.68 (d, J = 5.4 Hz, 3H), 2.73-2.81 (m, 6H), 2.92 (d, J = 11.8 
Hz, 1H), 2.97 (d, J = 11.8 Hz, 1H), 3.18 (dd, J = 17.3, 6.1 Hz, 1H), 3.50-3.72 (m, 10H), 
3.84 (dd, J = 17.3, 12.3 Hz, 1H), 4.44 (q, J = 5.4 Hz, 1H), 4.69 (q, J = 5.4 Hz, 1H), 5.29 
(dd, J = 12.3, 6.1 Hz, 1H), 5.66 (t, J = 7.1 Hz, 1H), 6.90 (d, J = 8.6 Hz, 1H), 7.04 (dd, J = 
8.6, 2.2 Hz, 1H), 7.16 (ad, J = 9.0 Hz, 2H), 7.35 (d, J = 2.2 Hz, 1H), 7.65 (ad, J = 9.0 Hz, 
2H), 7.84-7.89 (m, 4H). ). 
13
C NMR (CDCl3) δ 20.0, 23.5, 23.8, 27.4, 27.5, 29.3, 29.4, 
31.3, 31.9, 35.0, 35.1, 37.8, 38.5, 39.4, 43.2, 44.5, 63.5, 65.6, 65.7, 66.5, 66.7, 98.4, 98.6, 
111.2, 113.0, 117.4, 126.3, 127.5, 127.7, 127.8, 128.7, 128.8, 133.4, 136.3, 138.5, 146.8, 
147.3, 150.1.  
 
Sulfonyl fluoride 5.11 
 Triarylpyrazoline 5.10 (150 mg of material containing 6% MTBE, 153 µmol) and 
N,N-diisopropylethylamine (200 µL, 7.5 equiv.) were dissolved in anhydrous DCM (1.5 
mL) under argon, and ethenesulfonyl fluoride (38 µL, 3 equiv.) was added to the stirred 
mixture. After 3 hours, the mixture was diluted with toluene (3 mL) and concentrated to 
dryness. The residue was separated by column chromatography (2:1 DCM-hexanes plus 0 
→17% MTBE) to give the product as a yellow glassy solid after solvent evaporation 
under high vacuum. Yield 142 mg (81%). 
1
H NMR (CDCl3) δ 1.38 (s, 3H), 1.41 (s, 3H), 
1.436 (s, 3H), 1.443 (s, 3H), 1.94 (p, J = 6.4 Hz, 2H), 2.57 (s, 2H), 2.75-2.80 (m, 6H), 
2.82 (s, 3H), 2.90 (s, 3H), 2.96 (d, J = 11.7 Hz, 1H), 3.00 (d, J = 11.7 Hz, 1H), 3.20 (dd, J 




J = 17.4, 12.3 Hz, 1H), 5.30 (dd, J = 12.3, 6.1 Hz, 1H), 5.69 (t, J = 7.1 Hz, 1H), 6.90 (d, J 
= 8.6 Hz, 1H), 7.03 (dd, J = 8.6, 2.2 Hz, 1H), 7.19 (ad, J = 8.9 Hz, 2H), 7.38 (d, J = 2.2 
Hz, 1H), 7.61 (ad, J = 9.1 Hz, 2H), 7.84 (ad, J = 8.7 Hz, 2H), 7.90 (ad, J = 8.7 Hz, 2H).
 
19
F NMR (CDCl3) δ 56.3 (t, J = 4.8 Hz 1F), 56.6 (t, J = 4.7 Hz, 1F). ESI-HRMS m/z calcd 
for [M+H]
+
 C46H64N5O12S7F2 1140.2559, found 1140.2561. 
 
Probe 5.8  
 Sulfonyl fluoride 5.11 (117 mg, 103 µmol) was dissolved in acetonitrile (1.7 mL) 
and 3 M aqueous HCl (340 µL, 10 equiv. HCl, ~190 equiv. H2O) was added to the stirred 
mixture. After 15 minutes, triethylamine (570 µL, 40 equiv.) was added. The mixture was 
stirred overnight and then concentrated to dryness. The residue was taken up in methanol 
(3 mL) and heated in a 40°C bath. NaHCO3 129 mg, 15 equiv. was added, followed by 
sufficient water for complete dissolution. The mixture was concentrated to dryness, taken 
up in methanol-water mixture, and concentrated again. After repetition of this procedure 
to remove triethylamine, the residue was taken up in methanol (4 mL), diluted with 
ethanol (2 mL), filtered to remove NaCl, and concentrated to dryness. The product was 
obtained as the ammonium salt by RP-HPLC as described for reference compound 5.1 as 
a yellow glassy solid. Yield 49 mg (45 µmol, 44%). 
1
H NMR (CD3OD) δ 1.82 (p, J ≈ 7 
Hz, 2H), 2.50 (t, J = 6.8 Hz, 2H), 2.56 (t, J = 6.9 Hz, 2H), 2.59 (s, 2H), 2.72 (s, 3H), 2.76 
(s, 2H), 2.82 (s, 3H), 2.88 (d, J = 12.4 Hz, 1H), 2.96 (d, J = 12.4 Hz 1H), 3.00-3.06 (m, 
4H), 3.16-3.22 (m, 3H), 3.38-3.42 (m, 2H), 3.47-3.58 (m, 10H), 3.90 (dd, J = 17.6, 12.2 
Hz, 1H), 5.41 (dd, J = 12.2, 5.8 Hz, 1H), 6.69 (d, J = 8.6 Hz, 1H), 7.01 (dd, J = 8.5, 2.1 
Hz, 1H), 7.22 (ad, J = 9.0 Hz, 2H), 7.33 (d, J = 2.1 Hz, 1H), 7.58 (ad, J = 9.1 Hz, 2H), 
7.85 (ad, J = 8.6 Hz, 2H), 7.96 (ad, J = 8.6 Hz, 2H). ESI-HRMS m/z calcd for [M]
2-
 






Iodide 5.15  
A mixture of thietane 3.15 (10.08 g, 57.8 mmol), methyl iodide (4.3 mL, 1.2 
equiv.), powdered K2CO3 (200 mg), and acetonitrile (15 mL) was stirred under argon at 
60°C for 20 hours. The mixture was concentrated under reduced pressure, and the oily 
residue was taken up in DCM (50 mL), stirred with silica gel (3 g), and filtered through a 
2 x 2 cm pad of silica gel. The silica gel was washed with a further 50 mL of DCM, and 
the combined filtrate and washing were concentrated under reduced pressure to give the 
product as a colorless oil. Yield 17.23 g (54.5 mmol, 94%). 
1
H NMR (CDCl3) δ 1.41 (s, 
3H), 1.42 (s, 3H), 2.19 (s, 3H), 2.69 (s, 2H), 3.42 (s, 2H), 3.73 (d, J = 11.8 Hz, 2H), 3.80 
(d, J = 11.8 Hz, 2H). Note: in some samples, a partly resolved long-range coupling (< 0.5 
Hz) is observed in the methyl signals at 1.41 and 1.42 ppm. 
13
C NMR (CDCl3) δ 12.9, 
17.9, 23.1, 24.0, 37.1, 39.2, 66.3, 98.6. EI-MS m/z 316 ([M]
+
, 65), 301 (67), 131 (82), 




A mixture of benzothiazolin-2-one-6-carboxaldehyde
11
 (5.14, 255 mg, 1.42 
mmol), iodide 5.15 (562 mg, 1.25 equiv.), and K2CO3 (600 mg, 3 equiv.) in DMF (5 mL) 
was stirred at 90°C for 12 hours. The mixture was diluted into a solution of 1 M NaOH in 
20% aqueous methanol (100 mL), and the resulting emulsion was extracted with MTBE 
(100 mL). The extract was washed with a further 100 mL of the aqueous-methanolic 
NaOH solution, dried with Na2SO4, and concentrated under reduced pressure to a yellow 
oily residue. Crystallization from diethyl ether-pentane under stirring gave the product as 
a slightly tan crystalline powder. Yield 306 mg (833 µmol, 59%). Mp 134-134.5°C 
1
H 
NMR (CDCl3) δ 1.49 (br. s, 6H), 2.13 (s, 3H) 2.66 (s, 2H), 3.64 (d, J = 12.5 Hz, 2H), 
4.03 (d, J = 12.5 Hz, 2H), 4.24 (s, 2H), 7.74 (d, J = 8.5 Hz, 1H), 7.87 (dd, J = 8.5, 1.6 Hz, 
1H), 7.97 (d, J = 1.6 Hz, 1H), 9.95 (s, 1H). 
13




40.1, 46.6, 64.7, 98.6, 111.7, 123.3, 123.4, 129.4, 132.0, 143.1, 171.4, 190.2. EI-HRMS 
m/z calcd for C17 H21NO4S2 367.0912, found 367.0921 
 
Aldehyde 5.13 
 A solution of intermediate 5.16 (253 mg, 688 µmol) in DMSO (10 mL) was 
heated to 80°C under argon, and 15% aqueous NaOH (830 µL, 4.5 equiv.) was added 
under rapid stirring. After 50 minutes, iodide 5.15 (272 mg, 1.25 equiv. was added as a 
solution in DMSO (2 mL). After 30 minutes, the mixture was partitioned between water 
(80 mL) and MTBE (80 mL). The organic layer was separated, washed with twice with 
water (80 mL) plus brine (10 mL), dried with MgSO4, and concentrated. The residue was 
separated by column chromatography (hexanes-MTBE) to give the product as a pale 
yellow oil. Yield 181 mg (342 µmol, 50%). 
1
H NMR (CDCl3) δ 1.39 (s, 3H), 1.41 (s, 
3H), 1.46 (s, 3H), 1.48 (s, 3H), 2.12 (s, 3H), 2.17 (s, 3H), 2.59 (s, 2H), 2.75 (s, 2H), 2.98 
(s, 2H), 3.58 (d, J = 6.6 Hz, 2H), 3.71 (d, J = 12.2 Hz, 2H), 3.77 (s, 4H), 3.83 (d, J = 12.2 
Hz, 2H), 6.11 (t, J = 6.6 Hz, 1H), 6.93 (d, J = 8.6 Hz, 1H), 7.71 (dd, J = 8.6, 2.0 Hz, 1H), 
7.98 (d, J = 2.0 Hz, 1H), 9.69 (s, 1H). 
13
C NMR (CDCl3) δ 17.7, 21.1, 23.6, 23.7, 26.3, 
38.0, 38.1, 38.5, 38.8, 38.9, 45.4, 65.3, 66.2, 98.5, 98.6, 109.4, 118.0, 126.3, 133.0, 138.1, 
154.0, 189.6. EI-MS m/z 529 ([M]
+
, 100), 354 (25), 180 (27), 164 (40), 117 (55), 61 (50). 
EI-HRMS m/z calcd for [M]
+
 C25H39NO5S3 529.1990, found 529.1993. 
 
Chalcone 5.17 
 A solution of aldehyde 5.13 (764 mg, 1.44 mmol), acetophenone 5.3 (308 mg, 
1.44 mmol), and pyrrolidine (241 µL, 2.88 mmol) in ethanol (6 mL) was stirred for 2 
days at 50°C. The resulting oily biphasic mixture was poured into water (50 mL) + 1 M 
NaH2PO4 (10 mL) and extracted with MTBE (60 mL). The extract was dried with 
MgSO4 and concentrated, and the residue was separated by column chromatography (2:1 




305 mg (420 µmol, 29%). 
1
H NMR (CDCl3) δ 1.39 (s, 3H), 1.42 (s, 3H), 1.47 (s, 3H), 
1.49 (s, 3H), 2.13 (s, 3H), 2.17 (s, 3H), 2.61 (s, 2H), 2.71 (d, J = 5.3 Hz, 3H), 2.76 (s, 
2H), 3.00 (s, 2H), 3.55 (d, J = 6.6 Hz, 2H), 3.72 (d, J = 12.1 Hz, 2H), 3.78 (s, 4H), 3.83 
(d, J = 12.1 Hz, 2H), 4.67 (q, J = 5.3 Hz, 1H), 5.89 (t, J = 6.6 Hz, 1H), 6.91 (d, J = 8.7 
Hz, 1H), 7.29 (d, J = 15.5 Hz, 1H), 7.53 (dd, J = 8.7, 2.1 Hz, 1H), 7.73 (d, J = 15.5 Hz, 
1H), 7.80 (d, J = 2.1 Hz 1H), 7.98 (ad, J = 8.6 Hz, 2H), 8.11 (ad, J = 8.6 Hz, 2H). 
13
C 
NMR (CDCl3) δ 17.8 (2C), 21.3, 23.5, 23.9, 26.2, 29.3, 38.1, 38.2, 38.6, 38.9, 39.1, 45.5, 
65.4, 66.3, 98.5, 98.6, 110.2, 116.8, 118.3, 123.4, 127.3, 128.9, 131.7, 137.0, 141.8, 
142.4, 146.5, 151.8, 189.3. EI-MS m/z 724 ([M]
+
, 100), 375 (40), 373 (25), 198 (25), 131 
(30), 117 (83), 61 (92). EI-HRMS m/z calcd for [M]
+




 This compound was synthesized according to the procedure described for 
triarylpyrazoline 5.10 using chalcone 5.17 (162 mg, 223 µmol), PPTS (112 mg, 2 equiv.), 
and arylhydrazine 5.2 (90 mg, 2 equiv.) Yield 74 mg (81 µmol, 36%), yellow glassy 
solid.
1
H NMR (CDCl3) δ 1.35 (s, 3H), 1.39 (s, 3H), 1.44 (s, 6H), 2.06 (s, 3H), 2.14 (s, 
3H), 2.60-2.63 (m, 5H), 2.66-2.69 (m, 5H), 2.88 (d, J = 12.9 Hz, 1H), 2.94 (d, J = 12.9 
Hz, 1H), 3.19 (dd, J = 17.3, 6.0 Hz 1H), 3.41 (dd, J = 6.6, 2.1 Hz, 2H), 3.68-3.81 (m, 
8H), 3.84 (dd, J = 17.3, 12.3 Hz, 1H), 4.37 (q, J = 5.5 Hz, 1H), 4.59 (q, J = 5.4 Hz, 1H), 
5.30 (dd, J = 12.3, 6.0 Hz, 1H), 5.33 (t, J = 6.6 Hz, 1H), 6.81 (d, J = 8.6 Hz, 1H), 7.05 
(dd, J = 8.6, 2.2 Hz, 1H), 7.16 (ad, J = 9.0 Hz 2H), 7.32 (d, J = 2.2 Hz 1H), 7.65 (ad, J = 
9.0 Hz, 2H), 7.84-7.89 (m, 4H). 
13
C NMR (CDCl3) δ 17.77, 17.83, 21.6, 23.7, 23.7, 25.9, 
29.3, 29.4, 38.0, 38.3, 38.6, 38.72, 38.73, 43.2, 45.9, 63.4, 65.3, 65.4, 65.4, 66.2, 98.4, 
98.5, 111.1, 113.1, 118.6, 126.4, 127.5, 127.6, 127.9, 128.75, 128.83, 132.9, 136.4, 138.6, 





Sulfonyl fluoride 5.19 
 This compound was synthesized as described for sulfonyl fluoride 5.11 using 
triarylpyrazoline 5.18 (60 mg, 66 µmol), ethenesulfonyl fluoride (39 µL, 7 equiv.), and 
diisopropylethylamine (202 µL, 18 equiv.) with a reaction time of 2 hours. Yield 54 mg 
(48 µmol, 72%), yellow glassy solid.
1
H NMR (CDCl3) δ 1.36 (s, 3H), 1.40 (s, 3H), 1.44 
(s, 6H), 2.07 (s, 3H), 2.15 (s, 3H), 2.60 (s, 2H), 2.65 (d, J = 13.3 Hz 1H), 2.69 (d, J = 
13.3 Hz, 1H), 2.82 (s, 3H), 2.90 (s, 3H), 2.91 (d, J = 12.8 Hz, 1H), 2.96 (d, J = 12.8 Hz, 
1H), 3.21 (dd, J = 17.4, 6.0 Hz, 1H), 3.38-3.46 (m, 2H), 3.49-3.52 (m, 2H), 3.56-3.59 (m, 
2H), 3.68-3.82 (m, 12H), 3.86 (dd, J = 17.4, 12.2 Hz, 1H), 5.31 (dd, J = 12.2, 6.0 Hz, 
1H), 5.36 (t, J = 6.7 Hz, 1H), 6.82 (d, J = 8.6 Hz, 1H), 7.05 (dd, J = 8.5, 2.2 Hz, 1H), 
7.19 (ad, J = 8.9 Hz, 2H), 7.34 (d, J = 2.2 Hz, 1H), 7.61 (ad, J = 9.1 Hz, 2H), 7.84 (ad, J 
= 8.7 Hz, 2H), 8.00 (ad, J = 8.7 Hz, 2H). 
19
F NMR δ 56.3 (t, J = 4.8 Hz, 1F), 56.6 (t, J = 
4.7 Hz,1F). ESI-HRMS calcd for [M+H]
+
 C45H64N5O12S7F2 1128.2559, found 1128.2560. 
 
Probe 5.12   
 This compound was synthesized as described for probe 5.8 except that K2CO3 (10 
equiv.) was used in place of NaHCO3 during workup for more efficient removal of 
triethylamine. Starting material: sulfonyl fluoride 5.19 (50.6 mg, 44 µmol). Isolated yield 
of pure product ammonium salt 3.5 mg (3.6 µmol, 8%), yellow glassy solid containing ~ 
1 molar equiv. (3%) methanol by 
1
H NMR. The low yield is due to difficult HPLC 
separation requiring low column loading, and only a small fraction of the total yield has 
been purified. 
1
H NMR (CD3OD) δ 1.98 (s, 3H), 2.10 (s, 3H), 2.54 (d, J = 13.0 Hz, 1H), 
2.57 (d, J = 13.0 Hz, 1H), 2.69 (s, 2H), 2.73 (s, 3H), 2.79 (d, J = 12.7 Hz, 1H), 2.83 (s, 
3H), 2.84 (d, J ≈ 13 Hz, 1H, obscured by previous signal), 2.97-3.05 (m, 4H), 3.21-3.55 
(m, 11H, partly obscured by CHD2OH and CH3OH signals), 3.71 (m, 4H), 3.95 (dd, J = 
17.5, 12.2 Hz, 1H), 5.46 (dd, J = 12.2, 5.6 Hz, 1H), 6.72 (d, J = 8.6 Hz, 1H), 7.08 (dd, J = 




2H), 7.88 (ad, J = 8.6 Hz, 2H), 8.01 (ad, J = 8.6 Hz, 2H). ESI-HRMS m/z calcd for [M]
2-
 
C39H55N5O14S7 520.5901, found 520.5891. 
 
Benzothiazolinone 5.22 
 A mixture of 6-bromobenzothiazolin-2-one (5.21, 4.37 g, 19.0 mmol), iodide 5.15 
(6.61 g, 1.1 equiv.), Cs2CO3 (9.3g, 1.5 equiv.), and DMF (10 mL) was stirred at 90°C 
under argon overnight. The mixture was diluted with water (100 mL) and extracted with 
MTBE (100 mL). The extract was washed with 5% aqueous NaOH (100 mL) followed 
by water (100 mL) + brine (10 mL), dried with MgSO4, filtered, and concentrated to give 
a yellow oil that solidified on contact with methanol. The resulting material was 
recrystallized from methanol under stirring to give a colorless crystalline powder. Yield 
6.90 g (87%). 
1
H NMR (CDCl3) δ 1.47 (s, 6H), 2.13 (s, 3H), 2.66 (s, 2H), 3.62 (d, J = 
12.5 Hz, 2H), 4.00 (d, J = 12.5 Hz, 2H), 4.14 (s, 2H), 7.44 (dd, J = 8.7, 1.7 Hz, 1H), 7.47 
(dd, J = 8.7, 0.6 Hz, 1H), 7.54 (dd, J = 1.7, 0.6 Hz, 1H). 
13
C NMR (CDCl3) δ 18.4, 21.4, 
26.3, 38.1, 40.2, 46.4, 64.6, 98.5, 112.9, 115.8, 124.1, 124.8, 129.6, 137.4, 170.7. EI-MS 
m/z 419 (27) 417 ([M]
+
, 25), 404 (35), 402 (32), 361 (35), 359 (32), 328 (50), 326 (45), 





417.0068, found 417.0050. 
 
Bromide 5.23 
Benzothiazolinone 5.22 (4.80 g, 11.5 mmol) was dissolved in DMSO (40 mL) 
under argon at 80°C. Aqueous NaOH (5 M, 8.3 mL, 3.6 equiv.) was injected as a slow 
stream into the rapidly stirred solution. After 30 minutes, the reaction was complete by 
TLC (5:1 hexane-EtOAc ). The mixture was cooled to 60°C and acetic acid (0.85 mL, 1 
equiv) was added, followed by 1-chloro-3-methylthiopropane (1.43 g, 1 equiv.) in DMSO 
(2 mL). After 30 minutes, a trace of the intermediate thiophenol remained distinguishable 




After 15 minutes, TLC indicated complete consumption of the thiophenol. The mixture 
was partitioned between water (300 mL) and MTBE (140 mL), and the organic layer was 
washed twice with water (200 mL) + brine (10 mL), dried with MgSO4, and 
concentrated. The residue was separated by column chromatography (hexanes-MTBE) to 
give the product as a colorless oil. Yield 4.93 g (10.3 mmol, 89%). 
1
H NMR (CDCl3) δ 
1.45 (s, 3H), 1.46 (s, 3H), 1.83 (p, J = 7.1 Hz, 2H), 2.06 (s, 3H), 2.16 (s, 3H), 2.58 (t, J = 
7.0 Hz, 2H), 2.60 (s, 2H), 2.81 (t, J = 7.1 Hz, 2H), 3.38 (d, J = 6.6 Hz, 2H), 3.71 (d, J = 
12.0 Hz, 2H), 3.78 (d, J = 12.0 Hz, 2H), 5.32 (t, J = 6.5 Hz, 1H), 6.71 (d, J = 8.8 Hz, 1H), 
7.28 (dd, J = 8.8, 2.4 Hz, 1H), 7.48 (d, J = 2.4 Hz, 1H). 
13
C NMR (CDCl3) δ 15.4, 17.8, 
21.8, 25.6, 28.5, 32.8, 33.6, 38.3, 38.7, 45.9, 65.4, 98.5, 107.6, 111.7, 119.1, 132.8, 137.6, 
148.7. EI-MS m/z 481 (70), 479 ([M]
+
, 65), 306 (43), 304 (39), 216 (40), 214 (35), 89 








 An oven-dried 50 mL rb flask was charged with bromide 5.23 (642 mg, 1.34 
mmol), sealed with a rubber septum, and flushed with argon. Anhydrous THF (14 mL) 
was added, and the solution was cooled in a dry ice-acetone bath. After 15 min, n-
butyllithium (2.5 M in hexanes, 1.1 mL, 2 equiv.) was added dropwise to the stirred 
solution. After 5 min, t-butyllithium (1.6 M in pentane, 2.5 mL, 3 equiv.) was added 
dropwise. After 30 min, anhydrous DMF (1.0 mL, 10 equiv.) was added, the cooling bath 
was removed, and the mixture was quenched with water once the temperature rose to 
~0°C. The mixture was partitioned between water (100 mL) and MTBE (100 mL), and 
the organic layer was washed with water + brine (100 mL + 10 mL), dried with MgSO4, 
and concentrated. The residue was separated by column chromatography (hexanes-
MTBE) to give the product as a pale yellow oil. Yield 458 mg (83%). 
1
H NMR (CDCl3) δ 




2H), 2.59 (t, J = 7.0 Hz, 2H), 2.83 (t, J = 7.1 Hz, 2H), 3.56 (d, J = 6.5 Hz, 2H), 3.70 (d, J 
= 12.2 Hz, 2H), 3.82 (d, J = 12.2 Hz, 2H), 6.16 (t, J = 6.4 Hz, 1H), 6.91 (d, J = 8.6 Hz, 
1H), 7.72 (dd, J = 8.6, 2.0 Hz, 1H), 7.92 (d, J = 2.0 Hz, 1H), 9.70 (s, 1H). 
13
C NMR 
(CDCl3) δ 15.3, 17.8, 21.1, 26.3, 28.5, 32.7, 33.7, 38.2, 38.7, 45.5, 65.4, 98.7, 109.2, 
117.5, 126.1, 133.1, 138.2, 154.2, 189.6. EI-MS m/z 429 ([M]
+
, 85), 254 (38), 164 (34), 
89 (100), 61 (40). EI-HRMS calcd for C20H31NO3S3 429.1466, found 429.1475. 
 
Chalcone 5.25 
 A solution of aldehyde 5.24 (420 mg, 978 µmol), acetophenone 5.3 (208 mg, 1 
equiv.), and pyrrolidine (163 µL, 2 equiv.) in ethanol (5 mL) was stirred at 45°C for two 
days. The resulting biphasic mixture was partitioned between water (100 mL) + 1 M 
NaH2PO4 (10 mL) and MTBE (100 mL). The organic layer was dried with MgSO4 and 
concentrated, and the residue was separated by column chromatography (DCM-MTBE) 
to give the product as a red-orange glassy solid. Yield 296 mg (474 µmol, 48%). 
1
H 
NMR (CDCl3) δ 1.47 (s, 3H), 1.49 (s, 3H), 1.85 (p, J = 7.1 Hz, 2H), 2.05 (s, 3H), 2.18 (s, 
3H), 2.59 (s, 2H), 2.60 (t, J = 7.0 Hz, 2H), 2.70 (d, J = 5.3 Hz, 3H), 2.84 (t, J = 7.1 Hz, 
2H), 3.53 (d, J = 6.5 Hz, 2H), 3.72 (d, J = 12.1 Hz, 2H), 3.83 (d, J = 12.1 Hz, 2H), 4.97 
(q, J = 5.3 Hz, 1H), 5.96 (t, J = 6.5 Hz, 1H), 6.89 (d, J = 8.7 Hz, 1H), 7.29 (d, J = 15.5 
Hz, 1H), 7.55 (dd, J = 8.7, 2.1 Hz, 1H), 7.74 (d, J = 15.4 Hz, 1H), 7.75 (d, J = 2.1 Hz, 
1H), 7.98 (ad, J = 8.5 Hz, 2H), 8.10 (ad, J = 8.5 Hz, 2H). 
13
C NMR (CDCl3) δ 15.3, 17.7, 
21.2, 26.2, 28.4, 29.3, 32.7, 33.7, 38.2, 38.7, 45.5, 65.4, 98.6, 110.0, 116.6, 117.6, 123.0, 
127.3, 128.8, 131.8, 137.4, 141.7, 142.2, 146.5, 152.0, 189.2. EI-MS m/z 624 ([M]
+
, 70), 
449 (25), 89 (100), 61 (25). EI-HRMS m/z calcd for [M]
+









 This compound was synthesized according to the procedure described for 
triarylpyrazoline 5.10 using chalcone 5.25 (126 mg, 202 µmol), arylhydrazine 5.2 (61 
mg, 1.5 equiv.), and PPTS (101 mg, 2 equiv.). Yield 105 mg (129 µmol, 64%). 
1
H NMR 
(CDCl3) δ 1.44 (s, 6H), 1.69 (p, J = 7.1 Hz, 2H), 2.00 (s, 3H), 2.15 (s, 3H), 2.44-2.55 (m, 
2H), 2.59 (s, 2H), 2.61 (d, J = 5.5 Hz, 3H), 2.68 (d, J = 5.4 Hz, 3H), 2.74 (t, J = 7.1 Hz, 
2H), 3.19 (dd, J = 17.4, 5.9 Hz, 1H), 3.35-3.43 (m, 2H), 3.70 (d, J = 12.0 Hz, 2H), 3.79 
(d, J ≈ 12 Hz, 2 H), 3.85 (dd, J = 17.4, 12.3 Hz, 1H), 4.42 (q, J = 5.5 Hz, 1H), 4.66 (q, J 
= 5.4 Hz, 1H), 5.31 (dd, J = 12.3, 5.9 Hz, 1H), 5.39 (t, J = 6.6 Hz, 1H), 6.80 (d, J = 8.6 
Hz, 1H), 7.08 (dd, J = 8.5, 2.2 Hz, 1H), 7.15 (ad, J = 9.0 Hz, 2H), 7.25 (d, J = 2.2 Hz, 
1H), 7.65 (ad, J = 9.1 Hz, 2H), 7.84-7.90 (m, 4H). 
13
C NMR (CDCl3) δ 15.4, 17.8, 21.6, 
25.9, 28.4, 29.30, 29.34, 32.6, 33.4, 38.3, 38.6, 43.2, 45.9, 63.4, 65.4, 65.5, 98.6, 110.9, 
113.0, 117.8, 126.4, 127.6, 127.6, 127.9, 128.5, 128.7, 133.3, 136.3, 138.6, 146.7, 147.4, 
149.5. MALDI-HRMS m/z calcd for [M+H]
+
 C36H50N5O6S5 808.2365, found 808.2395. 
 
Sulfonyl fluoride 5.27 
 This compound was synthesized according to the procedure described for sulfonyl 
fluoride 5.11 using triarylpyrazoline 5.26 (78 mg, 97 µmol), ethenesulfonyl fluoride (40 
µL, 5 equiv.), and diisopropylethylamine (211 µL, 12.6 equiv.). Yield 67 mg (65 µmol, 
68%). 
1
H NMR (CDCl3) δ 1.44 (s, 6H), 1.71 (p, J = 7.1 Hz, 2H), 2.01 (s, 3H), 2.15 (s, 
3H), 2.49-2.56 (m, 2H), 2.58 (s, 2H), 2.75 (t, J = 7.1 Hz, 2H), 2.82 (s, 3H), 2.90 (s, 3H), 
3.21 (dd, J = 17.4, 5.9 Hz, 1H), 3.40 (d, J = 6.7 Hz, 2H) 3.49-3.53 (m, 2H), 3.56-3.59 (m, 
2H), 3.68-3.81 (m, 8H), 3.87 (dd, J = 17.4, 12.3 Hz, 1H), 5.32 (dd, J = 12.3, 5.9 Hz, 1H), 
5.42 (t, J = 6.6 Hz, 1H), 6.81 (d, J = 8.6 Hz, 1H), 7.08 (dd, J = 8.5, 2.2 Hz, 1H), 7.19 (ad, 
J = 9.0 Hz, 2H), 7.26 (d, J = 2.2 Hz, 1H), 7.61 (ad, J = 9.1 Hz, 2H), 7.84 (ad, J = 8.7 Hz, 
2H), 7.90 (ad, J = 8.7 Hz, 2H). 
19




1F). MALDI-HRMS m/z calcd for [M+H]
+




 Sulfonyl fluoride 5.27 (48 mg, 47 µmol) was stirred in a mixture of methanol (1.5 
mL), THF (0.5 mL), and 3 M aqueous HCl (47 µL, 3 equiv.). After 40 min, the mixture 
was concentrated to dryness under a stream of argon, and the residue was stirred in a 
mixture of methanol (2 mL), THF (1 mL), and 5 M NaOH (112 µL, 12 equiv.). After 4 
hours, the reaction was quenched by adding a small piece of dry ice and concentrated to 
dryness. The residue was taken up in methanol (5 mL), filtered through cotton to remove 
NaHCO3, and concentrated to dryness. The resulting material was taken up in 75% 
H2O/25% CH3CN and separated by RP-HPLC using a gradient of 30-34% CH3CN in 
0.1% aqueous NH4HCO4 to give the product ammonium salt as a yellow glassy solid 
after drying under high vacuum. Purification of 37.5% of the total crude material gave 
13.3 mg (13 µmol, 75% yield). 
1
H NMR (CD3OD) δ 1.62 (p, J = 7.0 Hz, 2H), 1.93 (s, 
3H), 2.09 (s, 3H), 2.39-2.52 (m, 2H), 2.66 (s, 2H), 2.71-2.74 (m, 5H), 2.83 (s, 3H), 2.97-
3.04 (m, 4H), 3.21 (s, 2H), 3.22 (dd, J = 17.5, 5.7 Hz, 1H), 3.36-3.44 (m, 2H), 3.47-
3.51(m, 2H), 3.59 (s, 4H), 3.94 (dd, J = 17.5, 12.2 Hz, 1H), 5.47 (dd, J = 12.2, 5.6 Hz, 
1H), 6.73 (d, J = 8.6 Hz, 1H), 7.12 (dd, J = 8.5, 2.2 Hz, 1H), 7.23-7.25 (m, 3H), 7.61 (ad, 
J = 9.0 Hz, 2H), 7.87 (ad, J = 8.5 Hz, 2H), 8.00 (ad, J = 8.5 Hz, 2H). 
13
C NMR (CDCl3) δ 
15.3, 17.7, 29.5, 33.4, 33.8, 35.9, 36.0, 37.8, 44.1, 46.2, 47.2, 47.7, 47.8, 50.7, 50.8, 64.7, 
64.8, 111.7, 114.3, 118.9, 127.3, 127.8, 128.9, 128.9, 129.9, 130.0, 134.7, 138.1, 138.6, 
148.6, 149.8, 151.1. ESI-HRMS m/z calcd for [M]
2-









 m-Aminoacetophenone (9.09 g, 67.3 mmol) was dissolved in pyridine (27 mL, 5 
equiv.), and the solution was cooled in an ice bath under a slow stream of argon. 
Methanesulfonyl chloride (6.8 mL, 1.3 equiv.) was added dropwise to the stirred solution. 
After 5 min, the reaction was quenched by adding crushed ice and poured over a slurry of 
crushed ice (~100 g) and concentrated HCl (25 mL). The resulting red emulsion was 
extracted with dichloromethane (100 mL) + MTBE (200 mL). The yellow organic layer 
(top), dried with MgSO4, filtered, and concentrated. The residue was recrystallized from 
cyclohexane-ethyl acetate to give the product as a slightly yellowish crystalline powder. 
Yield 10.41 g (48.8 mmol, 73%) A further 1.26 g of pure product was recovered from the 
emulsion layer remaining after extraction, bringing the total yield to 11.67 g (81%). 
1
H 
NMR (CDCl3) δ 2.63 (s, 3H), 3.06 (s, 3H), 7.38 (br. s, 1H), 7.48 (t, J = 7.9 Hz 1H), 7.56 
(ddd, J = 8.1, 2.3, 1.1 Hz, 1H), 7.77 (dt, J = 7.7, 1.2 Hz, 1H), 7.84 (t, J = 1.8 Hz, 1H). 
13
C 
NMR (CDCl3) δ 26.7, 39.6, 120.0, 125.1, 125.2, 130.0, 137.5, 138.4, 197.7. 
 
Chalcone 5.31 
 A solution of acetophenone 5.30 (2.10 g, 9.85 mmol), 4-
dimethylaminobenzaldehyde (1.50 g, 1.02 equiv.), and pyrrolidine (250 µL, 0.3 equiv.) in 
ethanol (30 mL) was stirred for 2 days at 40-50°C. The resulting dark red slurry was 
allowed to cool, and the product was collected by filtration, washed with cold ethanol 
until the washings were yellow-orange rather than red, and dried under high vacuum at 
50°C to give a yellow-orange crystalline powder. Yield 2.42 g (7.03 mmol, 71%). Mp 
215-217°C 
1
H NMR (DMSO-d6) δ 3.01 (s, 6H), 3.05 (s, 3H), 6.75 (ad, J = 9.0 Hz, 2H), 
7.46-7.49 (m, 1H), 7.51-7.56 (m, 2H), 7.68-7.72 (m, 3H), 7.85 (br. t, J ≈ 1.8 Hz, 1H), 
7.90 (dt, J = 7.5, 1.2 Hz, 1H), 9.97 (br. s,1H). 
13
C NMR (CDCl3) δ 39.4, 39.6, 111.7, 






, 100), 265 (45), 174 (38). EI-HRMS m/z calcd for [M]
+
 C18H20N2O3S 
344.1195, found 344.1187. 
 
Triarylpyrazoline 5.32 
 A mixture of chalcone 5.31 (488 mg, 1.42 mmol), arylhydrazine 5.2 (399 mg, 1.4 
equiv.), and PPTS (496 mg, 1.4 equiv.) in methanol (4 mL) was stirred under argon in a 
sealed vessel at 90°C for 3 hours. The mixture was partitioned between water (100 mL) 
and DCM (40 mL). The organic layer was collected, and the aqueous layer was extracted 
with DCM (2 x 20 mL). The combined organic layers were dried with MgSO4 and 
concentrated to a foamy glassy solid. This material was dissolved in a small volume of 
DCM and scratched with a Pasteur pipette until crystals appeared. A seed crystal was 
collected, and the remaining material was concentrated to dryness, dissolved in acetone, 
filtered through a tight cotton plug to remove a small amount of insoluble material, and 
diluted with MTBE to the point of permanent turbidity (required 30 mL). The mixture 
was diluted dropwise with acetone until clear and then seeded with the initial crystalline 
material. After 4 hours of slow stirring, the product was collected by filtration, washed 
with MTBE, and dried under high vacuum to give a colorless crystalline powder. Yield 
510 mg (967 µmol, 68%). Mp 183-184°C. 
1
H NMR (Acetone-d6) δ 2.49 (d, J = 5.3 Hz, 
3H), 2.89 (s, 6H), 3.04 (s, 3H), 3.17 (dd, J = 17.5, 5.7 Hz, 1H), 3.97 (dd, J = 17.5, 12.1 
Hz, 1H), 5.49 (dd, J = 12.1, 6.7 Hz, 1H), 5.99 (q, J = 5.3 Hz, 1H), 6.71 (ad, J = 8.8 Hz, 
2H), 7.15 (ad, J = 8.8 Hz, 2H), 7.19 (ad, J = 8.9 Hz, 2H), 7.38-7.41 (m, 1H), 7.42-7.46 
(m, 1H), 7.56-7.61 (m, 3H), 7.84 (br. t, J ≈ 1.7 Hz, 1H), 8.69 (br. s, 1H). EI-MS m/z 527 
([M]
+
, 95), 223 (25), 147 (100), 146 (40). EI-HRMS m/z calcd for [M]
+
 C25H29N5O4S2 







Sulfonyl fluoride 5.33 
 A mixture of triarylpyrazoline 5.32 (254 mg, 481 µmol), triethylamine (201 µL, 3 
equiv.), and ethenesulfonyl fluoride (241 µL, 6 equiv.) in dry DCM (5 mL) was stirred 
under argon for 5 hours. The mixture was diluted with toluene (2 mL), concentrated to 
dryness under a stream of nitrogen, and partitioned between DCM (50 mL) and water + 1 
M NaH2PO4 (50 mL + 10 mL). The organic layer was collected, and the aqueous layer 
was extracted with DCM (25 mL). The combined organic layers were dried with MgSO4, 
filtered, and concentrated to dryness. The residue was dissolved in DCM and filtered 
through a 3 cm plug of silica gel in a Pasteur pipette. The silica plug was washed with 
10:1 DCM-MTBE (5 mL), and the combined filtrate and washings were concentrated to 
dryness. The residue was crystallized from boiling acetone-MTBE under slow stirring to 
give the product as an ivory-colored crystalline powder. Yield 269 mg (360 µmol, 75%). 
Mp 182-183°C 
1
H NMR (CDCl3) δ 2.80 (s, 3H), 2.94 (s, 6H), 3.00 (s, 3H), 3.20 (dd, J = 
17.4, 6.0 Hz, 1H) 3.47-3.50 (m, 2H), 3.68-3.74 (m, 4H), 3.86 (dd, J = 17.4, 12.2 Hz, 1H), 
4.27 (br. t, J ≈ 7 Hz, 2H), 5.32 (dd, J = 12.2, 6.0 Hz, 1H), 6.68 (ad, J = 8.8 Hz, 2H), 7.11 
(ad, J = 8.8 Hz, 2H), 7.17 (ad, J = 9.0 Hz, 2H), 7.36 (ddd, J = 8.0, 2.1, 0.9 Hz, 1H), 7.50 
(t, J = 7.9 Hz, 1H), 7.58 (ad, J = 9.1 Hz, 2H), 7.70-7.72 (m, 1H), 7.76 (br. t, J ≈ 1.8 Hz, 
1H). 
19
F NMR (CDCl3) δ 56.3 (t, J = 4.8 Hz, 1F) 57.3 (t, J = 4.3 Hz, 1F). 
 
Reference triarylpyrazoline 5.29 
 A mixture of sulfonyl fluoride 5.33 (101 mg, 135 µmol), 1M aqueous DABCO 
(1.08 mL, 8 equiv), 1 M aqueous DABCO saturated with CO2 (540 µL), water (540 µL), 
and THF (1.44 mL) was stirred overnight and then concentrated to dryness. Excess 
DABCO was removed by sublimation under high vacuum, and the residue was taken up 
in methanol (2 mL). A solution of K2CO3 (47 mg, 2.5 equiv) in 4:1 methanol-water (3 
mL) was added, and the resulting precipitate was collected by filtration and dried. This 




not pure by 1H NMR, so the filtrate was concentrated to dryness, taken up in water, and 
separated by RP-HPLC with a gradient of acetonitrile in 0.5% aqueous NH4HCO3 to 
obtain the product ammonium salt as a pale yellow glassy solid. Yield 14 mg (13%). 
1
H 
NMR (CD3OD) δ 2.72 (s, 3H), 2.90 (s, 6H), 2.98-3.04 (m, 4H), 3.04 (s, 3H), 3.18 (dd, J 
= 17.6, 5.8 Hz, 1H), 3.33-3.45 (m, 2H), 3.94 (dd, J = 17.6, 12.1 Hz, 1H), 4.12-4.16 (m, 
2H), 5.43 (dd, J = 12.1, 5.8 Hz, 1H), 6.79 (ad, J = 8.7 Hz, 2H), 7.14 (ad, J = 8.8 Hz, 2H), 
7.20 (ad, J = 9.0 Hz, 2H), 7.45-7.47 (m, 1H), 7.49-7.53 (m, 1H), 7.57 (ad, J = 9.0 Hz, 
2H), 7.79-7.80 (m, 1H), 7.84 (br. dt, J = 7.6, 1.3 Hz, 1H). ESI-HRMS m/z calcd for [M]
2-
 
C29H35N5O10S4 370.5639, found 370.5632.  
 
Chalcone 5.34 
A solution of aldehyde 5.24 (975 mg, 2.27 mmol), acetophenone 5.30 (484 mg, 1 
equiv.) and pyrrolidine (95 µL, 0.5 equiv.) in ethanol (6 mL) was stirred for 25 hours at 
45°C, producing a red, oily biphasic mixture. A small aliquot (~50 µL) of the lower 
phase was removed, concentrated, and separated by column chromatography in a Pasteur 
pipette (2:2:1 hexanes-DCM-MTBE). The presumed chalcone product (bright orange 
band) was crystallized from MTBE-hexane. The bulk reaction mixture was diluted with 6 
mL MTBE, stirred until homogeneous, and seeded with the crystalline material. The 
resulting crystalline slurry was stirred for 4 days at 30°C, diluted into toluene (100 mL) 
and washed with a mixture of sat. aqueous Na2CO3 (15 mL), sat. aqueous NaHCO3 (15 
mL) and water (70 mL) followed by 1 M NaH2PO4 (25 mL). The organic layer was dried 
with Na2SO4 and concentrated, and the residue was separated by column 
chromatography (2:2:1 hexanes-DCM-MTBE). The resulting orange, glassy, slightly 
impure product was crystallized from MTBE to give chocolate-colored leaflets that 
turned yellow-orange after drying under vacuum. Yield 981 mg (1.57 mmol, 69%). 
1
H 
NMR (CDCl3) δ 1.47 (s, 3H), 1.49 (s, 3H), 1.86 (p, J = 7.1 Hz, 2H), 2.06 (s, 3H), 2.18 (s, 




J = 6.5 Hz, 2H), 3.72 (d, J = 12.1 Hz, 2H), 3.82 (d, J = 12.1 Hz, 2H), 5.92 (t, J = 6.5 Hz, 
1H), 6.88 (d, J = 8.7 Hz, 1H), 7.37 (d, J = 15.4 Hz, 1H), 7.51 (t, J = 7.9 Hz, 1H), 7.61 
(dd, J = 8.7, 2.0 Hz, 1H), 7.72 (ddd, J = 8.1, 2.3, 0.9 Hz, 1H), 7.81 (d, J = 2.0 Hz, 1H), 
7.83-7.85 (m, 1H), 7.97 (d, J = 15.4 Hz, 1H), 8.10 (br. s, 1H), 8.14 (br. t, J = 1.9 Hz, 1H). 
13
C NMR (CDCl3) δ 15.4, 17.8, 21.4, 26.1, 28.6, 32.8, 33.8, 38.3, 38.8, 39.5, 45.5, 65.5, 
98.7, 110.0, 116.0, 117.7, 120.6, 123.5, 124.1, 124.8, 129.8, 132.1, 137.3, 138.2, 139.9, 
146.8, 151.9. EI-MS m/z 624 ([M]
+
, 45), 198 (10), 121 (12), 89 (100), 73 (45), 61 (37). 
EI-HRMS m/z calcd for [M]
+
 C29H40N2O5S4 624.1820, found 624.1833. 
 
Triarylpyrazoline 5.35 
 A mixture of chalcone 5.34 (343 mg, 549 µmol) and PPTS (276 mg, 2 equiv.) in 
methanol (5 mL) was boiled for 15 min, then concentrated to an oily residue under a 
stream of argon. Arylhydrazine 5.2 (144 mg, 1.3 equiv.) and methanol (3 mL) were 
added, and the mixture was stirred under argon in a sealed vessel at 90°C for 2 hours. The 
mixture was concentrated to dryness, and the residue was taken up in acetone (5 mL) + 
2,2-dimethoxypropane (3 mL). The mixture was boiled for 15 min, allowed to cool, and 
partitioned between water (100 mL) and DCM (50 mL). The organic layer was collected, 
and the aqueous layer was extracted with DCM (20 mL). The combined organic layers 
were dried with Na2SO4 and concentrated, and the residue was separated by column 
chromatography (DCM-MTBE) to give the product as a pale yellow glassy solid. Yield 
282 mg (349 µmol, 64%). 
1
H NMR (CDCl3) δ 1.440 (s, 3H), 1.444 (s, 3H), 1.69 (p, J = 
7.1 Hz, 2H), 2.00 (s, 3H), 2.14 (s, 3H), 2.44-2.55 (m, 2H), 2.59 (s, 2H), 2.60 (d, J = 5.4 
Hz, 3H), 2.73 (t, J = 7.1 Hz, 2H), 3.05 (s, 3H), 3.15 (dd, J = 17.3, 5.9 Hz, 1H), 3.34-3.43 
(m, 2H), 3.70 (d, J = 12.0 Hz, 2H), 3.79 (d, J ≈ 12 Hz, overlaps with subsequent signal, 
2H), 3.81 (dd, J = 17.3, 12.2 Hz, 1H), 4.45 (q, J = 5.5 Hz, 1H), 5.23 (dd, J = 12.2, 6.0 Hz, 
1H), 5.37 (t, J = 6.6 Hz, 1H), 6.79 (d, J = 8.6 Hz, 1H), 7.06 (br. s, 1H), 7.07 (dd, J = 8.5, 




1.0 Hz, 1H), 7.38 (t, J = 7.9 Hz, 1H), dt (J = 7.9, 1.2 Hz, 1H), 7.61-7.74 (m, 3H). 
13
C 
NMR (CDCl3) δ 15.3, 17.8, 21.7, 25.8, 28.4, 29.4, 32.6, 33.4, 38.3, 38.7, 39.5, 43.5, 45.9, 
63.1, 65.4, 65.5, 98.6, 110.8, 112.8, 117.8, 118.0, 121.2, 122.9, 127.0, 127.7, 128.7, 
128.9, 130.0, 133.3, 133.7, 137.3, 147.1, 148.5, 149.4. 
 
Sulfonyl fluoride 5.36 
 A solution of triarylpyrazoline 5.35 (169 mg, 209 µmol), triethylamine (87 µL, 3 
equiv.), and ethenesulfonyl fluoride (105 µL, 6 equiv.) in dry DCM (2 mL) was stirred 
under argon for 3 hours, then diluted with toluene (2 mL) and concentrated to dryness. 
The residue was separated by column chromatography (1:1 DCM-hexanes plus 
increasing MTBE) and the resulting glassy product was crystallized from DCM-MTBE to 
give an ivory-colored crystalline powder. Yield 125 mg (122 µmol, 58%). 
1
H NMR 
(CDCl3) δ 1.44 (br. s, 6H), 1.72 (p, J = 7.1 Hz, 2H), 2.01 (s, 3H), 2.15 (s, 3H), 2.46-2.57 
(m, 2H), 2.59 (s, 2H), 2.75 (t, J = 7.1 Hz, 2H), 2.81 (s, 3H), 3.01 (s, 3H), 3.19 (dd, J = 
17.4, 6.0 Hz 1H), 3.40 (d, J = 6.6 Hz, 2H), 3.48-3.52 (m, 2H), 3.70 (d, J = 11.8 Hz, 2H), 
3.71-3.76 (m, 4H), 3.80 (d, J = 11.8 Hz, 2H), 3.86 (dd, J = 17.4, 12.2 Hz, 1H), 4.28 (br. t, 
J ≈ 7 Hz, 2H), 5.27 (dd, J = 12.2, 6.0 Hz, 1H), 5.41(t, J = 6.6 Hz, 1H), 6.81 (d, J = 8.6 
Hz, 1H) 7.09 (dd, J = 8.5, 2.2 Hz, 1H), 7.16 (ad, J = 9.0 Hz, 2H), 7.27 (d, J = 2.2 Hz, 
1H), 7.37 (ddd, J = 8.0, 2.1, 1.0 Hz, 1H), 7.51 (t, J = 7.9 Hz, 1H), 7.60 (ad, J = 9.1 Hz, 
2H), 7.72 (dt, J ≈ 8.0, 1.2 Hz, 1H), 7.76 (t, J = 1.8 Hz, 1H). 
19
F NMR (CDCl3) δ 56.3 (t, J 
= 4.9 Hz, 1F), 57.3 (t, J = 4.3 Hz, 1F. 
 
Probe 5.28 
 Sulfonyl fluoride 5.36 (60 mg, 58 µmol) was stirred in a mixture of methanol (1 
mL), THF (0.5 mL), and 1 M aqueous HCl (116 µL, 2 equiv.). The resulting suspension 
was heated briefly to boiling until the starting material completely dissolved and then 




DABCO (0.7 mL) and THF (0.3 mL) were added, and the mixture was stirred overnight 
and then concentrated to dryness. The product was isolated as the ammonium salt by RP-
HPLC with a gradient of acetonitrile in 0.5% aqueous NH4HCO3 to give a pale yellow 
glassy solid after drying under high vacuum. Isolated yield 38 mg (37 µmol) separated 
from 83% of the total crude material, 77%. 
1
H NMR (CDCl3) δ 1.62 (p, J = 7.0 Hz, 2H), 
1.93 (s, 3H), 2.09 (s, 3H), 2.39-2.52 (m, 2H), 2.66 (s, 2H), 2.72 (s, 3H), 2.73 (t, J = 7.0 
Hz, 2H), 2.98-3.02 (m, 4H), 3.03 (s, 3H), 3.20 (dd, J = 17.6, 5.6 Hz, 1H), 3.21 (s, 2H), 
3.37-3.41 (m, 2H), 3.59 (m, 4H), 3.93 (dd, J = 17.6, 12.1 Hz, 1H), 4.12-4.16 (m, 2H), 
5.41 (dd, J = 12.1, 5.6 Hz, 1H), 6.72 (d, J = 8.6 Hz, 1H), 7.11 (dd, J = 8.5, 2.2 Hz, 1H), 
7.21 (ad, J = 9.0 Hz, 2H), 7.24 (d, J = 2.2 Hz, 1H), 7.44-7.47 (m, 1H), 7.50 (t, J ≈ 7.7 Hz, 
1H), 7.59 (ad, J = 9.1 Hz, 2H), 7.80 (br. t, J = 1.7 Hz, 1H), 7.85 (dt, J = 7.6, 1.4 Hz, 1H). 
13
C NMR (CDCl3) δ 13.8, 16.3, 28.0, 32.0, 32.3, 24.5, 36.3, 36.6, 42.9, 44.7, 45.7, 46.3, 
49.4, 50.0, 63.0, 63.3, 110.3, 112.6, 117.4, 125.2, 125.4, 126.1, 127.4, 128.6, 128.7, 
129.0, 129.5, 133.3, 133.9, 139.8, 147.4, 149.2, 149.5. ESI-HRMS m/z calcd for [M]
2-
 
C37H51N5O12S7 490.5795, found 490.5787. 
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SULFONATED THIOETHER-BASED LIGANDS AND THEIR 
CRYSTALLINE COPPER(I)-COMPLEXES AS COLORLESS, 
WATER-SOLUBLE, AND AIR-STABLE AFFINITY STANDARDS 
 
6.1. Introduction 
6.1.1. The need for copper(I)-affinity standards 
 For an accurate understanding of the molecular mechanisms of copper trafficking 
in living organisms, knowledge of the copper binding affinities of the ligands involved is 
essential. Accurate binding affinity determination for Cu(I)-transport proteins, however, 
is not straightforward, and gross inconsistencies abound in the literature. For example, 
the values reported for Cu(I)-binding affinity of the metallochaperone Atox1 span a range 
of more than two trillion-fold from 2.5 x 10
5







 Difficulties in binding affinity determination for biologically relevant Cu(I)-
ligands stem from several different sources.  As mentioned in Chapter 1, aqueous Cu
+
 is 
highly reactive toward molecular oxygen. It is also prone to disproportionation at 
concentrations above about 1 µM and to precipitation as Cu2O at neutral pH,
3
 all of 
which may lead to losses during titrations with copper(I). Furthermore, while the most 









 are difficult to determine by direct titration 
because the protein and cation will be almost completely associated even at the lowest 






 Metal-binding affinities which are too high to measure by direct titration can 
instead be determined by competition experiments, where the metal ion is allowed to 
equilibrate between the ligand under study and another ligand of known binding affinity. 
In the case of Cu(I), use of a competing ligand can also protect against aerial oxidation or 
disproportionation, provided that the ligand selected preferentially stabilizes Cu(I) over 
Cu(II). There are two additional requirements, however, for determining metal binding 
affinities through ligand competition methods: The affinity standard ligand and test 
ligand must not form heteroleptic ternary complexes with the metal cation to a significant 
extent under the conditions of measurement, and the binding affinity of the standard must 
be accurately known.  
 
6.1.2. Ligands previously employed as copper(I)-affinity standards 
 For Cu(I), the above conditions have been surprisingly difficult to meet with 





are sometimes employed as Cu(I) affinity standards, but this is likely to result in 
heteroleptic complex formation during competition experiments, as Cu(I) typically 
exhibits a coordination number of up to four.
7
 Dithiothreitol (DTT), a 1,4-dithiol 
typically employed as a reducing agent for protein disulfides, has also been utilized as a 
competitive ligand against Cu(I) –binding proteins, but is far from ideal due to its high 
reactivity with oxygen and variable coordination stoichiometry.
8
  
 The water-soluble, ortho-substituted bipyridine-type ligands bicinchoninic acid 
(BCA) and bathocuproine disulfonic acid (BCS) (Figure 6.1) yield colored, air-stable 2:1 
complexes with Cu(I) and are frequently used as affinity standards,
4
 but their binding 
affinities have been controversial in the literature, with values of the 2:1 ligand metal 
complex stability constant β2 ranging from log β2 = 11.4 to 17.3 for BCA
8,9
 and 19.5 to 
22.5 for BCS.
9,10




demanding than small monodentate ligands such as cyanide and thiourea, are presumably 
still prone to heteroleptic complex formation, particularly with other ligands of low 
denticity. As previously noted,
8
 this is a likely source of error in an earlier attempt to 






Figure 6.1: Structures of the Cu(I)-selective ligands BCA and BCS 
 
6.1.3. The promising properties of tetradentate thioether-based ligands 
 Tetradentate sulfur-rich ligands including thiocrown macrocycles and tripodal 
thioether-amines have been extensively investigated as Cu(I)-ligands by Rorabacher and 
coworkers, and often form air-stable 1:1 complexes with Cu(I). By saturating the Cu(I) 
coordination sphere, these chelators should provide greater resistance to heteroleptic 
complex formation during Cu(I)-competition experiments than ligands of lower denticity. 
Additionally, these chelators often exhibit a low to moderate Cu(II)-binding affinity and  
electrochemically reversible interconversion of the Cu(II) and Cu(I) complexes, allowing 
the relatively high Cu(I)-binding affinity to be calculated from the directly measurable 
Cu(II) affinity and the ligand-bound Cu(II)/Cu(I) redox potential using a thermodynamic 
cycle method
11
 as previously described for CTAP-2 (Chapter 3, Section 3.7.3). 
Furthermore, the Cu(I)-complexes of aliphatic polythioethers are typically colorless with 






providing the potential for spectrophotometric or fluorimetric monitoring of the Cu(I)-
occupancy of the ligand under study rather than the affinity standard ligand in 
competition titrations. This is potentially a valuable asset for competition experiments 
with copper proteins: If the affinity standard ligand can be used in large excess over the 
protein, then it would yield a buffer-like effect rendering the concentration and initial 
copper occupancy of the protein, which may be imprecisely known, inconsequential to 
the results of the titration. The one major impediment to the use of previously reported 
thioether-rich tetradentate Cu(I)-ligands in direct competition experiments with copper 
proteins is their inherent lipophilicity, which not only results in limited aqueous solubility 
but might also lead to interfering hydrophobic interactions with the protein. 
 
6.2. Sulfonated NS3 Tripods 
6.2.1. Ligand design 
 Previous studies by Rorabacher et al indicated that tripodal amine ligands have 
somewhat higher Cu(I)-association constants than linear or macrocyclic ligands with 
similar donor atom sets and also provide a greater stabilization of the Cu(I) oxidation 
state over Cu(II).
13,14
 These trends are exemplified by the respective Cu(I)-association 
constants of log K
Cu(I)
 = 13.6, 13.1, and 15.8 and the respective ligand-bound Cu(II)/Cu(I) 
reduction potentials of 0.38, 0.41, and 0.69 V vs. SHE for the chelators [14]aneNS3-a, 
[14]aneNS3-b, and TMMEA shown in Figure 6.2.
13,14
 Replacing the NS3-donor set of the 
macrocycles with S4 improves the ligand-bound Cu(II)/Cu(I) reduction potential but not 
the Cu(I) affinity, which is instead somewhat decreased to log K
Cu(I)
 = 12.1 and 12.2, 










Figure 6.2: Structures of Cu(I)-ligands [14]aneNS3-a, [14]aneNS3-b, and TMMEA 
 
 
 Based on the higher affinity provided by the tripodal topology and a relatively 
recent report of subfemtomolar Cu(I)-binding affinity for Atox1 and related Cu(I)-
transport proteins,
4
 we chose TMMEA as a starting point for the design of water-soluble 
thioether-based Cu(I)-ligands. Replacing the methyl groups of TMMEA with ionic 3-
sulfopropyl moieties yields design 6.1, shown in Figure 6.3 as its sodium salt. Given the 
substantial distortion from the preferred tetrahedral coordination geometry of Cu(I) 
apparent in the x-ray crystal structure of the TMMEA-CuClO4 complex,
13
 we also 
devised ligand 6.2, in which the N-S bridges are lengthened from two carbons to three, to 
determine whether this modification could increase the binding affinity by better 







Figure 6.3: Structures of the sulfonated NS3 tripodal ligands 6.1 and 6.2 
6.2.2. Synthesis and properties of the ligands and their Cu(I)-complexes 
 Both 6.1 and 6.2 were prepared from the corresponding tris(ω-chloroalkyl)amines 
by reaction with commercially available sodium 3-mercaptopropanesulfonate in the 
presence of sodium hydroxide. The desired products were separated from the byproduct 
sodium chloride by recrystallization from methanol-rich mixtures, as the solubility of 
sodium chloride exhibits a negative temperature dependence in methanol.
15
 After drying 
under vacuum, both ligands were obtained as fine white powders that gave NMR spectra 
and elemental analyses consistent with the intended structures in anhydrous form. 
Ligands 6.1 and 6.2 were each reacted with a stoichiometric quantity of 
tetrakis(acetonitrile)copper(I) hexafluorophosphate to produce the respective copper 
complexes 6.3 and 6.4, which were obtained as colorless crystalline powders from 
alcohol-water mixtures. These were dried under high vacuum to yield fine white 
powders, which were determined to be the 1:1 adducts with sodium hexafluorophosphate 
as shown in Scheme 6.1. The hexafluorophosphate stoichiometry was initially determined 




F NMR using 2,2,2-trifluoroethanol as an internal standard 
to link the proton and fluorine NMR integrals, then confirmed by elemental analysis, 
which yielded results consistent with the proposed structures in anhydrous form. 
Recrystallization of complex 6.4 from ethanol-water had no effect on the 
hexafluorophosphate 
19
F integral value. 
  Ligands 6.1 and 6.2 as well as their respective copper(I)-complexes 6.3 and 6.4 
dissolve readily in water to concentrations greater than 100 mM. Remarkably, the Cu(I) 
complexes are air-stable in aqueous solution, showing no sign of oxidation to blue Cu(II) 
after several days. The formation of water-soluble, air-stable Cu(I)-complexes should be 
a valuable asset for the use of 6.1 and 6.2 as affinity standards in ligand competition 




effective buffered concentration of Cu
+
, can be varied using an aqueous stock solution of 
the pre-formed copper complex, thus eliminating the need for Cu(I)-stabilizing solvents 
such as acetonitrile which may participate in undesired additional coordination equilibria 
or promote denaturation of proteins. Additionally, the air-stability of the Cu(I)-complexes 
should eliminate the need for rigorous deoxygenation or the presence of reducing agents 
provided that the ligand under study is also air-stable. 
 
 
Scheme 6.1: Synthesis of ligands 6.1-6.2 and Cu(I) complexes 6.3-6.4. 
 
6.2.3. X-ray crystal structures of the Cu(I)-complexes 
 Initial attempts to obtain crystals of 6.3 or 6.4 suitable for x-ray diffraction 
analysis were unsuccessful, yielding only fibrous acicular crystals by thermal 
recrystallization from dilute solutions and fine powders by vapor diffusion or solvent 




amount of clear tablet-shaped granules in addition to the previously obtained fibrous 
crystals when recrystallization was conducted in the presence of a larger fraction of water 




F NMR spectra identical to those of the fibrous form, and slow stirring overnight 
converted all of the fibrous material to the granular form. The granules slowly 
decomposed to a powder under dry argon or vacuum but were found to be completely 
stable in ambient air, remaining clear and colorless after drying under air flow overnight. 
Careful thermal recrystallization of the granular form from ethanol-water yielded a 
sample suitable for x-ray diffraction. Attempts to crystallize complex 6.3 under the 
conditions that yielded the granular form of 6.4 were unsuccessful, but crystallization in 
the presence of a large excess of sodium perchlorate in 2:1 ethanol-water yielded clear 
prisms suitable for x-ray diffraction. 
 Data collection and structural refinement for the crystals obtained from both 6.3 
and 6.4 were carried out by Dr. John Bacsa of Emory University. The crystal structure of 
6.4 contains the expected 1:1 Cu(I)-ligand complex with one equivalent of 
hexafluorophosphate per copper center. The asymmetric unit (Figure 6.4) contains two 
enantiomeric forms of the copper complex stacked in opposing directions with both sets 
of sulfonate groups bridged by sodium cations and water molecules, giving an overall 
composition of Na6(CuL)2(PF6)2 •15 H2O where CuL represents the dianionic 








Figure 6.4: Ball-and-stick representation of the asymmetric unit of complex 6.4 
(hydrogen atoms omitted for clarity) 
Colored spheres represent atoms as follows:  Gray, carbon; red, oxygen; blue, nitrogen; 
yellow, sulfur; purple, sodium; brown, copper; orange, phosphorus; yellow-green, 





 The crystals obtained from complex 6.3 in the presence of perchlorate contain the 
expected 1:1 ligand-Cu(I) complex structure and form a sodium-bridged dimer similar to 
that observed for 6.4 but with the incorporation of three partly disordered perchlorate ions 
per two copper centers and no hexafluorophosphate, corresponding to a formula of 
Na7(CuL)2(ClO4)3 • 4 H2O. This compound is hereafter referred to as 6.3-ClO4. For 
structural comparison, the dianionic copper-ligand complex structures for both 6.3-ClO4 
and 6.4 are shown in ORTEP representation in Figure 6.5, and bond lengths and angles 
about the respective Cu(I) centers are given in  Table 6.1. Atom numbers in the table 







Figure 6.5: ORTEP representations of the dianionic Cu(I)-complex unit from the crystal 
structures of complexes 6.3-ClO4 (left) and 6.4 (right). Images generated by Dr. 





Table 6.1: Selected bond lengths and angles for Cu(I) complexes 6.3-ClO4 and 6.4 
 6.3-ClO4 6.4 
Bond lengths (angstroms) 
Cu(1)-S(1) 2.2486(7) 2.2868(6) 
Cu(1)-S(2) 2.2886(7) 2.2870(6) 
Cu(1)-S(3) 2.2680(7) 2.2889(6) 
Cu(1)-N(1) 2.1610(17) 2.1261(17) 
Bond angles (degrees) 
S(1)-Cu(1)-N(1) 91.91(6) 98.78(5) 
S(2)-Cu(1)-N(1) 89.88(5) 97.86(5) 
S(3)-Cu(1)-N(1) 91.32(5) 98.51(5) 
S(1)-Cu(1)-S(2) 121.41(2) 117.60(2) 
S(1)-Cu(1)-S(3) 125.49(2) 118.36(2) 
S(2)-Cu(1)-S(3) 112.99(3) 117.77(2) 




 As is clearly visible in the ORTEP, the Cu(I)-center in 6.3-ClO4 is highly 
distorted from the preferred tetrahedral ligand arrangement of Cu(I), assuming instead a 
trigonal pyramidal structure with a near-planar CuS3 unit. The S-Cu-N bond angles of 
this complex are all close to 90°, and the sum of the three S-Cu-S angles is 359.9°, nearly 
equal to the 360° sum expected for a perfectly planar arrangement.  The Cu(I)-center in 
6.4 is somewhat closer to tetrahedral, with S-Cu-N angles of 97.9-98.8° and an S-Cu-S 
bond angle sum of 353.7° versus 328.4° for a perfect tetrahedral arrangement. Neither the 
sulfonate groups nor the associated water molecules participate in Cu(I)-coordination in 
either complex; even though the Cu(I)-center of 6.3-ClO4 appears to present an open site 
for trigonal bipyramidal coondination, the nearest oxygen atom (O8) is over 4.2 Å away. 
Overall, the Cu(I)-coordination mode displayed by ligand 6.1 in 6.3-ClO4 is similar to 
that of TMMEA, which gave N-Cu-S angles of 91.2 ±0.6° and S-Cu-S angles 120 ± 2°.
13
 
As expected, ligand 6.2 provides a coordination geometry closer to tetrahedral in its 
Cu(I)-complex 6.4, although the structure is still clearly distorted toward  trigonal 
pyramidal coordination. 
 
6.2.4. Coordination properties of ligands 6.1 and 6.2 in aqueous solution 
All experiments described in Section 6.2.4 were conducted by Pritha Bagchi 
 The acid dissociation constants (pKa values) for the N-protonated forms of 6.1 
and 6.2 were determined by direct potentiometric titration as 7.00 and 8.98, respectively 
at 0.1 M ionic strength. These concentration-based pKa values can be converted to mixed 
mode pKa values, in which H
+
 is expressed in terms of activity, by adding a correction 
factor of 0.11.
18
 Interestingly, the resulting value of 7.11 for ligand 6.1 is substantially 





 ligand 6.1 forms a colored Cu(II) complex with a strong S-






 at pH 5 gave a complex stability constant of log KCu(II) = 6.42 ± 0.02. Cyclic 
voltammetry revealed a quasi-reversible one-electron process for 6.1-Cu(II) with a formal 
potential of 0.716 V vs. SHE, yielding a calculated Cu(I)-complex stability constant of 
log KCu(I) = 16.33 by the thermodynamic cycle method.
11
 Interestingly, this is actually 
slightly larger than reported for TMMEA (log KCu(I) = 15.80)
13
 despite the lower pKa of 
6.1. 
 Attempts to determine the Cu(I) affinity of 6.2 by similar methods were not 
successful, as this ligand gave no spectrophotometrically detectable interaction with Cu
2+
 
at pH 5. While raising the pH would be expected to increase the apparent Cu(II) affinity 
by increasing the fraction of 6.2 present in its unprotonated form, a pH below about 5.3 is 
necessary for titrations with Cu(II) to prevent formation of hydroxo-Cu(II) species.
19
 
Consistent with a very low Cu(II) affinity, cyclic voltammetry of the pre-formed 6.2-
Cu(I)-complex 6.4 revealed only an irreversible process, suggesting dissociation of Cu(II) 
from the ligand upon oxidation of the Cu(I)-complex. The Cu(I)-affinity of ligand 6.2 
was instead determined by competition titrations with BCA at pH 7, which in turn was 
calibrated against 6.1 at pH 5. Compared to 6.1, the Cu(I)-complex stability constant of 
6.2 was found to be over 1000-fold lower at log KCu(I) = 13.08. This effect is probably 
due to a greater entropic penalty for conformational restriction of the longer N-S bridges 
of ligand 6.2 compared to 6.1, which apparently overwhelms any enthalpic stabilization 
associated with the more favorable bond angles about the Cu(I)-center in the 6.2-Cu(I) 
complex. At present, however, we have not attempted to dissect the Cu(I)-complex 
stability constants of these ligands into enthalpic and entropic terms. 
 In addition to the substantial difference in the actual Cu(I)-complex stability 
constant KCu(I), the apparent Cu(I)-binding affinities of 6.1 and 6.2 at pH 7 diverge even 
further due to the higher pKa of 6.2. This is explained as follows: For 1:1-binding 
ligands, the effective Cu(I)-binding affinity at a given pH is equal to the conditional 




constant KCu(I) except that the free ligand concentration [L] is replaced with the total 
concentration of free and protonated ligand [L’]. This is given by Equation 6.1, where 
[Cu(I)L] is the concentration of the ligand-Cu(I) complex and [Cu
+
] is the effective 
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 Assuming any protonated forms of the ligand have negligible Cu(I)-affinity, the 
ratio K’Cu(I)/KCu(I) is equal to the fraction of the non(metal-bound) ligand present in un-
protonated form, or [L]/[L’], which in turn is set by the pKa of the protonation site(s) and 
the pH of the medium. For a ligand with a single protonation site, the pH dependence of 
K’Cu(I) is  given by Equation 6.2, where the pKa term is the mixed-mode value. 
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Alternatively, the dependence of apparent binding affinity on pH can be expressed in 
logarithmic form as Equation 6.3. 
 
     ′  ( ) =       ( ) −    ( +   
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 Note that when the ligand pKa exceeds the pH of the medium by more than about 
1, the term log(1+ 10
pKa – pH
) can be approximated as pKa − pH, and the apparent Cu(I)-
affinity can therefore be estimated as log K’Cu(I) ≈ log KCu(I) + pH – pKa.  Therefore, the 
apparent Cu(I)-affinity at pH 7 of ligand 6.2, which has a mixed-mode pKa of 9.09, will 




magnitude. Based on Equation 6.3, the apparent Cu(I)-binding affinities at pH 7 of 6.1 
and 6.2 are separated by nearly five orders of magnitude at log K’Cu(I) = 15.97 and 10.99 
for 6.1 and 6.2, respectively. Due to this very large difference in the apparent Cu(I) 
affinities at neutral pH, 6.1 and 6.2 alone cannot be used to provide a continuous range of 
buffered Cu(I) concentrations: Assuming that a metal occupancy of at least 5% and no 
more than 95% can be regarded as providing a useful buffering capacity, the buffering 
range of each ligand would be log[Cu
+
] = log K’Cu(I) ± 1.3, requiring a difference in 
Cu(I)-affinity of no more than 2.6 log units for two 1:1-binding ligands to provide a 
continuous buffering range.  Therefore, a third ligand of intermediate Cu(I)-affinity is 
required to bridge the gap between the Cu(I)-buffering ranges provided by 6.1 and 6.2 at 
neutral pH. 
 Although the relatively low apparent Cu(I)-affinity of 6.2 does not provide an 
overlapping buffering range with the higher affinity ligand 6.1, it does offer an important 
potential benefit: the corresponding water-soluble and air-stable Cu(I)-complex 6.4 
should be useful as a Cu(I)-supplying agent for quantitative metalation of higher affinity 
ligands such as copper proteins. This role is currently served mostly by tetrakis-
(acetonitrile)copper(I) complexes such as Cu(CH3CN)4PF6, which decomposes on 
prolonged exposure to ambient air, is oxidized almost instantly in aerated aqueous 
solution, and requires organic solvents such as acetonitrile for preparation of stable stock 
solutions. The hydrated granular crystalline form of 6.4 (Section 6.2.3) will likely be 
especially useful as a copper supplying agent, as it appears to be minimally hygroscopic 
and completely stable in air under ambient humidity. 
6.3. A water-soluble tetrathioether macrocycle designed for enhanced Cu(I)-affinity 




 The area between the Cu(I)-buffering ranges offered by ligands 6.1 and 6.2 might 
in principle be covered using a third tripodal amine containing a mixture of 2- and 3-
carbon N-S bridges; however, such a structure would be less symmetrical than 6.1 and 
6.2 and may therefore be more difficult to purify by crystallization. Bridging the affinity 
gap with a water-soluble tetrathioether macrocycle would provide the additional benefit 
of a pH-independent Cu(I)-affinity standard, but the Cu(I)-complex stability constants of 
known tetradentate thiocrown ligands such as [16]aneS4, [14]aneS4-a and [14]aneS4-b are 
too low (log KCu(I) = 12.0-12.2) to provide a Cu(I)-buffering range contiguous with that of 
the high affinity tripodal ligand 6.1 at neutral pH. Furthermore, direct hydroxylation of 
the thiocrown ligand backbone, introduced by Rorabacher et al. as a means to increase 
aqueous solubility,
19-21
 usually results in a decreased Cu(I)-affinity.
20,21
  We suspected, 
however, that the ligand solubilization strategy previously developed for CTAP-2, which 
entails functionalization of the ligand backbone with geminal pairs of hydroxymethyl 
groups at the middle carbons of trimethylene bridges, might actually increase the Cu(I)- 
affinity of a flexible thiocrown such as [16]aneS4 by favoring endo-conformations of the 
thioether moieties. A similar effect has been previously noted by Desper et al.
22
 regarding 
the Ni(II)-affinities of methylated [14]aneS4 derivatives, where the tetramethyl derivative 









 While an effect observed for square planar Ni(II)-complexes in nitromethane is 
not necessarily expected to apply to tetrahedral Cu(I)-complexes in aqueous solution, the 
increased Ni(II) affinity of 6.5 appears to be due to destabilization of exodentate 
conformations of the thiocrown ring rather than a specific preorganization toward the 
preferred coordination geometry of the Ni(II) cation,
22
 and is therefore likely to be 
general. An effect of equal magnitude applied to the Cu(I)-affinity of [16]aneS4 (log 
KCu(I) = 12.0) would provide a value of log KCu(I) = 13.7, which is almost centered 
between the apparent Cu(I)-affinities of 6.1 and 6.2 at pH 7. To investigate this 
possibility, we devised ligand 6.6, a derivative of [16]aneS4 containing hydroxymethyl 
groups in analogous positions to the methyl groups of  the [14]aneS4 derivative 6.5. 
Although it was unclear whether 6.6 itself would be adequately water-soluble for use as a 
Cu(I)-buffering agent, it could also serve as a precursor to the presumably more soluble 





Figure 6.7: Structures of [16]aneS4 and proposed water-soluble ligands 6.6 and 6.7 
 
 
6.3.2. Synthesis and properties of ligands 6.6 and 6.7 and their Cu(I)-complexes 
 Like the other hydroxylated thioether ligands reported in this work, 6.6 was 
derived from the versatile thietane precursor 3.15. As shown in Scheme 6.2, double ring-




propanedithiol under Kellogg conditions to give thiocrown 6.9. Interestingly, this 
macrocyclization proceeded in high yield despite its reliance on two consecutive 
nucleophilic substitutions at neopentyl centers. These apparently facile substitutions 
presumably proceed via the non-chain single electron transfer-radical coupling 
mechanism described by Ashby et al., which is particularly favorable for alkyl iodides 
and is less sensitive to steric hindrance than the classic SN2 pathway.
23
  
 Hydrolysis of the acetonide moieties of 6.9 under acidic conditions yielded ligand 
6.6, which was found to be highly crystalline and poorly soluble in most common 
solvents including water, alcohols, and even acetone. Reaction with tetrakis(acetonitrile)-
copper(I) hexafluorophosphate gave the crystalline, air-stable copper(I) complex 6.10, 
which dissolves readily in methanol or hot water.  
 
 




 Although the Cu(I)-complex is reasonably water soluble, efforts to accurately 
determine the Cu(I)-complex stability constant of ligand 6.6 were hampered by the 
exceedingly low solubility of the free ligand. Dilution of a DMSO stock solution of 6.6 to 
10 µM in aqueous buffer yielded an initially homogeneous solution, but the ligand began 
to crystallize out within minutes even at this low concentration, indicating inadequate 
solubility for use as a Cu(I)-buffering agent. Therefore, we proceeded with the synthesis 
of the sulfonated derivative 6.7.  
 An obvious route for the conversion of 6.6 to 6.7 is deprotonation of the hydroxyl 
moieties with a strong base such as sodium hydride followed by alkylation with 1,3-
propanesultone, but this approach was unsuccessful. Treatment of 6.6 with 8 molar 
equivalents of NaH in DMF followed by addition of 8 molar equivalents of 1,3-
propanesultone resulted in only about 60% alkylation of the hydroxyl groups as 
determined from the proton NMR spectrum of the product mixture in D2O. This mixture, 
which was obtained as a colorless, water-soluble amorphous powder after washing with 
ethanol and vacuum drying, did not dissolve to any visible extent in DMF or DMSO even 
with heating, and further treatment with NaH and 1,3-propanesultone in DMF did not 
significantly alter the proton NMR integrals. Attempts to carry out the alkylation using 
potassium tert-butoxide and 1,3-propanesultone in DMSO yielded similar results. 
Apparently, the sodium or potassium sulfonate salts resulting from partial O-alkylation of 
6.6 have insufficient solubility in aprotic solvents such as DMF and DMSO for further 
alkylation to proceed. We reasoned that this difficulty might be overcome using lithium 
as the counter-ion, as lithium salts of strong acids are generally much more soluble in 
polar organic solvents than the corresponding sodium and potassium salts. This was first 
attempted using n-butyllithium as the base in ether solvents, but 6.6 was surprisingly 
unreactive under these conditions, apparently due to exceedingly low solubility of both 
the starting material and its lithium alkoxides. Remarkably, a mixture containing the 




(diethylene glycol dimethyl ether) gave a positive test for unreacted alkyllithium (intense 
purple color with 1,10-phenanthroline) even after stirring for 1 hour at 80°C!  
 Since 6.6 is soluble in DMSO, the reaction was next attempted in this solvent. 
Although DMSO is itself deprotonated by n-BuLi, the resulting “dimsyllithium” is able 
to deprotonate alcohols, and has been previously employed for dialkylation of α-hydroxy-
carboxylic acids to form α-alkoxy-esters.
24
 Dropwise addition of n-butyllithium to a 
solution of 6.6 in anhydrous DMSO resulted in a transient white precipitate, presumably 
a sparingly soluble lithium alkoxide, which became permanent once the amount n-BuLi 
exceeded one molar equivalent. This precipitate began to redissolve upon addition of 1,3-
propanesultone, consistent with conversion of the lithium alkoxide to a more soluble 
lithium sulfonate. Addition of alternating portions of n-butyllithium and 1,3-
propanesultone eventually yielded a solution that remained clear upon further addition of 
n-BuLi. The solution remained homogeneous upon dilution with ethanol, but yielded a 
voluminous white precipitate upon addition of ethanolic sodium iodide, demonstrating 
the much lower solubility of the sodium sulfonate versus the lithium sulfonate. 
Recrystallization from ethanol-water gave the desired product 6.7 in 69% yield after 
vacuum drying as a colorless, water-soluble powder. Reaction of 6.7 with a 
stoichiometric quantity of with tetrakis(acetonitrile)copper(I) hexafluorophosphate 
followed by crystallization and vacuum drying gave the colorless, water-soluble, and 




F NMR to be a 1:1 
adduct with sodium hexafluorophosphate as previously noted for the sulfonated tripodal 







Scheme 6.3: Synthesis of ligand 6.7 and Cu(I)-complex 6.11 
 
6.3.3. Coordination properties of ligand 6.7 
All experiments described in Section 6.3.3 were conducted by Pritha Bagchi 
 Similarly to the high-affinity tripodal ligand 6.1, thiocrown ligand 6.7 was found 
to form a colored complex with Cu
2+
 at pH 5, allowing the Cu(II)-complex stability 
constant to be determined spectrophotometrically by direct titration with CuSO4. The 
resulting value of log KCu(II) = 3.47 is 18-fold higher than reported for the parent 
thiocrown ligand [16]aneS4 (log KCu(II) = 2.20),
12
 but significantly lower than that of 
ligand 6.1 (log KCu(II) = 6.42). Cyclic voltammetry of 6.7 in the presence of excess Cu
2+
 
revealed a quasi-reversible single electron process with a formal potential of 0.729 V vs. 
SHE, which would correspond to log KCu(I) = 13.6, but the observed peak separation (90 
mV at 20 mV/s scan rate) is too large for this result to be considered reliable. 
Competition titrations with BCA and BCS, both of which had been cross-calibrated 
against ligand 6.1, yielded a uniform complex stability constant of log KCu(I) = 13.80 ± 




basis of the steric effect reported by Desper et al. for the Ni(II) affinities of [14]aneS4 
derivatives (See section 6.3.1) and is indeed nearly centered between the apparent Cu(I)-
affinities at pH 7 of log K’Cu(I) = 10.99 and 15.97 for the  tripodal ligands 6.2 and 6.1, 
respectively. Together, ligands 6.2, 6.7, and 6.1 provide a nearly continuous buffering 







6.3.4. X-ray crystal structures of ligand 6.6 and Cu(I)-complex 6.10 
 To examine the Cu(I)-coordination mode of ligand 6.7 and also its degree of 
preorganization relative to the parent structure [16]aneS4, we attempted to obtain crystal 
structures of both the free ligand and its Cu(I)-complex 6.11. Although both compounds 
readily formed fibrous acicular crystals suitable for purification purposes, we were unable 
to obtain crystals suitable for x-ray diffraction after many attempts under a variety of 
conditions. Therefore, we turned to the neutral ligand 6.6 and its Cu(I)-complex 6.10 as 
model compounds. Ligand 6.6 could only be obtained as twinned needles, but these could 
be grown to a large size and otherwise good quality by recrystallization from DMSO-
water. Copper complex 6.10 initially gave only very thin fibers from ethanol, methanol, 
or water. When the fibrous crystals were removed by filtration from a rapidly cooled 
ethanolic solution before crystallization was complete, a slower-growing form, consisting 
of clear, colorless prisms suitable for x-ray diffraction, nucleated after several hours. Data 
collection and structural refinement for both 6.6 and 6.10 were carried out by Dr. John 
Bacsa of Emory University.  
 The crystals obtained from 6.10 were found to be an ethanol solvate of the 
expected 1:1 Cu(I)-complex containing two diastereomeric conformers (A and B) of [6.6-
Cu(I)]
+
, two ethanol molecules, and two disordered hexafluorophosphate counter-ions per 
asymmetric unit. As shown in Figure 6.8 and Table 6.2, the Cu(I)-coordination geometry 
is distorted tetrahedral with S-Cu-S bond angles ranging from 97.0° to 118.9° for 





Figure 6.8: ORTEP representation of the cationic unit of Cu(I)-complex 6.10 





Table 6.2: Selected bond lengths and angles in Cu(I)-complex 6.10 
 Conformer A Conformer B 
Bond lengths (angstroms) 
Cu(1)-S(1) 2.2558(2) 2.2729(3) 
S(2)-Cu(1) 2.2577(2) 2.2576(2) 
S(3)-Cu(1) 2.3024(2) 2.3339(2) 
S(4)-Cu(1) 2.3108(2) 2.3088(3) 
Average Cu-S 2.282 2.293 
Bond angles (degrees) 
S(1)-Cu(1)-S(3) 118.896(9) 116.703(10) 
S(1)-Cu(1)-S(4) 110.019(9) 104.482(9) 
S(1)-Cu(1)-S(2) 106.648(9) 106.517(9) 
S(2)-Cu(1)-S(3) 106.772(9) 109.358(9) 
S(2)-Cu(1)-S(4) 117.871(9) 123.669(10) 




 As observed for the tripodal ligand-Cu(I) complexes 6.3-ClO4 and 6.4, the 
structure of 6.10 contains S-Cu-S bond angles that differ considerably from the 
tetrahedral ideal of 109.5°, but the Cu-S bond lengths average less than the typical value 
of 2.33 Å previously noted for Cu(I)-thioether complexes.
13
 
 The twinned crystals of 6.6 yielded a partly disordered structure, which was 
modeled using two components for one of the -S(CH2)3S- units to give a final R-factor of 
10.1% for the structural refinement. The differences in atomic locations for the two 
components are not large, with maximum values of 0.42 Å for carbon and 0.41 Å for 
sulfur, so a single component was selected for structural comparison purposes. As shown 
in Figure 6.9, the respective crystal structures indicate that ligand 6.6 is indeed 
substantially preorganized toward Cu(I) coordination compared to the parent structure 
[16]aneS4.
25
 Two of the thioether moieties of [16]aneS4 point directly away from the 
macrocyclic cavity, with a transannular S-S distance of 8.5 Å. By contrast, the maximum 
S-S distance in 6.6 is only 6.1 Å, which is significantly closer to the value of 4.0 Å 




Figure 6.9: Comparison of the crystal structures of [16]aneS4,
25
 6.6, and 6.10 









While the molecular geometries found in crystal structures do not necessarily 
represent the most abundant species in solution, particularly for a flexible structure such 
as 16aneS4, the differences in ring conformation observed for 6.6 versus [16]aneS4 are 
similar to those noted by Desper et al. for 6.5 versus [14]aneS4-a. Assuming that 
functionalization of the hydroxyl groups of 6.6 does not significantly alter the 
conformational preferences of the macrocyclic ring, the increase in Cu(I)-complex 
stability constant for the sulfopropylated analog 6.7 versus [16]aneS4 is most likely due to 
the intended preorganizational effect. 
 
6.4. Applications of the water-soluble thioether ligands and Cu(I)-complexes 
All experiments described in Section 6.4 were conducted by Pritha Bagchi 
6.4.1. Verification of Cu(I)-complex stability constants 
 As discussed in Section 6.1.2, the water-soluble bidentate ligands BCA and BCS 
are frequently employed as Cu(I)-affinity standards, but there is no consensus in the 
literature as to the Cu(I)-complex stability constants of either of these ligands. Recently, 
Xiao et al.
8
 determined the 2:1 ligand-Cu(I) complex stability constant β2 of BCS based 
on the thermodynamic cycle method
11
 using the corresponding Cu(II)-complex stability 
constant and ligand-bound Cu(II)/Cu(I) reduction potential, yielding a value of log β2 = 
19.9. The complex stability constant for BCA-Cu(I) was then determined as log β2 = 17.3 
based on indirect competition with BCS using a protein intermediary ligand.
8
 These 
values, however, differ significantly from our results of log β2 = 17.67 and 20.81 for 
BCA and BCS, respectively, which were obtained by direct competition with ligand 6.1. 
Correct Cu(I)-complex stability constants for BCA and BCS are critical not only for the 




Cu(I)-complex stability constants of ligands 6.2 and 6.7. Therefore we carefully 
investigated the source of the discrepancy.  
 In our hands, determination of log β2 for BCS-Cu(I) using the thermodynamic 
cycle method did not agree with the results of Xiao et al. but instead yielded a value 
identical to that obtained by direct competition with 6.1. There are two factors likely 





 couple. Xiao et al. used an older value of 0.164 V,
10
 whereas we used 
a “concentration potential” of 0.130 V derived by correcting the standard  reduction 




 at 0.1 M ionic 
strength.
11
 The significance of this difference is explained as follows: Cu(I) affinities are 
calculated by the thermodynamic cycle method according to Equation 3.1 as previously 





 couple and ECu(II/I)L is the reduction potential of the ligand-bound Cu(II)/Cu(I) 
couple. Note that Equation 3.1 also holds for 2:1-binding ligands such as BCS provided 
that the Cu(I) and Cu(II)-ligand complexes have identical stoichiometries, and K is 
simply replaced by β2. 
 
 𝐸  (  / ) = 𝐸  (  / )    − 
  (  ) 𝑇
 
    
   (  )
   ( )
 (3.1) 
 
At 25°C (298 K), the term ln(10)RT/F is equal to 0.0592 V, so the dependence of log 
KCu(I) on ECu(II/I)L, ECu(II/I)solv,  and log KCu(II) can be expressed by Equation 6.4. 
 
       ( ) =       (  ) + 
𝐸  (  / ) − 𝐸  (  / )    






According to Equation 6.4, log KCu(I) (or log β2) increases by 1 for every 59 mV increase 
in ECu(II/I)L − ECu(II/I)solv. Therefore, the 34 mV higher value used by Xiao et al. for 
ECu(II/I)solv should reduce the apparent log β2 for BCS-Cu(I) by 0.57. 
 The 0.3 log unit discrepancy remaining after the above correction is probably due 
to the methodology used to measure log β2 for BCS-Cu(II). Xiao et al. determined this 
value by the Bjerrum method,
26
 which relies on the shift in apparent acid dissociation 
constant of the protonated ligand in the presence of Cu(II). A BCS concentration of 4 
mM was employed for direct potentiometric determination of the acid dissociation 
constant,
8
 but BCS has been reported to aggregate significantly in aqueous solution at 
concentrations above about 1 mM.
27
 To avoid aggregation, we determined log β2 for 
BCS-Cu(II)  at a BCS concentration of 0.3 mM by competition titrations against the 
ligand N,N-bis(2-hydroxyethyl)-N-(2-pyridylmethyl)amine (DHEAMP, Figure 6.10), and 
the Cu(II)-affinity of this ligand was in turn verified by direct titration with Cu
2+
. 
 Based on the above considerations, our value for log β2 of BCS-Cu(I) determined 
by the thermodynamic cycle method is most likely more accurate than that of Xiao et al., 
and the internal consistency between the Cu(I)-affinities determined for 6.1 and BCS by 
this method is encouraging. Any inaccuracy in the value we employed for ECu(II/I)solv, 
however, would affect the apparent affinities of 6.1 and BCS equally, giving an 
undetected error in the Cu(I)-affinities not only for these ligands but also for BCA, 6.2, 
and 6.7. Therefore, we sought to independently verify the Cu(I)-complex stability 
constants of these ligands using an independent method. The Cu(I)-complex stability 
constants β1, β2, and β3 of acetonitrile have been previously determined using a method 
based on the kinetics of Cu(I)-oxidation by Co(III) complexes,
7
 which does not depend 




 reduction potential, but the Cu(I) affinity of 
acetonitrile is insufficient for competition with 6.1. Furthermore, the Cu(I)-complexes of 




competition titrations between any of these ligands and acetonitrile, which also forms 
colorless Cu(I)-complexes, would be difficult to monitor spectrophotometrically. We 
realized, however, that the Cu(I)-complex stability constants of higher affinity ligands 
could be linked to those of acetonitrile using the tripodal pyridine-thioether ligand 
PEMEA
13




Figure 6.10: Structures of pyridine ligands DHEAMP and PEMEA 
 
 
 PEMEA is a 1:1-binding ligand with a Cu(I)-complex stability constant of log 
KCu(I) = 15.76, but has two sites that can be protonated in dilute aqueous solution with 
mixed-mode pKa values of 7.33 and 3.26. As its upper pKa and its value of log KCu(I) are 
similar to those of 6.1, it should be suitable for competition titrations with 6.1 at pH 5 or 
above, and the pyridine ring should provide a spectroscopic handle for monitoring Cu(I)-
occupancy. At pH values significantly below the lower pKa, however, Cu(I)-coordination 
will compete with two consecutive protonation equilibria, reducing log K’Cu(I) by 
approximately 2 for every unit reduction pH. At pH 2, log K’Cu(I) should fall to about 9.2, 
a value well suited for competition with acetonitrile. Furthermore, the PEMEA-bound 
Cu(II)/Cu(I) couple has a relatively high reduction potential of 0.595 V vs. SHE, so the 




 For verification purposes, we re-determined the acid dissociation constants of 
PEMEA as well as the value of log KCu(I) by the thermodynamic cycle method, then 
determined the Cu(I)-affinity independently by competiton with acetonitrile. Remarkably, 
the two different methods yielded exactly the same value of log KCu(I) = 15.71 with an 
estimated uncertainty of ± 0.08 for the thermodynamic cycle and ± 0.02 for the 
competition titration. The Cu(I)-complex stability constants of 6.1 and BCA were then 
verified directly against PEMEA by competition titrations. The resulting value of log 
KCu(I) = 16.33 for 6.1 exactly matches the result obtained by the thermodynamic cycle 
method, thus also verifying our value log β2 for BCS, which was obtained by competition 
with 6.1 and verified independently by the thermodynamic cycle method. The value of 
log β2 = 17.63 ± 0.05 obtained for BCA matches the result of log β2 = 17.67 ± 0.03 
obtained by competition with 6.1 within experimental error. The latter value was obtained 
using an aqueous stock solution of the air-stable Cu(I)-complex 6.3 as the copper source, 
so it is most likely more accurate than the former, which relied on an acetonitrile stock 
solution of Cu(CH3CN)4PF6. Therefore, our values of log KCu(I) for 6.2 and 6.7, which 
were obtained by competition with BCA assuming log β2 = 17.67, are also confirmed. 
Taken together, these results constitute a web of accurately cross-verified Cu(I)-affinity 
standards anchored in two independent primary methods for determining Cu(I)-complex 
stability constants. The Cu(I)-complex stability constants, concentration-mode pKa 
values, and apparent Cu(I)-complex stability constants at neutral pH for the three 
sulfonated thioether ligands 6.1, 6.2, and 6.7, as well as the previous Cu(I)-affinity 
standards BCA and BCS, are compiled in Table 6.3. To facilitate comparison between 
1:1 and 2:1 binding ligands, we have also included the values of pCu, which we define as 
the  thermodynamic free Cu
+
 concentration in a solution containing 10 µM ligand and 
1µM Cu(I) by analogy to a similar metric used on iron coordination chemistry.
28
 Notably, 
6.1 actually binds Cu
+




though the 2:1 Cu(I)-complex stability constant of BCS is numerically much larger than 
the 1:1 Cu(I)-complex stability constant of ligand 6.1. Increasing the ligand concentration 
to 500 µM while maintaining the same fractional occupancy, however, would result in  
-1og[Cu
+
] = 18.3 for BCS, while the value for ligand 6.1 would remain constant at 16.9. 
 
 
Table 6.3. Cu(I)-complex stability constants of water-soluble affinity standard ligands 
 
Ligand pKa log KCu(I)





6.1 7.00 16.33 15.97 16.9 
6.2 8.98 13.08 10.99 11.9 








 Mean value weighted inversely by the internal standard deviations of the individual 
determination methods. 
b




] calculated for a solution containing 10 µM ligand 
and 1 µM Cu(I) at pH 7 
 
 
6.4.2. Determination of the Cu(I)-affinity of the metallochaperone CusF  
 To demonstrate the utility of the new water-soluble thioether-based Cu(I)-ligands 
as affinity standards, we sought to determine the Cu(I)-binding affinity of a copper 
protein by ligand competition titrations. We selected the bacterial copper chaperone CusF 
in part because it contains a single tryptophan residue reported to engage directly in a 
cation-π interaction with Cu(I), which allows fluorimetric monitoring of Cu(I) occupancy 
due to nearly complete quenching of tryptophan fluorescence in the Cu(I)-bound 
protein.
29
 The Cu(I) affinity of CusF has been determined previously as log K’Cu(I) = 6.43 




7300, where Kd = 1/K’Cu(I),
27
 corresponding to log K’Cu(I) = 13.80 based on our value of β2 
for BCA-Cu(I).  As is common for the Cu(I)-binding affinities of proteins, these literature 
values disagree by over 7 orders of magnitude. If the latter value is correct, however, the 
Cu(I)-affinity of CusF is exactly the same as that of 6.7 (Table 6.3), making this ligand 
ideal for competition titrations. 
 Titration of the apo-form of CusF with Cu(I), which was produced in situ from 
CuSO4 and 100 µM sodium ascorbate under deoxygenated conditions, gave a linear 
decrease in fluorescence intensity with sharp saturation at 1 molar equivalent. Back-
titration with 6.7 gave a gradual increase in fluorescence intensity toward the original 
value, indicating effective competition (Figure 6.11). 
 
 
Figure 6.11: Fluorescence-monitored titration of Cu(I)-saturated CusF with ligand 6.7 
Conditions: 20 µM CusF, 21µM Cu(I), 0-283 µM 6.7, pH 7. Black points: experimental 
data. Red trace: fit. Experiment performed by Pritha Bagchi 
 
 
 The above competition titration yielded a value of log K’Cu(I) = 14.29 ± 0.11, 




BCA (see above). Due to this discrepancy, we re-determined the Cu(I)-affinity of CusF 
by direct competition with BCA using spectrophotometric monitoring of the BCA2Cu(I) 
absorption at 562 nm. This was performed both by titrating a mixture of BCA and Cu(I) 
with the protein and by titrating a mixture of BCA and the protein with Cu(I), yielding 
identical results of log K’Cu(I) = 14.21 ± 0.03 and confirming the value obtained by 
fluorimetric titration with 6.7 within experimental error. The discrepancy between our 
data and that obtained by Xue et al.
29
 may be due to the choice of wavelength for 
spectrophotometric monitoring; the latter authors appears to have calculated the Cu(I)-
occupancy of BCA using an absorption peak of the Cu(I)-complex at 358 nm,
29
 which is 
overlapped slightly by the absorption spectrum of free BCA, whereas we used the 
completely isolated absorption peak at 562 nm. Based on these data, it appears that we 
have not only demonstrated the utility of sulfonated thioether-based Cu(I)-ligands as 
affinity standards for Cu(I)-proteins but also provided a more accurate value of  log 
K’Cu(I) for the bacterial metallochaperone CusF than was previously available. 
 
6.5. Conclusions 
 To aid in the challenging problem of accurately determining the Cu(I)-binding 
affinities of biomolecules, we have created a series of water-soluble, 1:1-binding Cu(I)-
ligands for use as affinity standards. These sulfonated thioether-based ligands form 
colorless, air-stable, and water-soluble Cu(I)-complexes that are optically transparent 
down to 300 nm, allowing spectrophotometric or fluorimetric monitoring of the Cu(I)-
occupancy of other ligands under study, including proteins, without interference from the 
affinity standard ligand or its Cu(I) complex during competition experiments. In this 
respect, our sulfonated thioether ligands are complementary to the previously known 
Cu(I)-affinity standards BCA and BCS, which absorb strongly in the near UV but form 




 All three sulfonated thioether ligands 6.1, 6.2, and 6.7 as well as their respective 
Cu(I)-complexes 6.3, 6.4, and 6.10 are readily isolated by recrystallization and stable in 
solid form, allowing preparation of solutions with precisely defined, buffered 
concentrations of available Cu
+
 by mixing the free ligands and Cu(I)-complexes in the 
appropriate ratio without the need for auxiliary Cu(I)-ligands such as acetonitrile. 
Aqueous solutions of the Cu(I)-complexes are air-stable for many hours, consistent with 
the presence of little or no free Cu
+
 in solution, yet rapid equilibration was observed in all 
ligand competition titrations, indicating that Cu(I)-exchange likely proceeds via an 
associative mechanism and is not limited by the slow kinetics of complete Cu(I)-
dissociation from the ligand. This behavior is essential for high affinity ligands to be 
useful as Cu(I)-buffers or affinity standards: Ligand 6.1, for example, has an apparent 




 implying that even if the ligand-Cu
+
 













, corresponding to a 
half-life of  over two years for dissociation of the complex to free Cu
+
.  
 In addition to use as an affinity standard, the isolated Cu(I)-complex 6.4, which 
contains the lowest affinity ligand 6.2, may also serve as an alternative to the previously 
available tetrakis(acetonitrile)-copper(I)-salts for quantitative metalation of higher 
affinity ligands such as copper proteins. Unlike Cu(I)-acetonitrile complexes, 6.4 forms a 
well-defined crystalline hydrate that is stable in ambient air and can be dissolved directly 
in water to provide air-stable aqueous stock solutions at concentrations up to 100 mM. 
 The Cu(I)-complex stability constants of 6.1, 6.2, and 6.7 have been accurately 
determined, along with those of BCA and BCS, by a network of competition titrations 
anchored in two independent primary methods, providing a unified series of five total 









accurate binding affinity determination for Cu(I)-proteins and possibly other biologically 
relevant Cu(I)-ligands. 
 
6.6. Experimental section 
Compound synthesis and crystallization procedures are described below. 
Potentiometric and ligand competition titrations, which were conducted by Pritha Bagchi, 
and full details of X-ray diffraction analysis and structural refinement, which were 
conducted by Dr. John Bacsa of Emory University, will be presented in an upcoming 





F spectra are reported in ppm relative to internal 2,2,2-trifluoroethanol 
(TFE), which was employed both as a chemical shift standard and an integration standard 




H integrals. The resulting fluorine integration values were between 
5.2 and 6 for the PF6
-




C spectra acquired in 
D2O are referenced to internal sodium 3-trimethylsilylpropionate-2,2,3,3-d6. 
1
H spectra 
acquired in other solvents are reported in ppm relative to internal TMS, while 
13
C spectra 
acquired in other solvents are referenced to the known chemical shift of the solvent peak 
(CDCl3: 77 ppm, (CD3)2SO: 39.5 ppm). 
 
Ligand 6.1  
A solution of tris(2-chloroethyl) amine hydrochloride (2.16 g, 8.97 mmol), 
sodium 3-mercaptopropanesulfonate 5.28 g, 3.3 equiv. and NaOH (1.58 g, 4.3 equiv.) in 
methanol (45 mL) plus water (5 mL) was stirred under argon overnight at 60°C. The 




boiling. Water was then added slowly until almost all solids had dissolved (required 15 
mL). The mixture was filtered while hot, boiled down to 200 mL, diluted back to 300 mL 
with methanol, and allowed to cool to room temperature under slow stirring. The 
resulting crystalline slurry was stirred for 2 hours at 0°C, and the colorless product was 
collected by filtration, washed with cold methanol followed by acetone, and dried under 
high vacuum to give a fine powder. Yield 3.75 g (5.95 mmol, 66%). 
1
H NMR (D2O, 400 
MHz)  2.00-2.07 (m, 6H), 2.69-2.75 (m, 12H), 2.77-2.83 (m, 6H), 3.01-3.05 (m, 6H). 
13
C NMR (D2O, 100 MHz) δ 27.1, 30.4, 32.8, 52.6, 55.5. Elemental analysis calcd (%) 
for C15H30NNa3O9S6 (629.76): C 28.61, H 4.80, N 2.22; found C 28.27, H 4.70, N 2.17. 
 
Complex 6.3 
Solid Cu(CH3CN)4PF6 (511 mg, 1.37 mmol) was added to a solution of 6.1 (864 
mg, 1.37 mmol) in H2O (10 mL). Ethanol (10 mL) was added, and the mixture was 
stirred in a 60°C bath until all solids dissolved. The resulting green solution was 
decolorized by adding the minimum amount (<100 mg) of sodium ascorbate, diluted with 
40 mL ethanol, boiled down to half its original volume, and diluted slowly with ethanol 
until slightly turbid. The solution was then removed from the heat source and diluted 
dropwise with water to the point of clarity. Methanol (15 mL) was added, and the mixture 
was allowed to cool to room temperature under slow stirring. The resulting crystalline 
suspension was stirred in an ice bath for 2 hours, and the colorless product was collected 
by filtration, washed with ethanol, and dried under high vacuum to give a fine powder. 
Yield 719 mg (858 mmol, 63%). 
1
H NMR (D2O, 400 MHz)  2.11 (p, J = 7.4 Hz, 6H), 
2.79-2.86 (m, 12H), 3.02-3.06 (m, 12H). 
19
F NMR (D2O, 376 MHz)  (TFE) 4.62 (d, J = 
708 Hz, 6F). Elemental analysis calcd (%) for C15H30CuF6NNa3O9PS6 (838.27): C 21.49, 






Tris(3-chloropropyl)amine (2.00 g, 8.11 mmol), sodium 3-mercaptopropane-
sulfonate (4.48 g, 3.1 equiv.), and sodium hydroxide (1.01 g, 3.1 equiv.) were stirred in 
methanol (35 mL) under argon at 60 °C overnight. The resulting pasty mixture was 
diluted into 150 mL methanol + 10 mL water and heated to boiling. The resulting slightly 
turbid solution was suction-filtered through a pre-heated glass frit, re-heated to boiling, 
and allowed to cool to room temperature under slow stirring. The product separated as a 
colorless crystalline powder, which was collected by filtration, washed with methanol 
followed by diethyl ether, and dried under vacuum to give a fine powder. Yield 3.53 g 
(5.18 mmol, 64%) 
1
H NMR (D2O, 400 MHz)  1.75-1.83 (m, 6H), 1.99-2.07 (m, 6H), 
2.58-2.64 (m, 12H), 2.72 (t, J = 7.2 Hz, 6H), 3/00-3.05 (m, 6H). 
13
C NMR (D2O, 100 
MHz) . Elemental analysis calcd (%) for 
C18H36NNa3O9S6 (671.84): C 32.18, H 5.40, N 2.08; found C 31.79, H 5.41, N 2.06. 
 
Complex 6.4 anhydrous 
 Ligand 6.2 (679 mg, 1.01 mmol) and Cu(CH3CN)4PF6 (377 mg, 1.01 mmol) were 
stirred in methanol (20 mL). The mixture was heated to reflux under argon, and water 
was added slowly until all colorless solids had dissolved. A small amount of blue solid 
remained at this point, but dissolved upon addition of 60 µL (1 mmol) of acetic acid. The 
mixture was concentrated nearly to dryness, and the residue was stirred in boiling 
isopropanol (50 mL), decolorized with the minimum amount of sodium ascorbate, and 
diluted dropwise with water until all solids had dissolved. The resulting biphasic liquid 
was diluted with methanol until monophasic (required 15 mL), and allowed to cool to 
room temperature under slow stirring. The resulting colorless crystalline powder was 
collected by filtration, washed with cold isopropanol, and dried under vacuum. Yield 520 
mg (0.607 mmol, 60%). 
1




6H), 2.93-2.98 (m, 12H), 3.02-3.06 (m, 6H). 
19
F NMR (D2O, 376 MHz)  (TFE) 4.64 (d, 
J = 708 Hz, 6F). Elemental analysis calcd (%) for C18H36CuF6NNa3O9PS6 (880.35): C 
24.56, H 4.12, N 1.59; found C 24.47, H 4.22, N 1.59. 
 
Complex 6.4 hemi(pentadecahydrate) 
 Ligand 6.2 (1.12 g, 1.67 mmol) and Cu(CH3CN)4PF6 (621 mg, 1.67 mmol) were 
added to a 50 mL rb flask containing a magnetic stir bar. The flask was sealed and 
flushed with argon, and water (10 mL) and ethanol (10 mL) were injected. The mixture 
was stirred until all solids had dissolved and then shaken with air, which resulted in a 
blue coloration. Triethylamine (100 µL) was added, resulting in a small amount of blue 
precipitate which was removed by centrifugation. The mixture was heated to boiling, 
diluted slowly with ethanol (required 35 mL) to the point of permanent turbidity, and 
allowed to settle while hot. The clear solution was decanted, filtered through a glass frit, 
and allowed to cool. A mixture of fibrous acicular crystals and irregular hexagonal tablet-
shaped granules was deposited. The fibrous crystalline form was separated from the 
granular crystalline form by swirling and decantation, and a sample of each crystalline 




F NMR spectra identical to those of anhydrous 6.4. The two crystalline slurries were 
recombined, and the mixture was stirred slowly overnight, resulting in complete 
conversion to the granular form. This was collected by filtration, washed with cold 4:1 
ethanol-water, and dried by suction in ambient air to give a free-flowing, colorless 
granular powder consisting of irregular hexagonal tablets. A sample of this material was 
recrystallized from 3:1 ethanol-water to give larger tablets of identical crystal habit. X-
ray diffraction analysis yielded an empirical formula of C36H102Cu2F12N2Na6O33P2S12 
(2030.93 g/mol), corresponding to C18H36CuNNa3O9S6PF6 • 7.5 H2O (1015.46 g/mol) per 






 A mixture of thietane 3.15 (10.70 g, 61.4 mmol), 1,3-diiodopropane (9.11 g, 30.8 
mmol), potassium iodide (5.10 g, 30.7 mmol), and powdered potassium carbonate (200 
mg, 1.5 mmol) was stirred under argon in a sealed, foil-wrapped flask for 3 days at 65°C 
followed by 8 days at 45 °C.
a
 The mixture was diluted into methanol (120 mL), treated 
with concentrated aqueous ammonia (20 mL), heated briefly to boiling, and concentrated 
to a viscous oil. This material was stirred for 2 hours with 1 M aqueous citric acid (100 
mL) and cyclohexane (200 mL). The organic layer was separated, dried with MgSO4, 
concentrated under reduced pressure, and rotated under high vacuum overnight to 
completely remove cyclohexane, giving the product as a viscous, slightly yellow yellow 
oil which was used in the next step without further purification. Yield 14.83 g (20.0 
mmol, 75%). 
1
H NMR (CDCl3, 400 MHz)  1.41 (s, 6H), 1.42 (s, 6H), 1.92 (p, J = 7.1 
Hz, 2H), 2.69 (t, J = 7.1 Hz, 4H), 2.70 (s, 4H), 3.40 (s, 4H), 3.72 (d, J = 11.8 Hz, 8H), 
3.78 (d, J = 11.8 Hz, 8H). 
13
C NMR (CDCl3, 100 MHz) δ 12.8, 23.4, 23.7, 29.6, 32.5, 
36.7, 36.8, 66.3, 98.6. EI-MS m/z 644 (56, [M]
+
), 375 (100), 343 (50), 45 (181), 83 (67). 
EI-HRMS m/z calcd for [M]
+
 C19H34NI2O4S2 643.9988, found 643.9985. 
a 
Alternatively, 
the product can be obtained in 73% yield by column chromatography on silica gel 
(hexanes-MTBE) after reaction for only 4 days at 65 °C. 
 
Macrocycle 6.9 
 Solutions of diiodide 6.8 (14.81 g, 24.2 mmol) and 1,3-propanedithiol (2.62 g, 
24.2 mmol) in DMF (20 mL total solution volume each) were loaded into all-plastic 
syringes and added by syringe pump over 48 hours to a stirred suspension of cesium 
carbonate (23.6 g, 72.5 mmol) in DMF (750 mL) at 80°C (internal temperature) under 




dryness. The solids remaining after decantation were stirred in boiling toluene (200 mL), 
and the liquid phase was decanted and added to the residue remaining after evaporation 
of the initial liquid phase. The resulting mixture was concentrated to dryness, and the 
process was repeated. The residue was taken up in DCM (250 mL) and filtered through a 
4 cm diameter column containing sequential beds of sand (3 cm), celite (3 cm) and silica 
gel (4 cm). The column was flushed with an additional 250 mL of DCM, and the 
combined fitlrates were concentrated under reduced pressure. The residue was taken up 
in boiling acetone (100 mL), diluted slowly with hot hexanes until crystallization 
initiated, and allowed to cool under slow stirring. The product was collected by filtration, 





H NMR (CDCl3, 400 MHz)  1.41 (s, 12H), 1.93 (p, J = 6.9 Hz, 4H), 2.74 (t, J = 
6.9 Hz, 8H), 2.79 (s, 8H), 3.71 (s, 8H). 
13
C NMR (CDCl3, 100 MHz) δ 23.7, 28.7, 32.4, 
35.2, 37.9, 66.7, 98.4. EI-MS m/z 496 (100, [M]
+
), 355 (50), 106 (45). EI-HRMS m/z 
calcd for [M]
+
 C22H40O4S4 496.1809, found 496.1813. 
b 
With chromatographic 
purification of the starting diiodide 6.8, macrocycle 6.9 was obtained in 75% yield 
following the above procedure at half scale. 
 
Ligand 6.6 
 Macrocycle 6.9 (7.58 g, 15.3 mmol) was dissolved in boiling isopropanol (200 
mL) and 1 M aqueous HCl (15 mL) was added. The resulting crystalline slurry was 
boiled down to 150 mL total volume and then allowed to cool to room temperature under 
slow stirring. The colorless product was collected by filtration, washed with cold 
isopropanol followed by hexanes, and dried under high vacuum at 120 °C. Yield 6.25 g 
(98%). Mp 220.5-222°C. 
1
H NMR (DMSO-D6, 400 MHz)  1.80 (p, J = 7.0 Hz, 4H), 
2.58 (s, 8H), 2.61 (t, J = 7.0 Hz, 8H), 3.30 (d, J = 5.1 Hz, 8H), 4.50 (t, J = 5.1 Hz, 4H). 
13






), 241 (70), 106 (62). EI-HRMS m/z calcd for [M]
+




 Ligand 6.6 (395 mg, 0.948 mmol) and Cu(CH3CN)4PF6 (353  mg, 0.948 mmol) 
were stirred in pyridine (10 mL) under argon until all solids had dissolved. The mixture 
was concentrated to a thick paste, diluted with water (10 mL), and concentrated again to a 
thick paste under a stream of argon in a 50°C bath. The residue was taken up in methanol 
(15 mL), centrifuged to remove a small amount of pale blue precipitate, concentrated to 
dryness, and recrystallized from water to give the product as colorless fibrous crystals. 
Yield 408 mg (69%). 
1
H NMR (DMSO-D6, 400 MHz) δ 1.93-2.01 (br. m, 4H), 2.74 (s, 
8H), 2.93 (br. t, J ≈ 5 Hz, 8H), 3.39 (d, J = 5.2 Hz, 8H), 4.88 (t, J = 5.2 Hz, 4 H). 
13
C 
NMR (DMSO-D6, 100 MHz) δ 22.8 (br.), 34.6, 37.4, 43.3, 62.3. 
  
Ligand 6.7 
Ligand 6.6 (1.52 g, 3.66 mmol) was added to an oven-dried 100 mL rb flask 
containing a 25 mm egg-shaped magnetic stir bar.  The flask was sealed with a rubber 
septum and flushed with argon, and anhydrous DMSO (25 mL) was added. The mixture 
was stirred until the starting material had completely dissolved, and a solution of n-
butyllithium in hexane (2.5 M, 3.07 mL, 2.1 equiv.) was added dropwise under rapid 
stirring. A white precipitate appeared and subsequently redissolved after addition of each 
drop, then became persistent once the amount of added n-BuLi exceeded 1.0 molar equiv. 
The resulting suspension was stirred for 30 minutes under a stream of argon to allow 
cooling by evaporation of hexane, and 1,3-propanesultone (893 mg, 2.0 equiv.) in 
anhydrous DMSO (2 mL) was added. The mixture was stirred for 4 hours, after which 
most of the precipitate had redissolved. A further 2 equiv. of n-BuLi followed by 2 equiv. 




overnight. The reaction vessel was manually agitated to dislodge material deposited on 
the flask walls, and a further 1.4 equiv. of n-BuLi and 2 equiv. of 1,3-propanesultone 
were added as described above. After 4 hours, the mixture was almost clear. A final 1.0 
equiv. of n-BuLi and 1.0 equiv. 1,3-propanesultone were added, and the mixture became 
completely clear after stirring overnight. The resulting solution was diluted with ethanol 
(75 mL), treated with activated carbon to remove colored material leached from the 
rubber septum, and filtered through Celite. The carbon-Celite pad was washed with 30 
mL of ethanol, and the combined filtrate and washings were treated with a solution of 
sodium iodide in 15 mL ethanol, producing a voluminous white precipitate. The mixture 
was heated to boiling, diluted slowly with water under rapid stirring until the precipitate 
completely dissolved (required 20 mL) and allowed to cool to room temperature under 
slow stirring. The resulting crystalline slurry was cooled to 4 °C, and the slightly colored 
product was collected by filtration, dissolved in 25 mL water, filtered through cotton to 
remove a small amount of insoluble material, heated to boiling, and diluted gradually 
with ethanol (required 75 mL) to the point of permanent turbidity. The mixture was 
diluted dropwise with water until clear and then allowed to cool under slow stirring. The 
resulting colorless crystalline powder was collected by filtration and dried overnight at 
100°C/0.05 torr to give a fine powder. Yield 2.52 g (2.54 mmol, 69%) 
1
H NMR (D2O, 
400 MHz) 1.93-2.05 (m, 12H), 2.75 (s, 8H), 2.76 (t, J = 6.9 Hz, 8H), 2.97-3.01 (m, 8H), 
3.44 (s, 8H), 3.62 (t, J = 6.2 Hz, 8H). 
13
C NMR (D2O, 100 MHz) δ 27.1, 31.2, 34.7, 37.2, 
46.5, 50.9, 72.5, 74.6. Elemental analysis calcd (%) for C28H52Na4O16S8 (993.18): C 









 A solution of Cu(CH3CN)4PF6 (221 mg, 0.593 mmol) in acetonitrile (10 mL) was 
added to a solution of ligand 6.7 (589 mg, 0.593 mmol) in water (10 mL). The mixture 
was concentrated to a viscous residue, which was taken up in boiling ethanol (50 mL) and 
concentrated to dryness. The resulting material was stirred in boiling ethanol (30 mL) and 
diluted gradually with water until almost all solids had dissolved to give a yellow, 
slightly turbid solution. This was decolorized with the minimum sufficient amount (< 50 
mg) of ascorbic acid, allowed to settle while hot, decanted from the small amount of solid 
sediment, and allowed to cool under slow stirring to give a colorless crystalline slurry. 
The product was collected by filtration and dried overnight at 50°C/0.05 torr followed by 
1 hour at 100°C/0.05 torr to give a fine powder. Yield 539 mg (0.449 mmol, 76%). 
1
H 
NMR (CDCl3, 400 MHz) 1.99-2.06 (m, 8H), 2.07-2.11 (m, 4H), 2.89 (s, 8H), 2.97-3.01 
(m, 16H), 3.55 (s, 8H), 3.65 (t, J = 6.2 Hz, 8H). 
13
C NMR (CDCl3, 100 MHz) 
 
19
F NMR (D2O, 376 MHz)  (TFE) 4.66 
(d, J = 708 Hz, 6F). Elemental analysis calcd (%) for C28H52CuF6Na4O16PS8•2H2O 
(993.18): C 27.17, H 4.56, S 20.73; found C 27.20, H 4.51, S 20.76. 
 
6.6.2. Crystallization procedures for X-ray diffraction 
Complex 6.3-ClO4 
 Complex 6.3 (20 mg) was dissolved in water (100 µL) and diluted with ethanol 
(200 µL.). To this solution was added 500 µL of a solution prepared by dissolving 
NaClO4 • H2O (3.0 g), in ethanol (8 mL) plus water (4 mL). The mixture was filtered 
through a 0.2 µM nylon membrane and allowed to stand overnight in a sealed vial, 







 The granular form of complex 6.4 (30 mg) was recrystallized from 3:1 ethanol-
water (1 mL) using hot tap water as the heat source.
c
 The resulting irregular hexagonal 
tablets contained areas of turbidity at the center, so they were broken, heated under hot 
tap water until a single clear fragment remained, and allowed to cool, giving a cluster of 
clear irregular hexagonal tablets up to about 3 mm in width. Due to the large size, the 
crystals were cut into smaller pieces for X-ray diffraction (carried out by Dr. John Bacsa). 
c




 Ligand 6.10 (30 mg) was dissolved in DMSO (1 mL) and the mixture was diluted 
with water until crystallization occurred, resulting in fine needles. The mixture was 
repeatedly agitated under hot tap water (~40°C), and diluted further with DMSO until 
complete dissolution occurred. The resulting solution was filtered through a tightly 
packed cotton plug and allowed to stand overnight, resulting in clear, twinned needles up 
to about 6 mm in length.  
 
Complex 6.10 
 Complex 6.10 (35 mg) was dissolved in boiling ethanol (~ 1 mL) and filtered 
through a 0.2 mm nylon membrane. Long, twinned fibers, nearly identical to the 
anhydrous form obtained by crystallization from water, were deposited. The mother 
liquor was removed, and fresh ethanol (3 mL) was added. The solution was heated to 
boiling and loaded into an all-plastic syringe, which was fitted with a 0.2 µM nylon 
membrane filter. The assembly was quickly cooled to room temperature, initiating 




After several hours, the clear solution deposited tiny, shining prisms, which grew up to 
about 4 mm long after standing overnight. 
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CONCLUSION AND OUTLOOK 
7.1. Copper(I)-selective fluorescent probes 
 At the outset of the work described in this dissertation, the available copper(I)-
selective fluorescence turn-on probes were best regarded as proofs of concept, providing 
fluorescence contrast ratios only up to 10 and fluorescence quantum yields up to 15% in 
response to aqueous Cu(I).
1,2
 While preliminary cellular imaging experiments yielded 
promising results, especially for CTAP-1,
1
 these experiments relied on high-dose copper 
supplementation involving direct exposure of cells to 100-150 µM CuCl2 to produce an 
observable response. For comparison, 150 µM Cu
2+
 is approximately three times the 
human toxicity threshold
3
 of 3 ppm for copper in drinking water.  
Efforts to improve the utility of Cu(I)-probes for biological imaging applications 
have thus far concentrated primarily on improving the fluorescence contrast ratio and 
quantum yield, which has been a major focus of this work. The inherent fluorescence 
quenching abilities of Cu(I), formerly considered the greatest obstacle to effective 
fluorescent probe design, have now been definitively overcome using a PET-based 
fluorescence switching mechanism, resulting in fluorescence contrast ratios exceeding 
150 and fluorescence quantum yields of up to 49% in methanolic solution or 41% in 
aqueous solution, the latter from probe 5.28 developed in Chapter 5.  
During the course of this work, it became apparent that aqueous solubility and 
probe aggregation in aqueous solution are equally important factors, and much of the 
effort of this author was devoted to overcoming the inherent lipophilicity of the 
fluorophore and ligand structures previously applied for Cu(I)-sensing. This effort was 




in fact the first truly water-soluble Cu(I)-selective fluorescent indicator with a reversible 
turn-on response.  
 Subsequent refinements in probe design since CTAP-2 have now brought the 
fluorescence quantum yield and contrast ratio available from water-soluble Cu(I)-probes 
to a point which should be quite adequate for biological imaging applications, and the 
quest to optimize these parameters can now be considered complete. Based on the current 
best estimates
4
 for the Cu(I)-binding affinity of copper chaperones such as Atox1, 
however, the Cu(I)-affinities of all previously reported Cu(I)-probes including CTAP-2 
and its descendents are probably several orders of magnitude lower than required for 
imaging of endogenous intracellular Cu(I)-pools, despite reports to the contrary by Chang 
et al.
5,6
 The latter are based on experiments with highly lipophilic probes characterized in 
aqueous buffer, draw sweeping conclusions from threshold-level data, and provide 
interpretations which are highly questionable in the opinion of this author. Furthermore, 
Price et al.
7
 recently presented detailed studies demonstrating a lack of intracellular 
copper-sensing efficacy for Coppersensor-1, the first Cu(I)-selective fluorescent probe 
introduced by Chang et al.,
2
 which has also been demonstrated to form colloidal 
aggregates in aqueous solution.
8
 
 While the achievements detailed here represent important steps toward 
development of Cu(I)-selective fluorescent probes truly worthy to serve as mainstream 
tools in the elucidation of copper(I)-biochemistry, this ultimate goal has not yet been 
achieved. In the opinion of this author, further development of water-soluble Cu(I)-
selective fluorescent probes should first focus on improving Cu(I)-affinity. 
 
7.2. Copper(I)-affinity standards 
 Small-molecule ligands that are freely water-soluble, easily purified, and form 




but to the knowledge of this author, no ligands meeting all of the above characteristics 
existed prior to the work described in Chapter 6.  Rorabacher et al.
9-11
 came close,  
producing several moderately lipophilic, slightly water-soluble thiocrown Cu(I)-ligands 
that may otherwise meet the above characteristics, but these were not tested as affinity 
standards. 
 Due in part to a lack of suitable affinity standards, binding affinity determination 
for Cu(I)-proteins has been challenging, and to refer the aggregate literature on protein-
Cu(I) affinities as inexact would be a gross understatement. Thanks in part to the 
synthetic contributions of the author, but more so to a total of roughly 170 painstakingly 
careful potentiometric and competition titrations conducted by Pritha Bagchi, we have 
now constructed a small but robust series of Cu(I) affinity standards, including three 
freely water-soluble sulfonated thioether-based ligands suitable for competition 
experiments with lower affinity Cu(I)-proteins. The sulfonated thioether ligands form 
colorless Cu(I) complexes which are air-stable even in aqueous solution, readily purified 
by crystallization, and have sufficiently low near-UV absorptivity to allow fluorimetric 
monitoring of the Cu(I) occupancy of the bacterial copper chaperone CusF during 
competition titrations without significant inner-filter effects from the Cu(I)-complex of 
the affinity standard. While we have currently demonstrated only one instance of protein 
Cu(I)-affinity determination using the new affinity standard series, our values for the 
Cu(I)-complex stability constants of the previously employed standards BCA and BCS, 
which have been cross-verified against our new ligands, could allow the re-assessment of  
published protein-Cu(I) affinities based on less accurate values. While the Cu(I)-affinities 
of the current sulfonated thioether ligands are not quite high enough for effective 
competition against eukaryotic copper chaperones such as Atox1, it is probable that the 
affinity range of the current series can be extended with new designs providing better 
ligand preorganization or more strongly coordinating donors, which would provide a 
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X-RAY CRYSTALLOGRAPHIC DATA 
 
Table A1: Crystal data and structure refinement of complex 6.3-ClO4  
([Cu(I)-(6.1)]2Na7(ClO4)3(H2O)4) 
 
Empirical formula  C30H68Cl3Cu2N2Na7O34S12 
Formula weight  1780.08 
Temperature  173(2) 
Wavelength  0.71073 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 9.8246(15) Å α = 82.967(2)° 
 b = 9.8488(15) Å β = 84.686(2)° 
 c = 18.657(3) Å γ = 64.474(2)° 
Volume 1615.2(4) Å3 
Z 1 
Density (calculated) 1.830 g/cm3 
Absorption coefficient 1.308 mm–1 
F(000) 912 
Crystal size 0.721 x 0.249 x 0.092 mm 
Theta range for data collection 2.202 to 31.126° 
Index ranges -14<=h<=14, -14<=k<=14, -27<=l<=27 
Reflections collected 25301 
Independent reflections 10289 [R(int) = 0.0316] 
Completeness to theta = 25.242° 100.0 %  
Absorption correction numerical 
Max. and min. transmission 1.000 and 0.5883 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10289 / 572 / 574 
Goodness-of-fit on F2 1.029 
Final R indices [I>2sigma(I)] R1 = 0.0390, wR2 = 0.1038 
R indices (all data) R1 = 0.0474, wR2 = 0.1098 
Extinction coefficient n/a 









Table A2: Atomic coordinates  (x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for complex 6.3-ClO4 ([Cu(I)-(6.1)]2Na7(ClO4)3(H2O)4). U(eq) is defined as 
one third of the trace of the orthogonalized Uij tensor. 
 
 
Atom Label x y z U(eq) 
Cu(1) 6651(1) 1120(1) 1824(1) 17(1) 
Cl(1A) 3097(2) -2233(2) 1814(1) 24(1) 
S(1) 8747(1) 1442(1) 1941(1) 18(1) 
S(2) 6560(1) -1133(1) 1789(1) 18(1) 
S(3) 7086(1) 3356(1) 4243(1) 14(1) 
S(4) 2455(1) 1625(1) 3965(1) 14(1) 
S(5) 4317(1) 3117(1) 1799(1) 19(1) 
S(6) 8896(1) -1962(1) 3902(1) 13(1) 
Na(1) 6015(1) 946(1) 4739(1) 17(1) 
Na(2) 2527(1) -1884(1) 3827(1) 18(1) 
Na(3) 10000 0 5000 14(1) 
Na(4) 1664(1) 4761(1) 4732(1) 25(1) 
O(1) 7867(2) 2157(2) 4801(1) 19(1) 
O(2A) 2856(6) -1970(6) 2563(2) 68(1) 
O(3A) 3020(5) -871(4) 1415(2) 42(1) 
O(4A) 4590(5) -3410(7) 1680(4) 53(1) 
O(5A) 1955(4) -2615(4) 1597(2) 51(1) 
O(6) 1716(2) 601(2) 4096(1) 19(1) 
O(7) 3694(2) 1189(2) 4451(1) 22(1) 
O(8) 1388(2) 3203(2) 3976(1) 22(1) 
O(9) 9820(2) -1208(2) 4053(1) 20(1) 
O(10) 7280(2) -971(2) 3953(1) 21(1) 
O(11) 9282(2) -3414(2) 4328(1) 21(1) 
O(12) 6961(2) 4820(2) 4399(1) 22(1) 
O(13) 3002(2) 5586(2) 3739(1) 29(1) 
O(14) 4999(2) -2176(2) 4142(1) 21(1) 




Table A2 continued 
N(1) 6864(2) 1408(2) 658(1) 20(1) 
C(1) 9324(2) 1319(3) 986(1) 24(1) 
C(2) 8023(3) 2001(3) 477(1) 24(1) 
C(3) 5383(3) 2485(2) 377(1) 23(1) 
C(4) 7361(3) -118(2) 413(1) 23(1) 
C(5) 6479(3) -960(2) 810(1) 23(1) 
C(6) 8134(2) 3438(2) 2049(1) 19(1) 
C(7) 7255(2) 3822(2) 2769(1) 18(1) 
C(8) 8175(2) 2904(2) 3422(1) 18(1) 
C(9) 3330(2) 1414(2) 3084(1) 19(1) 
C(10) 2213(2) 2217(3) 2489(1) 22(1) 
C(11) 2994(2) 2282(3) 1747(1) 23(1) 
C(12) 4535(3) 3763(2) 858(1) 25(1) 
C(13) 9323(2) -2310(2) 2984(1) 17(1) 
C(14) 8571(3) -3220(2) 2728(1) 21(1) 
C(15) 8298(3) -2850(2) 1920(1) 23(1) 
Cl(1B) 3334(6) -2371(6) 1917(3) 24(1) 
O(2B) 3390(15) -1807(16) 2580(5) 68(1) 
O(3B) 2821(14) -1145(12) 1347(6) 42(1) 
O(4B) 4836(13) -3409(18) 1699(10) 53(1) 
O(5B) 2322(9) -3087(10) 2001(5) 51(1) 
Cl(2) 10040(20) 5030(20) 4(16) 26(1) 
O(16) 8986(5) 6543(5) -183(3) 55(2) 
O(17) 10036(6) 4493(5) 736(2) 58(2) 
O(18) 9597(6) 4035(6) -425(3) 64(2) 







Table A3: Crystal data and structure refinement of complex 6.4 ([Cu(I)-
(6.2)]2Na6(PF6)2(H2O)15) 
 
Empirical formula  C36H102Cu2F12N2Na6O33P2S12 
Formula weight  2030.87 
Temperature  173(2) 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 11.8551(17) Å α = 91.273(2)° 
 b = 11.9311(17) Å β = 98.023(2)° 





Density (calculated) 1.725 g/cm3 
Absorption coefficient 1.047 mm–1 
F(000) 2100 
Crystal size 0.783 x 0.451 x 0.316 mm 
Theta range for data collection 1.284 to 32.106° 
Index ranges -17<=h<=17, -17<=k<=17, -45<=l<=46 
Reflections collected 50063 
Independent reflections 25380 [R(int) = 0.0266] 
Completeness to theta = 32.106° 99.7 %  
Absorption correction none 
Max. and min. transmission 0.8602 and 0.6223 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 25380 / 54 / 1278 
Goodness-of-fit on F2 1.022 
Final R indices [I>2sigma(I)] R1 = 0.0484, wR2 = 0.1242 
R indices (all data) R1 = 0.0631, wR2 = 0.1339 
Extinction coefficient n/a 








Table A4: Atomic coordinates  (x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for complex 6.4 ([Cu(I)-(6.2)]2Na6(PF6)2(H2O)15). U(eq) is defined as one third 
of  the trace of the orthogonalized Uij tensor. 
 
 
Atom Label x y z U(eq) 
Cu(1) -3220(1) -1624(1) 233(1) 15(1) 
Cu(2) 3196(1) 1603(1) 4774(1) 14(1) 
S(1) -4998(1) -1427(1) 323(1) 15(1) 
S(2) -4964(1) -3905(1) 1761(1) 15(1) 
S(8) 397(1) -698(1) 1740(1) 15(1) 
S(3) -425(1) 682(1) 3259(1) 17(1) 
S(6) 3233(1) 3515(1) 4673(1) 15(1) 
S(5) 4991(1) 1462(1) 4659(1) 15(1) 
S(4) 4730(1) 4063(1) 3289(1) 16(1) 
S(7) 1209(1) -268(1) 4666(1) 15(1) 
S(9) -3317(1) -3554(1) 346(1) 15(1) 
S(10) -1206(1) 215(1) 346(1) 15(1) 
S(11) -2878(1) 1435(1) 1726(1) 16(1) 
S(12) 2952(1) -1343(1) 3288(1) 17(1) 
Na(3) -2185(1) -948(1) 2272(1) 23(1) 
Na(5) 3065(1) -867(1) 2307(1) 21(1) 
Na(4) 2246(1) 997(1) 2828(1) 21(1) 
Na(1) 3134(1) 3803(1) 2421(1) 25(1) 
Na(6) -2888(1) -4041(1) 2606(1) 27(1) 
Na(2) 3598(1) 6847(1) 2524(1) 34(1) 
O(8) 3339(2) 3098(2) 3175(1) 22(1) 
O(1) -5688(2) -4284(2) 2116(1) 22(1) 
O(5) -3575(2) -2986(2) 1903(1) 24(1) 
O(15) -468(2) -189(2) 1819(1) 20(1) 
O(14) 1086(2) -827(2) 2137(1) 21(1) 
O(13) 2518(2) -2299(2) 2925(1) 37(1) 
O(11) 4078(2) -1225(2) 3578(1) 24(1) 






Table A4 continued 
O(7) 438(2) 146(2) 3212(1) 21(1) 
O(6) -1008(2) 852(2) 2851(1) 23(1) 
O(25) -1421(2) -84(2) 3513(1) 23(1) 
O(9) 5300(2) 4522(2) 2912(1) 27(1) 
O(26) -897(2) -2078(2) 2614(1) 39(1) 
O(27) -3051(2) -2220(2) 2900(1) 44(1) 
O(28) -3204(3) -5458(2) 2020(1) 50(1) 
O(29) -1637(2) -4938(2) 2964(1) 29(1) 
O(2) 2076(2) 4796(2) 2726(1) 41(1) 
O(24) 1118(2) 1965(2) 2393(1) 26(1) 
O(4) 3225(2) 2674(2) 1818(1) 29(1) 
O(10) 4948(2) 5113(2) 3591(1) 26(1) 
O(20) 4006(2) 1476(2) 2445(1) 24(1) 
O(21) 5073(2) -948(2) 2463(1) 23(1) 
O(22) 1948(2) -3135(2) 2031(1) 30(1) 
O(3) 4588(2) 6912(2) 3200(1) 42(1) 
O(23) 3474(2) -537(2) 1615(1) 29(1) 
O(16) 1304(2) 60(2) 1460(1) 23(1) 
O(17) -3122(2) 240(2) 1911(1) 22(1) 
O(18) -2393(2) 2525(2) 2052(1) 27(1) 
O(19) -4011(2) 1268(2) 1432(1) 26(1) 
O(30) -5170(2) -5024(1) 1496(1) 20(1) 
N(1) 3566(2) 1825(2) 5443(1) 15(1) 
N(2) -3562(2) -1847(2) -437(1) 14(1) 
C(3) -5639(2) -3111(2) 1447(1) 17(1) 
C(2) -5079(2) -2746(2) 1042(1) 17(1) 
C(1) -5494(2) -1839(2) 832(1) 17(1) 
C(9) 578(2) 2237(2) 3538(1) 19(1) 
C(8) 1263(2) 2172(2) 3969(1) 19(1) 
C(7) 2354(2) 3508(2) 4162(1) 17(1) 
C(6) 5450(2) 1919(2) 4147(1) 17(1) 
C(5) 5011(2) 2837(2) 3965(1) 18(1) 





Table A4 continued 
C(15) 6219(2) 2890(2) 5008(1) 19(1) 
C(14) 6047(2) 2696(2) 5466(1) 20(1) 
C(13) 4950(2) 2855(2) 5608(1) 19(1) 
C(12) 2678(2) 2201(2) 5619(1) 19(1) 
C(11) 2690(2) 3423(2) 5480(1) 20(1) 
C(10) 2088(2) 3348(2) 5022(1) 19(1) 
C(16) 3362(2) 603(2) 5615(1) 19(1) 
C(17) 2019(2) -609(2) 5476(1) 20(1) 
C(18) 1712(2) -1181(2) 5019(1) 19(1) 
C(19) 813(2) -1201(2) 4160(1) 17(1) 
C(20) 2011(2) -938(2) 3968(1) 18(1) 
C(21) 1644(2) -1871(2) 3576(1) 18(1) 
C(22) -645(2) -2273(2) 1477(1) 17(1) 
C(23) -1349(2) -2218(2) 1049(1) 19(1) 
C(24) -2465(2) -3551(2) 863(1) 16(1) 
C(25) -2161(2) -3422(2) 7(1) 20(1) 
C(26) -2728(2) -3482(2) -455(1) 21(1) 
C(27) -2665(2) -2240(2) -597(1) 20(1) 
C(28) -4943(2) -2854(2) -615(1) 19(1) 
C(29) -6038(2) -2677(2) -483(1) 20(1) 
C(30) -6225(2) -2862(2) -24(1) 19(1) 
C(31) -3317(2) -613(2) -608(1) 19(1) 
C(32) -1967(2) 579(2) -466(1) 20(1) 
C(33) -1658(2) 1153(2) -8(1) 20(1) 
C(34) -801(2) 1142(2) 853(1) 17(1) 
C(35) -1991(2) 903(2) 1049(1) 18(1) 
C(36) -1581(2) 1851(2) 1440(1) 17(1) 
P(2) 475(1) 5284(1) 5853(1) 20(1) 
F(1) 925(2) 4408(1) 6131(1) 28(1) 
F(2) -569(2) 4025(2) 5546(1) 39(1) 
F(3) 1516(2) 6528(1) 6171(1) 36(1) 
F(4) 1567(2) 5537(2) 5572(1) 37(1) 





Table A4 continued 
F(6) 36(2) 6154(2) 5584(1) 39(1) 
P(3) 419(1) 5245(1) 833(1) 19(1) 
F(7) -575(2) 3908(2) 557(1) 44(1) 
F(8) -136(2) 5981(2) 539(1) 40(1) 
F(9) -650(2) 4983(2) 1128(1) 36(1) 
F(10) 991(2) 4529(2) 1137(1) 36(1) 
F(11) 1506(2) 5522(2) 548(1) 39(1) 
F(12) 1417(2) 6596(1) 1118(1) 31(1) 
O(31) 6419(2) 10356(2) 3264(1) 26(1) 
O(32) 6701(2) 2403(2) 2803(1) 26(1) 







Table A5: Crystal data and structure refinement of ligand 6.6. 
 
Empirical formula  C16H32O4S4 
Formula weight  416.65 
Temperature  173.15 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 9.5948(9) Å α = 100.741(2)° 
 b = 9.6412(9) Å β = 107.2010(10)° 
 c = 12.1268(12) Å γ = 97.413(2)° 
Volume 1032.38(17) Å3 
Z 2 
Density (calculated) 1.340 g/cm3 
Absorption coefficient 0.477 mm–1 
F(000) 448 
Crystal size 0.774 x 0.212 x 0.196 mm 
Theta range for data collection 1.809 to 31.051° 
Index ranges -13<=h<=13, -13<=k<=13, 0<=l<=17 
Reflections collected 10217 
Independent reflections 10217  
Completeness to theta = 35.0° 98.3 %  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10217 / 73 / 248 
Goodness-of-fit on F2 1.054 
Final R indices [I>2sigma(I)] R1 = 0.1009, wR2 = 0.2508 
R indices (all data) R1 = 0.1150, wR2 = 0.2612 
Extinction coefficient n/a 





Table A6: Atomic coordinates  (x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for ligand 6.6. U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
 
 
Atom Label x y z U(eq) 
C(1) 6909(4) 1686(4) 1563(3) 23(1) 
C(2) 7008(5) 2954(5) 2576(3) 24(1) 
C(3) 8301(5) 3011(5) 3706(3) 29(1) 
S(2A) 10104(6) 3426(13) 3483(10) 34(1) 
C(4A) 11398(15) 3172(13) 4804(12) 43(2) 
C(5A) 11487(16) 1619(13) 4817(14) 44(2) 
C(6A) 12487(14) 1040(15) 4139(13) 39(2) 
S(3A) 12432(4) -815(5) 4186(3) 32(1) 
S(2B) 10131(6) 3246(13) 3512(10) 34(1) 
C(4B) 11121(15) 2923(13) 4917(11) 43(2) 
C(5B) 11161(16) 1354(13) 4850(14) 44(2) 
C(6B) 12060(14) 788(15) 4050(13) 39(2) 
S(3B) 12046(4) -1064(5) 3953(3) 32(1) 
C(7) 13290(6) -1365(5) 3064(4) 34(1) 
C(8) 12806(5) -2920(5) 2344(4) 28(1) 
C(9) 11200(5) -3246(6) 1490(4) 34(1) 
C(10) 8990(5) -2102(5) 62(4) 30(1) 
C(11) 8645(5) -1125(5) 1045(4) 26(1) 
C(12) 6984(4) -1148(5) 724(4) 26(1) 
C(13) 13898(5) -3156(5) 1659(4) 27(1) 
C(14) 12861(6) -3973(5) 3151(4) 34(1) 
C(15) 5553(5) 2780(5) 2874(4) 30(1) 
C(16) 7261(6) 4356(5) 2174(4) 31(1) 
O(1) 13559(4) -4590(4) 936(3) 32(1) 
O(2) 14288(5) -3748(4) 4033(3) 48(1) 
O(3) 5544(4) 3990(4) 3759(3) 41(1) 
O(4) 6069(4) 4390(4) 1146(3) 43(1) 
S(1) 6456(1) -55(1) 1862(1) 32(1) 






Table A7: Crystal data and structure refinement of complex 6.10 ([(Cu(I)-6.6]PF6•EtOH) 
 
Empirical formula  C18H38CuF6O5PS4 
Formula weight  671.26 
Temperature  110(2) 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 13.4862(5) Å α = 71.5710(10)° 
 b = 13.6947(4) Å β = 77.6760(10)° 
 c = 15.8096(5) Å γ = 78.8850(10)° 
Volume 2681.45(15) Å3 
Z 4 
Density (calculated) 1.663 g/cm3 
Absorption coefficient 1.256 mm–1 
F(000) 1392 
Crystal size 0.712 x 0.356 x 0.184 mm 
Theta range for data collection 1.376 to 40.718° 
Index ranges -24<=h<=24, -24<=k<=25, -28<=l<=28 
Reflections collected 110771 
Independent reflections 33773 [R(int) = 0.1632] 
Completeness to theta = 35.0° 99.5 %  
Absorption correction semi-empirical from equivalents 
Max. and min. transmission 0.9848 and 0.6912 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 33773 / 253 / 683 
Goodness-of-fit on F2 1.022 
Final R indices [I>2sigma(I)] R1 = 0.0374, wR2 = 0.0959 
R indices (all data) R1 = 0.0454, wR2 = 0.1019 
Extinction coefficient n/a 






Table A8: Atomic coordinates  (x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for complex 6.10 ([(Cu(I)-6.6]PF6•EtOH). U(eq) is defined as one third of  the 
trace of the orthogonalized Uij tensor. 
 
 
Atom Label x y z U(eq) 
P(2A) 2414(1) -2417(1) 9998(1) 19(1) 
F(7A) 1461(1) -3065(1) 10313(1) 28(1) 
F(8A) 3389(2) -1804(2) 9710(2) 41(1) 
F(9A) 1681(1) -1380(1) 9590(2) 50(1) 
F(10A) 2652(1) -2649(1) 9041(1) 34(1) 
F(11A) 2195(2) -2187(2) 10956(1) 57(1) 
F(12A) 3153(1) -3494(1) 10387(1) 46(1) 
P(2B) 2475(4) -2429(4) 10060(3) 19(1) 
F(7B) 1647(5) -3214(6) 10391(6) 28(1) 
F(8B) 3225(8) -1566(8) 9657(10) 41(1) 
F(9B) 1563(5) -1505(4) 10081(6) 50(1) 
F(10B) 2371(5) -2342(5) 9059(3) 34(1) 
F(11B) 2499(7) -2597(8) 11094(4) 57(1) 
F(12B) 3304(5) -3428(5) 10044(5) 46(1) 
C(17) 5834(1) 240(1) 7347(1) 15(1) 
C(18) 5434(1) 892(1) 8017(1) 13(1) 
C(19) 5129(1) 2052(1) 7541(1) 15(1) 
C(23) 2308(1) 2558(1) 4877(1) 15(1) 
C(24) 2017(1) 1577(1) 4771(1) 13(1) 
C(25) 2423(1) 556(1) 5436(1) 15(1) 
C(26) 2529(1) -733(1) 7188(1) 20(1) 
C(27) 3601(1) -1302(1) 6975(1) 19(1) 
C(28) 4431(1) -1070(1) 7381(1) 21(1) 
C(29) 2482(1) 1444(1) 3831(1) 15(1) 
C(30) 841(1) 1734(1) 4902(1) 17(1) 
C(31) 4578(1) 423(1) 8755(1) 14(1) 
C(32) 6360(1) 895(1) 8453(1) 16(1) 
O(5) 2074(1) 2265(1) 3122(1) 18(1) 
O(6) 515(1) 852(1) 4807(1) 26(1) 




Table A8 continued 
O(8) 6796(1) -118(1) 8910(1) 18(1) 
S(5) 4998(1) 78(1) 6650(1) 15(1) 
S(6) 3826(1) 2410(1) 7298(1) 16(1) 
S(7) 3659(1) 2458(1) 4949(1) 16(1) 
S(8) 2274(1) 642(1) 6583(1) 14(1) 
Cu(2) 3702(1) 1419(1) 6433(1) 15(1) 
C(4) 235(1) 6259(1) 7688(1) 18(1) 
O(2) 4700(1) 4256(1) 9722(1) 18(1) 
O(4) -1039(1) 3587(1) 5885(1) 22(1) 
O(1) 3477(1) 2942(1) 11629(1) 17(1) 
C(14) 4196(1) 3436(1) 9706(1) 14(1) 
C(10) 1051(1) 1566(1) 10190(1) 17(1) 
C(11) 1571(1) 1154(1) 9389(1) 18(1) 
S(3) 2503(1) 4658(1) 8372(1) 13(1) 
S(4) 1217(1) 2881(1) 10129(1) 13(1) 
C(13) 2892(1) 3754(1) 11039(1) 15(1) 
C(8) 3051(1) 3641(1) 10076(1) 12(1) 
S(2) -264(1) 5059(1) 8388(1) 13(1) 
O(3) -107(1) 5647(1) 5809(1) 20(1) 
C(9) 2603(1) 2686(1) 10081(1) 14(1) 
Cu(1) 1094(1) 3816(1) 8647(1) 13(1) 
S(1) 1085(1) 2729(1) 7834(1) 14(1) 
C(3) -1029(1) 4822(1) 7669(1) 15(1) 
C(2) -538(1) 4154(1) 7023(1) 13(1) 
C(6) 2142(1) 6035(1) 7844(1) 18(1) 
C(15) 315(1) 4649(1) 6300(1) 15(1) 
C(7) 2553(1) 4682(1) 9506(1) 14(1) 
C(5) 1041(1) 6506(1) 8114(1) 18(1) 
C(1) -185(1) 3017(1) 7519(1) 15(1) 
C(12) 958(1) 1433(1) 8619(1) 19(1) 
C(16) -1425(1) 4112(1) 6564(1) 18(1) 
C(33) 9315(1) -596(1) 7383(1) 24(1) 
C(34) 9255(1) 515(1) 7377(1) 29(1) 




Table A8 continued 
C(35) 4924(1) 4234(1) 2494(1) 23(1) 
O(9) 8324(1) -927(1) 7745(1) 21(1) 
C(36) 4039(1) 5090(1) 2513(1) 33(1) 
C(20) 4040(1) 3696(1) 6495(1) 16(1) 
C(21) 3292(1) 4053(1) 5803(1) 17(1) 
C(22) 3611(1) 3800(1) 4983(1) 19(1) 
C(20') 3789(2) 3748(2) 6618(2) 16(1) 
C(21') 4266(2) 3912(2) 5647(2) 22(1) 
C(22') 3807(2) 3745(2) 4908(2) 19(1) 
P(1A) 7092(1) 2798(1) 4873(1) 22(1) 
F(1A) 7916(4) 3586(4) 4427(4) 44(1) 
F(2A) 6240(3) 2046(3) 5349(3) 45(1) 
F(3A) 7588(5) 2136(4) 4186(3) 38(1) 
F(4A) 6607(3) 3462(4) 5578(2) 49(1) 
F(5A) 6350(4) 3519(5) 4187(4) 44(1) 
F(6A) 7819(3) 2104(4) 5572(3) 64(1) 
P(1B) 7332(1) 2511(1) 4869(1) 22(1) 
F(1B) 8126(2) 3337(2) 4415(2) 44(1) 
F(2B) 6530(2) 1708(1) 5316(1) 45(1) 
F(3B) 7685(2) 2063(2) 4015(1) 38(1) 
F(4B) 7010(1) 2978(2) 5724(1) 49(1) 
F(5B) 6482(2) 3331(2) 4353(2) 44(1) 
F(6B) 8187(2) 1714(2) 5377(1) 64(1) 
 
 
 
 
 
